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Abstract
This  thesis  deals  with  the  structural  biology  of  two  integral  membrane  proteins, 
prohibitin1 and prohibitin 2, and the membrane-associated protein Annexin B1. The 
biophysical properties of the proteins were characterised and their  interaction with 
different ligands was investigated. Furthermore, crystallisation trials were undertaken 
in both projects.
Prohibitins  are  members  of  the  evolutionary  well-conserved  SPFH 
(stomatin/prohibitin/flotillin/HflK/C)  super-family  and  exert  important  cellular 
functions  such  as  cell-cycle  control,  tumour suppression and regulation of  protein 
turnover in mitochondria. In vivo, prohibitins consist of two proteins, prohibitin 1 and 
prohibitin  2,  that  form  a  transmembrane  complex  in  the  inner  mitochondrial 
membrane. The complex of full-length prohibitins 1 and prohibitin 2 could be refolded 
successfully but only generation of truncation mutants enabled characterisation of the 
protein  complex  using  spectroscopic  methods.  Homology  modelling  of  the  PHB 
domains of prohibitin 1 and 2 allowed insights into their three-dimensional structures, 
their  dimer  formation  and  the  interactions  with  target  proteins  and  melanogenin. 
Furthermore, an interaction with the inter-membrane space region of mitochondrial m-
AAA-protease was proposed. The intermembrane space region of  m-AAA-protease 
from  E.  coli was  investigated  using  spectroscopic  methods  and  subjected  to 
crystallisation trials.
Annexin B1 belongs to the well-conserved family of annexins that are versatile adapter 
and regulator proteins in membrane-associated processes. Similar to other annexins, 
annexin  B1  was  found to  bind  to  liposomes  and heparin  in  a  calcium-dependent 
fashion. Interestingly, its liposome binding behaviour is reminiscent of plant annexins 
suggesting the presence of a calcium-independent binding mode, whereas its lectin 
property is a shared feature with mammalian annexins. Annexin B1 shows Redox-
dependent oligomer formation in solution. 
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Summary
Aim of this work was to gain insights into biochemical and structural features of the 
prohibitin  complex,  an  integral  membrane  complex,  and  the  membrane-associated 
protein annexin B1.
The full-length prohibitin complex, consisting of prohibitin 1 (BAP32) and prohibitin 
2  (BAP37),  was  produced  recombinantly  and  refolded  from inclusion  bodies.  To 
increase solubility of the proteins, several truncation mutants were generated, refolded 
and subjected to CD spectroscopy. The complex consisting of N-terminally truncated 
prohibitins 1 and 2 was proven to be folded revealing both -helices and -sheets as 
secondary structure elements. Thermal denaturation experiments revealed a two-state 
transition process upon unfolding giving a melting temperature of 62ºC. This indicated 
that both, dissociation of the complex and unfolding of the monomers, occur in one 
step. Gel filtration analysis determined the apparent molecular weight of the complex 
to be 63kDa which is slightly higher than its theoretical molecular mass of 56kDa. 
This discrepancy might be due to an elongated shape of the complex. In a protein 
engineering approach to further increase the solubility and stability of the complex, the 
N-terminal  hydrophobic helix of BAP32 was replaced by an artificial,  self-folding 
soluble helix. Introduction of this helix did not lead to successful refolding of the 
prohibitin complex. In a modelling study, the PHB domains of BAP32 and BAP37 
were generated using an NMR structure of mouse flotillin-2 as template. Dimerisation 
was achieved by manual rigid body movement leading to a parallel alignment of both 
domains  with  their  N-termini  pointing  in  the  same  direction  as  required  by  their 
function as an integral membrane complex. Possible interaction interfaces with target 
proteins were elucidated as well as possible binding to melanogenin, a precursor in 
melanogenesis.  Furthermore,  a  dimerisation  of  their  N-terminal  helices  in  the 
membrane  was  proposed  which  could  mask otherwise  exposed  charged and polar 
residues within the membrane. A model of the prohibitin complex in the membrane 
was suggested. 
Interaction of the prohibitin complex with m-AAA-protease was elucidated, and two 
possible interaction interfaces proposed: interaction of the N-terminal helices of both 
proteins in the membrane and interaction of the PHB domains of the prohibitins with a 
newly  identified  intermembrane  space  (IMS)  region of  the  m-AAA-protease.  This 
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region  was  identified  by  comparing  multiple  sequence  alignments  with  secondary 
structure predictions and indicates a conserved fold within the N-terminal domain of 
m-AAA-proteases  from different  species.  The  IMS-region  of  the  E.coli m-AAA-
protease FtsH was produced as recombinant protein and subjected to CD spectroscopy 
where it was shown to be folded revealing both  -helical and  -sheet content in its 
secondary structure. Analysis of the protein by gel filtration and SAXS revealed the 
presence of a dimer in solution. A two-state transition process was observed in thermal 
denaturation  monitored  by  CD.  The  FtsH-IMS  region  was  also  subjected  to 
crystallisation trials but no crystals were obtained thus far.
Annexin B1 from the  tape  worm larva  Cysticercus  cellulosae was  produced as  a 
recombinant protein. CD spectroscopy revealed an -helical protein which undergoes 
a two-state transition process upon thermal denaturation with a melting temperature of 
51ºC. Addition of both 1mM DTT and 5mM CaCl2 has a stabilising effect on the 
protein as seen in thermal denaturation experiments. In gel filtration experiments, a 
mixture of monomers, dimers and trimers in solution was observed. Addition of 1mM 
DTT induced  monomer  formation  indicating  a  Redox-dependent  dimer  formation. 
Using mass spectrometry and molecular modelling, two of the four cysteins present in 
the protein could be identified as likely to form inter-molecular disulfide bonds which 
could lead to oligomerisation. A cysteine on the concave side of the protein and the N-
terminal cysteine residue are likely to form an intra-molecular disulfide bridge locking 
the N-terminus to the C-terminal core domain of the protein. In biochemical assays, 
annexin  B1  showed  calcium-dependent  phospholipid  binding  with  preference  for 
acidic  liposomes.  The  protein  also  exhibited  calcium-independent  phospholipid 
binding with a binding degree of about 50% for PS/PC (3:1) liposomes, a behaviour 
akin  to  bell  pepper  and  cotton  annexins,  although  the  latter  proteins  have  a  less 
stringent requirement for PS in this context. In a newly developed heparin-binding 
assay,  annexin  B1  showed  calcium-dependent  heparin  binding  in  a  cooperative 
manner. Two main heparin binding sites, one on the convex side and the other on the 
concave side of the protein, are thought to engage in recognition or binding of heparin. 
This feature may be employed as an infection strategy by the parasite to attach to the 
extra-cellular matrix of host cells. Annexin B1 was subjected to  crystallisation trials 
yielding in crystals that diffracted to 3.8Å.
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1 Introduction to prohibitins
1.1 The super family of SPFH (PHB) domain proteins
Prohibitins were first described by Nuell and colleagues in 1991 and thought to be 
involved in cancer development . They belong to a larger family of proteins that share 
an evolutionarily conserved stomatin/prohibitin/flotillin/HflK/C (SPFH) domain with 
significant homology to several eukaryotic and prokaryotic proteins. Members of this 
protein  family  are  membrane-associated  and  implicated  in  cellular  processes 
concerned with protein turnover , senescence  and proliferation control . However, 
different data mining tools describe the conserved domain as either a SPFH, PHB or 
band 7 domain, but it appears that regardless of the slight variation in determination of 
the domain boundaries, essentially the same domain is described .  The core motif of 
the SPFH domain is partially described in the Pfam database (Pfam entry: Band_7, 
accession number: PF01145).
Members of the SPFH domain family can be found in divergent species. They are 
present in higher eukaryotes (prohibitin, stomatin and podocin), as well as in lower 
eukaryotes  and prokaryotes (vacuolin  A and vacuolin  B,  HflK and HflC,  UNC-1, 
UNC-24 and MEC-2). The SPFH domain is conserved in proteins that are ubiquitously 
expressed like flotillin, as well as in proteins that show extremely restricted expression 
like the stomatin-related olfactory protein (SROP), whose expression is constrained to 
olfactory sensory neurons . The evolutionary significance of this domain is unclear but 
its prokaryotic conservation suggests that it is indeed a primordial motif as there are 
more than 700 non-redundant sequences containing the SPFH domain throughout all 
kingdoms.  It  is  clear  that  this  domain  is  likely  to  perform an  important  cellular 
function and worthy of further examination . Interestingly, most mutations that disrupt 
or  alter  the activities  of MEC-2,  UNC-1 and UNC-24 in  C. elegans are  found in 
conserved amino acids within the SPFH domain which suggest that this domain is 
crucial for function of the protein . 
Classification of proteins into the SPFH superfamily is based mainly on similarities in 
fold and protein architecture. Rather poor matches in amino acid sequences reveal only 
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ambiguous relationships within this superfamily. While domain databases recognize all 
these protein families as members of the same superfamily, their SPFH domains are so 
variable that it is virtually impossible to obtain a consensus sequence  (see figure 1-1). 
Greater sequence similarity can be found within the subfamilies such as prohibitins, 
flotillins,  stomatins  and  HflC/K  indicating  independent  origins  for  the  individual 








Figure  -1:  Phylogenetic  tree of  SPFH domain proteins from different  species as average 
distance of percent identity. Indicated are subfamilies vacuolins, flotillins, prohibitins, stomatins 
and stomatin-like proteins. Figure prepared with Jalview .
The prohibitin proteins BAP32 and BAP37 reveal a sequence similarity of 60% and an 
identity of 47%, the similarity of both proteins to mouse flotillin-2 is only 4% and 7%, 
respectively. As found with prohibitins, flotillin paralogues also show a high degree of 
conservation, e.g. mouse flotillin-1 and flotillin-2 that show 47% identity and 68% 
similarity.
However,  several  hallmark  features  are  shared  among members  of  SPFH domain 
proteins. They are integral membrane proteins with the SPFH domain situated in the 
cytosol but close to the membrane.  The proteins insert into plasma or mitochondrial 
membranes via their hydrophobic N–terminal domain  which is often preceded by a 
palmitoylation site as found in flotillin-1 , flotillin-2  and podocin and mec-2 . In case 
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of flotillins, stomatin and podocin, the hydrophobic N-terminal domain does not span 
the membrane but is suggested to form a horseshoe-like structure, with both N- and C-
termini  facing  the  cytosol  (see  review ),  while  prohibitins  possess  transmembrane 
helices that, in mitochondria, protrude from the inner mitochondrial membrane into the 
intermembrane space (see figure 1-2) . In the bacterial HflK/C subfamily, the SPFH 
domain resides on the periplasmic side of the plasma membrane .
Figure -2: Membrane association found with flotillins and prohibitins. The N-terminus of flotillin 
integrates into the membrane in a horseshoe-like fashion whereas prohibitins have an N-
terminal  membrane  helix.  Palmitoylation  sites  as  found  in  flotillins  might  aid  membrane 
localisation.
Additionally, SPFH domain proteins tend to form oligomers mediated through their C-
terminal domains, as shown for stomatin , podocin , prohibitin  and flotillins . Similar 
structural  features  among this  super-family suggest  related functions  for  all  SPFH 
proteins.
First structural data on SPFH proteins were obtained from an NMR structure of mouse 
flotillin-2  (PDB  accession  no.  1WIN).  As  member  of  the  SPFH  protein  family, 
flotillin-1 and its homologue flotilltin-2 are thought to bind to membranes  and have 
thus been associated with lipid-rafts . Palmitoylation sites close to the N-terminus have 
been identified in flotillin-1 which would enhance membrane binding of the protein . 
Recent studies suggested a similar topology for flotillin-2, which is both palmitoylated 
and  myristoylated  close  to  the  N-terminus  .  As  observed  in  other  SPFH  family 
members, the C-terminal region contains a coiled coil domain which is thought to be 
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involved in homo-oligomerisation and commonly referred to as flotillin-domain in 
those proteins. The SPFH domain spans the first 250 amino acid residues of flotillin-2 
as  described in  different  prediction tools  .  Residues  1 to  123 of  this  region were 
synthesised and subjected to  NMR analysis  by Miyamoto and colleagues  in  2004 
(PDB accession no. 1WIN, see figure 1-3). 
Flotillin-2(1-123) presents itself as a  compact, ellipsoid structure containing five  -
helices and six  -strands. Two anti-parallel  -helices are packed against a strand of 
anti-parallel  -sheets; and the N-terminal and C-terminal sides of this structure are 
“sealed” by short -helices. The flotillin domain starts at the C-terminus by a short -
helix.  This NMR structure represents the only available experimental information on 
PHB proteins and might give first clues as to how the PHB domain in prohibitin 1 and 
2 might look like.
Figure -3: NMR-structure of mouse flotillin-2 PHB domain (PDB accession no. 1WIN).
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1.2 Structural features of prohibitin proteins
1.2.1 Homology of prohibitin proteins
Prohibitins,  the  archetypal  SPFH  domain-containing  proteins,  are  ubiquitously 
conserved in eukaryotes , and their SFPH domain is commonly referred to as PHB 
domain. PHB1 is the yeast orthologue of mammalian prohibitin 1 (BAP32), and its 
paralogue,  prohibitin  2  (BAP37),  is  called PHB2 in yeast,  respectively .  Multiple 
sequence  alignments  of  prohibitin  proteins  from different  species  show that  both 
proteins are well conserved throughout the eukaryotic animal and plant kingdoms (see 
tables 1-1 and 1-2). While human and mouse prohibitin have identical BAP32 primary 
structures,  identity  of  human  prohibitin  1  to  orthologues  from  yeast  and  plants 
decrease to around 50%. A much higher degree of identity can be found between 
prohibitin  1  from multicellular  animal  organisms  such  as  Caenorhabditis  elegans 
(65%) and  Xenopus tropicalis (91%). On the other hand, both plant proteins from 
Nicotiana benthamiana and Petunia x hybrid show a high sequence identity of 96% 
amongst each other.
Table -1: Sequence identity of prohibitin 1 proteins in different species in percent [%].
Mouse Human Xenopus Caenorhab-
ditis
Nicotiana Petunia Yeast
Mouse 100 ── ── ── ── ── ──
Human 100 100 ── ── ── ── ──
Xenopus 91 91 100 ── ── ── ──
Caenorhabditis 65 65 66 100 ── ── ──
Nicotiana 52 52 52 53 100 ── ──
Petunia 53 54 53 53 96 100 ──
Yeast 52 52 52 52 53 53 100





Mouse 100 ── ── ── ── ── ──
Human 99 100 ── ── ── ── ──
Xenopus 88 89 100 ── ── ── ──
Caenorhabditis 62 63 61 100 ── ── ──
Nicotiana 51 52 52 53 100 ── ──
Petunia 60 60 62 62 96 100 ──
Yeast 48 49 51 49 50 67 100
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Human and mouse prohibitin 2 are different from each other in only two amino acids 
resulting in a sequence identity of 99% (see table 1-2). The next highest identity to 
human prohibitin 2 is observed with proteins from X. tropicalis (89%), followed by C. 
elegans (63%), Petunia x hybrid (60%), N. benthamiana (52%) and yeast (49%).
The  generally  high  degree  of  conservation  between  prohibitins  from  unicellular 
organisms  such  as  yeast,  and  multicellular  organisms  such  as  plants  and  humans 
emphasises  their  involvement  in  important  cellular  functions.  On  the  other  hand, 
prohibitins show a high degree of identity within mammalians or plants reflecting the 
evolutionary relatedness between different species and changes in the proteins during 
evolution.
1.2.2 Topology of prohibitins
In 1991, Nuell and co-workers predicted a 12 amino acid long hydrophobic N-terminal 
tail  for  yeast  PHB1 from its  primary  structure  ,  later  specified as  transmembrane 
domain encompassing residues 10 – 30 .  A transmembrane domain for PHB2 was 
allocated to  amino acids 36-54 .  Sub-mitochondrial  fractionation using yeast  cells 
identified  PHB1  and  PHB2  as  integral  components  of  the  mitochondrial  inner 
membrane  indicating that the N-terminal region is the membrane anchor, while the C-
terminal region of each protein protrudes into the inter-membrane space. 
Combining  previous  findings  by  other  groups  and secondary  structure  predictions 
using PSIPRED , extends of the three-divided topology of mammalian prohibitins 1 
and 2 were suggested as seen figure 1-4. 
Figure  -4: Domain topology of mammalian BAP32 and BAP37. Extends of transmembrane 
(orange),  PHB  domain  (blue)  and  coiled-coil  domain  (purple)  are  indicated  as  residue 
numbers.
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The  N-terminal  transmembrane  domain  (orange)  of  BAP32  spans  residues  2-24, 
followed by the predicted PHB domain (blue, residues 55-172) and the C-terminal 
coiled-coil domain (purple, residues 175-252). BAP37 is divided into its N-terminal 
region (residues 2-36), the PHB domain (residues 68-185), and the coiled-coil domain 
from residue 190 to 264.
1.2.3 Complex formation between prohibitin 1 and prohibitin 2
In previous years, several observations have been made which led to a potential model 
where  prohibitin  1  and  prohibitin  2  interact  strongly  with  each  other,  are 
interdependent in their stability , are co-localized in the cell and also co-precipitate. 
Observations  suggested  a  physical,  as  well  as  a  functional,  interaction,  which 
influences the function of mitochondria and thus the life span of the cell . The amount 
of both proteins produced in the cell was found to be equal despite different levels in 
different tissues, and prohibitin 1 is unable to functionally replace prohibitin 2 despite 
their  highly  similar  sequences  .  In  1998,  Berger  and  Yaffe  suggested  a  complex 
formation of both proteins in the mitochondrial inner membrane  which was supported 
by findings by Nijtmans and co-workers . They also suggested a barrel-like structure as 
seen in chaperones and proposed a similar function for prohibitins as a chaperon-like 
holdases  .  Evidence  for  such  a  complex  in  yeast  was  later  provided  by  electron 
microscopy, and the complex formation could be assigned to the conserved C-terminal 
coiled-coil regions in both proteins . Electron microscope studies revealed an elliptical 
ring-like (32%) or more rectangular structure (68%) of the yeast prohibitin complex 
comprising 16 to 20 individual protein molecules (see figure 1-5) . The function of this 
large prohibitin complex in mitochondria is still unclear. In a recent study, a stretch of 
EA repeats  at  the  start  of  the  C-terminal  domain  was  proven to  be  essential  for 
oligomerisation of the protein .
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Figure  -5:  Micrograph showing prohibitin rings as observed in electron microscopy. Figure 
taken from . A - Representative section of an electron microscope micrograph, the bar is 200 
nm. B - Class averages of typical end-on or side-on projection views, bar is 200 Å.
1.2.4 Complex formation with m-AAA-proteases
Membranes of mitochondria, chloroplasts and bacteria contain membrane embedded 
ATP-dependent proteases, termed AAA proteases (ATPases Associated with a variety 
of cellular Activities), to perform essential roles in cellular regulation and homeostasis 
.  They degrade misfolded polypeptides  ,  and are  involved in  maturation of  target 
proteins  such  as  the  respiratory  complex  .  AAA-proteases  are  well  conserved 
throughout the animal and plant kingdom being divided in several sub-families with 
even  greater  conservation  .  AAA-proteases  assemble  to  large  complexes  in  the 
membrane,  and  are  composed  of  up  to  3  closely  related  subunits  with  molecular 
masses of 70–80 kDa .  Human AAA-proteases contain 2 subunits,  paraplegin and 
AFG3L2,  whereas  mouse expresses 3  different  subunits,  paraplegin,  AFG3L1 and 
AFG3L2 . Most bacteria contain only one AAA protease subunit, such as FtsH from 
Escherichia coli which is thought to form a homo-oligomeric complex in the plasma 
membrane . FtsH-like proteases have also been found in plants . In yeast, two AAA-
proteases  are  present  within  the  inner  membrane  of  mitochondria  exposing  their 
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catalytic sites either to the matrix (m-AAA protease) or the intermembrane space (i-
AAA protease) . A direct interplay between m-AAA und i-AAA protease was found 
important for effective substrate recognition and proteolysis . 
Prohibitins and m-AAA proteases have been found in a large superstructure within the 
inner mitochondrial membrane of yeast cells  and were shown to interact physically in 
gel filtration experiments . These protein complexes with a diameter of 20–25 nm are 
thought to provide a scaffold within the membrane . Deletion of either PHB1 or PHB2 
in yeast results in an accelerated degradation of non-assembled membrane proteins by 
the m-AAA protease , and a regulatory role for prohibitins was suggested where they 
would  either  interact  directly  with  protease  substrate  proteins  or  modulate  the 
enzymatic activity of the m-AAA protease. A genetic interaction with prohibitins has 
also been described for YTA10 and YTA12, coding for subunits of the m-AAA protease 
in yeast  that suggests additional functions of prohibitins which are not exerted via 
their physical interaction with the  m-AAA protease. Additionally, a complex of two 
homologous prohibitin related proteins in E. coli,, HflK and HflC, has been found to 
reside on the periplasmic side of the plasma membrane and was found to assemble 
with FtsH , the bacterial m-AAA protease. Furthermore, HflK and HflC were found to 
interact directly with substrate polypeptides of FtsH. 
The functional relationships of AAA proteases and prohibitins in the mitochondrion 
are schematised in figure 1-6.  i-AAA protease and m-AAA protease are anchored to 
the inner mitochondrial membrane via N-terminal regions of their subunits, while the 
conserved C-terminal ATPase and metallopeptidase domains protrude into either the 
intermembrane space or the mitochondrial matrix . The inhibitory effect of prohibitins 
on the m-AAA protease is thought to be executed on the protein level , and is indicated 
by a grey arrow. ATP hydrolysis and protease function of the m-AAA protease are also 
indicated by grey arrows.
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Figure -6: Schematic interpretation of the proposed interaction between prohibitins and AAA-
proteases as they reside in the inner mitochondrial membrane.
ATPase and protease domains of the AAA protease FtsH have been crystallised in 
nucleotide-bound  and  apo  state  (PDB  entries  1LV7,  2DHR,  1IXZ,  1IY2 and  ). 
However,  little structural  information is  available about  the N-terminal region that 
anchors the protein to the membrane.
1.3 Functions of prohibitins in the cell
Prohibitins  were  first  identified as  negative  regulators  of  cell  division  in  cultured 
animal cells  and human tumour cells .  They were also thought to be involved in 
cancer development as a significant percentage of patients with sporadic breast cancer 
had mutations in the human prohibitin gene  whereas studies of prohibitin homologues 
in  yeast  suggested  that  these  proteins  may  be  involved  in  cellular  senescence  . 
However,  more  recent  studies  showed  that  the  cell-cycle  arresting  property  of 
prohibitin is restricted only to certain cell types, and supposedly carried out by its 
3’-untranslated region (3’-UTR) acting as a riboregulator .
A great variety of interaction partners for the prohibitin protein has been discovered in 
almost all cellular locations: mitochondria , nucleus , cytosol , plasma membrane  and 
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endoplasmatic reticulum . A hypothesis has been put forward where the N-terminal 
sequences  of  PHB-domain  containing  proteins  are  responsible  for  the  subcellular 
targeting of these proteins . BAP32 and BAP37 have also been shown to translocate to 
different cell compartments in the presence of extracellular and intracellular stimuli . 
The diversity of cellular locations and interaction partners reflects the wide range of 
important  cellular  functions assigned to these proteins  such as protein turnover  in 
mitochondria, regulation of gene expression, involvement in apoptosis and oxidative 
stress release.
Prohibitins interact with their target proteins mostly through their PHB domain and 
their C-terminal coiled-coil domain , but for most interactions it is not clear whether it 
is formed by the intact prohibitin complex or either monomer. Different groups report 
interaction  of  proteins  with  prohibitin  monomers  or  dimers  in  different  cell 
compartments such as the mitochondrial membrane , the nucleus  and the cytosol . 
These controversial findings could be explained by the formation of a prohibitin dimer 
upon binding to membranes. 
However,  prohibitins  seem  to  be  able  to  interact  with  several  target  proteins 
simultaneously with moderate in vitro binding affinities . An overview of interaction 
partners of the BAP32:BAP37 complex in different  cell  compartments is  given in 
figure  1-7.  Depicted  are  extracellular  ligands  for  a  membrane  bound  complex, 
cytosolic proteins, cell cycle proteins and nuclear receptors and the m-AAA protease in 
mitochondria.
In  recent  years,  prohibitin  research  has  been  focussing  on  prohibitin-ligand 
interactions,  including protein-protein interactions,  and interactions  with  peptides  , 
sugars  and other organic molecules . 
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Figure -7: Interaction partners of prohibitin in different cell compartments. BAP32 (prohibitin 1) 
is shown as blue oval, and BAP37 (prohibitin 2) as purple oval.
1.3.1 Functions in cell cycle regulation
Prohibitin mRNA and its protein product are present in cells of all tissues in varying 
levels where they seem to have a natural function in the regulation of cell proliferation. 
Prohibitin mRNA levels were found to fluctuate throughout the cell cycle three- to 
four-fold and inhibit  initiation of  DNA synthesis  with the largest  inhibitory effect 
when the cells are entering G1 phase ( and see figure 1-8). 
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Figure  -8: Progression of prohibitin 1 mRNA (a) and protein levels (b) in Rat1 cells through 
their cell cycle. Figure taken from .
Observations in higher species showed a correlation between the expression of PHB 
genes and ageing , and the life span of yeast cells increased upon the knock out of the 
prohibitin  complex   but  the  mechanisms  by  which  expression  of  the  PHB genes 
influences ageing are not yet fully understood. Interestingly, all immortal cell lines of 
the complementation group B were found to possess base changes in the prohibitin 
3’UTR; resulting in loss of antiproliferative activity . Jupe and colleagues also found 
that all tumour cell lines express high levels of the PHB proteins, probably in an effort 
to produce more transcript  that would increase anti-proliferative action. 
In early studies, a shortened replicative life span was observed in yeast with disrupted 
prohibitin genes . While disruption of prohibitin genes in  Saccharomyces cerevisiae 
does  not  result  in  a  lethal  phenotype  ,  the  deletion of  a  prohibitin  homologue in 
Drosophila  melanogaster  and  Caenorhabditis  elegans  is  lethal  during  larval 
development.  These findings were supported by results from recent studies,  where 
severe growth inhibition and apoptosis upon knock-out or silencing of the prohibitin 
gene were observed in granulosa cells  and with plant prohibitins . Furthermore, the 
transcription of multiple genes has been found to be modulated by increased cellular 
levels  of  prohibitin  in  transfection  experiments  involving  prohibitin  in  cell  cycle 
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regulation . These findings substantiate a proposed role for prohibitins in cell cycle 
regulation.
1.3.2 Extracellular prohibitin
Despite  contrary  statements  about  prohibitin  1  and  2  localizing  to  the  plasma 
membrane and acting as a receptor for extracellular ligands, an immunohistochemical 
study revealed that prohibitin 1 is present in the vasculature of mouse and human white 
adipose tissue .  A pro-apoptotic peptide was conjugated to a CKGGRAKDC motif 
which interacted with prohibitin 1 at the protein level possibly as part of a higher order 
complex. The peptide was also successful in reversing obesity in the mouse model . 
These findings deserve further attention, since the addition of prohibitin 1 to cultured 
adipocytes  has  been  reported  to  result  in  inhibition  of  mitochondrial  pyruvate 
carboxylase and subsequent  suppression of  glucose and fatty acid oxidation .  The 
importance of these findings is evident when the use as a target for apoptosis inducing 
drugs to fight obesity is imagined.
Cell surface-associated prohibitins 1 and 2 have also been shown to interact with Vi 
capsular polysaccharide of Salmonella typhi  in a human model intestinal epithelium 
cell line. S. typhi is a pathogen that enters the human body by intake of contaminated 
food  or  water  causing  typhoid  fever  and  leading  to  considerable  morbidity  and 
mortality  in  third  world  countries  .  To  date,  the  host-pathogen  interactions  of 
Salmonella remain incompletely characterised, and the virulence factor Vi capsular 
polysaccharide is  currently  one of the most  efficient  available vaccines  for  use in 
humans .  Investigations on the interaction between prohibitins and the Vi capsular 
polysaccharide  may  provide  leads  for  development  of  new drugs  against  S.  typhi 
infection.
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Extracellular recognition, possibly 
inflammatory response
C3 Blood serum Non-specific immune response
In 2007, Mishra and colleagues reported that prohibitin 1 binds to and activates C3, a 
component of the complement system involved in non-specific immune response to 
pathogens  in  the  blood  .  Prohibitin  1  could  be  cross-linked  to  the  human  serum 
proteins C3a and C3b, descendents of C3, assigning a potential role for prohibitin in 
innate immunity and inflammation. This is in agreement with findings that prohibitins 
localise to the plasma membrane of human intestinal epithelial cells  and lymphocytes . 
Intriguingly, during infection with S. typhi, serum complement activation is inhibited, 
if the strains carry the Vi antigen . 
Recently,  prohibitin  1  and  prohibitin  2  were  identified  as  antigens  released  from 
colorectal tumours in vivo . The source of circulating prohibitin is unclear but it may 
be shed from the plasma membrane or released from adipocytes and possibly other 
cells  in  lipid  droplets  .  Translocation  via  lipid  droplets  might  be  one  possible 
mechanism by which prohibitin could be transported to the endothelium, a mechanism 
that has been reported for lipoprotein lipase .
1.3.3 Interactions with cytoskeletal proteins 
Employing an yeast two-hybrid screen, annexin A2 and -actinin have been identified 
as binding partners for BAP32 and BAP37 . Similar to annexin A2 ,  -actinin was 
found to interact with target proteins in a calcium-dependent fashion  and to associate 
calcium-independently  with  membrane-bound  proteins   and  adhesion  proteins. 
Similarly, annexin A2 is a calcium-dependent actin binding protein , and mainly exists 
as a heterotetramer with S100A10 in the cell  cytosol  but can also bind to acidic 
phospholipid membranes in a calcium-dependent  fashion .  Using yeast  two-hybrid 
screens, Bacher and colleagues found that each prohibitin was able to bind to each 
target protein, but stronger affinities were observed between BAP32 and annexin A2, 
and  BAP37  and  -actinin,  respectively  .  The  association  with  annexin  A2  links 
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prohibitins to lipid rafts, a notion that is further supported by the discovery of the 
PHB-domain containing proteins erlin-1 and erlin-2 in lipid rafts of the endoplasmic 
reticulum , and the association of lipid rafts with prohibitin 1 and prohibitin 2 on the 
cell surface . Notably, palmitoylated PHB domains of the prohibitin-related proteins 
podocin and mec-2 have been proven to be essential for the ability to bind cholesterol 
and thus locate the proteins to the cell membrane.
1.3.4 Nuclear prohibitin and regulation of gene expression
In  recent  studies,  prohibitins  were  found to  act  as  transcription  regulators  via  an 
interaction with cell cycle regulators, transcription factors and nuclear receptors but 
detailed mechanisms remain to be elucidated . Interactions of both prohibitins with 
nuclear proteins are summarised in figure 1-9.
In 1999, Wang and colleagues found that prohibitin 1 could effectively interact with 
the cell cycle proteins Rb, p107 and p130 . Prohibitin 1 is also capable of physically 
interacting with p53  in vivo and  in vitro,  and was found to enhance p53-mediated 
transcriptional  activity .  Moreover,  it  was  found to repress the activity of all  five 
translation factors E2F1 to 5 supposedly by utilising the MAPK pathway , and thus 
inhibiting  cell  proliferation  .  Repression  of  E2F-mediated  transcriptional  activity 
requires  the  co-repressors  HP1 and  Brg1/Brm ,  and  is  enhanced  in  response  to 
estrogen antagonist treatment of breast cancer cells involving the estrogen receptor . 
Depletion of prohibitin, on the other hand, diminishes the growth-inhibitory effects of 
anti-estrogens. The regions on prohibitin 1 required for repression of E2F activity are 
the Rb-binding domain and an additional region mapped to the C-terminal part of the 
PHB domain (residues 185 to 214) . The Rb binding region on BAP32 spans residues 
74-116, where three of four point mutations of prohibitin are found in sporadic breast 
cancer cells . 
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Figure  -9: Role of the prohibitin complex in the nucleus. Prohibitin 1 and 2 were found to 
interact with nuclear receptors, DNA binding proteins and transcription factors.
Recently, prohibitin 2 was found to interact with the transcription factor families of 
MyoD and myocyte enhancer factor-2 (MEF2) possibly with the help of co-activators 
such as histone deacetylases . Amino acids 120-232 of prohibitin 2 were identified as 
the  interaction  interface  with  Akt,  an  indirect  activator  of  the  transcription  factor 
families of MyoD and MEF2. Prohibitin 2 might thus act as a miogenic repressor by 
competing with Akt to prevent its interaction with MyoD and MEF2 . 
In  the  nucleus,  prohibitins  were  also  found  to  interact  directly  with  the  steroid 
receptors  estrogen receptor   and  androgen receptor  .  BAP37,  originally  known as 
repressor of estradiol activity (REA), binds directly to the estrogen receptor (ER) in the 
presence of its ligand estradiol repressing its transcriptional activity . While BAP37 
possesses the common ER-binding motif L-X-X-L-L N-terminal of its PHB domain, 
residues 175-198 are also required for binding to ER . On the other hand, BAP32 was 
shown  to  repress  androgen  receptor  (AR)–mediated  transcription  and  androgen-
dependent cell growth without an apparent direct interaction with AR . A binding site 
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for the vitamin D receptor has been identified in the promoter region of prohibitin 1, 
and cellular levels of the protein were increased after treatment with vitamin D . 
The  great  variety  of  important  nuclear  binding  partners  shows  the  versatility  of 
prohibitin action and highlights their involvement in important cellular functions. The 
prohibitin complex is mostly involved in regulating the activity of proteins which are 
responsible for regulating cell proliferation and cell growth rather than directly binding 
to specific sited on the DNA. 
1.3.5 Implications for mitochondrial functions
Prohibitins were first located to the inner mitochondrial membrane , and have been 
implicated in various  mitochondrial  functions such as a chaperone,  in scaffolding, 
programmed cell death and regulation of m-AAA-protease activity. 
A recent study by Coates and colleagues reported that prohibitin 1 and prohibitin 2 
were induced by metabolic stress caused by imbalances of mitochondrial and nuclear 
encoded proteins . An increase in improperly processed respiratory enzyme complexes 
would lead to oxidative stress due to leakage of electrons leading to the hypothesis of a 
chaperone  function  for  prohibitins  to  stabilize  mitochondrial  proteins  such  as 
cytochrome C oxidase . This hypothesis was supported by findings showing that  in 
vitro ageing is associated with increased oxidative stress in higher species . 
Prohibitin  1  and  2  were  found  to  assemble  to  hetero-oligomers  in  the  inner 
mitochondrial membrane yielding high molecular weight complexes of about 1.2 MDa 
as  shown  for  yeast  ,  mammals   and  C.  elegans .  These  high  molecular  weight 
prohibitin complexes are thought to play an important role in maintaining the integrity 
of  mitochondrial  membranes   as  prohibitin  mutations  in  yeast  are  lethal  when 
combined with disruption of the phosphatidylethanolamine (PE) biosynthetic pathway 
. A functional PE biosynthetic pathway is important as PE and phosphatidylcholine are 
the two major lipid constituents in mitochondrial membranes . Electron micrographs 
showing  the  high  molecular  weight  complexes  support  the  idea  of  a  scaffolding 
function of prohibitin 1 and prohibitin 2 in mitochondria since the ring-like structures 
have a  similar  diameter  to cristae junctions and pose  a  direct  effect  on the ultra-
structure of the inner mitochondrial membrane . In tobacco, prohibitin depletion causes 
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abnormal  mitochondria  that  lack  inner  cristae  and  contain  fibre-like  structures 
probably representing disintegrated inner mitochondrial membranes . The disrupted 
mitochondrial biogenesis or stimulated mitochondrial degeneration is accompanied by 
a reduced number and mass of mitochondria and excessive production of reactive 
oxygen species . Accumulation of aberrant mitochondria and defect in mitochondrial 
segregation  from the  mother  to  the  daughter  cell  are  frequent  in  cells  possessing 
mutations in the prohibitin genes . A defect of the mitochondrial membrane potential 
and disruption of mitochondrial biogenesis have been found in  C. elegans deletion 
mutants  .  RNAi-mediated  elimination  of  prohibitin  2  was  found  to  lead  to 
mitochondrial fragmentation in HeLa cells .
Table -4: Proposed functions for prohibitins in the mitochondrion.
Implemented function as/in Interaction partner Reference
Chaperone COX, respiratory chain proteins   
Maintenance of 
mitochondrial integrity Prohibitin hetero-dimer complexes   
Programmed cell death Prohibitin interacting proteins
Regulation of m-AAA-
protease activity m-AAA-proteases  
Prohibitin’s crucial  role in mitochondrial  integrity might entail  their  importance in 
programmed cell death, as suggested by recent studies in plants . Since prohibitins 
seem to maintain inner  membrane proteins,  modifications  such as phosphorylation 
might change their functional properties or interactions with other proteins and finally 
lead to cell death. In this context, the high-molecular weight complexes of prohibitins 
formed with  m-AAA protease is of particular interest.  Recently,  the PHB domain-
containing protein QmcA was identified in E. coli as a factor involved in membrane 
protein quality control . As concluded from pulldown assays, QmcA interacts with 
FtsH to form oligomers just as prohibitin and m-AAA protease do. 
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1.4 Prohibitins in disease
1.4.1 Prohibitins in cancer
A potential role in tumour suppression for prohibitins was proposed when a growth 
arrest was found to occur in HeLa cells after microinjection of prohibitin transcripts . 
Later studies found that the ability to inhibit cell cycle activity is restricted to certain 
cell  strains  ,  and  authenticated  to  the  3’-UTR  of  prohibitin  mRNA  where  a 
polymorphism had been identified as a risk modifier in breast cancer in the presence of 
BRCA1 mutations .
Intriguingly,  Sato and colleagues found that the prohibitin gene located on human 
chromosome 17q21 has mutations in exon 4 in four out of 23 sporadic human breast 
cancers . The four mutations are amino acid changes at positions 88 (Val to Ala) and 
105 (Arg to His), as well as a frame shift leading to a truncation at position 53 . It was 
also suggested that a cell’s sensitivity to the inhibition of cell cycle traverse is related 
to its prohibitin genotype and that the prohibitin protein expressed in immortalised 
populations is altered . Furthermore, a C to T change was observed in an intron which 
may interfere in the splicing process. Interestingly, almost all mutations reported in 
sporadic breast cancer lie within the Rb binding domain of prohibitin . Figure 1-10 
shows the  topology  of  the  PHB1 gene  indicating  the  position  of  the  3’UTR and 




Exons 1 to 6
3’ UTR
Figure -10: Topology of prohibitin 1 gene. PHB1 is located on the minus strand of the DNA 
double helix (black lines). The gene’s exons 1 to 6 are coloured in light grey, the 3’UTR is in 
dark grey. Light grey arrows indicate locations of mutations that have been identified in exons 
of the PHB1 gene.
BAP32 has also been localised to the nuclei of breast cancer cells , and the cellular 
expression of the non-mutated protein is generally up-regulated in tumour cells  as 
compared to normal cells . Notably, BAP32:BAP37 was observed to be secreted from 
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cultured colorectal tumour cells. While some cell surface localisation was observed, 
significant levels of both proteins were found in the blood serum . It is not entirely 
clear whether BAP32 and BAP37 are intentionally released into the blood or whether 
this  is  a  direct  consequence  of  the  necrosis  of  tumour  cells.  In  any  case,  these 
observations support a potential usability of prohibitins as tumour markers (see also ).
The  involvement  of  BAP32  in  repression  of  estrogen-dependent  transcription  has 
brought the prohibitin proteins back into focus as potential targets for breast cancer 
therapy .  Estrogen antagonists  are the commonly used endocrine therapy in breast 
cancer,  but  are  limited  due  to  development  of  cellular  resistance  .  The  re-gained 
attention as potential cancer targets is also deserved by the finding that BAP32 is a 
novel  target  gene  of  vitamin  D which  stimulates  down-regulation  of  proliferation 
through activation of its receptor. The growth-inhibitory effects of vitamin D in breast 
cancer  cell  lines  were  increased  by  over-expression  of  BAP32,  and  a  vitamin  D 
receptor binding site had been predicted in the promoter region of BAP32, but direct 
interactions on protein level remain to be clarified . 
These findings encourage further investigations in this field, and might lead to the 
discovery  of  new  anti-cancer  drugs  or  therapies.  A  recent  study  elucidated  the 
mechanisms of a synthetic drug that interferes with microtubule dynamics and thus 
exerts  antimitotic  actions  .  In  this  study,  an E130K mutation in  prohibitin  2  was 
identified to be responsible for occurrence of multidrug resistance in a  C. elegans 
model which might also be responsible for resistance to other drugs binding to tubulin 
and  camptothecin.  In  a  quest  for  drug-regulated  genes  in  osteosarcoma cells,  the 
cytotoxic  chemicals  cis-platin,  methotrexate  and  doxorubicin  were  found  to 
significantly decrease the expression of prohibitin leading to apoptsis . The role of 
prohibitin  in  modulation  of  drug-induced  apoptosis  was  further  confirmed  by  the 
finding that its overexpression reduced chemosensitivity of the cells by about 50%.
Cancer cells are known to have increased reliance on anaerobic glycolysis compared 
with  normal  non-transformed  cells   due  to  their  increased  proliferation  rate.  An 
increased expression of prohibitin 1 may be part of a co-ordinated response in rapidly 
proliferating cells to allow for reduced oxidative stress in the presence of enhanced 
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anaerobic glycolysis. Vessal and colleagues found that prohibitin 1 inhibits pyrovate 
carboxylase  in  adipocytes  and  shifts  their  metabolism  away  from  oxidative 
phosphorylation towards anaerobic glycolysis  for faster ATP production. This might 
be the mechanism that links prohibitin expression levels and localisation to a high 
proliferation rate, and thus tumour development.
1.4.2 Mitochondrial disorders and apoptosis
Apoptosis  is  an  important  and  controlled  process  to  protect  the  organism  from 
malfunctioning  cells  caused  by  different  stimuli  such  as  UV irradiation,  reactive 
oxygen species, hormones and growth factors . Mitochondria play an important role in 
the signal transduction of apoptosis, since they release cytochrome C which triggers 
activation of caspases, apoptosis-inducing factor and Smac/Diablo in a process called 
mitochondrial permeability transition .
Very recently,  BAP37 has been reported to interact with the anti-apoptotic protein 
Hax-1 , an integral membrane protein of the outer mitochondrial membrane that is 
exposed to the intermembrane space. Notably, the authors indicate that the interaction 
of  BAP37  with  Hax-1  is  stonger  than  the  BAP32-BAP37  interaction  .  The 
transforming growth factor- (TGF-) acts as a tumour suppressor via induction of 
apoptosis and inhibition of cell proliferation.  Upon treatment with TGF-prohibitin 
translocates from the nucleus to the cell cytosol where it is strongly associated with the 
mitochondrial apoptosis-suppressor bcl-2 in human prostate cancer cells , and possibly 
repressing its activity. Table 1-5 summarises apoptotic processes where prohibitins 
were found to function as a regulator.
Table -5: Implementation for prohibitins in apoptosis.
apoptosis inducer regulation References
drug-
induced















translocation of prohibitin 
from nucleus to cytosol
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Mitochondrial  disorders  can  give  rise  to  a  broad  spectrum  of  diseases  such  as 
myopathies, loss of hearing, optic neuropathy  and the inflammatory disease ulcerative 
colitis . Disturbances in mitochondrial function might be common in aged population 
and probably  contribute  to  age-related  diseases,  such  as  Type  2  Diabetes   and 
Parkinson’s disease . 
Insulin resistance plays an important role in the pathogenesis of Type 2 Diabetes, and 
oxidative  stress  in  ageing  mitochondria  leads  to  accumulation  of  superoxide. 
Superoxide then activates uncoupling protein 2 (UCP2) , an integral membrane protein 
that leaks protons across the inner membrane when activated. One might speculate that 
prohibitins  could  play  a  role  in  this  process,  especially  when  considering  that 
prohibitin depletion leads to an excessive production of reactive oxygen species in 
plants . Prohibitin might act as a cellular defence against oxidant injury and thus be an 
interesting  target  for  tissue  injury  and  inflammatory  diseases  such  as  bowel  and 
Crohn’s  disease  .  Several  mitochondrial  proteins  have  been  found  to  be  down-
regulated  in  colon  mucosa  from  patients  with  ulcerative  colitis  accompanied  by 
pathological  alterations  of  the  mitochondrial  ultra-structure  .  In  a  recent  study,  a 
significant reduction in prohibitin levels was found in the substantia nigra of patients 
with Parkinson’s  disease  and related  to  deficiencies  in  complex  I  subunits  of  the 
respiratory chain . 
1.4.3 Prohibitins and melanogenesis
Agents  that  promote  pigmentation  hold  the  potential  to  reduce  UV-induced  skin 
damage,  carcinogenesis,  and  might  also  be  the  key  in  the  treatment  of 
hypopigmentation  disorders  such  as  certain  forms  of  albinism.  With  a  chemical 
genetics approach searching for pigment-enhancing chemicals, melanogenin has been 
found  to  enhance  melanin  production  in  melanocytes  and  to  bind  specifically  to 
prohibitin .  Melanogenin induced a dose-dependent up-regulation in both level and 
activity of tyrosinase, the rate-limiting enzyme in melanogenesis . Li and colleagues 
proposed  a  mechanism  by  which  binding  of  melanogenin  to  prohibitin  disrupts 
interactions between prohibitin and one or more transcriptional factors . The released 
transcription factors would be able to traffic to the nucleus, thus altering the level of 
tyrosinase gene transcription. Using RNA interference experiments, these authors also 
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observed an impaired melanin induction by melanogenin upon silencing of prohibitin 
expression .
1.4.4 Prohibitins as drug targets
Prohibitins  have  been  found  in  the  mitochondrion,  the  cytosol,  the  nucleus  and 
extracellular  where  they  interact  with  different  targets  such  as  nuclear  receptors, 
cellular  and mitochondrial  proteins  or  organic  molecules.  If  these  interactions  are 
impaired,  serious  diseases  are  introduced  such  as  cancer,  diabetes  and  intestinal 
inflammation. It is not surprising that prohibitins have been identified as drug target 
for many of those diseases . As prohibitins are implicated in basic functions of the cell, 
structural and functional information about these proteins is vital for understanding 
and curing prohibitin-related diseases.  Table 1-6 summarises the different  areas of 
disease in which prohibitins are thought to be involved.
Table -6: Potential mechanisms to target multiple prohibitin functions in various diseases.
Potential mechanisms Disease states
Mitochondrial 
prohibitin
Induction of apoptosis, stabilisation 
of mitochondrial function




Disruption of interactions with 
Brg/Brm, E2F, Rb, p53, ER, AR
Breast and other cancers
Cell-surface 
prohibitin
Inhibition of inflammatory 
responses in the gut, vascular 
remodelling in adipose tissue, anti-
angiogenesis
Intestinal infections, 
inflammatory bowel disease, 




Inhibition of translation and RNA 
degradation Breast and other cancers
This work aims at providing first insights into the atomic and molecular structure of 
prohibitins  and  characteristics  of  their  possible  interaction  interfaces  with  target 
molecules. Understanding the mechanisms by which prohibitins are involved in gene 
regulation, mitochondrial biogenesis and tumour suppression is crucial in finding new 
ways in fighting common diseases such as cancer, adiposity or diabetes.
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2 Results and Discussion
Prohibitin  1  and  prohibitin  2  were  overexpressed in  E.  coli,  purified as  inclusion 
bodies and refolded. The identity of the full-length protein’s was verified by Edman 
degradation. Truncation mutants of both proteins were designed, overexpressed and 
refolded to improve solubility and stability of the protein complex. The N-terminally 
truncated  prohibitin  complex  was  analysed  for  its  fold  and  stability  using  CD 
spectroscopy, and was subjected to gel filtration to investigate its oligomeric state. 
Homology models of the PHB domains of both proteins were generated and a hetero-
dimer proposed. Additionally, possible interaction sites with melanogenin and other 
proteins  were  elucidated.  Furthermore,  the  interaction  between  prohibitins  and  m-
AAA-protease was investigated.
2.1 Production of recombinant full-length protein
Previously, prohibitin complexes were purified from yeast mitochondria with yields of 
around 1mg from a 20litre yeast culture . As over-expression of the protein complex 
leads to decreased cell growth, increasing the yield of protein product is rather difficult 
(T. Tatsuta, personal communication). To overcome this problem, the proteins were 
over-expressed in bacterial cells which resulted in production of inclusion bodies. In 
order to obtain properly folded native complex,  protocols to purify and refold the 
proteins from inclusion bodies were established. Refolding of an isolated prohibitin 
protein was not successful in previous trials (A. Hofmann, personal communication). 
In  order  to  improve  solubility  of  the  proteins,  truncation  mutants  were  generated 
lacking the predicted N-terminal  hydrophobic tail   and/or the predicted coil-coiled 
domain.
2.1.1 Expression and purification of protein from inclusion bodies
The construct His6-BAP32:BAP37_pETDuet (kind gift from T. Tatsuta) was used for 
co-expressing His-tagged BAP32 and untagged BAP37 from mouse.  BAP32 (276 
amino acids, GeneID: 18673) has a molecular weight of 30kDa and a calculated pI of 
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5.22. BAP37 (GeneID: 12034) consists of 298 residues resulting in a molecular weight 
of 33kDa with a calculated pI of 10.22. 
The  complex  was  over-expressed  in  BL21(DE3)  cells  as  stated  in  Materials  and 
Methods, section 5.3.2. Processing 500ml of bacterial solution yielded up to 40mg of 
protein  in  inclusion  bodies  which  could  be  purified  to  high  purity.  During  this 
purification procedure both over-expressed proteins were enriched and separated from 
bacterial proteins (see figure 2-1). 
Figure -11: Protein expression in inclusion bodies. 10µl of supernatant fractions (S1, S2, S3), 
5µl of pellet fractions (P1, P2) and 1µl of the inclusion body suspension (InB) were run on the 
gel for comparison.
Bacterial cells of E.coli strain BL21(DE3) were induced for only 2 hours with IPTG 
(final concentration 0.5M) before harvesting. Cell pellets containing inclusion bodies 
were light brown in colour. Inclusion bodies were purified as stgated in section 5.3.4 
and appeared as white solid particles. The proteins were unfolded and extracted from 
the inclusion bodies using urea buffer (8M urea, 50mM NaCl, 20mM Tris, pH 8.0).
Progress in protein purification was monitored by running samples of each purification 
step on a 12% SDS-PAGE (figure 2-1). Over-expressed His6-BAP32 and BAP37 are 
clearly visible in the whole cell extract (WC) as distinct bands at 30kDa (BAP32) and 
33kDa (BAP37). After cell  lysis and high speed centrifugation (see section 5.3.3), 
His6-BAP32 and BAP37 were exclusively found in the pellet fraction (P1). No protein 
was found in the soluble fraction (S1) or in the supernatants of further washing steps 
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(S2, S3, see section 5.3.3). Comparing pellet fractions P1, P2 and InB, an increase in 
purity caused by repeated washing and centrifugation steps can be clearly seen. The 
inclusion bodies (InB) were free from most contaminating proteins. Over-expressed 
His6-BAP32 and BAP37 are the major proteins in the cell after induction indicating a 
very good level of over-expression of the target proteins.
2.1.2 Co-refolding of full-length BAP32 and BAP37
Pioneers in the prohibitin field such as Nijtmans, Coates and Berger  found that both 
proteins co-localise in the cell,  and are most stable  in a complex with each other 
interacting  via  their  natural  interface.  Therefore,  refolding  both  proteins  in  the 
presence of each other was thought to lead to immediate complex formation which 
would  aid  the  refolding  process  and  help  stabilize  the  proteins.  Therefore,  a 
simultaneous expression of both proteins followed by a co-refolding procedure was the 
approach chosen to produce the refolded proteins into a stable complex. 
In  general,  refolding  is  a  difficult,  time-consuming  and  unpredictable  procedure. 
Nevertheless,  there  are  several  suggested  procedures,  buffer  compositions  and 
additives that might lead to successful refolding . Refolding of solubilised inclusion 
body proteins is usually performed by rapid dilution or dialysis. Precipitation could 
result from rapid refolding under conditions that are very similar to the native solvent. 
In this case, gradual removal of the denaturant by dialysis or a stepwise dilution of the 
protein may lead to successful refolding. When removing the denaturant by dialysis, 
the protein is exposed to intermediate denaturant concentrations for a period of time. 
This could be beneficial for correct folding, as the protein can enter an intermediate 
folded state which might be important for finding the correct folding pathway. On the 
other hand, proteins in an intermediate folding state can also be prone to aggregation. 
Thus, the optimum procedure has to be determined on a case-by-case basis, because 
the preference for either refolding strategy cannot be predicted from the  molecular 
properties of the protein. 
In  in  vitro folding,  misfolding,  as  well  as  aggregation,  competes  with the  correct 
folding pathway . Aggregation may originate both from non-specific (hydrophobic) 
interactions of predominantly unfolded polypeptide chains, as well as from incorrect 
interactions  of  partially  structured  folding  intermediates.  When  increasing  the 
concentration of unfolded polypeptide chains, an increase in the rate of aggregated 
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protein is observed. Thus, aggregation predominates in renaturation experiments when 
a threshold concentration of denatured protein is exceeded . Therefore, renaturation 
must often be performed at an extremely high dilution . 
Disulfide bond formation is always critical during refolding as the number of possible 
disulfide combinations increases dramatically with the number of cysteine  residues 
present  in  the  polypeptide  chain.  Therefore,  substances  functioning  as  “oxido-
shuffling” reagents should be included in the refolding buffer if there are cysteine 
residues present in the protein to be folded. Reduced and oxidized glutathione (GSH, 
GSSG) are commonly used in this context, but other low molecular weight thiols such 
as  cysteine/  cystine,  cysteamine/  cystamine,  or  di-hydroxyethyl  disulfide/  -
mercaptoethanol can be used as well, and may be superior for disulfide bond formation 
depending on the respective insoluble protein . 
Considering literature about protein refolding, physical parameters such as pH, ionic 
strength, or temperature seem to have a tremendous effect on the efficiency of in vitro 
folding  processes.  Furthermore,  buffer  components  or  prosthetic  groups  may  be 
essential  for  correct in vitro folding.  For  instance,  addition  of  Tris  buffer  at  a 
concentration  of  at  least  0.4  M improved the  refolding  efficiency  of  various  test 
proteins from E. coli  inclusion bodies . L-Arginine functions as a very efficient low 
molecular weight “folding enhancer”, and is known to have a positive effect on protein 
stability.  Other  additives  like  guanidine  chloride,  lauryl-maltoside,  Chaps,  mixed 
micelles  consisting  of  Triton  X-100  and  phospholipids,  glycerol,  metal  ions,  and 
ligands  can  also  enhance  the  refolding  process  .  Nonionic,  as  well  as  ionic  and 
zwitterionic detergents, have been found to have a favourable effect on renaturation, as 
very efficient protein folding at relatively high concentrations has been achieved using 
mixtures  composed  of  detergents  (e.g.,  Triton  X-100  or  lauryl-maltoside)  and 
phospholipids . These mixed micelles contain both polar and nonpolar moieties that 
can interact with various sites of folding intermediates, thereby preventing misfolding 
or aggregation. 
The following considerations for refolding the proteins were taken into account when 
designing  a  refolding  procedure:  1)  Both  proteins  possess  a  predicted  membrane 
anchor,  the  presence  of  glycerol  and  detergent  in  the  refolding  buffer  might  be 
important to shield and stabilise the hydrophobic region. 2) There is only one cysteine 
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present in BAP32, addition of an “oxido-shuffling” reagent would not be necessary for 
correct  refolding.  Nevertheless,  adding a  reducing reagent  might  still  be  useful  to 
prevent aggregation via formation of disulfide bonds between BAP32 monomers. 3) 
The prospective refolding buffer will need a suitable buffering agent at a relatively 
high concentration, and a neutral pH is recommended. 4) To enhance the refolding 
process, a certain amount of L-arginine (or other amino acid) should be included in the 
refolding buffer. 5) It is not known whether the prohibitin complex needs a ligand to 
help maintain its stability.
A “stepwise refolding” approach was preferred over the “fast dilution method” in order 
to  keep  the  sample  volume  small.  Furthermore,  the  proteins  were  purified  after 
refolding by immobilised nickel affinity chromatography which would also indicate 
successful refolding. One of the proteins (BAP32) was constructed with an N-terminal 
His6-tag, and can be purified by nickel affinity chromatography. If His6-tagged BAP32 
and the untagged BAP37 are successfully refolded in a complex, BAP37 will bind to 
BAP32 via its natural interface. The complex should bind to the nickel resin via His6-
tagged BAP32, and both proteins could be eluted from the column as a complex. The 
procedure is indicated in figure 2-2. First, the proteins are co-expressed in E.coli cells. 
After extracting the proteins from inclusion bodies using urea (A), both proteins are in 
their unfolded state. They undergo a refolding procedure (B), and are applied to a 
nickel affinity column for purification and to determine successful refolding (C).
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Figure  -12:  Strategy to refold the His6-BAP32:BAP37 complex from inclusion bodies. After 
production in inclusion bodies (A), the unfolded proteins are subjected to refolding by dialysis 
(B) and purified using nickel affinity chromatography (C).
The unfolded proteins were subjected to several refolding trials using various refolding 
buffer  compositions,  including  1mM DTT,  1% Triton  X-100  and  25mM dodecyl 
maltoside. The most successful refolding procedure was performed using a buffer that 
contained  0.5M  Tris,  20%  glycerol,  1%  Nonidet-P40,  150mM  KCl,  1mM  DTT, 
0.113M L-arginine,  0.275M L-serine,  11.86mM L-histidine at  pH 8.0 (see section 
5.3.4).  Refolding was  carried  out  twice  by  1:10 dialysis  of  the  unfolded  proteins 
against the refolding buffer at 4ºC for at least 8 hours per step. The sample was then 
dialysed against a buffer containing only 150mM KCl, 100mM Tris, 10% glycerol, 1% 
Nonidet-P40 at pH 8.0 to reduce the amount of glycerol, DTT and amino acids in the 
protein solution. After the last refolding step, the protein was further purified using 
nickel  affinity  chromatography,  where  the  protein  complex  could  be  eluted  with 
500mM imidazole (see figure 2-3).
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Figure -13: SDS-PAGE of nickel affinity chromatography of refolded His6-BAP32:BAP37. The 
gel shows the marker (M) I lane 1, the refolding mixture (S) in lane 2, flow through (F) and 
wash (W) in lanes 3 and 4, and elution fractions 2 to 6 in lanes 5–9. BSA, applied in lane 10, 
was used as a calibrator to determinate the amounts of protein in the respective fractions.
Figure 2-3 shows all fractions of the purification step. The second lane (S) represents 
the refolded protein mixture that has been loaded onto the column. It contains both 
proteins in equal amounts as both proteins have been overexpressed with the same 
ratio. A significant amount of protein, but not all, can be found in the flow through (F), 
but nearly none in the washing step (W), which indicates binding to the column. The 
presence of some protein in the flow through is most likely due to improperly folded 
protein  in  the  case  of  BAP37  and  inaccessible  His6-tag  in  the  case  of  BAP32. 
Inaccessibility of  the His6-tag might  be  caused by improper  refolding.  The bound 
proteins eluted with 0.5M imidazole in fractions 2-4 (lanes 5-7). Notably, the protein 
band representing BAP32 is stronger than the band representing BAP37 indicating an 
excess of BAP32 in the elution fractions. BAP32 possesses a His6-tag, and is therefore 
able to bind to the nickel column both in its refolded as well as unfolded state. Not all 
of BAP32 would be refolded correctly, and not every molecule was able to form a 
complex with BAP37. One can expect a mixture of monomers (His6-BAP32), probably 
unfolded, and refolded dimers (His6-BAP32:BAP37) in the elution fractions. A BSA 
standard  of  known  concentration  (0.075mg/ml)  was  utilized  to  determine  the 
concentration of total protein in each fraction as well as the amounts of each protein by 
densitometrical analysis using the software ImageJ . Using the respective volumes, the 
amount of protein present in each fraction could be determined (see table 2-1).
Table -7: Densitometric analysis of refolding yield of full-length His6-BAP32:BAP37.
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S 3933 3872 0.092 0.090 0.182 49.61 50.39 29.06
F 3966 3460 0.092 0.081 0.173 46.59 53.41 25.92
W 211 151 0.005 0.004 0.008 41.71 58.29 0.84
fr. 2 2114 690 0.049 0.016 0.065 24.61 75.39 0.44
fr. 3 7787 4155 0.181 0.097 0.278 34.79 65.21 1.86
fr. 4 1479 603 0.034 0.014 0.048 28.96 71.04 0.33
2.63  ≈ 
9%
BSA 3223 0.075mg/ml
The  amounts  of  His6-tagged  BAP32  and  untagged  BAP37  are  comparable  at  the 
beginning of the refolding experiment (see fraction S). A large amount of protein, both 
His6-BAP32 and BAP37,  did  not  bind  to  the  column and was  found in  the  flow 
through (F). In all elution fractions (fractions 2 to 4), His6-BAP32 represents 65-75% 
of the total protein confirming observations made from the gel. 2.63mg protein could 
be eluted from the nickel column in this experiment which would give an approximate 
yield of refolding of 9% if all protein was refolded in a complex.
The sample  still  contains  glycerol,  a  disadvantage  when trying to  concentrate  the 
protein complex. Different methods were tried to concentrate the proteins, including 
Vivaspin  concentration  devices  (VivaScience),  Centricon  concentration  devices 
(Millipore) and removal of water using a dialysis bag placed in PEG, molecular weight 
20000Da. Neither method led to high protein concentrations that could be used in 
crystallization  trials.  Moreover,  glycerol  and  detergents  also  interfered  with  data 
aquisition from spectroscopic methods such as UV-spectroscopy and CD which makes 
any  further  analysis  of  the  samples  more  difficult.  The  detergents  Triton  X-100, 
dodecyl maltoside and Nonidet-P40 were tested in order to improve the refolding yield 
and allow the solution to be more suitable for concentrating. However, no considerable 
difference  in  refolding  yield  or  solubility  could  be  observed  with  the  different 
detergents. Furthermore, the usage of any detergent such as  -octyl glycoside in a 
refolding set  up is  very  expensive  and did  not  justify  the  minor  improvement  in 
refolding yield or solubility seen. Instead, truncation of the N-termini of both proteins 
has a better chance in increasing the refolding yield and solubility.
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2.1.3 Identification of the full-length proteins by Edman degradation
To identify the proteins seen on the SDS-PAGE (see figure 2-3), Edman degradation 
was performed by the Mass Spectrometry facility using protein samples blotted on 
PVDF membrane by Western blotting. After a brief staining with Coomassie, each 
protein  bands  were  cut  out  and  used  for  Edman  sequencing. The  degradation 
experiment confirmed the identity of both proteins as His6-BAP32 and BAP37. The 
first 17 amino acids of BAP32 and the first 10 residues of BAP37 could be clearly 
identified. In both cases, the starting methionine was processed.
Table -8: Results from Edman degradation of His6-BAP32 and BAP37. Shown are the first 20 
residues for each protein, and residues identified by Edman degradation are in bold.
Sequence BAP32 M G S S H H H H H H S Q D P A A A K V F
Sequence BAP37 M A D L A A Q N L K D L A G R L P A G P
2.1.4 Conclusions: Protein expression and characterisation
Full-length His6-tagged BAP32 and BAP37 were over-expressed in BL21(DE3) cells 
resulting in inclusion bodies with a protein amount of up to 80mg per litre of bacterial 
culture. Inclusion bodies were purified to high purity using a protocol developed by C. 
Rückert  (Institut  für  Immungenetik,  Universitätsklinikum  Charité,  Humboldt-
Universität zu Berlin, Germany). A novel approach was taken to refold BAP32 and 
BAP37  from  inclusion  bodies  where  the  proteins  were  jointly  subjected  to  the 
refolding procedure. As a result, the proteins could be eluted from a nickel column 
indicating  a  refolding  of  both  proteins  and  subsequent  complex  formation.  The 
proteins could be refolded with a refolding yield of up to 9%. 
Both proteins, His6-BAP32 and BAP37, were identified by Edman degradation using 
the  respective  bands  from  an  SDS-PAGE which  was  first  blotted  onto  a  PVDF 
membrane. 
Despite success in producing and refolding the proteins, difficulties were experienced 
in concentrating the sample due to the considerable amount of glycerol in the protein 
solution.  Residual  amounts  of  detergent  hampered  further  analysis  of  the  protein 
complex by spectroscopic methods such as UV and CD.  In order  to  improve  the 
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solubility  of  both proteins  in  aqueous solution,  truncation mutants were generated 
lacking the hydrophobic N-terminal helix.
2.2 Generation  and  production  of  prohibitin  truncation 
mutants
2.2.1 Secondary structure predictions
Secondary structure predictions of BAP32 and BAP37 were done using the PSIPRED 
server   and  revealed  an  overall  similar  secondary  structure  reflecting  their  high 
sequence similarity (see figure 2-4). 
BAP32 showed an N-terminal helix encompassing the first 24 amino acids which was 
in  good  agreement  with  findings  by  other  groups  .  This  domain  of  BAP32  was 
previously predicted using the GCG software , and encompassed the first 20 amino 
acids. In both predictions, the next few amino acids downstream of the protein chain 
would form a -sheet consisting of mostly hydrophobic amino acids. BAP37 showed a 
40 amino acid spanning hydrophobic helix at its N-terminus thus allowing the protein 
to span a membrane. 
Secondary structure predictions of both proteins revealed a PHB domain consisting of 
6 -sheets followed by 3 -helices and one -sheet. Extends of the secondary structure 
elements coincide nicely between both proteins (see figure 2-4).
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Previous page - Figure -14: Secondary structure prediction of BAP32 and BAP37. The N-terminal 
domain (orange), the PHB domain (blue) and the C-terminal domain (purple) are indicated. The 
predicted secondary structure (Pred) of the target amino acid sequence (AA) is displayed both as 
a letter code and in symbols. “H” or tubes indicate a helix, arrows or “E” symbolise strands, and 
coiled structures are indicated as black lines or “C”. The confidence of prediction for each amino 
acid is displayed as blue bars at the top.
The  C-terminal  domains  of  both  proteins  are  large  helices  thought  to  be  coiled-coil 
regions. In BAP37, this region spans residues 175 to 252 and is followed by a predicted -
sheet.  The C-terminal region of BAP37 encompasses residues 190 to 264 and is also 
followed by a -sheet. In contrast to BAP32, the C-terminal coiled-coil helix in BAP37 is 
predicted to be separated into two fragments around residues 243/244. As the predictions 
for those residues were made with low confidence, the helix might instead proceed in 
those two residues. On the other hand, there is a prediction, although with low confidence, 
for an -helix around residue 231 of BAP 32. In this region, the predicted helix might also 
be separated into two fragments, similar to BAP37. This controversy might be solved by 
analysing structural data of this region.
In order to increase the solubility of each protein, the first 30 N-terminal amino acids of 
BAP32 and the first 40 amino acids of BAP37 were truncated. The predicted C-terminal 
coiled coil regions of both proteins are thought to allow the proteins to stick to artificial 
membranes e.g. in concentration devices. Therefore, constructs were generated that lack 
the C-terminal coiled-coil domain as well. In BAP32, the C-terminus was truncated at 
residue 178 whereas the C-terminus of BAP37 was truncated at residue 192.
2.2.2 Cloning of prohibitin truncation mutants
Two truncation variants  were designed for  each BAP32 and BAP37,  one lacking the 
hydrophobic  N-terminus,  the  other  lacking  both  the  hydrophobic  N-terminus  and  the 
coiled-coil region at the C-terminus. Although constructs were generated in accordance 
with findings from secondary structure predictions, a few residues were included on either 
side of the respective domains to ensure proper formation of secondary structure elements. 
In  figure  2-5,  the  constructs  that  have been  produced are  listed  on  the  left  side;  the 
dimensions of the truncation mutants generated are shown as pictograms on the right. 
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Figure  -15: Truncation mutants created for BAP32 and BAP37, one lacking the N-terminus; the 
other lacking both the N- and C-terminus. PHB domains are shown in blue, coiled coil regions are 
in purple. Numbers indicate amino acid residues representing the edges of the domains.
All BAP32 constructs contain an N-terminal His6-tag which is necessary for the refolding 
and purification  procedure  developed for  the full-length protein  complex  (see  section 
5.3.4). Truncation mutants were generated using the construct received from T. Tatsuta 
(His6-BAP32:BAP37_pETDuet) and according to procedures described in section 5.2.2. 
Each construct was verified by DNA sequencing. 
2.2.3 Expression of truncation mutants 
An expression trial with 250ml bacterial culture was performed inducing the expression 
plasmid His6-BAP32(1-30)_pTrcHis_B for 2.5 hours, 6 hours and overnight (see section 
5.3.5).  After harvest and cell lysis, a centrifugation step was introduced to separate the 
supernatant with soluble proteins from the cell pellet. Pellets from 2.5 hours and over-
night induction were then treated with 8M urea to extract insoluble proteins. The extracts 
were analysed on SDS-PAGE where the truncated His6-BAP32 (27kDa) could be found in 
the  pellet  of  the  lysed  cells  (see  figure  2-6,  lanes  2  and  3).  This  indicates  protein 
expression is in inclusion bodies. 
In order to confirm the presence and identity of the protein as His6-BAP32(1-30), an 
immobilised nickel affinity chromatography (IMAC) batch experiment (see section 5.4.4.) 
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was performed using the remaining urea-extract of the cell pellet from 6 hour induction 
(P6). The strong band visible near the 26.5kDa marker band in the pellets P2.5 and Po/n , 
lanes 2 and 3, respectively, is also present in the first supernatant (F) and third supernatant 
(E) of the IMAC batch experiment carried out using pellet P6. No protein was found in the 
second supernatant (W), lane 5.
Figure  -16: Expression and batch purification of His6-BAP32(1-30). The protein is visible as a 
thick band near the 26.5kDa marker in the pellet after 2.5 hours induction (P2.5) and over-night 
(Po/n) inductions. Fractions from IMAC batch experiment (first supernatant (F), second supernatant 
(W) and third supernatant (E)) are shown in lanes 4-6.
Furthermore, specific binding of this protein to the nickel resin indicates the presence of a 
His6-tag, therefore confirming  that the expressed protein was  His6-BAP32(1-30). This 
result indicates that the N-terminally truncated BAP32 is produced as an insoluble protein, 
probably present in inclusion bodies. Truncation of the hydrophobic N-terminus did not 
result in a folded, soluble protein. In subsequent expression experiments carried out as 
stated in section 5.3.2., the other truncation mutants were also found to be expressed in 
inclusion bodies.  The inclusion bodies were purified using the protocol stated in section 
5.3.3. Although the amount of protein gained from one expression experiment varied with 
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the construct that was expressed, all purifications show an increase of purity and protein 
amount in the inclusion body fractions (see figure 2-7).
None of the truncation mutants were produced as  soluble protein despite altering the 
expression  conditions  (IPTG  concentration  and  induction  temperature).  Therefore, 
truncating the N-termini did not result in soluble protein which would be found in the cell 
cytosol.
Figure -17: Expression of prohibitin truncation mutants. Increase of the purity of inclusion bodies of 
BAP32 truncation mutants (top panel) and BAP37 truncation mutants (bottom panel) can be seen 
on SDS-PAGE. For comparison, 10µl of all supernatants (S1, S2, S3), 5µl of pellet fractions (P1, 
P2) and 1µl of inclusion bodies (InB) were loaded on the gel.
There are various possible reasons why the proteins are still  not  produced as soluble 
proteins: a) all truncation mutants were produced separately, thus, no complex formation 
and  subsequent  stabilization  of  the  proteins  was  possible  during  expression.  b)  The 
bacterial cell might not be able to properly fold these mammalian proteins due to lack of 
chaperones or other helper proteins. Therefore, the proteins still need to be refolded in a 
co-refolding  approach  similar  to  the  procedure  used  for  the  full-length  proteins. 
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Furthermore,  all  truncation  mutants  were  subjected  to  refolding  trials  combining  a 
BAP32-truncation mutant  with  different  BAP37-truncation  mutants  in  order  to  find  a 
combination of truncation mutants that leads to a high refolding yield.
2.2.4 Co-refolding of truncation mutants with glycerol and detergent
As truncating the N-termini did not result in soluble proteins, a co-refolding approach 
similar to that used for the full-length proteins was the next step. BAP32 and BAP37 
truncation mutants were co-refolded in different combinations (see table 2-3), trying to 
find a  combination of  two truncation mutants  that  produced water-soluble  and  stable 
prohibitin complex. Truncation mutants were refolded using the protocol developed for 
full-length  His6-BAP32:BAP37  (see  section  5.3.4),  and  success  of  co-refolding  was 
determined  by  nickel  IMAC  (see  section  5.4.1.).  The  refolding  yield  was  analysed 
densitometrically using the programme ImageJ .
Co-refolding  of  His6-BAP32(1-30)  (27kDa)  and  BAP37(41-191)  (16kDa)  led  to  a 
decrease in sample volume in the dialysis bag to about 60% and heavy precipitation in the 
third  dialysis  step.  The  precipitation  was  centrifuged  at  20000rpm  in  the  Beckman 
centrifuge J2-21 for 30 minutes at 4ºC, and the remaining supernatant was applied to a 
nickel column. The SDS-PAGE showed only one band in the elution fractions and in 
accordance with a marker, this band could easily be assigned to His6-BAP32(1-30). The 
initial refolding mixture contained both proteins, but since His6-BAP32(1-30) could be 
eluted from the column this indicates that it was truncated BAP37 that had precipitated. 
Subsequent dialysis of the pooled elution fractions using a buffer containing 20mM tris, 
pH 7.5 and 100mM KCl led to precipitation of  His6-BAP32(1-30) suggesting that the 
protein was kept in solution by the high amount of imidazole used for elution, and that the 
protein might not have refolded in the first place. Co-refolding of His6-BAP32(1-30) and 
BAP37(41-191) was not successful in producing soluble prohibitin complex.
After the third dialysis step in co-refolding His6-BAP32(1-177) with BAP37(1-40), the 
sample volume decreased by about 30% and heavy precipitation was visible. The sample 
was centrifuged at 20000rpm in the Beckman centrifuge J2-21 for 30 minutes at 4ºC. The 
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remaining supernatant was applied to a nickel column, and the fractions from the nickel 
column and the precipitation were analysed on SDS-PAGE. Both proteins were found in 
the precipitate indicating an unsuccessful refolding procedure. 
Only very little precipitation was observed during the refolding of His6-BAP32(1-30) 
and  BAP37(1-40), and the volume of the protein sample in the dialysis bag decreased 
slightly. Analysis of the fractions from nickel IMAC on SDS-PAGE revealed a double 
band in the elution fractions representing His6-BAP32(1-30) with 27kDa and BAP37(1-
40) with 29kDa. Some protein was found in the flow through, but none was found in the 
wash.  Densitometric  analysis  using  the BSA standard that  was  run with the  samples 
estimates the protein found in the elution fractions to 54% of the initial protein amount. 
Elution fractions were pooled and subjected to a 1:20 buffer dialysis  step twice with 
20mM tris, pH 7.5 and 100mM KCl order to remove glycerol and Nonidet P-40. The 
pooled  fractions  did  not  precipitate  during  dialysis  and  could  be  concentrated  using 
Vivaspin concentration devices (Vivascience) where a large amount  precipitated.  UV-
spectrum and fluorescence spectrum taken from the sample were not interpretable. The 
sample was thus not used for further analysis, as traces of Nonidet P-40 and glycerol seem 
to affect any spectroscopic method. Refolding without using either glycerol or Nonidet P-
40 might result in a complex suitable for spectroscopic analysis.
Results from all co-refolding trials carried out with full-length BAP32 and BAP37 and 
their truncation mutants are summarised in table 2-3. The pictograms show the topology 
of the proteins subjected to co-refolding trials including the N-terminal hydrophobic helix 
(orange),  the  PHB  domain  (blue)  and  the  C-terminal  coiled-coil  region  (purple). 
Furthermore, the refolding yield and maximum concentration of the purified complex are 
stated.
Table -9: Summary of results from co-refolding trials carried out with full-length His6-BAP32 and 
BAP37 and their truncation mutants.
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                         BAP32
      BAP37
 N-terminus PHB domain Full length
 N-terminus
up to 54% refolded
0.1mg/ml





completely,  small 
fraction  of  His6-






From table 2-3, one combination was not tried: PHB domains only of both BAP32 and 
BAP37. This is because whenever a truncation mutant consisting of the PHB domain only 
was subjected to the refolding trial, the experiment resulted in precipitation of the protein 
with only the PHB domain,  at  the  very least.  Therefore,  co-refolding of  BAP32 and 
BAP37 PHB domain-truncation mutants would inevitably lead to precipitation of both 
components.  Furthermore,  co-refolding of  His6-BAP32(1-30)  and BAP37(1-40)  has 
already led to a successful refolding of both proteins.
2.2.5 Co-refolding of His6-BAP32(1-30) and BAP37(1-40) without glycerol and 
detergents
All refolding trials with truncation mutants so far were carried out in the presence of 
glycerol and Nonidet P-40 which interferes with sample concentration and analysis by 
spectroscopic methods. His6-BAP32(1-30) and BAP37(1-40) were therefore subjected 
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to a refolding trial lacking glycerol and detergents in refolding buffers. During refolding, 
slight  precipitation  was  visible  and  was  separated  by  centrifugation.  The  remaining 
supernatant was applied to the nickel column, and the protein eluted as a double band near 
the 32kDa marker representing both His6-BAP32(1-30) and BAP37(1-40) (see figure 2-
8).
Figure  -18: Co-refolding of His6-BAP32(1-30) and BAP37(1-40) without glycerol or Nonidet in 
the refolding buffers. On this SDS-PAGE, protein bands can be seen in lanes for the loaded 
sample (S), flow through (F) and elution fractions 1 to 5. No protein band is present in the wash 
(W). 50g BSA was run in lane 10 as a mass calibration standard for densitometric analysis. 
Protein found in the flow through (F) indicates impaired binding of His6-BAP32(1-30) to 
the resin, possibly caused by misfolding or aggregation where the His6-tagged N-terminus 
is not accessible. Densitometric analysis of the protein bands using the protein standard 
that was run with the samples revealed that 33% of the protein could be recovered from 
the column. The elution fractions 3 to 6 were pooled and concentrated by centrifugation at 
4ºC  and  4000g  using  Centricon  devices  with  a  molecular  weight  cut  off  of  10kDa 
(Millipore).  The  final  concentration  was  determined  via  UV-spectroscopy  to  be 
0.54mg/ml.
2.2.6 Protein engineering
The aim of this protein engineering approach was to replace the hydrophobic N-terminus 
of BAP32 with a self-folding water soluble helix instead of introducing a truncation. It is 
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still not known how secondary structures form, what triggers them to start at a certain 
amino acid residue or at  which residue it  is likely that a secondary structure element 
progresses. Truncation of the N-terminus of a protein might cause problems in folding the 
C-terminal protein since a crucial structural element will be missing.
In 1987, Shoemaker and colleagues investigated the secondary structure of the C-peptide 
helix of RNase A . This peptide, residues 3-13 in RNase A, is helical and only a few of its 
residues are in contact with the rest of the protein. The unusually stable C-peptide helix of 
RNase A was proposed to be an autonomous folding unit  and would be stabilised by 
specific intra-helical side-chain interactions which may also provide start and stop signals 
for localising the helix . Marqusee and Baldwin investigated helix formation on artificial 
peptides of 17 amino acids in length, and found that certain criteria favour stability of a 
helix such as a (i+4)-spacing between charged groups within the helix rather than a (i+3)-
spacing. Moreover, these artificial helices showed a helix content of up to 80% in 0.01M 
NaCl and at 1ºC which was temperature- and pH-dependent . Replacing the hydrophobic 
N-terminal helix by a soluble helix could increase the solubility and stability of the N-
terminally truncated prohibitin complex to a great extent.  As this N-terminal artificial 
helix would also self-induce its helix formation, secondary structure formation in the C-
terminal protein sequence might be enhanced resulting in an increase of refolding yield.
2.2.6.1 Cloning and expression of His  6-helix-BAP32(    1-24)  
The 16 amino acid long artificial helix AKAAAAKAAAAKAAAA  was introduced at the 
N-terminus of His6-BAP32(1-24) as described in section 5.2.3.
Expression trials were undertaken to find optimal expression conditions for His6-helix-
BAP32(1-24) in BL21(DE3) (see section 5.3.5.). All protein was found in the insoluble 
fraction. The best expression yield was obtained from induction at 37ºC, and there was 
little effect when the IPTG concentration was varied.
His6-helix-BAP32(1-24) was expressed (see section 5.3.2), the inclusion bodies purified 
(see section 5.3.3), and the purification process traced on SDS-PAGE (see figure 2-9). 
His6-helix-BAP32(1-24) has a molecular weight of 30kDa, and is detectable in the pellet 
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fractions P1 and P2 and in the inclusion body fraction InB. In the InB fraction, the protein 
appears as a strong band just below the 32.5kDa-marker. 
Figure  -19: Protein production of His6-helix-BAP32(1-24) in inclusion bodies. The protein was 
purified in inclusion bodies from pellet fractions (P) of the washing steps, and appeared as a 
strong  band near  the  32.5kDa  marker.  No  protein  was  found  in  the  supernatants  (S).  For 
comparison, 10l  of the supernatant fractions, 5l  of pellets and 1l  of inclusion bodies were 
loaded onto the gel.
The protein could be purified to a high degree as there are only a few weak bands of 
contaminating proteins visible.
The artificial helix did not improve the solubility of BAP32 but this might also be due to 
the absence of its  homologue BAP37 which is  known to stabilize  the protein.  A co-
refolding of His6-helix-BAP32(1-24) and BAP37(1-40) using the protocol established 
for His6-BAP32(1-30):BAP37(1-40) might produce a greater yield of refolded protein 
due to an increased solubility of the BAP32 truncation mutant.
2.2.6.2 Co-refolding of His  6-helix-BAP32(    1-24) and BAP37(    1-40)  
During refolding of  His6-helix-BAP32(1-24)  and BAP37(1-40),  the  sample volume 
decreased and precipitation was visible which was cenrifuged for 30 minutes and 4000rpm 
at 4ºC. Nickel affinity chromatography was applied as described in section 5.4.1., and an 
SDS-PAGE was run to determine successful refolding (see figure 2-10). 
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Figure -20: Co-refolding of His6-helix-BAP32(1-24) and BAP37(1-40). Both proteins were found 
in the precipitate (P) after refolding, only His6-helix-BAP32(1-24) was present in the supernatant 
(S) after centrifugation of the refolding mix. His6-helix-BAP32(1-24) could be eluted form the 
column in fractions 2 to 5 (lanes 5-8).
The  supernatant  after  centrifugation  (lane  2,  S)  shows  only  one  protein,  and  when 
compared to the third lane (precipitate, P) where both proteins are visible as a double 
band, the protein in the supernatant is thought to be His6-helix-BAP32(1-24). During 
refolding, a majority of both proteins were precipitated but since His6-helix-BAP32(1-
24) was able to bind to the nickel column, it could be eluted from the column in fractions 
2 to 7 (lanes 5-10).  To determine the possible  refolding of  His6-helix-BAP32(1-24), 
elution fraction 3 (lane 6) was subjected to further dialysis in 20mM tris, pH 7.5 and 
100mM NaCl in order to decrease the concentration of imidazole in the protein solution. 
Shortly after placing the dialysis bag in the new buffer, the protein precipitated which 
indicates that the protein was stabilised by high amounts of imidazole in the elution buffer, 
thus masking its insolubility. 
2.2.7 Conclusions: Generation and production of truncation mutants
The prohibitin complex consisting of full-length BAP32 and BAP37 is not water-soluble 
due to hydrophobic membrane-anchoring helices at the N-termini of both proteins. N-
terminal truncation mutants of both proteins were generated to overcome this problem. 
However,  truncating  the  N-termini  did  not  result  in  stable,  water  soluble  BAP32  or 
BAP37.  Co-refolding trials  with different  combinations of  truncation mutants  of  both 
proteins led to the production of a stable complex using His6-BAP32(1-30) and BAP37(
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1-40). The refolding yield was 54% which decreased to 33% in the absence of glycerol 
and Nonidet-P40.  The N-terminally  truncated complex could be concentrated up to  a 
concentration  of  0.5mg/ml.  Nevertheless,  the  main  goal  of  production  of  a  truncated 
prohibitin complex suitable for concentrating and application in further experiments was 
achieved. In subsequent experiments, the complex will be examined to further determine 
its state of folding and thermal stability using CD spectroscopy, and its size distribution 
using gel filtration analysis.
In 2005, Langhorst and colleagues found that truncation of the first EA repeat in the C-
terminal helix lead to loss of oligomerisation function in stomatin and supposedly other 
SPFH family members . In BAP32 and BAP37, these EA-repeats are located at position 
181/182 (BAP32) and at position 198/199 (BAP37) C-terminal to the PHB domain. The 
N-terminal and C-terminal truncation mutants of BAP32 and BAP37 were designed on the 
basis of secondary structure predictions, and the constructs were generated before this 
information was known. Assessing the truncation mutants generated in this work, the first 
EA-repeats both in BAP32 and in BAP37 were truncated in constructs lacking the C-
terminal domains. That might be the reason why truncated proteins expressed from those 
constructs did not refold but rather precipitated. Their dimerisation potential might have 
been destroyed by truncating the protein before the first EA-repeat. This first EA-repeat is 
obviously present in the N-terminal truncation mutants that still  contain the whole C-
terminal region leading to refolding. On the other hand, coiled-coil regions are prone to 
aggregation and attachment to membranes, for example in centrifugation devices which 
might  be the cause of protein loss  in the concentration process.  Design of  truncation 
mutants lacking the N-terminal hydrophobic helix and the C-terminal coiled-coil domain 
but including the first EA-repeat C-terminal of the PHB domain might be the next step in 
improving  refolding  yield  of  those  proteins  and,  equally,  obtaining  a  high  protein 
concentration suitable for crystallography.
Replacement  of  the  hydrophobic  N-terminal  helix  with  an  artificial  soluble  helix  in 
BAP32 did not lead to refolding into a prohibitin complex. Here, the artificial helix did not 
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fold and the overall folding process of the protein might have been disturbed. Re-design of 
the construct will be necessary to achieve folding of the protein.
2.3 Biophysical experiments on prohibitin truncation mutants
Biophysical  methods such as CD spectroscopy or gel  filtration are  used to  analyse a 
protein solution with respect to its protein folding and oligomerisation state. The complex 
His6-BAP32(1-30):BAP37(1-40) was successfully refolded without either glycerol or 
detergents which leaves the protein in a buffer suitable for spectroscopic analysis. 
2.3.1 Gel filtration analysis of refolded His6-BAP32(1-30):BAP37(1-40)
Gel filtration analysis is used to investigate the oligomerisation state of a protein and to 
determine the size of the different species. The gel filtration runs were carried out as stated 
in section 5.7.4.
Figure 2-11 shows a gel filtration run of N-terminally truncated prohibitin complex (thick 
line) overlaid by the calibration runs (thin line) which consists of Dextran Blue (2MDa), 
albumin (67kDa) and chymotrypsin (25kDa).
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Figure  -21: Gel filtration analysis of refolded His6-BAP32(1-30):BAP37(1-40) complex shows 
two peaks at apparent molecular masses of 63kDa and 40kDa.
The trace of the prohibitin complex shows two peaks at 12.29ml and 13.65ml elution 
volume. Kav values were calculated for both peaks, which were converted into molecular 
weights using the equation generated from the calibration curve. His6-BAP32(1-30) has a 
predicted  molecular  mass  of  27kDa  and  BAP37(1-40)  has  a  mass  of  29kDa.  The 
complex has a theoretical molecular mass of 56kDa. As His6-BAP32(1-30) and BAP37(
1-40) are the only components in the protein sample, the peak at the higher elution 
volumes could represent a monomer and the other a dimer. The theoretical  molecular 
masses for either monomer (27kDa or 29kDa) or the dimer (56kDa) are lower than the 
respective molecular masses determined by gel filtration, 40kDa and 63kDa, respectively. 
The results are summarised in table 2-4.
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1 12.29 63.2 56 dimer
2 13.65 40.0 27 and 29 monomer
Recent  reports  in  the  literature  suggest  that  the  presence  of  a  His6-tag  can  promote 
dimerisation of  recombinant  proteins  .  Attempts to  verify the  identity  of  the proteins 
represented by the peaks using SDS-PAGE analysis were not successful due to the low 
protein concentration in the elution fractions.
As the above calculations are only valid for globular proteins, prohibitin monomer and 
truncated  prohibitin  complex  probably  display  an  elongated  shape  which  affects  its 
hydrodynamic flow during gel filtration analysis. Determination of their Stokes’ radii, Rs, 
could give clues about the dimensions of the protein species. Theoretical Kav values for 
His6-BAP32(1-30)  and  the truncated prohibitin  complex were determined from their 
molecular masses using the formula obtained from the calibration runs (see section 5.7.4). 
Using the theoretical Kav values, their theoretical Stokes’ radii could be calculated. Results 
reveal that the observed Kav values and Stokes’ radii are greater than the theoretical values 
based on the molecular weight of each molecule (see table 2-5). 
A greater difference in both Kav value and Stokes’ radius were found for His6-BAP32(1-
30) than for the prohibitin complex. The observed Stokes’ radius of His6-BAP32(1-30) is 
5.4Å bigger than the theoretical value which indicates an elongated shape of the particle. 
In contrast, the theoretical and the observed values for the Stokes’ radius for the truncated 
prohibitin complex differ only by 2Å. The data suggest that the protein complex might 
still display a slightly elongated shape.











0.2617 0.2844 34.50 32.48
His6-BAP32(1-30) 0.3471 0.4207 27.32 21.91
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2.3.2 CD spectroscopy of refolded His6-BAP32(1-30):BAP37(1-40)
Circular dichroism was used to analyse the complex with respect to its secondary structure 
content  and its  fold stability.  Presence of  secondary structure elements in the protein 
complex was investigated by recording a  wavelength spectrum and analysing it  using 
implementations of two algorithms, the K2D neural network and a linear combination of 
Fasman  spectra,  within  the  programme  ACDP   which  gave  estimates  for  secondary 
structure element contents. Furthermore, CD spectroscopy was also used to determine the 
thermal  stability  of  the  protein complex by recording changes  in  the CD signal  at  a 
specific wavelength during heating of the sample.
2.3.2.1 CD wavelength spectrum and secondary structure prediction  
The experimental spectrum in figure 2-12 (A) shows two minima at around 222nm and 
208nm indicating the existence of -helices. Furthermore, the spectrum displays a change 
of sign from 200nm towards lower wavelengths indicating a true fold of the protein (see 
figure 2-12, B).
The secondary structure was predicted using two algorithms, K2D and linear combination 
of Fasman spectra. The K2D algorithm predicts an  -helix content of 26%, a  -sheet 
content of 16%, and 57.7% as unordered. Using the linear combination of Fasman spectra, 
no -helix content but 62% -sheet were predicted. The least squares error was smaller 
for the fit using the K2D algorithm than for the fit using the linear combination of Fasman 
spectra.
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Figure  -22:  CD  spectrum  of  His6-BAP32(1-30):BAP37(1-40)  (A)  and  secondary  structure 
prediction (B) using the programme ACDP .
Theoretical values for the proportion of residues in the respective structural element from 
the total number of residues were calculated from PSIPRED  predictions and summarised 
in table 2-6. The N-terminal  -helices were excluded from the calculations as they are 
truncated in the protein sample.
Table -12: Theoretical distribution of residues in secondary structure elements
Proportion of structured residues
BAP32(1-30) BAP37(1-40) complex
-helix 0.58 0.50 0.53
-sheet 0.21 0.20 0.21
unordered 0.21 0.30 0.26
With PSIPRED , a higher  -helical content was predicted for both proteins, a tendency 
that was also found using the K2D algorithm. Linear combination of Fasman spectra is not 
in agreement with secondary structure prediction, as no -helical content was predicted. 
The K2D algorithm fits the experimental spectrum better in this case.
2.3.2.2 Thermal Denaturation  
To determine the wavelength at which the complex His6-BAP32(1-30):BAP37(1-40) 
experiences  greatest  change  in  its  CD  signal,  corresponding  to  an  unfolding,  two 
wavelength spectra were recorded at two different temperatures, 15ºC and 90ºC (see figure 
2-13 A). The spectrum recorded at 90ºC (dashed line) shows a flattening in the region 
from 235nm to 200nm as compared to the spectrum recorded at 15ºC (solid line) which 
indicates a loss of secondary structure caused by unfolding of the protein.
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Figure  -23:  Thermal denaturation of His6-BAP32(1-30):BAP37(1-40).  A – The CD spectrum 
recorded at 90 ºC indicates less secondary structure of the protein as compared to the spectrum 
recorded at 15 ºC. B –Denaturation was monitored at 216nm and revealed a two-state transition 
process with  a  melting temperature  Tm of  62ºC.  Denaturation curve shows average of  three 
independent experiments and respective error bars.
The greatest change in the CD signal during denaturation was observed at 216nm. Heat-
induced unfolding was monitored 216nm in three independent experiments. The thermal 
denaturation curve displays a one-step transition process (figure 2-13 B) from native to 
unfolded protein. The data were fitted using a sigmoidal equation in the programme Sigma 
Plot  giving a melting temperature, Tm, of 62ºC.
2.3.3 Conclusions: Biophysical experiments
Refolded N-terminally truncated BAP32/BAP37 complex was subjected to spectroscopic 
methods such as CD and gel filtration. In gel filtration, two peaks were visible at apparent 
masses of 63kDa and 40kDa which might represent the His6-BAP32(1-30):BAP37(1-
40) dimer and a BAP32(1-30) or BAP37(1-40) monomer, respectively. 
The secondary structure of the complex was analysed using CD, and the spectrum shows a 
clear indication of the presence of secondary structure proving a folded state of a BAP-
protein  dimer  without  N-termini.  The  best  prediction  of  secondary  structure  element 
contents was made using the K2D algorithm predicting both an  -helical and a  -sheet 
content. To assess its stability, the protein complex was unfolded by applying heat at a 
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defined rate. CD signal was measured at 216nm, the spectrum’s minimum for  -sheets, 
resulting in a two-state unfolding curve with a melting temperature of 62ºC. The BAP 
complex  consists  of  two molecules  bound  to  each  other  via  their  natural  interaction 
interface.  In the thermal unfolding experiment, one might have expected an unfolding 
curve  showing  at  least  two  transitions,  one  for  dissociation  of  the  dimer  at  lower 
temperatures and one at higher temperatures that represents unfolding of the monomers. 
There is no clear indication of a higher order unfolding process from the data obtained. 
Other  methods such as  fluorescence spectroscopy might  give results  that  reflect  both 
dissociation of the dimer and unfolding of the monomer.
This is  the first  time that  a  folded prohibitin  complex was produced by recombinant 
expression and subjected to experiments assessing its biophysical properties. Using the 
given refolding protocol, it would be possible to produce His6-BAP32(1-30):BAP37(1-
40) in significant amounts and utilise it in crystallisation trials and binding studies with 
other proteins. 
2.4 Computational experiments
In the absence of atomic details of prohibitin structures, and considering the difficulties 
faced with producing large amounts of soluble protein, a molecular modelling approach 
was undertaken in order to gain insights into the molecular structure of prohibitins. The 
structures of the PHB domains of BAP32 and BAP37 were modelled using the NMR 
structure of the band 7 (PHB) domain of the related mouse flotillin-2 as template (PDB 
accession number 1WIN). Both models were used to create a hetero-dimer employing two 
different approaches. 
In recent years, prohibitin research was focused on finding intracellular and extracellular 
binding partners. In this respect, possible interactions between BAP32 and melanogenin, a 
melanin  production  enhancer  in  the  skin,  were  elucidated.  Furthermore,  possible 
interaction sites with other proteins were mapped onto the PHB domain models of BAP32 
and BAP37 giving deeper insight into intracellular functions of prohibitins. 
All modelling was done with the help of A. Hofmann, and work on melanogenin-binding 
to the PHB domain of BAP32 was done with the help of O. Kämäräinen.
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Results from these studies were published in Proteins .
2.4.1 Molecular modelling
2.4.1.1 Alignment  
In a first step to predict the three dimensional structure of prohibitin, a fold prediction 
model of prohibitin 1 was generated by Khurshid and co-workers (PDB accession no. 
1LU7).  The only experimentally generated structure is an NMR structure of the band 7 
(PHB) domain of mouse flotillin-2 (PDB accession no. 1WIN), a distantly related protein 
within the SPFH super family. The theoretical model of the PHB domain of prohibitin 1 
shares a similar shape with the experimentally determined flotillin-2 structure but the fold 
differs in the position and orientation of secondary structure elements (see also ).
A sequence  alignment  of  BAP32,  BAP37 and flotillin-2 using Muscle  ,  was  slightly 
modified to satisfy conservations in the PHB domain region (boxed), and was combined 
with the secondary structure predictions for both prohibitins and the secondary structure 
elements found in the flotillin-2 NMR structure (see figure 2-14). 
When comparing locations of secondary structure elements of BAP32 as seen in the fold 
prediction model generated by Kurshid and co-workers to predictions made by PSIPRED , 
one can identify some differences. In both predictions, the secondary structure elements 
encompass slightly different residues. -sheets 2 and 4 are predicted to be shorter in the 
Kurshid model (full light grey arrows) but are roughly in the same region as predicted by 
PSIPRED (full middle grey arrows). Helices 1, 2and 3 are represented as two helices 
in the Kurshid model, and 5 was not predicted. 
Following page: Figure  -24: Sequence alignment for flotillin-2, BAP32 and BAP37 showing also 
their secondary structure elements. -helices are displayed as cylinders, and -strands are shown 
as arrows. Secondary structure predictions are indicated as full cylinders and arrows; experimental 
secondary  structure  of  flotillin-2  (PDB  accession  no.  1WIN)  is  represented  by  striped 
arrows/cylinders. The secondary structure obtained from the prohibitin fold prediction model (PDB 
accession no. 1LU7) is shown in light grey.
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Mouse Flotillin-2 NMR structure
1lu7 prediction of BAP32
Prediction of BAP32 using PSIPRED
Prediction of BAP37 using PSIPRED
BAP32       ---------- MAAKVFESIG KFGLALAVAG GVVNSALYNV DAGHRAVIFD RF-RGVQDI- 48
BAP37       MAQNLKDLAG RLPAGPRGMG TALKLLLGAG AVAYGVRESV FTVEGGHRAI FFNRIGGVQQ 60
flot2       SGSSGQRISL EIMTLQ-PRC EDVETAEGVA LTVTGVA--Q VKIMTEKELL -AVACEQ--- -F--LGKNVQ DIKNVVLQTL     70
BAP32       --VVGEGTHF LIPWVQKPII FDCRSRPRNV PVITGSKDLQ NVNITLRILF RPVA-SQLPR IFTSIGEDYD E--RVLPSIT    123
BAP37       DTILAEGLHF RIPWFQYPII YDIRARPRKI SSPTGSKDLQ MVNISLRVLS RPNA-QELPS MYQRLGLDYE E--RVLPSIV    137
flot2 EGHLRSILGT LTVEQIYQDR DQFAKLVREV AAPDVGRMGI EILSFTIKDV YDKVDYLSSL GKTQTSGPSS G 141
BAP32 TEILKSVVAR FDAGELITQR ELVSRQVSDD LTERAATFGL ILDDVSLTHL TFGKEFTEAV EAKQVAQQEA 193
BAP37 NEVLKSVVAK FNASQLITQR AQVSLLIRRE LTERAKDFSL ILDDVAITEL SFSREYTAAV EAKQVAQQEA 207 
BAP32  ERARFVVEKA EQQKKAAIIS AEGDSKAAEL IANSLATAGD GLIELRKLEA AEDIAYQLSR SRNITYLPAG QSVLLQLPQ- ---------- --- 272 
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Shortcomings in matching the two secondary structure predictions are mostly due to a 
poor prediction with confidences less than 0.5. For instance, the probability for helical 
geometry of helix 4 around residues 228/229 (BAP32) is less than 0.5 and thus it is quite 
likely, that 4 might also be divided into two segments as it is was predicted for BAP37. 
2.4.1.2 Homology modelling of PHB domains of BAP32 and BAP37  
Based on the agreement between the predicted secondary structures of BAP32 and BAP37 
and on the experimentally determined structure of mouse flotillin-2, homology models for 
the PHB domains of both prohibitins were generated. The NMR structure of flotillin-2 
(PDB accession no.  1WIN) was used as a template for homology modelling with the 
programme Modeller 4 , see also section 5.9.2. Ramachandran plots were generated using 
PROCHECK  to assess tensions in the proteins main chain angles (see Appendix). 87% of 
amino acids for the PHB domain of BAP32 were in most favoured regions and 11% in 
additionally allowed regions. No residues were found in disallowed regions indicating a 
good model for the protein. As for BAP37, 88% of amino acids were in most favoured 
regions. 10% of all residues were in additionally allowed regions. One residue, Leu99 was 
found in disallowed regions. Nonetheless, the model of BAP37 has almost all residues in 
most favoured regions and additionally allowed regions indicating a good model for the 
protein. However, prohibitins and flotillin-2 are distantly related proteins within the SPFH 
super family which might lead to slight differences in the fold of certain areas. Therefore, 
the  calculated  models  have  to  be  interpreted  with  caution  and  cannot  substitute  for 
experimental structures.
Homology models  of  BAP32 and BAP37 are shown in  figure  2-15 in  red and blue, 
respectively, and the predicted prohibitin fold by Khurshid and coworkers (PDB accession 
no. 1LU7) is shown in green for comparison. The modelled PHB domains of both BAP32 
and BAP37 adopt slightly elongated globular shapes where the two anti-parallel helices 
2 and 3 pack against the three-stranded anti-parallel -sheet formed by 1/2, 3/4 and 
5 (see figure 2-15). 
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Figure -25: Three-dimensional homology models of BAP32 (red) and BAP37 (blue) PHB domains 
in  comparison  with  prohibitin  fold  prediction  (green,  PDB  accession  number  1LU7).  Figure 
prepared with BOBSCRIPT  and rendered with PovRay .
The predicted helical segment 1 at the “bottom” (N-terminal) side of the protein appears 
like an extended loop and is probably an area of the model where the structure can be 
predicted  with  less  confidence.  The  generated  homology models  have  positional  rms 
distances to the experimental flotillin-2 structure of 10.5 Ǻ (BAP32) and 10.0 Ǻ (BAP37). 
Models of the PHB domains of BAP32 and BAP37 differ by an rms distance of 3.1 Ǻ. 
While there are some similarities between the homology model presented in this work and 
the predicted BAP32 model by Khurshid and colleagues (PDB accession no. 1LU7), the 
latter shows a much less globular fold. A -sheet feature is present in the predicted model, 
but it is exclusively built by the N-terminal -strands and there are no packing interactions 
to  the  two  anti-parallel  helices.  Unfortunately,  no  further  information  about  the  fold 
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prediction model generated by Khurshid and colleagues is available limiting the space for 
interpretation. 
In order to investigate the distribution of the electrostatic potential on the surface of the 
proteins,  surface representations of  the prohbitin  models  and flotillin-2 were prepared 
using PyMOL , and coloured according to their electrostatic potential with blue indicating 
positive and red indicating negative charge. The four structures within one panel show 
successive 90° rotations around the vertical axis (see figure 2-16).
A comparison of the surface properties of the proteins reveals interesting differences. The 
PHB domain of flotillin-2 is predominantly negatively charged with only a few isolated 
positive areas. In prohibitins, the surface appears to gradually have a more electropositive 
character. The surface of the PHB domain of BAP32 presents an electropositive patch at 
the C-terminal side (“top”) which is extended to the “bottom” side (membrane-proximal) 
in BAP37.
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Figure -26: Surface representations of mouse flotillin-2 (top panel) and of modelled PHB domains 
of BAP32 (middle panel) and BAP37 (bottom panel). Each panel shows successive 90º rotations 
of the proteins around the vertical axis. Figure prepared with PyMOL .
Anja Winter                                                                                                                              page  74  
Structural Biology of Prohibitins and Annexin B1
2.4.1.3 Modelling of the N-terminal regions of BAP32 and BAP37  
Results from the secondary structure predictions are well in agreement with the current 
state of knowledge where the N-terminal domains of prohibitins either form a membrane-
anchoring -helix (BAP32) or a transmembrane -helix (BAP37). With a predicted length 
of 36 Å, the N-terminal  -helix in BAP32 would just be able to span the lipid bilayer 
whereas the N-terminal helical segment in BAP37 has an expected length of 56 Å and is 
thus long enough to reach well into the mitochondrial matrix. 
In order to predict the nature of the anchor domain, models of the first 29 amino acids of 
BAP32 and the first 39 amino acids of BAP37 were generated using Garlic .  Helical 
wheels were created from the same programme showing hydrophilic residues in blue, 
hydrophobic residues in red (see figure 2-17).  The intensity of the colour describes the 
degree  of  hydrophilicity  or  hydrophobicity,  respectively,  with  dark  blue  being  very 
hydrophilic and dark red being very hydrophobic. 
Figure  -27: Helical wheels of amino acids 1 to 29 of BAP32 (left) and amino acids 1 to 39 of 
BAP37 (right). Hydrophobicity of residues is indicated by scales of red, and hydrophilic character is 
indicated in degrees of blue. Figure prepared using Garlic .
Both helices  of the predicted membrane regions showed no true ampiphilic nature or a 
hydrophilic  region,  and  is  not  as  hydrophobic  as  expected  for  a  membrane  inserting 
segment.  Surprisingly,  about  20% of  the  residues  present  in  the  proposed membrane 
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regions  are  hydrophilic  such  as  lysines  and  aspartates.  BAP32  possesses  lysines  at 
positions 3 and 10, and an aspartate in position 30. Two lysines can be found in the N-
terminal region of BAP37 at positions 9 and 27. Furthermore, the protein also possesses 
an arginine at position 14 and an aspartate at position 2.
Intriguingly, the few polar and charged residues are all positioned on one side of the helix 
but their exposure would be energetically unfavourable in a lipid bilayer. However, an 
exposure of those polar/charged residues to hydrophobic environment might be avoided 
by masking of the polar patches within a BAP32:BAP37 dimer. Homo-dimerisation was 
not considered as there is no experimental evidence for homo-oligomers . Helical models 
of BAP32(1-24) and BAP37(1-39) were dimerised using rigid body methods with the 
programme O  where oppositely charged residues were brought in close contact to enable 
formation of hydrogen bonds, thus stabilising the dimer (see figure 2-18, A). Isoforms of 
side chains were also considered in this approach. The model of the helix dimer was 
further  tested and its  conformation  improved by  subjecting  it  to  molecular  dynamics 
simulations with GROMACS  (done by A. Hofmann). Throughout the simulated time of 
500 ps, the two helices stayed in contact with each other, and the simulated complex 
equilibrated  as  judged by  analysis  of  rms  distances  and  potential  energies.  However, 
several polar/charged residues remained on the outside surface of the helix dimer: Lys4 
and Glu7 from BAP32 and Asp3, Gln7, Lys10, Arg15 and Arg21 from BAP37, and would 
still be in contact with the hydrophobic interior of the mitochondrial inner membrane. This 
result is best shown by calculating the electrostatic potential of the dimer surface with blue 
indicating  positive  and red  indicating  negative  charge.  Surface  representations  in  90º 
rotations around a vertical axis were generated using PyMOL  (see figure 2-18, B). 
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Figure -28: A – Models of the N-terminal helices BAP37(1-39) and BAP32(1-24) positioned in a 
helix dimer,  B – Surface representations of the helix-dimer with electrostatic potential.  Figure 
prepared with PyMOL .
One  could  speculate  that  these  non-masked  residues  engage  in  interactions  with 
transmembrane segments of m-AAA protease subunits in the mitochondrion, and thus be 
shielded from the hydrophobic environment. 
Comparing the membrane helices of BAP32 and BAP37 with the N-terminal helices of 
their yeast homologues, one finds some interesting differences. Phb2, the yeast homologue 
of  BAP37,  possesses  a  N-terminal  region that  consists  of  a  positively charged leader 
sequence and a hydrophobic -helix, and was shown to be responsible for mitochondrial 
targeting of Phb2 . Furthermore, the N-terminal segment shows a much higher enrichment 
of basic residues giving rise to a truly amphipathic  -helix which is characteristic for 
mitochondrial  sorting sequences.  These authors  have also been able  to show that  the 
presence of the N-terminal domain of Phb1, the yeast homologue of BAP32, is required 
for mitochondrial targeting. While the topology of residues on the helical wheel is very 
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similar for Phb1 and BAP32, the characteristic bipartite feature of Phb2 is not present in 
BAP37. These results suggest that mitochondrial targeting of BAP32 and BAP37 might be 
different from their homologues in yeast.
2.4.1.4 Analysis of t  he C-terminal coiled coil domain of BAP32 and BAP37  
The C-terminal domain of both prohibitins presumably adopts a coiled coil structure , and 
further analysis using MultiCoil  reveals that BAP32 shows a 30% probability to form a 
two-stranded coiled coil. BAP37, in contrast, is predicted to form a three-stranded coiled 
coil with a probability of almost 60%. 
Generally,  it  is  possible  that  the  different  strands  of  a  multi-stranded coiled  coil  are 
provided by either the same molecule or a neighbouring molecule. Especially, if the coiled 
coil region is divided into two segments like in BAP37, it is quite possible that the second 
segment adopts an antiparallel orientation with respect to the first one and thus forms the 
second strand of a two-stranded coiled coil. As there is no structural information available, 
further predictions remain pure speculation.
2.4.1.5 The BAP32:BAP37 oligomer  
A recent cross-linking study on isolated prohibitin complexes from yeast found that inter-
molecular cross-linking occurred mainly between two PHB domains or two coiled-coil 
regions  .  Intra-molecular  cross-linking  between  residues  in  close  distance  was  also 
reported. Based on the finding that prohibitins exist as high molecular weight oligomers , 
a ring-like assembly of alternating prohibitin homologues has been proposed consisting of 
hetero-dimeric building blocks. This model is supported by recent electron micrographs of 
purified  yeast  prohibitin  complexes  revealing  large  ring-shaped  structures   whose 
formation could be abolished by truncating the C-terminal coiled-coil regions. So far, no 
experimental evidence has been obtained that would suggest formation of homo-oligomers 
. Two methods were employed to generate prohibitin hetero-dimers using the homology 
models of the PHB domains of BAP32 and BAP37: an automated modelling approach 
using the programme Hex  and manual dimer generation with rigid body movement in the 
programme O . 
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Protein docking calculations using the programme Hex  resulted in a model where 2 and 
3 from BAP37 pack against 1 and 2 of BAP32 (see figure 2-19). 
Figure -29: Docking of modelled PHB domains of BAP32 and BAP37 using the programme Hex . 
Cys69 of BAP32 is indicated in yellow. Figure prepared with PyMOL .
Overall, this leads to an orientation where both molecules are positioned next to each other 
with a tilt angle of about 120° between their long axes. Thus, they are aligned in an almost 
anti-parallel fashion. The dimer is held together mainly by van-der-Waals interactions, and 
only one hydrogen bond between Thr124 (BAP32) and Glu139 (BAP37) can be identified. 
The buried surface area is about 2700 Ǻ2 corresponding to 13% of the surface of each 
monomer. However, the Hex-derived model does not agree with results from the earlier 
cross-linking study with yeast prohibitin  which showed that residues 74 and 154 in PHB1 
were found to be cross-linked with residue 103 in PHB2 and residue 151 (PHB1) with 176 
(PHB2). The respective residues in BAP32 and BAP37 identified by multiple sequence 
alignment are: 72 and 152 (BAP32) cross-linked to residue 86 (BAP37), and residue 149 
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(BAP32) linked to residue 159 (BAP37). Those residues are not in close proximity in the 
Hex-generated dimer.
In a second approach, the possibility of manually creating a model of a BAP32:BAP37 
dimer using the programme O  was attempted. Dimer formation was based on two criteria: 
the anticipated parallel orientation of the two protein molecules, as well as the spatial 
closeness  of  certain  residues  identified  from cross-linking  of  prohibitin  from yeast  . 
Inevitably, this leads to a model where helices  2 and  3 from both molecules form a 
four-helix bundle (figure 2-20). In this model, both proteins align parallel with both N-
termini  pointing  in  the  same  direction  satisfying  requirements  of  their  function  as 
membrane anchors. The residues found to be cross-linked in both proteins are close to 
each other (14Å to 18Å) as shown in the inset.
The starting model was subjected to a molecular dynamics simulation in order to test the 
stability  of  the  complex  and  to  improve  conformations  which  would  maximise  the 
interactions between both monomers (done by A. Hofmann). Within the timeframe of the 
simulation of 500ps, the potential energy decreased to a minimum, and the rms distance 
and the centre of gravity distance reached equilibrium. Depiction of the centre of gravity 
distance over time showed that, after initially drifting apart, both molecules anneal again 
resulting  in  a  final  distance  of  just  over  25Å between  their  centres  of  gravity.  The 
interaction interface covers about 1150Å2 (6% of the total surface area of each individual 
protein molecule) which is a smaller area than was generated by the automated docking. 
Two  hydrogen  bonds  can  be  identified,  one  between  Glu90  (BAP32)  and  Arg174 
(BAP37) and another between Asp104 (BAP32) and Ser231 (BAP37).
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Figure  -30: Manual modelling approach of PHB domains of BAP32 and BAP37 using O . Inset 
shows residues identified in cross-linking experiments in yeast prohibitin and their distances in the 
modelled dimer. Figure prepared with PyMOL .
The complex possesses pseudo-2-fold symmetry which establishes a prohibitin dimer as a 
building block for the ring-shaped high molecular weight complex and requires a different 
type of protein-protein interaction with the neighbouring prohibitin molecules in the ring. 
It is tempting to speculate that these interactions are provided by coiled-coil interactions 
between neighbouring BAP32 and BAP37 molecules. This speculation is in agreement 
with a report by Tatsuta and colleagues showing that C-terminally truncated yeast Phb1 is 
unable to form large assemblies . Furthermore, a number of residues in the coiled-coil 
region were found to be cross-linked in the study by Back and co-workers . One might 
therefore speculate that  a cooperative effect based on coiled-coil  strand exchange and 
four-helix-bundle  formation  enables  the  BAP32-BAP37  interaction  which  ultimately 
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results in formation of the large ring-shaped complexes. The fact that both proteins are 
membrane-bound through their N-terminal helices will most likely lower the activation 
energy for these interactions.
Intriguingly, all previous studies in this context agree that there is no prohibitin dimer 
detected  in  any  aqueous  environment  such  as  the  nucleus.  It  remains  to  be  clarified 
whether the single proteins are stabilised by other binding partners instead. This would be 
necessary in order to mask the hydrophobic patches present in the N-terminal region and 
improve protein stability.
2.4.2 Modelling of melanogenin binding to BAP32
Melanogenin has been found to enhance melanin production in melanocytes and to bind 
specifically to prohibitin , proposing a functional role for prohibitin in melanin induction. 
Snyder  and coworkers  identified prohibitin 1  as  a  specific  target  for  melanogenin by 
affinity  chromatography  with  immobilised  ligand  and  subsequent  identification  using 
mass spectrometry . It was further assumed that binding of the ligand would occur at a 
globular domain, i.e. the PHB domain of the protein. In order to investigate the interaction 
between melanogenin and BAP32, a docking study was carried out using the programme 
FlexX . The docking studies of melanogenin to the modelled PHB domain of BAP32 were 
carried out with the help of Outi Kämäräinen.
Melanogenin possesses  three substituents  at  a  central  triazine  ring:  a  polyether/amine 
chain, a mono-fluoro-benzyl group, and an ether-bonded penta-fluoro-hydroxy-benzol. By 
visual  inspection  and  surface  analysis  of  the  BAP32  homology  model,  two potential 
binding pockets were identified within the PHB domain. The first pocket (pocket 1; see 
figure 2-21, A) is located at the membrane-proximal side of BAP32 and constituted by 
helix 1 at the bottom, strands 5 and 4 at the side and the linker region between the N-
terminal  membrane helix and the PHB domain at  the back.  A slightly smaller pocket 
(pocket 2; see figure 2-21, B) is located in a groove between helices 2 and 3 in between 
residues Thr124 and Phe134. Both pockets are lined with hydrophobic residues in the 
cavities and polar/charged residues at the protein surface. 
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Figure  -31: Docking of melanogenin to two predicted binding pockets on BAP32. Pockets are 
shown as blue areas (A and B), the position and conformation of melanogenin in pocket 1 (A) is 
shown in C, and melanogenin in pocket 2 is shown in D. Interacting side chains of the protein are 
coloured in blue, the melanogenin molecule is coloured by its elements. Figure prepared by N.-J. 
Hu with PyMOL .
Attempts to fit the ligand into pocket 2 yielded a conformation where the triazine ring, as 
well as the polyether/amine chain are neatly accommodated in a groove, and two aromatic 
rings of the organic molecule are sticking out from the protein surface. This binding mode 
with a buried surface of 737 Ǻ2 is stabilised by hydrogen bonds provided by Ser129, 
Arg133, Gln149 and Asp153. 
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Docking of  melanogenin into pocket  1 yields  conformations with much larger  buried 
surface areas (839 Ǻ2) as compared to pocket 2. Here, the polyether/amine branch of the 
ligand protrudes into the cavity at the membrane-proximal side of the protein. The side 
chain amine group of Gln102 provides hydrogen bonds to interact with the two ether 
groups and the most extreme amine group of the ligand is held in position by hydrogen 
bonds with the backbone carbonyl groups of Phe161, Gln102, and Val99. At the protein 
surface, Thr160 and Arg157 provide hydrogen bonds to two nitrogen atoms of the triazine 
ring system which is further held in place by van-der-Waals interactions with Ile122. The 
fluorine  of  the  mono-fluoro-phenyl  group  is  hydrogen-bonded  by  the  side  chains  of 
Ser121 and Glu125, and the penta-fluoro-substituted ring system is only loosely held in 
place by van-der-Waals interactions with Thr160. An alternative binding mode where the 
two aromatic ring systems have switched places has also been obtained with slightly less 
scoring values. It thus remains unclear which binding mode might be preferred.
A common observation for both pockets is that the penta-fluoro-substituted ring system is 
not fully coordinated by protein residues, sticking out of the protein surface and available 
for external interactions. This is somewhat surprising, since Snyder and coworkers found a 
melanogenin derivative with a 2,3,6-tri-fluoro-hydroxybenzol group to bind less well to 
prohibitin . 
2.4.3 Binding of the prohibitin complex to other proteins
In various studies, BAP32 and BAP37 have been found to interact with other proteins in 
the cell  cytosol and the nucleus that  are involved in gene expression.  However,  only 
prohibitin  monomers  were  shown  to  be  involved  in  those  interactions  and  not  the 
BAP32:BAP37 complex. In all studies, the interaction sites were found to be localized 
mainly  on  the  PHB  domains  of  the  respective  prohibitin  which  appears  to  be  the 
functional  part  of  the  proteins.  Figure  2-22  visualises  the  interaction  sites  between 
prohibitins and Rb,  E2F,  estrogen receptor  (ER) and Akt  mapped onto the prohibitin 
homology models. Results from these studies were published as a review in CCB.
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Figure -32: Interactions of PHB domains of BAP37 (blue) and BAP32 (orange) with target proteins 
identified by other groups in interaction assays. Figure prepared with PyMOL .
BAP32 interacts with Rb protein and the transcription factor E2F indicating a role in gene 
expression control. The Rb binding region on BAP32 (shown in green) spans residues 74-
116, where three of four point mutations of prohibitin are found in sporadic breast cancer 
cells . Interestingly, those residues span the anti-parallel beta-sheet of BAP32, which is 
proposed  not  to  interact  with  its  homologue,  BAP37,  and  would  thus  be  potentially 
available for interactions with other target proteins. BAP32 also binds to the transcription 
factor  E2F  (shown  in  cyan)  ,  and  appears  to  act  as  a  repressor  in  E2F-mediated 
transcription.  Additional to the region at  the C-terminal end of the PHB domain,  this 
interaction also seems to require the RB-binding domain. Further research in this area 
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might  give  clues  to  the  nature  of  this  interaction  and  thus  provide  insights  in  the 
mechanism responsible for E2F repression.
Although  there  is  a  consensus  Akt  phosphorylation  site  present  in  prohibitin  2  (86-
RPRKIS-91), phosphorylation of yeast prohibitin 2 could not be confirmed in vitro or in 
vivo . Prohibitin 2 might thus belong to the third class of Akt-interacting proteins where 
Akt functions by competitive binding to prevent its interacting proteins from binding other 
proteins.  The  proposed  interaction  site  with  Akt  is  coloured  in  yellow ,  which  also 
includes the binding site for estrogen receptor (ER, purple) . BAP37 was found to bind 
directly to ER in the presence of its ligand estradiol.  The Akt binding site on BAP37 
attracts  attention  because  it  is  located  at  the  BAP32  interface.  One  might  therefore 
speculate that BAP37 would only be able to bind to either protein. On the other hand, 
BAP32 and Akt might share similar structural features to be able to bind to the same 
interface on BAP37. This finding strengthens results from other studies where prohibitins 
were found to bind to proteins in their monomeric state.
Furthermore,  putative phosphorylation sites are indicated by explicitly drawn residues. 
These modification sites were predicted using Expasy tools (www.expasy.org) and are 
analysed in detail in the following section. Additionally a putative palmitoylation site in 
BAP32 at Cys69 is indicated explicitly.
2.4.4 Prediction for posttranslational modifications
Posttranslational  modifications  were  predicted  for  both  proteins  in  order  to  evaluate 
possible conformational changes that could influence the function of prohibitins in the 
cell. Table 2-7 summarises the results from predictions that were run using Expasy tools 
(www.expasy.org)  indicating  also  whether  the  predicted  modification  sites  would  be 
accessible in the model. 
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Acetylation No n/a No n/a
Cellular localization unknown n/a Unknown n/a
Mito import sequence 32.5% yes n/a 21.8% yes n/a
N-glycosylation
N 89 Yes N 103
N 259
No  signal 
peptide
O-glycosylation no n/a No n/a
























































Sulfation in Y Y 155 (52%) none n/a
Predictions for post-translational modifications indicate that both proteins would not be 
acetylated by N-acetyltransferase A nor possess O-glycosylation sites. 
Their cellular localization was predicted unknown due to the absence of an N-terminal 
pre-sequence, and the possibility of a mitochondrial import sequence was predicted with 
only 32.5% for BAP32 and 21.8% for BAP37. This might reflect a ubiquitous distribution 
of  both  proteins  in  the  cell  exerting  functions  in  different  cell  compartments.  An 
interaction with a target protein or a post-translational modification of the proteins might 
specify their cellular localisation.
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Although  BAP37  possesses  two  N-glycolysation  recognition  sequences  (Asn-Xaa-
Ser/Thr), glycolysation is unlikely because it does not possess a signal peptide that would 
expose the protein to the N-glycosylation machinery, and thus may not be glycosylated in 
vivo even though it contains potential motifs. On the other hand, BAP32 does possess a 
signal peptide, and an N-glycolysation site has been predicted for asparagine 89 which is 
located at  the membrane proximal side (see figure 2-22). This residue lies within the 
suggested Rb interaction site with BAP32, and might therefore only be used when this 
interaction is not intended or BAP32 does not reside in the cytosol. Predictions for O-ß-N-
acetylglucosamine  (O-ß-GlcNAc)  attachment  sites  in  eukaryotic  protein  sequences 
revealed that BAP32 possesses one site at residue S147 which is not accessible according 
to our model. Two O-ß-GlcNAc sites were detected in BAP37, S95 and T267, where the 
latter  lies  in  the  C-terminal  coiled-coil  region and cannot  be assessed by our  model. 
Residue S95 was predicted with 46% confidence level and resides in the membrane-distal 
part of the protein. 
Proteins can be phosphorylated at serine, threonine and tyrosine residues which plays an 
important part in modifying their functions. In 2D-gel electrophoresis, several prohibitin 
species were found which indicated that the proteins are phosphorylated . In context with 
investigations  on  E2F  interaction  sites  on  BAP32,  Wang  and  colleagues  proposed  a 
possible involvement of JNK1 in phosphorylating the prohibitin . 
Possible  phosphorylation  sites  were  predicted  for  both  prohibitins  and  evaluated  on 
whether they were used  in vivo.  Phosphorylation sites on membrane-proximal side are 
unlikely to be used when the prohibitins are in the membrane bound complex because they 
are not accessible. Some proposed phosphorylation sites lie within the protein interface in 
the BAP dimer and are unlikely to be used in the dimerised state. Looking at a membrane-
bound BAP dimer, only three phosphorylation sites are likely for each BAP protein, T108, 
S109, T141 in BAP32 and T194, S190, S110 in BAP37. As visualised in figure 2-22, 
some of those residues lie within the interaction interfaces with other proteins. In BAP32, 
T108 and S109 lie within the Rb binding site, in BAP37, T194 and S190 are part of the 
interaction interface with Akt and estrogen receptor. It is therefore tempting to speculate 
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that phosphorylation is used in prohibitins to modify the interaction interfaces with other 
proteins, allowing or disallowing an interaction. 
Lipo-conjugation of the PHB domain as observed with podocin and mec-2 that are two 
PHB  domain  containing  proteins  ,  and  might  be  another  possible  posttranslational 
modification. As palmitoylation occurs at accessible cysteine residues, but only BAP32 
(one cysteine at position 69; see figure 2-22), and not BAP37 (no cysteine) is anticipated 
to possess this feature. Based on a preliminary secondary structure alignment of BAP32 
with podocin and mec-2, Cys69 seems to be located in a similar position to the conjugated 
cysteines in podocin and mec-2 . 
2.4.5 Conclusions: Computational experiments
In  the  absence  of  experimentally  determined  three-dimensional  structures  of  both 
prohibitins,  homology models  provide  valuable  insight  into  the  structural  features  of 
prohibitins, their interactions in the dimer and with other proteins. Dissecting the proteins 
into the three domains, the N-terminal hydrophobic helix, the PHB domain and the distal 
C-terminal coiled-coil region, allows some structural predictions.
Based  on  helical  wheel  interpretations  and  models  of  the  N-terminal  -helices,  an 
unusually high content of charged and polar amino acid was discovered within the mainly 
hydrophobic  membrane-inserting  helices.  Partial  masking  of  those  residues  could  be 
achieved by dimer formation of the N-terminal transmembrane helices of both BAP32 and 
BAP37. Homology models of the PHB domains of BAP32 and BAP37 were generated 
using an NMR structure of the related mouse flotillin-2 as a template (PDB accession 
number  1WIN). The domain adopts a slightly elongated globular shape where the two 
anti-parallel  -helices  pack  against  a  three-stranded  anti-parallel  -sheet.  In  a  cross-
linking  study  ,  two  groups  of  prohibitin  1-prohibitin  2  interactions  had  been  found: 
between the respective PHB domains and between coiled-coil domains. It seems likely 
that the main interactions between the globular PHB domains of BAP32 and BAP37 occur 
only on one side engaging in formation of the dimeric building block for high molecular 
weight assemblies observed in electron micrographs . One can imagine a prohibitin dimer 
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residing  in  the  inner  mitochondrial  membrane  where  both  the  PHB domains  and N-
terminal -helices of BAP37 and BAP32 engage in protein-protein interactions. 
The  C-terminal  coiled  coil  domains  will  most  likely  be  involved  in  inter-molecular 
interactions as well, although it is not clear at this point, whether these interactions occur 
within the dimeric building block or between two of these building blocks. Formation of 
ring-like assemblies would require interactions between the dimeric building blocks that 
could  be  provided  by  interactions  between  either  the  N-terminal  helices  (within  the 
membrane) or the C-terminal coiled coil domains. Alternatively, the ring-like assembly 
could also be promoted by an external factor such as the m-AAA protease.
Measurement of extends of the generated model reveals a width of  37Å, 16Å in the y-
direction, and 42Å (BAP32) or 45Å (BAP37) in the z-axis. Tatsuta and colleagues found 
ellipsoid ring-like assemblies of yeast prohibitin subunits with an outer diameter of 270Å 
x 200Å and an inner  diameter of  160Å to 90Å .  One can calculate the average ring 
thickness  to  be  55Å  which  coincides  nicely  with  the  z-dimension  of  the  prohibitin 
complex.  The  combination  of  results  from  this  study  with  findings  from  electron 
micrographs lead to the conclusion that the prohibitin complex is likely to lie flat on the 
membrane inserting its N-termini into the membrane. A spatial  closeness between the 
PHB  domain  and  the  membrane  would  be  a  preferred  scenario  for  a  possible 
palmitoylation of cysteine 69 in BAP32. Palmitoylation of the cysteine would create a 
second membrane anchor within BAP32 that could promote membrane binding of the 
complex thus decreasing the activation energy necessary for this process. An elliptical 
prohibitin  ring with an inner  diameter  of  160Å x 90Å would  lead to  a  perimeter  of 
approximately 816Å. 22 modelled prohibitin dimers would fit into the ring which is in 
agreement with Tatsuta and colleagues who proposed the presence of 16 to 20 molecules 
of both yeast prohibitin 1 and prohibitin 2 .
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Figure -33: Suggested model of prohibitin dimer residing in the inner mitochondrial membrane. A – 
Top view: Ring-like assemblies are formed by hetero-dimeric building blocks consisting of BAP32 
(red) and BAP37 (purple). B – Side view: Both proteins are anchored to the membrane via their N-
terminal hydrophobic helices whereas the C-terminal helices are engaged in formation of inter-
molecular  coiled-coil  structures.  BAP32  potentially  possesses a  second  membrane  anchor, 
palmytoylated Cys69 (black wave).
The homology models  generated  in  this  work were  used  to  depict  the  interaction  of 
prohibitin  1  with  melanogenin,  to  map  interaction  sites  of  target  proteins  on  both 
prohibitins and to investigate possible posttranslational modifications.
Results from the docking studies of modelled PHB domain of BAP32 with melanogenin 
suggest that the larger pocket in BAP32 constituted by helix 1, and strands 5 and 4 is 
a likely binding pocket for melanogenin although the model does not explain the apparent 
discriminating effect of the fluoro-substituents in position 4 and 5 of the penta-fluoro-
hydroxy-benzol group of melanogenin, but this might well be due to shortcomings of the 
homology model of the BAP32 PHB domain. A different conformation of amino acid 
residues in the area of the binding pocket might easily lead to a different conformation of 
the bound ligand, for example, a change of positions between the penta- and mono-fluoro-
substituted ring systems. 
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Both prohibitin 1 and prohibitin 2 have been found to interact with a variety of proteins . 
In these studies, the respective interactions were described for only one of the prohibitin 
homologues. The interaction sites lie mostly within the PHB domain of the proteins and 
could  be  mapped  onto  the  homology  models.  One  could  therefore  speculate  that  a 
complex consisting of both prohibitins acts as a mediator between several proteins, such 
as Rb and E2F (interacting with BAP32) on the one hand, and ER receptor (interacting 
with  BAP37)  on  the  other.  Furthermore,  these  functions  might  be  activated  by 
phosphorylation since some phosphorylation sites are situated in the proposed binding 
sites of Rb/E2F (see figure 2-22).
Interestingly, a recent study elucidating the mechanisms of a synthetic hemiasterlin variant 
identified the E130K mutation in prohibitin 2, located in the proposed Akt/ER binding 
site,  to be responsible for the occurrence of multidrug resistance in a  Caenorhabditis 
elegans model . Hemiasterlin is a naturally occurring peptidic toxin that interferes with 
microtubule  dynamics  and thus  exerts  antimitotic  actions.  A hemiasterlin  analogue  is 
currently  being  evaluated  in  clinical  trials  for  cancer  chemotherapy.  The  prohibitin  2 
missense mutation confers drug resistance not only in the case of hemiasterlin, but also for 
other drugs binding to tubulin and camptothecin. While direct binding of hemiasterlin to 
prohibitin 2 is reported to be unlikely, the location of Glu-130 in the region of prohibitin 2 
binding to Akt, MyoD and  -actinin might indicate the direction of further studies to 
elucidate the molecular mechanism.
The  interactions  of  prohibitins  with  different  proteins  might  be  modulated  by  post-
translational  modifications  within the  PHB domain enabling a  wide  range  of  cellular 
functions.  Phosphorylated species  of  prohibitins  were found in  2D-gel  electrophoresis 
experiments  in  plants  ,  and  it  was  also  shown  that  purified  JNK1  successfully 
phosphorylates  prohibitin  in  vitro  .  Examination  of  the  proposed PHB domain dimer 
model of BAP32 and BAP37 returns three possible phosphorylation sites in each BAP32 
(T108, S109, T141) and BAP37 (T194, S190, S110), all being located within protein-
protein interaction sites.
Bacher  and  coworkers  reported  that  both  isolated  prohibitins,  BAP32  and  BAP37, 
preferably form homotetramers as well as calcium-independent heteromeric complexes. 
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Affinities for homo- and heteromers were reported in the order of 10-7 M . Potentially, 
BAP32 could form dimers via its cysteine residue in position 69 and is a substrate of a 
disulphide  isomerise  .  Since  BAP37  does  not  have  any  cysteine  residues,  the 
BAP32:BAP37 interactions cannot involve disulfide bonds. These findings remain to be 
elucidated further as homomers have not been reported in other contexts.
Structural information about the prohibitin complex at atomic detail will undoubtedly be 
useful in understanding the molecular mechanisms of protein turnover in mitochondria, as 
well  as  in  structure-based  lead  compound  discovery  for  novel  drugs  in  a  variety  of 
diseases.  It  would  also  help  to  understand protein-protein  interactions  as  seen  in  the 
nucleus, where the prohibitins seem to act as monomeric binding partners being engaged 
in gene regulation processes with respect to proliferation control.
Initial  crystallisation trials did not result in the formation of crystalline material,  most 
likely  because  the  protein  solution  is  not  homogenous  (presence  of  monomers  and 
dimers), and the concentration is low. Improvement of protein production and purification 
protocols might result in higher refolding yield where isolation of the dimer would be 
feasible.
2.5 Interaction of prohibitins with m-AAA-proteases
It is known from previous studies that m-AAA-proteases interact with prohibitins but little 
is known about how this interaction is established . The highly conserved proteins are an 
interesting target in prohibitin research as they are thought to interact physically with the 
prohibitin complex.  m-AAA-proteases display a three-divided topology: an N-terminus 
with  two  transmembrane  segments,  APTase  domain  and  protease  domain  .  In 
mitochondria,  the  poorly  investigated  N-terminus  is  thought  to  anchor  the  m-AAA-
protease  in  the  inner  mitochondrial  membrane  possibly  forming  a  loop  in  the 
intermembrane space. An interaction between the prohibitin complex and the  m-AAA-
protease could possibly be established either in the inner mitochondrial membrane via 
their respective N-termini or in the intermembrane space via the N-terminal loop of the m-
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AAA-protease  and  the  prohibitin  PHB  domain.  Since  no  structural  information  is 
available about the intermembrane space (IMS) region of m-AAA-protease, thus, further 
investigation was focussed on this domain.
2.5.1 Multiple sequence alignment and secondary structure prediction
Sequences from  m-AAA-protease subunits  of  FtsH (E.coli),  Yta10 and Yta12 (yeast), 
AFL3G2 and paraplegin both from mouse and human were aligned using the programme 
ClustalW .  Information about their secondary structure was gained either from crystal 
structures (FtsH ATPase domain, PDB accession number  1LV7, and peptidase domain, 
PDB accession number  2DI4)  and/or  PSIPRED  secondary structure  predictions.  The 
multiple sequence alignment was adjusted to preserve structural features and conserved 
residues in the ATPase domain and protease domain. The remaining N-terminal sequences 
were  analysed  and compared  both  in  their  amino acid  sequences  and their  predicted 
secondary structures. Interestingly, the N-termini of the aligned sequences showed high 
similarity  in  their  secondary  structure  elements,  and  were  therefore  combined  to  a 
conserved secondary structure named intermembrane space (IMS) region. The IMS region 
consists of a hydrophobic  -helix (residues 3 to 21), a region of relatively hydrophilic 
residues structured in  -helices and  -sheets followed by another hydrophobic  -helix 
(residues 97 to 121). The first and last helices of the N-terminus are long enough to span a 
membrane and therefore are most likely transmembrane helices. In order to strengthen this 
hypothesis, the topology of FtsH as an integral membrane protein was predicted using 
MEMSAT . It revealed two possible transmembrane helices, one from amino acids 2 to 20 
(inout), the other spanning amino acids 97 to 124 (outin). Therefore, both helices were 
annotated TM1 and TM2, respectively.
Figure  2-24  presents  an  overview  of  the  topology  of  m-AAA-protease  subunits 
summarising the new features that have been found in this study. The N-terminal IMS 
region is shown in cyan including the sequence alignment of different  m-AAA protease 
subunits. The ATPase domain is depicted as a yellow diamond and the protease domain is 
shown as a green ellipsoid. The conserved secondary structure features of the IMS region 
are shown in the bottom line,  -helices () and  -sheets () are shown as red tubes or 
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green  arrows,  respectively,  and  are  numbered  accordingly.  The  sequence  alignment 
included in figure 2-24 shows hydrophobicity of amino acid residues as varying degree 
from  strongly  hydrophobic  (coloured  in  red)  to  strongly  hydrophilic  (in  blue).  The 
sequence alignment also shows that certain amino acid residues are either conserved or 
semi-conserved  in  nearly  all  aligned  sequences  revealing  a  consistent  pattern  in  the 
properties of -helices and -sheets.
.
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These findings led to the conclusion that the N-terminal regions of  m-AAA-proteases 
might  have  a  conserved  fold  that  could  provide  a  possible  interaction  interface  for 
interaction  with  other  proteins,  and  could  therefore  be  important  in  exerting  cellular 
functions.  It  is  known  that  m-AAA-proteases  interact  with  prohibitins  in  the  inner 
mitochondrial membrane forming a large multimeric complex . A structurally defined N-
terminal region of the  m-AAA-proteases might be the key to answering the question of 
how this interaction might be established.
In the PDB, this domain is referred to as FtsH_ext for bacterial m-AAA-proteases (E. coli 
and T. thermophilus) but no structural information is available. In order to extend this term 
to  include  m-AAA-proteases  from  other  species,  this  region  will  be  called  inter-
membrane-space (IMS) region for the continuation of this work.
2.5.2 Cloning of FtsH-IMS region from E.coli genomic DNA
Genomic DNA from E.coli strain BL21(DE3) was isolated as stated in section 5.2.6., and 
used as template in a PCR reaction to gain the construct His6-FtsH(20-97)_pRSET_C (see 
section 5.2.2.). The resulting protein has a molecular weight of 13488 g/mol including the 
hexa-His-tag and linker sequence. 
2.5.3 Expression and purification of FtsH-IMS region
The  IMS region  of  FtsH was  expressed  in  BL21(DE3)  cells  (see  section  5.3.1)  and 
purified using immobilised metal chromatography and anion exchange chromatography 
(see sections 5.4.1. and 5.4.2.).
Figure  2-25,  A,  shows  the  result  of  the  first  purification  step,  immobilised  metal 
chromatography, on an SDS-PAGE where the protein appears as a strong band near the 
lysozyme single marker band (14kDa) which has a similar molecular weight to the FtsH-
IMS region. No protein was found in the flow through (FT). The protein was eluted from 
the column in fractions 10 to 17 which corresponds to imidazole concentrations of 0.12M 
to  0.18M.  Fractions  containing  the  protein  showed  other  bacterial  proteins  at  higher 
molecular  weight  which were separated in  the next  purification step,  anion exchange 
chromatography. 
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Figure  -34:  Purification  of  His6-FtsH(20-97)  using  nickel  affinity  (A)  and  anion  exchange 
chromatography (B). Gels show the marker (M) in lane 1, sample (S), flow through (FT) and wash 
(W) in following lanes. Elution fractions are labelled by their fraction numbers.
Results from anion exchange chromatography are shown in figure 2-25,  B, where the 
protein appears as a strong band near the lysozyme marker. The sample (S) applied to the 
anion exchange column is shown in lane 2. No protein was found in the flow through of 
the column (lane 3, FT). After extensive washing of the column (lane 4, W), the eluted 
protein could be found in all fractions up to fraction 7 (lanes 5 and 6) corresponding to a 
NaCl  concentration  of  up  to  150mM.  The  other  proteins  eluted  at  a  higher  NaCl 
concentration and could thus be separated from the FtsH-IMS region. After pooling the 
fractions containing the protein, FtsH-IMS region could be concentrated up to 160mg/ml 
using Amicon Ultra concentration devices with 5kDa molecular weight cut off. The purity 
was determined to be greater than 95% as judged by SDS-PAGE. 
2.5.4 Biophysical characterization
2.5.4.1 Mass spectrometry  
The molecular  mass  of  the purified protein was determined using  mass  spectrometry 
(MALDI-MS).  Sample preparation and layout of the experiment  were as described in 
section  5.7.1.  The  mass  spectrum  in  figure  2-26  shows  a  single  dominant  peak  at 
13471g/mol which is in the range of the expected 13488g/mol.  The protein could be 
identified as His6-FtsH(20-97). 
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Figure -35: Mass spectrum of FtsH-IMS region. The single peak at 13471g/mol corresponds well 
with the expected molecular mass of 13488g/mol.
The identity of the protein fragment was verified by trypsin digest and subsequent analysis 
by mass spectrometry (see figure 2-27). 
Figure  -36:  Results  from mass spectrometry  of  the trypsin-digested FtsH-IMS region. Protein 
residues  in  red  were  identified  by  mass spectrometry.  Underlined residues  indicate  possible 
protease cleavage sites after basic residues according to trypsin specifity.
A custom search database had to be set up, because the FtsH-IMS region is a very small 
part of the full-length protein FtsH, and scores from the default set up were not sufficient 
to verify the identity of the FtsH-IMS region. The custom search database found that 64% 
(76 of 117 amino acids) of the peptides matched that of the protein (see figure 2-27). 
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2.5.4.2 Circular dichroism (CD)  
CD spectroscopy was utilised to analyse the fold of the protein and its thermal stability. 
The fold of the protein was investigated by recording a CD spectrum and analysing it 
using the programme ACDP  with implementations of two algorithms, K2D Neuronal 
Network  and  Linear  Combination  of  Fasman  Spectra,  to  predict  secondary  structure 
contents. Thermal stability of the protein was investigated by recording the change in the 
CD signal at a specific wavelength during heating of the sample. 
2.5.4.2.1 Wavelength spectrum
The smoothed experimental spectrum from 260nm to 190nm in figure 2-28 (A) shows two 
minima at around 208nm and 222nm indicating the presence of  -helices. Furthermore, 
the spectrum reaches the positive at 196nm indicating a true fold of the protein. 
Figure  -37:  CD wavelength spectrum (A)  and secondary structure prediction (B)  of  FtsH-IMS 
region using the programme ACDP .
The spectrum was best described with a Fasman Fit giving a lower least squares error than 
the K2D Neural  Network.  The Fasman algorithm predicted 7% of  the residues to be 
organised in an -helix, 38% in a -sheet and 55% to be unordered (see figure 2-28, B). 
Using the K2D neural network algorithm, an -helix content of 28.7% and -sheet content 
of 27.2% were predicted, 43.9% of the residues were predicted as unordered. Theoretical 
values for the ratio of residues in the respective structural element from the total number 
A
B
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of residues were calculated from PSIPRED  secondary structure predictions. Here, 25.3% 
of the residues were predicted to be structured in -helices, 37.3% in -sheets and 37.3% 
as  unordered.  The  -helical  content  seems  to  be  underrepresented  in  the  Fasman 
calculation whereas  the K2D fit  is  in  better  agreement  with the PSIPRED secondary 
structure prediction despite a higher error. 
2.5.4.2.2 Thermal denaturation
FtsH-IMS region was subjected to thermal denaturation from 20ºC to 90ºC as described in 
section  5.7.2.  Unfolding  experiments  were  monitored  at  222nm  which  provided  the 
greatest change in the CD signal during the denaturation process (see figure 2-29). 
Three independent experiments were carried out,  the data averaged and fitted using a 
sigmoidal equation in the programme Sigma Plot . The denaturation curve shows a two-
state transition curve with a melting temperature, Tm, of 49ºC.
Figure -38: Thermal denaturation of FtsH-IMS region displays a two-state transition curve with a 
melting temperature Tm of 49ºC. Shown is the average of three independent experiments and their 
standard deviation.
2.5.4.3 Gel filtration analysis  
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The oligomerisation state of FtsH-IMS region was investigated using gel filtration analysis 
as stated in section 5.7.4. The absorption peaks were fitted using the programme PeakFit , 
and the positions of the peak maxima were determined. 
Figure 2-30 shows a gel filtration run of FtsH-IMS region overlaid with a calibration run 
with Dextran Blue (2MDa), BSA (68kDa) and cytochrome C (12.4kDa). It reveals one 
peak which a shoulder which was fitted as two peaks with apparent molecular masses of 
29kDa (peak 1) and 15kDa (peak 2) (see table 2-8). 
Results suggest that the FtsH-IMS region eluted as a mixture of dimers and monomers 
with dimers as the predominant species (see table 2-8). As the protein was purified to 99% 
as judged by SDS-PAGE analysis, both peaks are resumed to represent oligomeric species 
of FtsH-IMS region. The oligomerisation state of the protein and its possible shape will be 
investigated in further experiments such as SAXS.
Figure -39: Gel filtration analysis of FtsH-IMS region. The major fraction of the protein eluted as 
peak 1 at an apparent molecular mass of 29kDa possibly representing a dimer. A second peak 
(peak 2) that is seen as a shoulder of the first peak eluted at 15kDa.
Table -14: Analysis of gel filtration experiment with FtsH-IMS region.
peak elution volume Apparent  molecular Apparent species
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[ml] weight [kDa]
1 13.7 29.3 dimer
2 14.7 15.2 monomer
2.5.4.4 Small angle X-ray scattering (SAXS)  
SAXS analysis was used to gain information about the shape of the protein and to confirm 
the proposed dimer formation of the FtsH-IMS region. The experiment was carried out in 
the laboratory of our collaborator, Jan Pedersen (University of Aarhus, Denmark). 
The sample showed aggregates which made analysis of the scattering curves difficult. The 
best set of data could be recorded using 5mg/ml of protein. After processing the data, they 
could be fitted with the programme GNOM  which determined the molecular mass to be 
between 30.0kDa to 37.4kDa. Results indicate a protein dimer which is consistent with the 
gel filtration analysis. 
Figure -40: Shape restoration of FtsH-IMS region dimer using the programme Dammin .
Shape restoration from SAXS data was carried out  using the dummy bead modelling 
program Dammin . The particle looks very much like a dimer and displays an elongated 
shape with a maximum radius, Rmax, of 95Å. Figure 2-31 shows the reference model for 10 
Dammin models found using data recorded with 5mg/ml protein.
2.5.5 Crystallization of FtsH-IMS region
The purified FtsH-IMS region was subjected to crystallisation trials but no crystals have 
been obtained so far. 
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2.5.6 Conclusions: FtsH-IMS region
In mitochondria, prohibitins have been found to physically interact with m-AAA-proteases 
forming a high molecular weight complex . The m-AAA-protease is anchored to the inner 
mitochondrial  membrane  by  the  N-terminal  domain  of  its  subunits,  while  the  well 
conserved  C-terminal  ATPase  and  metallopeptidase  domains  protrude  into  the 
mitochondrial matrix . Although the X-ray structures for both the ATPase domain and 
protease domain have been solved , only little structural information is available on the N-
teminal domain. In yeast, it  is thought that both  m-AAA-protease subunits,  Yta10 and 
Yta12, anchor the protease to the inner mitochondrial membrane via two tramsmembrane 
helices . Interactions between the dimeric building blocks of BAP32:BAP37 and the m-
AAA-protease could be established in either the membrane or the intermembrane space. 
Comparing a multiple sequence alignment  of different  m-AAA-protease subunits  with 
secondary  structure  predictions  and  available  crystal  structures  revealed  a  high 
conservation  of  the  ATPase  and  protease  domains.  Furthermore,  another  structurally 
conserved region was discovered: the N-terminal intermembrane space region referred to 
as FtsH-IMS region in this work. In order to investigate the structure of this region, the N-
terminal  region of FtsH (residues 20 to 97) was cloned, expressed and purified using 
immobilised  nickel  affinity  and  anion  exchange  chromatography.  The  identity  of  the 
protein  was  confirmed  by  mass  spectrometry.  The  folding  state  of  the  protein  was 
investigated  by  CD  spectroscopy  revealing  -helix  and  -sheet  contributions  to  the 
secondary structure indicating a folded state. Monitoring differences in the CD signal at 
222nm, a two-state transition curve upon heat induced denaturation could be recorded 
suggesting  one  folding  unit  for  the  protein.  The  melting  point  of  the  protein  was 
determined to be 322K (49ºC).
Gel filtration analysis revealed a major peak at an apparent mass of 29kDa, suggesting a 
FtsH-IMS  region  dimer  as  the  predominant  species  in  solution.  As  the  theoretical 
molecular  mass  of  a  dimer  is  smaller  than  the  value  determined  with  gel  filtration 
(27kDa), the dimer is likely to possess an elongated shape. To obtain information about its 
molecular shape, the protein was subjected to SAXS analysis. Fitting the SAXS data using 
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the programme GNOM  and analysis by the programme Dammin  confirmed a possible 
dimer formation. Here, the average molecular weight of the particles could be determined 
to be between 30 to 37.4kDa, which is in good agreement with findings in the gel filtration 
analysis. Using the SAXS data, a dimer was modelled with an elongated shape, and an 
Rmax of 95Å was estimated but this is value is likely to be biased towards higher numbers 
due to the presence of aggregates in the solution.
Dimer formation of the IMS-region might give clues as to how the  m-AAA protease is 
assembled  in  the  inner  mitochondrial  membrane.  Previous  findings  suggest  that  the 
protein is present as hexamers in the membrane which is thought to be important for its 
function . Furthermore, a varying composition of  m-AAA-protease subunits within one 
hexamer was observed  which, in combination with a proposed IMS-region dimer, leads to 
a model where the m-AAA protease might consist of three, possibly different, dimers of 
m-AAA-subunits. 
Including findings from the present work in the existing knowledge of oligomer formation 
in the inner mitochondrial  membrane,  one could imagine a module that  consists  of a 
building block of BAP32:BAP37 and an m-AAA-protease subunit. 
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Figure  -41: Suggested model of membrane-bound prohibitin and their interaction with  m-AAA-
protease subunits. A – Top view: The prohibitin hetero-dimer (red and purple) interacts with the 
IMS-region (cyan) of  m-AAA protease (yellow) forming modules to build large assemblies in the 
membrane. B – Side view: The ring formed by BAP32, BAP37 and the IMS-region is anchored to 
the membrane via N-terminal hydrophobic helices of the three proteins and a possible additional 
anchor formed by the palmitoylated Cys69 of BAP32. The m-AAA-protease resides on the matrix-
side of the membrane and is shown with its ATPase (yellow) and protease domain (green).
In this module, the inter-membrane-space regions of the m-AAA-subunits would interact 
with either BAP32 or BAP37 or both proteins and with themselves as indicated in figure 
2-32. BAP32 (red) and BAP37 (purple) interact to form a dimeric building block. The N-
terminal transmembrane helices of BAP32 (red) and BAP37 (purple) and of the m-AAA-
protease (cyan) could interact with each other in the membrane, which would satisfy the 
need  to  mask  the  remaining  exposed  polar  residues  of  the  two  prohibitin  membrane 
helices.  Additionally,  the N-terminal  IMS region of  m-AAA-protease (cyan)  which is 
exposed  to  the  inter-membrane  space  might  interact  with  the  PHB  domains  of  the 
BAP32:BAP37 building blocks.  These proteins assemble to ring-like structures in the 
membrane which have an average inner diameter of 125Å . This value coincides nicely 
with the value for the diameter of the cytosolic region of the FtsH hexamer as had been 
found in the crystal structure, 120Å . Therefore, a model is proposed where the m-AAA-
protease is located in the middle of the ring exposing the well conserved ATPase domain 
(yellow)  and  protease  domain  (green)  to  the  other  side  of  the  inner  mitochondrial 
membrane,  to  the  mitochondrial  matrix.  It  follows  that  the  N-termini  of  BAP32 and 
BAP37 would point to the inside of the ring whereas the C-terminal coiled-coil regions 
would point away from the ring.
2.6 Concluding remarks on prohibitins and outlook
The main goal of this work was to gain insights in the molecular structure of prohibitins 
and their complex formation. Both proteins were produced as recombinant proteins in E. 
coli, refolded into the stable complex and their biophysical properties analysed. Refolding 
of N-terminal truncation mutants gave a refolding yield of 33%, and provided protein 
suitable for analysis employing spectroscopical methods such as CD. Replacement of the 
hydrophobic N-terminal helix with an artificial self-folding soluble helix did not lead to 
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successful refolding of the complex possibly due to misfolding of the artificial helix or 
interference with the folding process of the protein.
In a recent study, EA repeats located C-terminal of the PHB domain were found to be 
important  for  oligomerisation  .  BAP32  possesses  four  EA-repeats  in  the  C-terminal 
coiled-coil region, the first being located at position 181/182. The first of five EA-repeats 
of  BAP37 is  located at  position  198/199.  In  the  present  work,  C-terminal  truncation 
mutants of BAP32 and BAP37 were generated excluding the EA-repeats which might 
have  caused  those  proteins  to  fail  to  refold.  Truncation  of  the  C-terminal  region  is 
desirable as coiled-coil regions tend to stick to artificial membranes, e.g. in concentration 
devices. Therefore, constructs of BAP32 and BAP37 including residues 181/182 (BAP32) 
and  residues  198/199  (BAP37)  might  lead  to  refolding  of  proteins  with  improved 
suitability for concentrating. 
Furthermore,  the  refolding  protocol  could  be  optimised  in  the  future  also  including 
binding partners that have been identified in functional studies such as the pro-apoptotic 
peptide   or  the  Salmonella  polysaccharide .  Although the  main  aim,  crystallising the 
protein  complex,  was  not  achieved,  valuable  information  could  be  obtained  from 
biophysical studies. In future studies, the refolded full-length prohibitin complex could be 
analysed as to its ability to bind to lipid layers using a Langmuir surface film balance. The 
proposed  dimer  formation  of  the  N-terminal  helices  of  both  prohibitins  in  the  inner 
mitochondrial  membrane  could  also  be  assessed  by  experiments  using  a  Langmuir 
balance.  In this context,  the proposed oligomer formation with transmembrane helices 
from m-AAA-proteases could also be investigated. Modelling of m-AAA-transmembrane 
regions  and  elucidation  of  a  possible  interaction  interface  with  the  prohibitin 
transmembrane dimer that was already modelled might give first insights as to whether an 
interaction is likely. 
PHB domains of BAP32 and BAP37 were subjected to molecular modelling using the 
NMR structure of mouse flotillin-2 (PDB accession number 1WIN) as template. Manual 
dimerisation  of  the  modelled  PHB domains  according  to  findings  from cross-linking 
experiments  gave first insights in how a prohibitin dimer might look like. This prohibitin 
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dimer would be the building block that  can assemble large prohibitin oligomers.  The 
interaction with  m-AAA-proteases in the inner mitochondrial membrane could either be 
mediated via their N-terminal membrane helices or via a newly found structural feature 
within  m-AAA-proteases, the IMS region. This region is predicted to possess a distinct 
fold conserved in many m-AAA-proteases, and was investigated further. 
FtsH-IMS  region  could  be  purified  to  over  95%  purity,  and  was  subjected  to  CD 
spectroscopy, gel filtration and SAXS experiments. In CD experiments, FtsH-IMS region 
appears as a single folding unit although formation of dimers in solution was proven by 
gel filtration and SAXS. In future studies, gel filtration experiments under different buffer 
conditions  could  be  carried  out  to  gain  information  about  the  nature  of  the  dimer 
interaction interface. Gel filtration under high salt conditions such as 1M NaCl would 
disrupt interactions via salt bridges whereas SDS would disrupt hydrophobic interactions. 
Furthermore, the interaction interface of the FtsH-IMS region monomers could be mapped 
by subjecting the purified dimer to cross-linking experiments, subsequent trypsin digest 
and  mass  spectrometry.  Crystallisation  trials  were  set  up  but  did  not  lead  to  crystal 
formation. Another method to gain information about the three-dimensional structure of 
FtsH-IMS region would be to perform NMR experiments. Once an experimental three-
dimensional  structure  could  be  obtained,  intermembrane  regions  of  other  m-AAA-
proteases  such  as  paraplegin,  AFG3L1  and  AFG3L2  could  be  modelled  using  the 
experimental  three-dimensional  structure  of  FtsH-IMS region as  template.  Subsequent 
docking studies could then be used to investigate a possible interaction between prohibitin 
PHB domains and m-AAA-protease IMS regions. 
Proposed functions for the prohibitin complex include regulation of m-AAA-proteases in 
the  inner  mitochondrial  membrane,  scaffolding  functions  in  the  mitochondrion,  gene 
regulation in the nucleus and exposure as an extracellular receptor. Investigations into the 
structure and biophysical properties of the prohibitin complex might give important clues 
to their true function in the cell and their mechanism of interaction with other proteins, 
sugars and small molecules. The modelled prohibitin dimer generated from the modelled 
PHB domains was used to elucidate possible interaction interfaces with their proposed 
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interaction partners. Results showed that the dimer could interact with different nuclear 
target proteins at the same time, and could thus serve as a mediator for gene expression in 
the cell. 
Prohibitins exert basic functions in the cell, and are therefore considered as potential drug 
targets  in  various  diseases such as  adiposity,  diabetes and cancer,  especially sporadic 
breast  cancer.  While  the  prohibitin  proteins  are  involved  in  cell  cycle  regulation, 
senescence and morphological change of mitochondria under oxidative stress, the 3’UTR 
of its mRNA is thought to be responsible for its function as tumour suppressors. It is not 
clear whether the prohibitin mRNA interacts directly on the DNA causing silencing of 
genes  needed  for  progression  into  the  S-phase  or  via  formation  of  an  RNA-protein 
complex. In this context, the term riboregulator was introduced to describe cellular effects 
caused by prohibitin mRNA .  Experimentally,  a  pull-down assay could be performed 
where the 3’UTR of the mRNA is covalently bound to a matrix and the binding proteins 
are extracted from cytosolic or nuclear fractions. Proteins identified by this method would 
be good targets for developing anti-cancer drugs besides providing insights into cancer 
development. 
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3 Introduction to Annexin B1
3.1 Annexins in plant and animal kingdom
Annexins are water-soluble, calcium-dependent phospholipid binding proteins. Members 
of the annexin family are ubiquitously distributed in different tissues and cell types of 
higher and lower eukaryotes. To date, more than 160 unique annexin proteins have been 
found in more than 65 different species ranging from fungi and plants to non-vertebrates 
and higher vertebrates . More than one thousand proteins of the annexin superfamily have 
been  identified  in  major  eukaryotic  phyla,  but  annexins  are  absent  from yeasts  and 
prokaryotes. A recent review by Moss and Morgan classes annexins in five subfamilies A 
to E . Annexins common to vertebrates were summarised in the annexin subfamily A; 
other annexins have been assigned to subfamilies B (invertebrates), C (fungi and some 
groups of  unicellular  eukaryotes),  D (plants),  and  E (protists).  At  least  40 additional 
subfamilies await formal classification into these families. Most eukaryotic species have 
one to twenty annexin (ANX) genes; even the primitive unicellular protist Giardia has at 
least seven . The 12 human annexin genes range in size from 15kb (ANXA9) to 96kb 
(ANXA10) and are dispersed throughout the genome on chromosomes 1, 2, 4, 5, 8, 9, 10 
and  15  .  Annexins  display  a  high  level  of  conservation  throughout  their  amino acid 
sequences.  The  overall  three-dimensional  structure  is  divided  into  a  C-terminal  core 
domain  and  the  N-terminal  domain.  The  N-terminal  domains  of  annexins  are  highly 
variable and confer specific properties to each particular protein.
Implications of annexin proteins for health and disease are increasingly being appreciated, 
and the term ‘annexinopathies’ has been put forward for annexin-related diseases . The 
importance of annexins A1 for inflammation  and annexin A2 for plasminogen-dependent 
fibrinolysis  has long been acknowledged, and in recent years, the role of membrane-
bound annexin A5 as a protective shield has clarified the molecular mechanisms of its 
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anticoagulant properties .  Altered gene regulation and/or distribution of annexins have 
been observed for a variety of conditions.
Annexins  were  also  found  in  parasitic  organisms  where  they  might  be  located 
extracellularly  and thus could be involved in host attachment and invasion. Annexin B1 
had recently been identified in the larval stage of the porcine tapeworm Taenia solium . 
First applications were focussed on the ability of annexin B1 to displace phospholipid-
dependent coagulation factors and to prolong clotting times of human serum emphasising 
its potential for antithrombotic treatments. The combination of thrombus-targeting and 
thrombolytic properties has also been suggested for the protein . Possessing anticoagulant 
activity,  this  protein  carries  a  significant  therapeutic  potential  due  to  its  thrombus-
targeting and thrombolytic properties. 
3.2 Structural features
3.2.1 Four-helix-bundle repeat and calcium binding sites
In  2001,  Pidcock  and  Moore  conducted  a  study  investigating  metal  binding  sites  in 
proteins as observed in different crystal structures . Interrogation of files deposited in the 
protein  data  base  (PDB)  in  the  years  between  1994  and  1999  revealed  515  crystal 
structures of calcium-containing proteins. Forty of the final 44 data sets with a resolution 
better than 2.3Å were selected for further analysis, and three general types of calcium 
binding sites in proteins were identified. Type I calcium binding sites bind calcium ions 
with a continuous short sequence of amino acids similar to those seen in lectins, human -
lactalbumin and flavodoxin. The type II binding site in contains a main binding sequence 
and an additional amino acid far removed from the main binding sequence. This type of 
motif can be found in annexins, amylase and collagenase. In the third category, type III 
calcium binding sites,  the residues  involved in  calcium binding are  remote from one 
another  in  the  sequence,  as exemplified  by  adamalysin.  Calcium  binding  sites  are 
generally located at the protein surface and in regions of loops or turns.
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All annexins share a C-terminal core region in the shape of a slightly curved disc made up 
of four similar domains. Each domain is approximately 70 amino acids long and generated 
by five  -helices, termed A to E. Figure 3-1 shows the ribbon diagram of full-length 
annexin  A5  and  the  calcium-binding  sites  on  the  convex  side  of  the  protein   (PDB 
accession number 1AVR).
Figure -1: Ribbon diagram of human annexin A5 (PDB accession number 1AVR). Calcium ions in 
type II calcium binding sites are represented by yellow spheres, Calcium ions in type III calcium 
binding sites are represented by magenta spheres. Domains I to IV are coloured in blue, green, 
orange and red, respectively. Numbering of helices A to E is shown exemplarily on domain IV.
Annexins possess both type II and type III calcium binding sites but the type II sites 
remain the main structural feature. Its binding motif is formed by residues from loops 
between helices A/B and D/E. Type II calcium binding sites can be found in each of the 
four domains, and are characterised by the endonexin sequence K-G-X-G-T residing in the 
loop between helices A and B. Additionally, an amino acid residue possessing bidentate 
properties, such as aspartic acid (D) or glutamic acid (E), and sitting 38 residues along the 
protein backbone is necessary to complete the endonexin sequence (see figure 3-2). In the 
type II calcium binding site the calcium ion is coordinated by main chain oxygens from 
residues in the endonexin sequence, two water molecules and the two oxygens from the 
acidic residue. 
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Figure  -2:  Type II  calcium binding site  formed by the endonexin sequence in  annexins. The 
calcium ion is coordinated by main chain oxygens, two water molecules and an amino acid with 
bidentate features.
The type III calcium binding site is mainly found in the loop between helices D and E of 
each annexin domain. Calcium ions in the traditional type III calcium binding site are 
coordinated  by  two  backbone  carbonyl  oxygen  atoms,  one  acidic  residue  located 
approximately eight residues downstream in sequence and one to three water molecules. 
The ubiquity and versatility of annexins suggest some fundamental role for the unique C-
terminal  core  domain  in  cellular  physiology,  possibly  involving  adhesion  mechanics, 
membrane traffic, signal transduction and/or developmental processes. The core domains 
of most vertebrate annexins have been analyzed by X-ray crystallography, revealing a 
great conservation of their secondary and tertiary structures  despite only 45-55% amino-
acid identity among individual members. Annexin B1 shares 35% amino acid identity with 
hydra annexin B12 and human annexin A5, and molecular modelling suggests a similar 
three-dimensional structure as observed with other annexins . 
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Figure  -3:  Alignment of annexins from different species and indication of their  type II  calcium 
binding  sites.  Type  II  calcium  binding  sites  of  annexins  B1,  A5,  Gh1  and  -1  giardin  are 
highlighted in blue, green, yellow and red, respectively. Dysfunctional calcium binding sites are 
shown as boxed residues.
Figure 3-3 shows a sequence alignment of annexin B1, mammalian annexin A5, plant 
annexin Gh1 and  -1 giardin from the protozoan  Giardia lamblia. These annexins are 
members of annexin subfamilies B, A, D and E. Their functional type II calcium binding 
sites are highlighted by colouring the respective residues whereas non-functional binding 
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sites are indicated by boxed residues. Distinct features of annexin B1 include the slightly 
longer N-terminal domain (about 30 amino acids as compared to 1 giardin), as well as 
an extended connector region between repeats II and III. The connector region of this 
protein comprises 30 amino acids compared to annexin A5 which has a connector of 14 
residues. 
3.2.2 Conservation of type II calcium binding sites in annexins
Mutations of the acidic residue disrupts the type II calcium binding sites in some annexins 
which,  as  a  consequence,  show  altered  calcium  binding  behaviour  with  great 
consequences for their cellular functions.
Mammalian annexin A5 is the only annexin shown in the multiple sequence alignment 
(figure 3-3) that possesses four intact type II calcium binding sites. In annexin B1, the 
calcium binding site in domain III is disrupted due to a lysine instead of an acidic residue 
in position 254 preventing a calcium coordination by the endonexin sequence . The plant 
annexin Gh1 from cotton possesses only 2 intact binding sites in domains I and IV, and -
1 giardin has only one in domain II. Strikingly, the type II calcium binding sites seem to 
be conserved to varying degree in different subfamilies. Mammalian annexins generally 
possess four intact calcium binding sites, whereas annexins from subfamily B possesses 
only three. Plant annexins of subfamily D have two functional calcium binding sites and 
annexins E only one or none (see figure 3-4).
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Figure -4: Functionality of type II calcium binding sites in different annexin subfamilies. Annexins 
from different sub-families A to E and one representative member are shown in blue (mammals), 
brown (invertebrates), black (fungi), green (plants) and yellow (protists). The predicted presence of 
type II calcium binding sites in each domain is indicated by “+”.
This is of course a generalisation observed in a large number of members of the respective 
subfamilies and should therefore be treated with caution. Despite exceptions that can be 
found in each subfamily, a general tendency remains striking and may be worth further 
investigation with respect to evolution of calcium binding mechanisms in annexins.
3.2.3 Oligomer formation in annexins
Annexins are preferably monomeric cytosolic proteins, although higher oligomers have 
also been found. In 2002, Hofmann and colleagues investigated oligomer formation in 
plant annexins  and observed a trimer formation of up to 80% in solution with annexins 
23(Ca38),  24(Ca32),  and  Anx(Gh1)  in  gel  filtration  experiments.  For  Anx(Gh2), 
analytical  gel  filtration  indicated  the  presence  of  a  dimeric  species  in  solution.  The 
presence of calcium quantitatively suppressed oligomerisation and yielded almost pure 
monomer. In sedimentation equilibrium experiments, monomer–trimer equilibriums were 
found where the trimer constitutes 55% to 65% of the total protein content in standard 
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buffer conditions. Association constants range from 0.9 × 10-10 M2 to 1.7 × 10-11 M2 at 
protein concentrations of about 1mg/ml. Both ultracentrifugation and gel filtration results 
suggest that plant annexins investigated in that study exhibit calcium-independent self-
association.
This behaviour certainly distinguishes the plant members of the annexin family from their 
mammalian counterparts. The oligomerisation states of mammalian annexins A1, A4, A5, 
A6, the heterotetramer [AnxA2 p11]2 , and annexin A7  have been investigated in solution 
using ultracentrifugation techniques. For all of these proteins, formation of a calcium-
dependent  monomer–dimer  equilibrium  has  been  observed  with  weak  association 
constants  in  the range of  10-3 M.  These studies  were carried out  using sedimentation 
equilibrium experiments  in  the  presence  of  10mM CaCl2.  Annexin  A1 was  found in 
preparations from human placenta where the dimer is particularly abundant accounting for 
approximately 20% of  the protein.  Here,  the dimer  consists  of  two covalently  linked 
monomers probably generated by a transglutaminase. Annexin B12 undergoes a transition 
from soluble monomer to membrane surface trimer upon addition of calcium at neutral 
pH. Although annexins are generally water-soluble cytosolic proteins, AnxB12 was found 
to be membrane-inserted at pH 4.5 and present as a monomer in its transbilayer form . 
Anx  A4   and  Anx  A5   have  also  been  found  to  show trimerisation  upon  calcium-
dependent binding to membranes.
3.3 Role and functions in the cell
Annexins are generally cytosolic proteins, although some, such as annexins A11 and A2, 
have been found in the nucleus under particular circumstances . The expression level and 
tissue  distribution  of  annexins  span  a  broad  range,  from  abundant  and  ubiquitous 
(annexins A1, A2, A4, A5, A6, A7, A11) to selective or restrictive such as annexin A3 in 
neutrophils, annexin A8 in the placenta and skin, annexin A9 in the tongue, annexin A10 
in the stomach and annexin A13 in the small intestine . 
Members  of  this  family  are  versatile  adapter  and  regulator  proteins  in  membrane-
associated processes. Accordingly, a role in endo- and exocytosis has been assigned for 
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many annexin proteins such as annexins A1 to A4 and A13 . Despite being intra-cellular 
proteins,  extra-cellular functions have also been described for several  annexins.  While 
annexin A2 is known to act  as a co-receptor for plasminogen and tissue plasminogen 
activator on the surface of endothelial cells , annexin A1 has been observed to bind to an 
extra-cellular domain of 2 integrin . Annexin A5 was found to bind to the intra-cellular 
part  of the  5 integrin receptor subunit  .  Annexins A2 and A5 have repeatedly been 
reported to act as cellular receptors for cytomegalovirus and hepatitis B virus , although 
this is still a matter of discussion within the community. Frequently, annexins are found to 
interact with cytoskeletal proteins. Annexins A1 , A2 , as well as the plant annexins p34 
and p35 from tomato , exhibit binding to F-actin, while others, for example plant annexins 
from corn , bell pepper  and cotton , tested negative in this context. Interactions between 
annexin A1 and profilin have also been demonstrated . 
Interactions are either mediated through their C-terminal core domain or their N-terminus. 
The C-terminal core domain with its four repeats of five  -helices is conserved in all 
annexins  exerting  similar  functions  such  as  calcium-  and  phospholipid-binding.  In 
contrast, the N-terminus is unique to each protein and thought to be responsible for the 
wide range of functions observed with annexins. In vertebrate annexins, its size varies 
from 11 to 19 residues (annexins A3 to A6, A10, A12, A13), 33 and 42 residues (annexins 
A2 and A1) to more than 100 residues in annexins A8 and A11. The N-terminal domain 
harbours binding sites for other proteins (annexins A1, A2, A11) and phosphorylation 
sites (annexins A1 and A2). As well as using their N-terminal domains, annexins also 
employ  posttranslational  modifications  to  specify  their  interactions  such  as 
phosphorylation, myristoylation and surface remodelling.
3.3.1 Calcium dependent membrane binding
It is known that annexins bind to liposomes in the presence of calcium (reviewed in ). This 
feature implicates annexins in platelet activation and coagulation as well as membrane 
association.  Cryoelectron  and  atomic  force  microscopy  of  annexins  bound  to  model 
membranes have provided compelling images of the proteins forming two-dimensional 
lattices  of  membrane  domains  organizing  the  interface  between  the  cytoplasm  (or 
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cytoskeleton) and the cytoplasmic face of cellular membranes (reviewed in ).  Thus, a 
potential role in membrane scaffolding has been proposed. 
Figure  -5:  Calcium-dependent membrane binding of  annexins. Annexins bind to  phospholipid 
membranes upon an increase in the calcium concentration in the cell. Shown is annexin  -11 
giardin from Giardia lamblia in its apo form (PDB accession number 2II2) and its calcium-bound 
state (PDB accession number 2IIC). Domains I to IV are highlighted in blue, green, orange and 
red, respectively, and calcium ions are shown in yellow.
As most annexins reside in the cellular cytosol, their membrane binding and membrane-
domain organizing function must be activated. Intracellular calcium mobilization induced 
by various stimuli triggers recruitment of annexins to membranes in several cell models 
(see figure 3-5). The free Ca2+ concentration required for membrane translocation differs 
between different  annexins (see ).  These findings connect  calcium-induced membrane 
binding of annexins to calcium signalling in the cell. However, although Ca2+-dependent 
phospholipid binding is shared by all annexins, individual members differ significantly in 
their Ca2+ sensitivity and phospholipid headgroup specificity. 
Calcium-dependent  membrane  binding  is  mediated  through  calcium  ions  that  are 
coordinated in type II or type III calcium binding sites. Mammalian annexins seem to rely 
almost entirely on a calcium-mediated binding mode regardless of the vesicle composition 
.  The protozoan annexin  -11 giardin does  not  posses  any proposed type II  calcium 
binding sites, and was recently crystallized with one calcium ion coordinated in a type III 
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calcium binding site (PDB accession number 2IIC) . Emphasis on the importance of this 
structural feature with respect to its functional aspects was taken when this protein was 
found to be unable to bind to phosphatidyl-serine (PS)/phosphatidylcholine (PC) (1:5) 
vesicles  in vitro  . However, recent findings suggest that some plant annexins employ a 
second,  calcium-independent  mechanism  that  may  utilise  conserved  exposed  surface 
residues . A large number of reports analyzing Ca2+-regulated phospholipid binding of 
annexins  in  vitro have  been  published  underlining  diverse  functions  in  structural 
organization of the cell,  intracellular  signaling by enzyme modulation and ion fluxes, 
growth control, and action as atypical calcium channels .
Recent studies revealed a participation of the N-terminal domain in membrane binding 
which was influenced by the presence of calcium ions. In annexin A3, the local mobility 
of Trp5 of the N-terminus is increased by calcium binding whereas interaction of the 
protein with membranes reduces the Trp5 mobility back to its level in the absence of Ca2+ . 
Annexin A1 undergoes a conformational change upon Ca2+-dependent binding to lipid 
bilayers  exposing  a  secondary,  less  headgroup-specific binding  site  .  When  great 
differences were observed in X-ray structures of annexin A1 including (PDB accession 
number  1HM6)  or  lacking  (PDB accession  number  1AIN)  its  N-terminal  region,  an 
involvement of the N-terminal domain in this new lipid binding mechanism was evident. 
In the absence of calcium, the amphipathic -helix of N-terminal domain is buried in the 
core domain causing a large conformational change and  disabling the type II calcium 
binding  site.  Upon  calcium and  membrane  binding,  the  N-terminal  domain  becomes 
solvent  exposed  and  engages  in  membrane  aggregation  whereas  the  type  II  calcium 
binding site of repeat III regains its original conformation .
These findings indicate a conformational change of the protein both upon calcium binding 
and membrane binding.
3.3.2 Calcium dependent heparin binding
The glycosaminoglycan heparan sulphate is ubiquitously distributed on the surface of cells 
and acts as a regulator of ligand-receptor encounters , promotes protein assembly  and thus 
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coordinates a variety of cellular functions. Heparan sulphate has a variable heparin-like 
structure  but  more  N-acetylated  and  less  N-  or  O-sulphonated  groups  than  heparin. 
Heparin itself is a highly potent anticoagulant due to its ability to activate serine protease 
inhibitors such as antithrombin .
Several annexins, including annexins A1 , A2 , A4 , A5 , A6  and Nex-1 , are known to 
possess glycosaminoglycan-binding properties. In 2003, Weiland and colleagues found 
that -1 giardin, an annexin from the parasite Giardia lamblia, displayed Ca2+-dependent 
binding to glycosaminoglycans (GAGs), in particular heparan sulphate, a common GAG 
in the intestinal tract . In immuno-EM experiments and immunofluorescence studies, this 
immunodominant  GAG-binding protein localised to  the plasma membrane  with some 
protein  on  the  extracellular  side  during  the  early  stages  of  the  parasite  infection 
implicating involvement in parasite-host attachment.
Crystal  structures  in  complex  with  heparin-derived  tetrasaccharides  (HTS)  have  been 
published for annexins A2 (PDB accession numbers 2HYU, 2HYV and ) and A5 (PDB 
accession number 1G5N and ). The crystal structure of complexed annexin A5 revealed 
two binding sites, a calcium-mediated binding site residing on the convex side (HTS-1) 
and a calcium-independent site on the concave side (HTS-2) of the protein  (see figure 3-
6).  Apart  from involving  calcium ions  in  HTS binding,  the  HTS-1  site  has  another 
important determinant: a basic cluster residing near the calcium binding loops IAB and 
IDE of domain I including the residues Arg25, Lys29, Arg63 and Arg151. This site is 
mainly involved in binding heparin once the initial recognition and binding of heparin has 
occurred via the HTS-2 binding site at residues Arg207 and Arg208. A proposed third 
heparin  binding  motif  that  was  not  complexed  with  HTS  in  the  annexin  V crystal 
structure lies on the concave surface and includes Arg-285, Lys-286, Arg-289 and Lys-
290.
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Figure  -6: Crystal structure of annexin A5 in complex with two heparin tetrasaccharides (PDB 
accession number 1G5N). Annexin domains are coloured in blue, green, orange and red, calcium 
ions are shown as yellow spheres. The heparin tetrasaccharides are bound on opposite sides of 
the protein (HTS-1 and HTS-2). 
Subsequent  binding  of  annexin  A5  to  the  membrane  surface  would  release  the 
glycosaminoglycan from the HTS-1 site since its affinity for the phospholipid membrane 
is considerably higher . In this latter state, the protein is attached to the membrane surface 
via its convex site and the heparin is bound with the binding sites only on the concave 
side. 
In that study, Capila and coworkers also presented a model where the heparin chain is 
wrapped around the annexin molecule occupying both binding sites. While binding of the 
carbohydrate to the site on the concave surface of the protein most likely does not interfere 
with the essential annexin-membrane association, the site on the convex surface would be 
affected by membrane binding.
However,  in vitro studies showed that heparin binding cannot compete effectively with 
phospholipid membrane binding to annexin A5 . Therefore, heparin might be displaced 
from the binding site on the convex surface of annexin A5 by phospholipid molecules, e.g. 
when membrane binding occurs. In the soluble state, calcium binding contributes to the 
overall  affinity of the annexin A5-heparin interaction.  Thus,  the annexin A5 -heparin 
interaction is calcium-dependent in vitro, but is thought to carry less significance in vivo .
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In contrast, heparin binding to annexin A2 occurs only on one binding site on the convex 
side of  domain IV .  In  this  study,  three heparin oligosaccharides  (tetramer,  hexamer, 
octamer) were co-crystallised with annexin A2. All oligosaccharides were bound near the 
IV-AB and IV-DE loops  mainly involving the first  four  to  five  non-reduced heparin 
residues. Residues six to eight were not observed in the crystal structures indicating that 
only the first four residues from the non-reducing end are critical for heparin recognition 
and binding. Comparing their findings with results from the previously published study by 
Capila and coworkers , Shao and colleagues concluded that calcium-dependent heparin 
binding can arise from two mechanisms: calcium-dependent conformational changes in 
the protein that produce a favourable heparin-binding site (indirect mechanism), and/or a 
protein-calcium-heparin ternary complex formation (direct mechanism). Both mechanisms 
are  evident  in  the  annexin  A2-heparin  oligosaccharide  complexes  involving  different 
calcium ions on the protein surface . The crystal structure of annexin A5 in complex with 
Ca2+ and heparin tetrasaccharide  shows a calcium-dependent mode of oligosaccharide 
binding that is very similar to the indirect mechanism observed in annexin A2. In the 
annexin A5-heparin-tetrasaccharide complex, the oligosaccharide does not coordinate the 
protein-bound  calcium  ion  but  instead  binds  solely  to  protein  atoms  residing  in  a 
conformationally sensitive I-AB Ca2+-binding loop. The Ca2+-independent annexin A5-
oligosaccharide binary complex occurring on the concave surface of that protein is not 
observed in the annexin A2 crystal structures. Heparin-binding sites at this location may 
be precluded in annexin A2 as a consequence of A2t heterotetramer formation, which 
involves the concave side of the protein surface .
3.4 Parasite annexin B1 and its medicinal potential as a drug 
target
In  an  attempt  to  find  novel  antigens  for  vaccine  development  against  cysticercosis, 
annexin B1 from Cysticercus cellulosae had originally been identified by immunological 
screening of a C. cellulosae expression library . In this study, Cysticercus-infected serum 
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from both pigs and humans recognized annexin B1 indicating an extracellular location of 
this protein.
Cysticercosis, the common parasitic infection induced by a larval stage of Taenia solium, 
seriously affects human health manifesting itself mostly in causing inflammatory reactions 
in the central nervous system, muscles, subcutaneous tissue and the globe of the eye . 
Mature  tapeworms harm their  human hosts  by  stealing vital  nutrients  causing  severe 
malnutrition,  greater  intestinal  disturbance,  pain,  and  inflammatory  response  but 
symptoms are still generally mild and the pathology minor. Of great clinical importance is 
the larval  infection of  humans with  T. solium, cysticercosis.  Tapeworm eggs that  are 
ingested from human faeces develop into larvae that infest specific sites in the central 
nervous  system.  Here,  they  can  induce  epilepsy,  mental  disturbances,  meningeal 
syndrome, and can even cause death. Dead or dying parasites provoke an inflammatory 
response and seizures which lead to swelling of the respective areas. Human cysticercosis 
is a serious and widespread disease, being especially common in Latin America, Asia, 
Africa, the Phillipines and parts of Southern Europe . The disease is frequently found 
among Mexican agricultural workers in California and other Western states. Cysticercosis 
can  be  treated  requiring  chemotherapy  followed  by  surgery  for  ophthalmic  or  brain 
involvement whereas tissue infection can be treated with anti-inflammatory drugs. Side 
effects of the drugs such as dizziness, vomiting and temporary hair loss are common. New 
therapies could help to lower infection rates and side effects in humans and to reduce great 
economic losses in live stocks in developing countries. 
Annexin  B1 cDNA encodes  a  347 amino acid  long  protein  (GenBank accession  no. 
AF147955) with a molecular mass of 38kDa and a predicted pI of 5.6. Yan and colleagues 
also found that annexin B1 shows high affinity to thrombocytes and anticoagulant activity 
in  vivo.  Large amounts  of  non-fusion,  full-length protein was previously produced in 
Escherichia  coli in  a  soluble  form  and  purified  by  employing  either  ion-exchange 
chromatography  or a procedure on the basis of its PS-binding affinity . Application as a 
novel imaging agent , anticoagulant  and thrombolytic agent  have been suggested, and 
PS-binding properties of annexin B1 lead to the development of a radiopharmaceutical for 
Anja Winter                                                                                                                 page  140  
Structural Biology of Prohibitin and Annexin B1
apoptosis imaging in vivo . Western blot analysis revealed that annexin B1 existed in the 
cystic fluid of  T. solium cysticerci  and sera of pigs infected with cysticercosis. Using 
monoclonal  antibodies,  annexin B1 was also  detected in the surrounding host-derived 
layer with granulomatous infiltration, the distribution of annexin B1 being in accordance 
with the degree of inflammation. Those results imply that annexin B1 may be secreted at 
the host-parasite interface . 
Investigating specific  features of annexin B1 such as membrane-  and heparin-binding 
properties could lead to development of new therapies against infestation with the parasite 
tapeworm T. solium. Therefore, membrane- and heparin binding behaviour of annexin B1 
will  be  investigated  in  this  work.  Furthermore,  its  oligomerisation  behaviour  and 
molecular three-dimensional structure will be researched.
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4 Results and Discussion of Annexin B1
In this work, annexin B1 was overexpressed and purified using ion exchange and heparin 
affinity chromatography. The protein’s identity was verified by protein mass spectrometry 
finger  printing,  and  its  fold  and  stability  were  determined  using  CD  spectroscopy. 
Annexin B1 was investigated for its liposome- and heparin-binding properties employing 
biochemical assays. The oligomerisation state was examined by gel filtration analysis, 
fluorescence  spectroscopy and mass  spectrometry.  Annexin  B1 was  also subjected to 
crystallization trials. 
4.1 Protein expression and purification
The construct annexin B1(P346H)_pRSET_6c was transformed into competent bacterial 
cells  of  the  strain  BL21(DE3)  and  overexpressed  as  described  in  section  5.3.1.  The 
purification of annexin B1 was carried out in two steps; anion exchange chromatography 
followed by heparin affinity chromatography as a further purification step (see sections 
5.4.2 and 5.4.3).
Fractions from each purification step were analysed on SDS-PAGE. Figure 4-1 A shows 
fractions resulting from anion exchange chromatography. The protein is already visible as 
a band near the 36.5kDa marker in the sample lane (S) that was loaded onto the column. 
After loading, some annexin B1 was washed off the column (W), probably because the 
capacity of the column was exceeded. Annexin B1 was eluted from the anion exchange 
column in elution fractions corresponding to 120-300mM NaCl (lanes 6-10) where it is 
visible as a band near the 36.5kDa marker (lane 1). 
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Figure  -7:  Purification of  Annexin  B1 using anion exchange chromatography (A)  and heparin 
affinity chromatography (B). The protein appears near the 36.5kDa single maker (M). Lanes are 
labelled protein sample (S), flow through (FT) and wash (W). Numbered lanes represent elution 
fraction colleted from the respective column. 
The fractions containing annexin B1 from the anion exchange purification were pooled, 
dialysed against a buffer containing 20mM Tris, pH 9.0, 250mM NaCl and 5mM CaCl2, 
and subsequently applied to a heparin column. During heparin affinity purification, some 
protein was found in the flow through (F) and wash (W) fractions. Annexin B1 was eluted 
from the heparin column using a buffer containing 20mM Tris, pH 9.0, 250mM NaCl and 
10mM EDTA, and appeared as a single band around 36.5kDa (see figure 4-1 B, lanes 4 - 
10).
Annexin B1 was successfully  purified as an untagged protein employing the two-step-
purification procedure. This protocol yielded up to 10mg of protein per 1 litre bacterial 




The mass of the purified protein was determined using ESI-mass spectrometry. Sample 
preparation  and  experimentation  were  done  by  the  COIL  facility  (University  of 
Edinburgh) and as described in section 5.7.1.1. The mass spectrum showed a dominant 
single peak at 38241Da which was higher than the expected average molecular mass of 
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37998Da  which  may  result  from  matrix  adducts  or  salt  present  in  the  sample.  An 
experimental mass 243Da higher than the theoretical value lies within an acceptable range. 
The protein was also subjected to trypsin digest and subsequent analysis using a MALDI-
TOF mass spectrometer (see section 5.7.1.2.). The identity of full-length annexin B1 from 
T. solium was verified by mass spectrometry using the Mascot database  (see figure 4-2). 
Figure  -8:  Mass spectroscopy  analysis  of  trypsin  digested annexin  B1 proved identity  of  the 
protein. Residues in bold red represent peptides found within the database analysis. 
4.2.2 Circular dichroism
4.2.2.1 Fold determination  
Protein fold and stability were analysed using CD spectroscopy as described in section 
5.7.2.1. Spectra were recorded in the presence (solid line) and absence (dashed line) of 
5mM calcium showing similar progressions for both. CD spectra showed highly negative 
values from 240nm to 200nm with a change in sign from 200nm to 190nm (see figure 4-3) 
indicating a folded protein. Furthermore, the spectrum in figure 4-3 A, shows two minima 
at around 222nm and 208nm characteristic for the presence of -helices.
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Figure -9: Results from CD wavelength scans. A - CD spectra of AnxB1 in the absence (dashed 
line) and presence of 5mM calcium (solid line). B - Secondary structure prediction of the spectrum 
without calcium using implementations of the K2D neural network and a linear combination of 
Fasman spectra within the programme ACDP .
CD spectra recorded in the presence and absence of 5mM calcium both show similar 
progression.  Secondary  structure  prediction  using  the  tools  in  the  programme ACDP 
revealed -helices to be the dominant species with a ratio of 82.5% as determined using 
the K2D algorithm or 60% as determined using a linear combination of Fasman spectra 
(see figure 4-3 B). Both methods calculated a low amount of unordered structure, 16.3% 
with  the  K2D  algorithm  and  24%  with  the  linear  combination  of  Fasman  spectra 
application. Furthermore, 16% -sheet was predicted using the latter algorithm. However, 
it is known that all annexins investigated so far, possess a tight fold of exclusively  -
helices. It is therefore unlikely to find -sheets as a secondary structure element in annexin 
B1. Additionally, the K2D algorithm also presents the lower least squares error with 2.01 
x 108 compared to 5.68 x 108 for the linear combination of Fasman spectra. The K2D 
algorithm  fits  the  experimental  CD  spectrum  of  annexin  B1  better  than  the  linear 
combination of Fasman spectra.  
4.2.2.2 Thermal stability  
Thermal unfolding of annexin B1 was carried out by applying heat at a constant heating 
rate monitored by CD spectroscopy. The CD wavelength spectrum shows two minima at 
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208nm and 222nm which indicate the existence of  -helices. Denaturation experiments 
were monitored at  222nm providing the greatest  change in  the CD signal  during the 
denaturation (see section 5.7.2.2.). Denaturation experiments were also carried out in the 
presence of 1mM DTT and 5mM CaCl2. Endogenous levels of calcium are considered to 
be negligible as the last purification step involves usage of 10mM EDTA which would 
sufficiently  remove  all  calcium.  Three  independent  datasets  were  recorded  for  each 
experiment and fitted using a sigmoidal equation in the programme Sigma Plot (see figure 
4-4 A). 
Figure -10: Determining thermal stability of annexin B1 in presence of calcium or DTT. The protein 
unfolds in a two-state process (A) with a melting temperature depending on the added compound 
(B).
Denaturation studies indicate a heat-induced single transition unfolding process depending 
on the added compounds, DTT or CaCl2 (see figure 4-4 A). The DTT curve (black) as well 
as the CaCl2 curve (green) displays a steeper progression and a shift of the transition point 
towards  higher  temperatures  as  compared  to  that  of  the  untreated  sample  (red).  The 
corresponding  melting  temperatures  Tm were  therefore  different  for  each  set  of 
experiments (see figure 4-4 B). Without adding any compound, the melting temperature 
was determined to be 52ºC; adding DTT or CaCl2 resulted in melting temperatures of 56ºC 
and 58ºC, respectively.
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The results indicate that both DTT and CaCl2 have a stabilising effect on annexin B1 
which  is  indicated  by  a  shift  of  the  melting  temperature  towards  higher  values  as 
compared to untreated sample. 
4.2.3 Gel filtration analysis
The oligomerisation state of annexin B1 was investigated using gel filtration analysis. 
Calibration utilising globular proteins of known size was used to determine the size of the 
different species. Gel filtration runs were carried out as stated in section 5.7.4. Figure 4-5 
shows a gel filtration run of annexin B1 (solid line) overlaid with the calibration runs 
(dashed  line).  The  absorption  peaks  of  the  annexin  B1  run  were  fitted  using  the 
programme PeakFit  to determine the positions of the peak maxima. 
Figure  -11:  Gel filtration analysis of  AnxB1 at  a concentration of  5mg/ml.  Representative gel 
filtration run of annexin B1 (solid line) overlaid by calibration runs. The molecular masses of the 
calibrators are indicated accordingly.
The gel filtration run of annexin B1 in figure 4-5 was fitted with three peaks with maxima 
at 11.18ml (peak 1), 12.44ml (peak 2) and 13.88ml (peak 3), respectively. Peaks 2 and 3 
are clearly visible in the trace whereas the first peak is only visible as a preceding shoulder 
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of the second peak. As the protein was purified to a purity greater than 95%, proteins 
represented by the peaks are presumed to be oligomeric species of annexin B1. Kav values 
were calculated for all peaks (see table 4-1), which were converted into molecular masses 
using  the  equation  generated  from  the  calibration  curve  (see  section  5.7.4.1.). 
Furthermore,  a  proposed oligomer species was assigned to each peak.  The calculated 
molecular weight of peak 3 (37kDa) is in good agreement with the expected molecular 
weight of an annexin B1 monomer of 38kDa. Peak 2 could represent an annexin B1 dimer, 
and peak 1 a trimer.






1 11.18 0.192 92.0 Trimer
2 12.44 0.271 60.1 Dimer
3 13.88 0.362 37.0 Monomer
The highly pure annexin B1 sample is not homogeneous and contains monomers, dimers 
and trimers according to gel filtration analysis. Investigations on conditions for oligomer 
formation and the interacting residues were undertaken in further experiments which are 
described in section 4.3.
4.2.4 Conclusions: Biophysical experiments
The identity of annexin B1 was verified by full-length mass spectrometry and peptide 
mass finger printing.  The purified protein was subjected to CD experiments where its 
secondary structure and fold stability was investigated. The spectra show that annexin B1 
is folded and has a high -helical content. Thermal denaturation experiments revealed a 
one-step unfolding transition with a  transition temperature,  Tm,  of  52ºC.  In additional 
denaturation experiments adding 1mM DTT or of 5mM CaCl2 to the protein sample, a 
shift in Tm towards higher temperatures was observed indicating a stabilising effect on the 
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protein.  Using gel filtration,  the oligomerisation state of annexin B1 was investigated 
where it was determined to be a mixture of monomers, dimers and trimers in solution. In 
order to learn more about the oligomerisation behaviour of annexin B1, more gel filtration 
runs under different buffer conditions, fluorescence experiments and mass spectrometry 
analysis were carried out (see following section).
4.3 Investigation on dimer formation
4.3.1 Gel filtration analysis
Gel  filtration runs  of  annexin B1 were  carried out  to analyse dimer  formation under 
different conditions: 5mM and 15mM CaCl2, 20mM EDTA, 10mM DTT, 1mM DTT or 
0.8mM H2O2. The protein concentration in all gel filtration runs was kept at 1mg/ml. 5mM 
calcium and 20mM EDTA represent concentrations of the compounds used for purifying 
the protein.  Gel  filtration runs in the presence of 15mM calcium were carried out to 
investigate calcium-dependent oligomerisation of the protein as was previously observed 
with annexins 23(Ca38), 24(Ca32), Gh1 and Gh2 . 1m DTT and 0.8mM H2O2 represent 40 
times molar excess of compound over protein. 
Elution of the protein was monitored at 280nm measuring the absorption of the protein. 
Traces showed appearance of up to four peaks representing different oligomeric states of 
annexin B1. Assignment of peaks to monomers, dimers or trimers of annexin B1 was done 
by determining their apparent molecular masses using the molecular mass calibrators (see 
section 5.7.4). In all runs, the peaks representing the individual oligomeric state of the 
protein  appeared  at  around  the  same  elution  volume.  These  experiments  have  been 
repeated with samples from different protein batches to account for any artefact resulting 
from contamination or specificities within the batch. In order to assess how much of the 
protein was present in an oligomeric state, the areas under the peaks were determined 
using the programme PeakFit . The area under a peak is dependent on the concentration or 
amount of the protein eluting in this fraction, and the sum of all areas represents 100% of 
the protein subjected to the gel filtration experiment. Each area under a peak was then 
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calculated as share of the sum of all areas. Shares of monomer (black), dimer (middle 
grey), trimer (dark grey) and aggregates (light grey) on the total amount of protein are 
depicted in figure 4-6. 
Figure  -12: Oligomer formation of AnxB1 in presence of different compounds analysed by gel 
filtration. Shown are the species observed under different conditions: monomers (black), dimers 
(middle grey) and trimers (dark grey) as share of total protein amount in the sample. The protein 
was treated with 10mM DTT, 1mM DTT, 0.8mM H2O2, 5mM CaCl2, 15mM CaCl2 or 20mM EDTA 
prior to the experiment. In all experiments, peak centre and area under the peak differed by less 
than 1% for each species.
In two samples, 15mM CaCl2 and 20mM EDTA, a proportion of the protein eluted at 
molecular masses greater than 600kDa or in the void volume of the column and was 
therefore considered to be aggregated protein and excluded from further analysis.
Results from gel filtration experiments show that the formation of monomers, dimers and 
trimers can be influenced by treating the protein with different agents. In the untreated 
sample and samples treated with 10mMDTT, 1mM DTT, 0.8mMH2O2 and 5mM CaCl2, 
the protein was present as monomers, dimers and trimers. Interestingly, addition of 1mM 
DTT mainly promoted formation of monomers, and only 20% of dimers were observed in 
this sample. Treatment of annexin B1 with 0.8mM H2O2 caused a slight increase in trimer 
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content although all three species could be observed. This suggests that, in comparison 
with the untreated sample, the oxygen in the air is sufficient to oxidise the protein.
In the presence of 5mM CaCl2,  the monomer content  was slightly higher than in the 
untreated sample. Contrary to findings from plant annexins , annexin B1 did not show a 
suppressed oligomerisation but rather aggregation as seen in samples treated with 15mM 
CaCl2. On the other hand, deprivation of calcium ions by treatment of the protein with 
20mM EDTA also led to aggregation (see figure 4-6). 
The results from gel filtration runs suggest that dimer formation is partly dependent on the 
presence of calcium ions, although depletion of those ions leads to aggregation of the 
protein. The biggest shift in the monomer/dimer equilibrium could be observed by adding 
1mM DTT. Monomer formation was increased by incubating the protein with 1mM DTT 
which suggests a Redox dependency and the involvement of disulfide bonds in dimer 
formation. This hypothesis was further investigated by native gel analysis, fluorescence 
spectroscopy and mass spectroscopy in the following sections.
4.3.2 Native gel
A native gel was run as stated in section 5.5.4 to determine particle sizes present in the 
protein  sample.  Bands  on  the  gel  were  analysed  by  determining  their  Rf value  and 
assigning molecular masses using the molecular mass marker as reference. The gel shows 
multiple bands from different species (figure 4-7) and /or different charged states of the 
protein species. A comparison of an untreated sample (sample 2, lane 3) with those treated 
with different compounds, showed the appearance or disappearance of some bands. 
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Figure  -13: Native gel of annexin B1 under different conditions: 50 times molar excess of H2O2 
(sample 1), untreated sample (sample 2), 5 times molar excess of DTT (sample 3), 50 times molar 
excess of DTT (sample 4). Lane 1 shows the molecular weight marker.
This experiment was repeated several  times with different protein batches due to low 
resolution of the bands or the quality of the gel. Figure 4-7 is a representative native gel of 
annexin B1. The sample with 50 times molecular excess of DTT (sample 4) shows only 4 
bands, among them a very strong band at 42.0kDa, presumably the annexin B1 monomer. 
In comparison to the untreated sample (sample 2), bands at higher molecular mass have 
disappeared in the DTT treated sample. This effect was less pronounced in the sample 
with only 5 times molecular excess of DTT (sample 3). Here, a strong band at 42kDa is 
visible  suggesting  a  mainly  monomeric  protein.  Treating  the  protein  with  50  times 
molecular excess of H2O2 seems to preserve species distribution as compared with the 
untreated sample (sample 1). These findings are consistent with our previous results from 
gel filtration experiments (section 4.3.1). 
Results from gel filtration and native gel suggest that oligomer formation of annexin B1 is 
Redox  dependent.  Although  treatment  with  H2O2 does  not  significantly  change  the 
oligomeric  state  of  annexin  B1,  DTT  treated  protein  shows  a  higher  proportion  of 
monomeric species. It is likely that the oxygen present in the air is sufficient to fully 
oxidize the protein. To gain further insight into the oligomer formation of annexin B1, 
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experiments employing fluorescence spectroscopy and mass spectrometry were performed 
(see following sections).
4.3.3 Molecular modelling of Annexin B1
The crystal structure of annexin A8 (PDB accession number  1W3W) was chosen as a 
template for homology modelling of annexin B1 based on the highest amino acid sequence 
identity to annexin B1 (39.7%). Modelling was carried out as stated in section 5.9.2., and 
Ramachandran plots were generated to assess tensions in the protein main chain angles 
(see Appendix). 95.1% of amino acids were in most favoured regions and 3.9% were in 
additionally allowed regions indicating a good model of annexin B1.
The C-terminal core domain of annexin B1 is completely modelled whereas the first 23 N-
terminal  amino acids are not  present  due to the lack of an N-terminal  domain in the 
template used (see figure 4-8). 
Figure -14: Homology model of annexin B1 based on the crystal structure of annexin A8. Domains 
I to IV are indicated in blue, green, orange and red, respectively. The extended connector between 
domains II and III is coloured in wheat. The N-terminal region is not present in the model due to 
shortcomings in the template. Figure prepared with PyMOL .
This homology model of annexin B1 will be used to analyse and visualize results from 
fluorescence spectroscopy and mass spectrometry.
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4.3.4 Fluorescence spectroscopy
Annexin B1 possesses 9 phenylalanines, 13 tyrosines and one tryptophan which can be 
used for intrinsic fluorescence spectroscopy. Using the intrinsic fluorescence of proteins 
one can obtain information about the folded state of the protein and its change during 
unfolding. Fluorescence, especially of tryptophans and tyrosines, depends significantly on 
their environment, e.g. solvent, pH, and presence of a quencher, or a neighbouring group 
in the protein. Unfolding of a protein domain is thought to take place in one step whereas 
unfolding of a second domain in the protein or dissociation of a dimer might occur in two 
steps. Annexin B1 was subjected to fluorescence-monitored unfolding experiments with 
urea under different conditions in order to assess oligomer formation. In the presence of a 
dimer, two transition processes might be observed when unfolding the protein. 
4.3.4.1 Spectra of folded and unfolded protein  
Two excitation wavelengths  were used to monitor fluorescence:  280nm (experimental 
setup A, excitation of mainly tyrosines) and 295nm (experimental setup B, excitation of 
tryptophans only). Emission spectra were recorded from 300nm to 400nm (experimental 
setup A) and 310nm to 400nm (experimental  setup B),  respectively.  Examples of the 
fluorescence emission spectra of annexin B1 for the native (solid line) and denatured 
states (dashed line) in the presence of 1mM DTT are shown in figure 4-9. Here, the native 
protein has a greater intrinsic fluorescence than the denatured protein. After excitation at 
280nm, the emission maximum of the native state of mostly monomeric annexin B1 is 
343nm compared to 359nm for the unfolded state, indicating a wavelength shift of 16nm 
to  higher  wavelengths  during  unfolding.  This  behaviour  could  be  observed  in  all 
experiments regardless of the compound used or the excitation wavelength applied. A red 
shift in the emission wavelength with maximum fluorescence intensity,  MAX(emission), 
represents a characteristic feature of fluorescent amino acid residues being exposed to 
aqueous  (polar)  environment  suggesting  progressive  unfolding  of  the  annexin  with 
increasing concentration of denaturant .
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Figure  -15:  Fluorescence emission spectra for  native (solid line) and denatured (dashed line) 
states of annexin B1 at 23°C,  excitation at 280nm. Samples were treated with 1mM DTT to 
promote formation of monomers as seen in gel filtration experiments.
Different phenomena such as shift of MAX(emission) or change of fluorescence intensity 
dependent on the added compounds could be observed in the fluorescence experiments. 
TheMAX(emission) of the untreated sample is significantly higher compared to samples 
treated with DTT or CaCl2 regardless of the excitation wavelength (see table table 4-2). 
The averaged emission maximum for the untreated sample is 355nm and decreased to 
342nm in the presence of CaCl2. In contrast, all unfolded protein samples showed their 
emission maximum at either 359nm or 360nm (excitation of mainly tyrosines) and 355nm 
(excitation of mainly tryptophans). Thus, the difference in fluorescence intensity between 
the folded and unfolded state is greater in DTT- or calcium-treated samples. This also 
indicates that the fluorescence-emitting residues present in the protein experience a greater 
change in their environment when treated with DTT or CaCl2 than in the untreated sample. 
Treatment of the protein with DTT or CaCl2 might have led to conformational changes 
which caused a burial of the fluorophores in an apolar environment, e.g. within the protein 
or  between  two  protein  molecules.  Fluorophores  in  an  apolar  environment  show 
fluorescence at lower wavelengths.
Table -2: Fluorescence emission maxima obtained in experimental setups A and B.
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Untreated 1mM DTT 5mM CaCl2
Excitation at 280nm 295nm 280nm 295nm 280nm 295nm
MAX(Folded) [nm] 355 350 343 346 342 347
X(Unfolded) [nm] 360 355 359 355 359 355
Interestingly, the fluorescence intensity at  MAX(emission) decreased or increased upon 
unfolding of  the protein sample in different  fluorescence experiments (see table  4-3). 
Compared to untreated annexin B1 and treatment with 5mM CaCl2, fluorescence intensity 
decreased upon treatment with DTT both when excitation occurred at 280nm and 295nm. 
Table -3: Fluorescence intensity at emission maxima in experimental setups A and B.
Untreated 1mM DTT 5mM CaCl2
Excitation at 280nm 295nm 280nm 295nm 280nm 295nm
IMAX(Folded) [cpm] 86066 44385 174835 89251 107421 49882
IMAX(Unfolded) [cpm] 120939 62552 126473 61740 114335 59515
A decrease in fluorescence intensity can be explained by the fluorophors becoming fully 
exposed to the solvent. Here, the contact of fluorophores with polar solvent molecules 
causes  a decrease in the energy of  the excited fluorophor,  and the emission intensity 
decreases. An increase in fluorescence intensity at MAX upon unfolding, as observed with 
the  untreated  sample  and  the  sample  treated  with  5mM CaCl2,  might  be  caused  by 
neutralisation of quenching effects upon unfolding of the protein. The quencher has to be 
near  the  fluorophor  and  could  either  come from residues  within the  protein  or  from 
another protein molecule in close proximity (ie. oligomerisation). Notably, fluorescence 
intensities of DTT-treated samples were higher than those of untreated or calcium-treated 
sample.
4.3.4.2 Denaturation curves  
Denaturation curves were generated by monitoring the change of fluorescence intensity, I, 
at two wave lengths, MAXof the folded protein (Ifolded) and of the protein in the unfolded 
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state (Iunfolded). In order to increase the signal-to-noise ratio and to account for wavelength 
shifts of the wavelength maxima, denaturation curves were plotted as Ifolded/Iunfolded (see 
figure 4-10). Data for experimental setups A and B were analysed separately, and fitted in 
the  programme  SigmaPlot   using  a  sigmoidal  curve  determining  the  half  maximal 
denaturant concentration, c1/2(urea), for each sample. Results show that the denaturation of 
annexin B1 is different for samples treatment with 1mM DTT or 5mM CaCl2 as compared 
to the untreated sample in both experimental set ups.
In  the  experimental  setup  A  (excitation  of  mainly  tyrosines),  denaturation  curves  of 
protein samples treated with 1mM DTT or 5mM CaCl2 show a sigmoidal progression with 
a  large change in  Ifolded/Iunfolded (see figure 4-10 A).  The sigmoidal  shape is  much less 
pronounced in the untreated sample where data show a nearly linear progression with 
negligible change in value between 0M urea and 8M urea.  Interestingly,  in 8M urea, 
Ifolded/Iunfolded is nearly equal for all samples. c1/2(urea) decreased from 4.2M to 3.4M upon 
treatment of the protein with 1mM DTT, and to 3.7M under 5mM CaCl2 (see figure 4-10 
B).
Figure  -16:  Experiment  A:  Chemical  denaturation  of  annexin  B1  using  urea  monitored  by 
fluorescence, excitation at 280nm. A – Denaturation curves of untreated protein (red) and samples 
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treated with  1mM DTT (black) or  5mM CaCl2 (green).  B  –  Table  showing the  half  maximal 
denaturant concentrations c1/2(urea) for each compound.
Denaturation  curves  recorded  with  an  excitation  wavelength  of  295nm (experimental 
setup B) are shown in figure 4-11 A. All curves were fitted with a sigmoidal function. The 
change of Ifolded/ Iunfolded in this set of experiments is not as pronounced as in the previous 
data  sets.  Fluorescence  intensities  measured  with  excitation  at  295nm were  generally 
lower than those recorded with excitation at 280nm which might be due to the fact that 
only one fluorophor was excited. In samples treated with 1mM DTT or 5mM CaCl2, the 
half  maximal  denaturant  concentrations  were  determined  to  be  3.3M  and  3.7M, 
respectively (see figure 4-11 B). In contrast, D1/2 for untreated annexin B1 was determined 
to be 2.8M. 
Figure  -17:  Experiment  B:  Chemical  denaturation  of  annexin  B1  using  urea  monitored  by 
fluorescence, excitation wavelength 295nm. A – Denaturation curves of untreated protein (red) 
and samples treated with 1mM DTT (black) or 5mM CaCl2 (green). B – Table showing the half 
maximal denaturant concentrations c1/2(urea) for each reagent.
Comparison of c1/2(urea) values determined in experimental setup A with values obtained 
in experimental setup B yields a great difference. c1/2(urea) values for samples treated with 
1mM DTT or 5mM CaCl2 are within the same range in both experimental setups whereas 
c1/2(urea) values for untreated sample are significantly different. In experimental setup A 
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(excitation at  280nm),  c1/2(urea)  is  4.19M,  and in  experimental  setup B (excitation at 
295nm) c1/2(urea) was determined with 2.84M.
Relating to gel filtration experiments previously performed, the untreated sample consists 
of 35% monomers, 43% dimers and 22% trimers as determined by gel filtration. In the 
untreated samples, the difference between c1/2(urea) determined from experiment A and 
experiment  B  suggests  that  tyrosines  and  Trp102  experience  the  unfolding  process 
differently.  Trp102  reports  its  exposure  to  a  polar  environment  at  a  lower  urea 
concentration than tyrosines. In comparison, the sample treated with 1mM DTT consists 
of 80% monomers and 20% dimers. Therefore, changes in fluorescence upon unfolding 
observed  in  this  sample  can  be  related  to  an  unfolding  of  an  annexin B1 monomer. 
c1/2(urea)  values  are  similar  in  both  experimental  setups  indicating  an  environmental 
change at the same urea concentration for both, tyrosines and Trp102. Here, Trp102 is as 
susceptive to changes in its environment as are the tyrosines present in the protein. Similar 
observations  were  made when the  protein  was  treated  with  5mM CaCl2 indicating  a 
similar exposure of Trp102 and tyrosines to the environment as compared to the DTT-
treated sample. Interestingly, the oligomer distribution in the calcium-treated sample is 
comparable to that of the untreated sample. 
4.3.4.3 Conclusions  
Three main phenomena were observed upon chemical unfolding of annexin B1: (i) shift of 
emission maxima to higher wavelength when exciting the protein both at  280nm and 
295nm, (ii) decrease of fluorescence intensity during unfolding for samples treated with 
1mM DTT but  increase  of  fluorescence  intensity  for  untreated  samples  and  samples 
treated with 5mM CaCl2 in both experimental setups and (iii) similar c1/2(urea) values for 
samples treated with 1mM DTT and 5mM CaCl2 in both experimental setups but a lower 
c1/2(urea) value in experiment B for the untreated sample.
A shift of emission maxima to higher wavelengths can be explained by a change from an 
apolar to a polar environment experienced by the fluorophors. Tyrosines as well as Trp102 
experienced the same change in environment indicating unfolding of the protein upon 
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treatment  with urea.  While  a  decrease in  fluorescence intensity  upon unfolding is  an 
indicator  of  unfolding,  an increase in fluorescence intensity as  seen for  the untreated 
sample and sample treated with 5mM CaCl2  indicates that the fluorophores are released 
from  a  quencher.  The  quencher  could  be  a  residue  within  the  molecule  or  from  a 
neighbouring molecule in the case of oligomer formation.  However, both,  the shift in 
wavelength and change in fluorescence intensity, suggest that annexin B1 was unfolded by 
subjecting the protein to increasing urea concentrations.
c1/2(urea) value determined from denaturation curves for the untreated protein are lower 
when  monitored  by  fluorescence  emission  of  Trp102  than  when  monitored  by 
fluorescence emission of mainly tyrosines. Inspecting the homology model of annexin B1, 
Trp102 can be found on the concave side of the protein but slightly inserted into the core 
domain.  It  is  located  between domains  I/IV and II/III  (see  figure  4-12),  which  have 
previously been described as modules of an annexin monomer . 
Figure -18: Top view of modelled annexin B1. Domains I to IV are indicated in blue, green, orange 
and red, respectively. Trp102 is drawn explicitly and coloured by its elements. Figure prepared 
with PyMOL .
Intra-modular  contacts  are  tight  and  mediated  by  hydrophobic  interactions  whereas 
interactions between the two modules are less tight and mostly provided by polar charged 
residues therefore forming a unique channel across the protein. In a chemical unfolding 
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experiment, urea is thought to interact directly with the protein showing shorter residence 
times around nonpolar residues as compared to polar residues . Therefore, the less tight 
polar interactions between the two modules would disrupt at a lower urea concentration 
than the tighter hydrophobic interaction within the modules. As Trp102 is located between 
domains I/IV and II/III, it would report unfolding at lower urea concentrations than other 
residues elsewhere in the protein. Therefore, Trp102 is likely to monitor the disruption of 
salt bridges between domains I/IV and domains II/III at the first stages of unfolding. 
Samples  treated  with 5mM CaCl2 or  1mM DTT show a  similar  progression  of  their 
unfolding curves in both experiments, and c1/2(urea) values were determined to be in the 
same range. This is in contrast to c1/2(urea) values obtained for the untreated sample, and 
does not seem to be related to the oligomeric state of the protein. The untreated sample 
and the calcium-treated sample both show a similar distribution of oligomers whereas 
mostly monomers are found upon treatment with DTT. Comparing denaturation curves 
from DTT-treated samples and untreated samples, no additional transition stages could be 
observed in the untreated sample that would reflect the dissociation of a protein oligomer. 
It must therefore be concluded that either dissociation of an oligomeric species coincides 
with unfolding of the annexin B1 monomer or that fluorescence spectroscopy is not a 
suitable method for analysing oligomer formation of annexinB1.
A similar behaviour of DTT- and calcium-treated sample in fluorescence experiments 
could be due to a  possible conformational change within the protein upon compound 
binding. It is known that annexins undergo conformational changes upon calcium binding 
that could affect the C-terminal or the N-terminal domain as seen with annexin A1 . A 
stabilisation  of  calcium-bound  annexins  against  thermal  denaturation  had  also  been 
observed . Crystal structures of the apo- and calcium bound form of annexin B1 could 
shed  light  on  a  possible  conformational  change upon calcium binding,  and  deliver  a 
possible explanation for the fluorescence data obtained with the calcium-treated sample. 
4.3.5 Mass spectrometry
Gel filtration experiments strongly suggested that oligomer formation in annexin B1 is 
Redox dependent. SDS-PAGE analysis of elution fractions from gel filtration experiments 
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confirms annexin B1 as the only protein present (data not shown). In an attempt to map 
the interaction sites on the protein that are responsible for oligomer formation, annexin B1 
was subjected to cross-linking experiments. Different cross-linkers were used to cross-link 
annexin B1 but  no distinct  bands were  visible  on SDS-PAGE that  would have  been 
suitable  for  trypsin  digest  and  mass  spectrometry.  Therefore,  the  naturally  occurring 
linkages  of  two  annexin  B1  molecules  via  disulfide  bonds  were  used  to  investigate 
possible interaction sites involved in oligomer formation. Comparison of peptide mass 
fingerprinting  results  from different  oligomeric  species  was  used  to  identify  cysteine 
residues involved in oligomer formation.
The  different  oligomer  species  were  separated  by  denaturing  but  non-reducing  gel 
electrophoresis, which  denatured the protein sample and applied a negative charge but 
would preserve any possible disulfide bonds between annexin B1 monomers. The samples 
were mixed with loading dye lacking DTT but included SDS and heated to denature but 
not reduce the sample. Present disulfide bonds will still be intact, and their presence or 
absence can be traced back to treatment with different compounds. The resulting SDS-
PAGE shows protein bands with varying intensity in each lane (see figure 4-13), where 
the migration of the respective species is now only dependent on size. Annexin B1 was 
treated with 20mM EDTA (sample 1), 15mM CaCl2 (sample 2), 5mM CaCl2 (sample 3) 
and  1mM DTT (sample  4)  and  subjected  to  electrophoresis  (see  section  5.5.3.).  The 
molecular masses of the protein bands were estimated using their Rf values and marker 
proteins (lane 1). 
The gel  shows bands of  similar  molecular  weight  in each lane indicating monomeric 
(34.7kDa), dimeric (64.3kDa) and trimeric (88.5kDa) annexin B1. Formation of tetramers 
and higher species could be observed in some samples. Bands were cut out and labelled 
according to the number of the lane: 1 (20mM EDTA), 2 (15mM CaCl2), 3 (5mM CaCl2), 
4  (1mM DTT),  and  5  (untreated  sample).  For  each  lane,  the  band  at  the  respective 
monomer  size  was  labelled  with  “a”,  the  band  supposedly  representing  dimer  was 
designated “b”, trimers “c” and tetramers “d” (see figure 4-13).
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Figure -19: Annexin B1 run under different conditions on a denaturing, non-reducing SDS-PAGE. 
Lane 1 is broad range marker. Samples treated with 20mM EDTA (sample 1, lane 2), 15mM CaCl2 
(sample 2, lane 3), 5mM CaCl2 (sample 3, lane 4) and 1mM DTT (sample 4, lane5) are run along 
with untreated sample (sample 5, lane 6). Examples for bands that were cut out are indicated on 
the gel.
In order to verify the identity of the proteins of each band, an in-gel trypsin digest was 
performed (see section 5.7.1.2) with samples incubated with 20mM EDTA and 15mM 
CaCl2, and the resulting peptide mixtures were subjected to mass spectrometry (peptide 
mass fingerprinting). The results for each sample are summarised in table 4-4 stating the 
probability  based  Mowse  score  with  which  annexin  B1  was  identified  including  the 
sequence coverage. The oligomeric species are also indicated, as well as the compounds 
with which the samples were treated.
Sequence coverages from all peptide mass fingerprint experiments were greater than 67% 
verifying annexin B1 from Taenia solium as the protein represented by the protein bands. 
As SDS-PAGEs and full-length mass spectrometry showed annexin B1 to be of high 
purity,  it  is  concluded  that  the  protein  bands  visible  on  the  gel  were  due  to  homo-
oligomerisation.  This  also  supports  the  hypothesis  of  an  oligomer  formation  through 
disulfide bonds.
Table -4: Mass spectrometry results from in-gel digest.
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1d 236 67 Tetramer
1c 238 71 Trimer
1b 225 71 Dimer
15mM 
CaCl2
2d 256 69 Tetramer
2c 219 63 Trimer
2b 256 72 Dimer
5mM 
CaCl2
3d 119 57 Tetramer
3c 85 40 Trimer
3b 95 45 Dimer
1mM DTT 4a 102 54 Monomer
Annexin B1 possesses 4 cysteins in positions 4, 130, 210 and 340 which are indicated in 
figure 4-14. Cysteine-containing peptides that can theoretically be obtained from trypsin 
digest are underlined, and the respective cysteine is indicated in bold red.
10         20         30         40         50         60 
AYCRSLVHLY APNGEKYKPT ITPTPGFSPT ADAEHLKRAM RGLGTNERAI IDILGNRTSA
70         80         90        100        110        120 
ERMAIRDAYP SISSKTLHDA LTSELSGKFR RFALLLIQSP WQVMAEALYD AMKGAGTKER
130        140        150        160        170        180 
VLNEIIAGCS KDDIPQLKKA FEEVSGGETL DDAIKGDTSG DYREALLLAL AGQADEPQAM
190        200        210        220        230        240 
QLKNLTPSTL SQVVNPGLAE TDAKELYACG EGRPGTAESR FMRPIVNRSF LQLNATNEAY
250        260        270        280        290        300 
NRAYGHPLID AIKKETSRDL EDFLITRVRY ATDRASLFAE LPHFAMRGAG TKDSTLQRVL
310        320        330        340 
ALRADTDLGS IKEKYAELYG ETLEAAIKGD TSGDYEALCL KLIGPA 
Figure  -20:  Trysin digest of annexin B1. Cysteine containing peptide fragments resulting from 
trypsin digest are underlined, and the respective cysteine is shown as bold red letter.
In order to preserve disulfide bonds for mapping of cysteins involved in oligomerisation, 
the protocol for peptide mass finger printing was altered slightly. The step involving IAA 
and DTT in the sample preparation was omitted which reduced the score in the finger 
printing slightly (see table 4-4). Annexin B1 treated with 5mM CaCl2 (samples 3b, 3c, 3d) 
and 1mM DTT (sample 4a)  were cut  out  from the  gel.  For  analysis,  peptide masses 
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identified by mass spectrometry of samples treated with 5mM CaCl2 (comprising dimers, 
trimers and tetramers) were compared to peptide masses identified in the sample treated 
with 1mM DTT (mostly monomers). 
After mass spectrometry, a peptide list containing all fragments present in the respective 
samples was obtained.  If  two cysteine-containing fragments are linked via a  disulfide 
bond, their respective individual peptide masses should not be present in the peptide list 
but a number that is the sum of the two individual peptide masses (also subtracting masses 
for 2 protons). The molecular mass of each cysteine-containing peptide was combined 
with the molecular mass of another cysteine-containing peptide, and 10 possible peptide 
masses were determined. Each peptide list obtained from mass spectrometry of samples 3b 
(dimer), 3c (trimer), 3c (tetramer) and 4a (monomer) was analysed for presence of those 
peptides. Table 4-5 summarises results from mass spectrometry experiments stating the 
disulfide-bonded peptides (column 1) with their expected molecular masses (column 2). 
Their presence or absence in the mass spectrum of an annexin B1 sample is indicated by 
(+) or (-). A peptide fragment was considered as present when the peptide mass that was 
determined in  the  experiment  was  within  1  Dalton of  the  theoretical  value  (personal 
communication with A. Cronshaw). 
Since annexin B1 possesses four cysteines,  the possibility of intra-molecular disulfide 
formation  cannot  be  out  ruled when those residues  are  close in  space  to  each other. 
Therefore,  disulfide-bond  containing  peptide  fragments  that  were  identified  in  mass 
spectrometry could belong to either intra- or inter-molecular disulfide bonds. To address 
this  problem,  the  previously  generated  molecular  model  of  annexin  B1  was  used  to 
visualise the positions of all cysteines in the protein.





Sample 3d Sample 3c Sample 3b Sample 4a
tetramer trimer dimer monomer
AYCR + AYCR 1022.4 + + – –
AYCR + VLNEIIAGCSK 1656.8 + + + +
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AYCR + 
GDTSGDYEALCLK
1881.8 + + + +
AYCR + 
ELYACGEGRPGTAESR
2206 + + + –
VLNEIIAGCSK + 
VLNEIIAGCSK
2291.2 – – – –
VLNEIIAGCSK + 
GDTSGDYEALCLK
2516.2 + + + +
VLNEIIAGCSK + 
ELYACGEGRPGTAESR
2840.4 + + – +
GDTSGDYEALCLK + 
GDTSGDYEALCLK
2741.2 + + – –
GDTSGDYEALCLK + 
ELYACGEGRPGTAESR
3065.4 + + + +
ELYACGEGRPGTAESR + 
ELYACGEGRPGTAESR
3389.6 – – – –
Figure 4-15 shows a cartoon of the annexin B1 model (green) with cysteine-containing 
fragments highlighted in light pink and cysteine residues drawn explicitly as red sticks. 
The 23 N-terminal amino acids including Cys4 are not present in the model due to an 
absence in the template but are indicated by a green dashed line. Cys 4 is indicated as a 
red dash to indicate its proposed position in the model. Cysteines in domains II, III and IV 
are all surface exposed, Cys130 points towards the concave side of the protein whereas 
Cys210 and Cys340 point towards the side. 
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Figure -21: Annexin B1(24-347) modeled on annexin A8. Cysteines are shown as red sticks, and 
the corresponding peptides identified in mass spectrometry are highlighted in wheat and labelled 
accordingly. The N-terminus in this model is missing due to its absence in the template but is 
indicated as a dashed green line. Figure prepared with PyMOL 
In the homology model, Cys130 (domain II) lies on the concave side of the protein. The 
N-terminus of the protein could align to the concave side of the protein and shield Cys130 
form formation of inter-molecular disulfide bridges. Considering a very flexible 26 amino 
acid long N-terminus of annexin B1 and a relative closeness in space between cysteines 4 
and 130, one could also speculate that both residues engage in an intra-molecular disulfide 
bridge. This hypothesis is supported by mass spectrometry data where the corresponding 
fragment,  AYCR  +  VLNEIIAGCSK,  was observed in  sample 4a (monomer).  In  contrast, 
fragments  AYCR  +  AYCR,  AYCR  +  ELYACGEGRPGTAESR and GDTSGDYEALCLK  + 
GDTSGDYEALCLK, involving Cys4, Cys210 and Cys340,  are likely to result from inter-
molecular disulfide bridges since peptide masses of those fragments were not identified in 
mass spectrometric analysis of sample 4a (monomer). 
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Summarising  the  results  from mass  spectrometry  experiments  and  findings  from the 
homology  model,  two  main  conclusions  can  be  drawn:  (i)  Cys210  (domain  III)  and 
Cys340 (domain IV) are likely to be surface exposed and could take part in formation of 
Redox dependent oligomers. (ii) Cys4 or Cys130 are potentially involved in formation of 
intra- and inter-molecular disulfide bridges (see table 4-6). 
Table -6: Involvement of cysteines in formation of intra- and inter-molecular disulfide bridges.
cysteine domain
formation of disulfide bridge
intra-molecular inter-molecular
Cys4 I potentially with Cys130 potentially
Cys130 II potentially with Cys4 not likely
Cys210 III not likely likely
Cys340 IV not likely likely
True involvement of these four cysteines in oligomer formation can only be assessed by 
mutational  studies  which will  be considered for  further  work on that  topic.  The best 
candidates  for  those  studies  would  be  Cys210  and  Cys340  of  domains  III  and  IV, 
respectively. Mutations of these residues to serines, for example, might impair oligomer 
formation.
4.3.6 Conclusions: Investigations on dimer formation
Gel filtration data and native gels showed that annexin B1 was present as a mixture of 
oligomers of different sizes in solution ranging from monomers to tetramers. Treating the 
protein with different  compounds  revealed that  oligomer  formation  of  annexin  B1 is 
Redox-dependent.  Using a  non-reducing but  denaturing SDS-PAGE and peptide mass 
fingerprinting, all species in a protein sample could be identified as annexin B1 indicating 
disulfide-dependent homo-oligomerisation. Although the presence of disulphide bonds in 
the in the protein in its intracellular form is highly unlikely, cell-surface exposed protein 
may form disulphide-dependent oligomers as part of its mechanism to interact with host 
cell surface molecules. 
Anja Winter                                                                                                                 page  168  
Structural Biology of Prohibitin and Annexin B1
The protein possesses four cysteine residues that could be involved in oligomer formation, 
one in each domain. Comparison of peptide mass fingerprinting experiments in concert 
with findings from molecular modelling revealed Cys210 and Cys340 of domains III and 
IV likely to be involved in the formation of inter-molecular disulfide bonds suggesting a 
side-to-side oligomer of annexin B1. Cys130 lies on the concave side of the protein and is 
not likely to be involved in homo-oligomerisation but rather in the formation of an intra-
molecular disulfide bond with the N-terminal Cys4. Disulfide bonding of the N-terminal 
Cys4 and Cys130 might have implications for the protein’s function as the flexible N-
terminus would be locked into the core domain. 
Denaturation experiments were monitored by fluorescence and carried out with untreated 
sample and samples treated with 1mM DTT and 5mM CaCl2.  DTT was added to the 
sample to promote presence of monomers, whereas addition of 5mM CaCl2 was used to 
study the influence of calcium on the stability of the protein and its unfolding process. All 
samples report unfolding in one step despite their presence in multiple oligomeric states. 
The  mostly  monomeric  DTT-treated  sample  reports  c1/2(urea) values  for  excitation  at 
280nm excitation at  295nm (Trp102)  to  be in  the same range.  This is  in  contrast  to 
findings with the untreated sample consisting of monomers, dimers and trimers where 
tyrosines  report  unfolding  at  a  higher  urea  concentration  than  Trp102.  Homology 
modelling shows that Trp102 resides in the cleft formed by domain I/IV and II/III. Upon 
treatment with low urea concentrations, weak polar interactions between the modules are 
distorted  causing  exposure  of  this  residue  to  the  environment.  At  higher  urea 
concentrations, the mostly hydrophobic interactions within the modules are disrupted, and 
the protein unfolds which is reported by tyrosine residues.  Results suggest  that,  upon 
unfolding, fluorescence spectroscopy is likely to monitor processes within the monomer 
rather than dissociation of protein oligomers.
The homology model also suggests that Trp102 is located towards the concave side of the 
protein (see figure 4-15), in close proximity to Cys130. In a scenario where the N-terminal 
domain nestles to the core domain and forms a disulfide bridge with Cys130, Trp102 
might experience quenching by residues in close proximity such as Tyr3, Tyr 11 or Tyr18 
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of the N-terminal region. Upon treatment with urea, the N-terminal domain might loose its 
structure releasing Trp102. This change in environment might also contribute to results 
from  fluorescence  spectroscopy  where  fluorescence  intensities  of  DTT-treated  native 
protein  were  generally  higher  than  those  of  the  untreated  or  calcium-treated  sample. 
Validation of a close proximity, and thus possible quenching, could be achieved when 
examining a crystal structure of the protein.
4.4 Biochemical characterization
4.4.1 Liposome binding behaviour
The calcium-dependent membrane binding of annexin B1 was investigated employing an 
assay developed by A. Hofmann and R. Huber . The experiments were carried out using 
large  unilamellar  vesicles  (LUVs)  with two different  PS:PC ratios,  1:3  and  3:1.  The 
amount of protein that had bound to the membrane in a calcium dependent manner was 
determined densitometrically and expressed as a degree of binding.
Annexin B1 displays calcium-dependent binding behaviour to PS/PC (1:3) vesicles to a 
moderate extent with a maximum binding of 30% in 10mM calcium (figure 4-17 A, closed 
circles). In contrast, the binding is more enhanced with more acidic PS/PC (3:1) vesicles 
where  the  maximum binding degree  in  10mM calcium is  90% (figure  4-16  A,  open 
circles). Here, binding of annexin B1 to PS/PC (3:1) vesicles reaches a maximum in 3mM 
CaCl2. The half-maximum calcium concentration, c1/2, of 0.1mM is at the lower end of the 
range observed with several plant annexins . The results are summarised in table format in 
figure 4-16 B stating c1/2 and degree of binding in 0mM and 10mM calcium. 
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Figure -22: Results from annexin B1 liposome binding assays. A - Calcium-dependent binding of 
the protein to PS/PC vesicles of the molar ratios 1:3 (closed circles) and 3:1 (open circles) is 
shown  as  degree  of  binding.  B  –  Table  showing  c1/2 and  degree  of  binding  at  a  calcium 
concentration of 0mM and 10mM.
More  interestingly,  annexin  B1  exhibits  calcium-independent  binding  with  a  binding 
degree of about 50% for PS/PC (3:1) liposomes. This behaviour is akin to that seen with 
bell  pepper  and  cotton  annexins,  although  the  latter  proteins  have  a  less  stringent 
requirement for PS in this context . One can therefore speculate that annexin B1 employs a 
similar mechanism whereby exposed residues on the convex surface engage in direct 
interactions with the membrane . 
4.4.2 Heparin binding behaviour
While experimenting with the purification procedure, annexin B1 was discovered to bind 
to heparin in the presence of calcium. In order to investigate the binding behaviour in 
more detail, a heparin binding assay was developed using heparin residues on a Heparin 
Sepharose resin (Amersham Biosciences). This assay is designed in the same way as the 
liposome binding assay used in section 4.3.2. Reversible heparin binding was assessed by 
first binding the protein to the resin, washing, and subsequent release of the protein by 
applying EDTA. The supernatant of the EDTA washes were run on an SDS-PAGE and the 
binding behaviour was evaluated using densitometric analysis. Calcium-dependent heparin 
binding was investigated with both annexin B1 (figure 4-17 A) and annexin A1 (figure 4-
18 B). From previous studies it is known that annexin A1 binds to heparin in a calcium-
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dependent manner , therefore it was used as a control in the assay. No protein was found 
to bind to the heparin resin in the absence of calcium implying a truly calcium-dependent 
process.  Both  proteins  show  reversible  (closed  circles  or  triangles)  and  irreversible 
binding (open circles or triangles) to heparin.
Figure -23: Reversible (closed signs) and irreversible (open signs) binding of annexins B1 and A1 
to heparin.
For the reversible binding, annexin B1 data suggest a cooperative binding behaviour with 
respect  to  calcium concentration that  can be  fitted with a  Hill  equation using  a  Hill 
coefficient of n=3. For comparison, annexin A1 displays a binding behaviour with less 
cooperativity (n=1.7; figure 4-19 B). Comparing the binding curves of the two proteins, it 
can be ruled out that the lag phase observed with annexin B1 is due to an artefact within 
the assay. 
Both annexin B1 and annexin A1 show calcium dependent binding to heparin with 70% 
maximum binding degree. The heparin sepharose resin pellet after the EDTA wash step 
was analysed and some protein could be detected.  The amount  of  irreversibly bound 
protein increases with higher calcium concentrations and reaches between 10% and 20% 
in 10mM calcium for both annexins (see open circles and triangles in figures 4-17 A and 
B). Results from a precipitation assay show that only insignificant amounts of annexin B1 
precipitate in the range between 0mM to 10mM calcium. A possible explanation for this 
calcium-independent  heparin  binding  could  be  a  mechanism  where  the  protein  is 
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dependent on calcium ions to form initial interactions with heparin. Once bound, a fraction 
of the protein might undergo a shift in the binding mode which “irreversibly” attaches it to 
the glycosaminoglycan. 
4.4.3 Conclusions: Biochemical assays
Annexin B1 binds  both  to  phospholipid vesicles  and heparin in  a  calcium-dependent 
manner. Moderate binding of annexin B1 can be observed when binding to PS/PC vesicles 
in a molar ratio of 1:3, but the binding is enhanced with vesicles with a higher PS content. 
Interestingly, annexin B1 also displays calcium independent binding to the latter vesicles 
with a half-maximal calcium concentration of 0.1mM. Annexin B1 also binds to PS-rich 
vesicles in the absence of calcium, a behaviour that had previously been observed with 
several plant annexins . Here, basic residues on the protein surface such as Trp35, Trp107 
and Lys190 (annexin 24(Ca32) numbering)  are involved in binding acidic phosphatidyl-
serine-rich phospholipid vesicles. This mechanism might also be responsible for calcium-
independent membrane binding of annexin B1. 
Results from heparin binding assays show that annexin B1 possesses lectin properties. The 
protein  binds  to  glycosaminoglycan  in  a  calcium-dependent  manner  and  displays 
cooperativity with respect to calcium. This feature might be traced back to the number of 
functional calcium binding sites in the protein as fitting the binding curve with a Hill 
equation revealed a Hill coefficient of n=3. 
For annexin A5, a model of heparin binding has been put forward where recognition and 
binding of  heparin occurs via  two binding sites (HTS).  One could envision a  similar 
mechanism with annexin B1, where the calcium-dependent binding step occurs through 
the calcium binding sites on the convex side. Assuming the presence of further heparin 
binding  sites  elsewhere  on  the  protein surface,  annexin B1 can  remain bound to  the 
glycosaminoglycan even in the absence of calcium ions. In this context, the amino acid 
sequence alignment of annexins A5 and B1 reveals that only the HTS-1 site of annexin A5 
(Arg25,  Lys29)  is  conserved  in  annexin  B1  by  Lys38,  Arg42,  which  could  mediate 
heparin binding via calcium ions. The binding sites on the concave surface (HTS-2) are 
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not observed with annexin B1, although a K-E-K motif is present instead of the R-K-X-X-
R-K motif of HTS-3 (see table 4-7). 
Table -7: Heparin binding sites observed in annexin A5 and predicted for annexin B1.
AnxA5 AnxB1 prediction
HTS-1 basic cluster: Arg-25, Lys-29, Arg-63, 
(Arg-151)
Lys-38, Arg-42, Lys-76 functional
HTS-2
charged N-terminus and Arg-206, Lys-
207 — Not present
HTS-3 Arg-285, Lys-286, Arg-289, Lys-290 Lys313, Glu314, Lys315 predicted
However, two other sites in annexin B1 merit  attention. The motifs Arg91-Arg92 and 
Lys139-Lys140 on the concave sides of domains I and II respectively could be potential 
calcium-independent heparin binding sites. A further possible motif, Lys254-Lys255 is 
found in the DE loop of domain III,  which is located in the anticipated dysfunctional 
canonical calcium binding site. Nevertheless, occupation of this site by heparin would 
compete with binding to the membrane surface. Further studies would be necessary to test 
these hypotheses.
4.5 Crystallography
A crystal could be obtained from a factorial condition (0.1mM sodium acetate, pH 5.3, 2M 
sodium formate, see figure 4-19), and with a protein concentration of 10mg/ml in the drop.
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Figure -24: Annexin B1 crystal obtained from 0.1mM sodium acetate, pH 5.3, 2M sodium formate. 
Crystallisation  conditions  were  optimised  to  0.1mM  sodium acetate,  pH  5.0,  1.45M 
sodium formate, and crystals grew to a size of 0.86mm x 0.11mm x 0.11mm. Resolution 
of the best data set recorded at the ESRF in Grenoble was 3.8Å (see figure 4-20), but it 
was not possible to index the data and determine the cell parameters with confidence.
Figure -25: Diffraction pattern of annexin B1 crystal.
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4.6 Concluding remarks on AnxB1 and future direction
The pig tapeworm  T. solium is a parasite that infests the human gut leading to  greater 
intestinal disturbance, pain, and inflammatory response. Humans who ingest  T. solium 
eggs may develop the larval infection resulting in the serious disease cysticercosis which 
can induce epilepsy, mental disturbances, meningeal syndrome, and can even cause death. 
This parasite causes great economic loss in Latin America, Asia, Africa, the Phillipines 
and parts of Southern Europe where it also a threat to public health. Reasearch on annexin 
B1 was aimed to investigate biophysical and biochemical properties of the protein that 
could  be  exploited  for  finding  new drug  leads  to  fight  infestation  with  the  parasite 
tapeworm.  In this study,  membrane- and heparin-binding properties  of annexin B1 have 
been investigated, and first insights into annexin B1 oligomer formation in solution have 
been gained.  Crystallisation trials yielded first  crystals  that diffracted to 3.8Å but  the 
three-dimensional structure could not be solved. 
4.6.1 Membrane binding
Biochemical  assays  revealed  that  annexin  B1  binds  to  phospholipids  in  a  calcium-
dependent manner supposedly via its type II calcium binding sites. A calcium dependent 
phospholipid  binding  mode  is  reminiscent  of  the  binding  behaviour  of  mammalian 
annexins which rely almost entirely on a calcium-mediated binding mode regardless of the 
vesicle composition . Results from this work show that annexin B1 binds more readily to 
vesicles  containing  a  higher  ratio  of  PS  which  is  a  natural  component  of  the  cell 
membrane.  In  the  absence  of  stimulation,  PS  is  almost  exclusively  located  on  the 
cytoplasmatic side of the cell membrane. By contrast, after stimulation by e.g. thrombin or 
collagen, PS becomes exposed to the outer side of the plasma membrane at a proportion 
depending on the nature of the stimulus . There is ample evidence that PS exposure is of 
crucial importance in cellular physiology being involved in the regulation of haemostatic 
mechanisms by providing a procoagulant surface on activated platelets, monocytes and 
endothelial cells . PS exposure is also required in the anticoagulant protein C pathway 
Anja Winter                                                                                                                 page  176  
Structural Biology of Prohibitin and Annexin B1
leading to  the inactivation of  factors  Va and VIIIa  at  the membrane interface.  Other 
annexins such as  the mammalian annexins  A1 and A5  have been known to display 
anticoagulant activity, which had recently been shown for annexin B1 as well . Notably, 
the glycoprotein lacadherin is able to compete with factors V and VIII for membrane 
binding sites at  acidic  PS  functioning as anticoagulant.  One could imagine a similar 
mechanism  for  binding  of  annexin  B1  to  PS-membranes  resulting  in  anticoagulant 
function.
Interestingly, calcium-independent membrane binding reminiscent of plant annexins was 
also observed whereby conserved surface exposed residues, including Trp35, Trp107 and 
Lys190  [annexin  24  (Ca32)  numbering]  might  engage  in  direct  interactions  with  the 
membrane  .  One  can  therefore  speculate  that  annexin  B1  might  employ  a  similar 
mechanism. In annexin B1, only Lys190 is semi-conserved as Arg214 but it is possible to 
identify a number of exposed basic residues on the convex surface of the protein such as 
Arg191, Arg236, Arg265 and Lys232. The involvement of these basic residues would help 
to explain the observation that a high PS content in the membrane is required in order to 
bind annexin B1 in the absence of calcium . This property might be important when the 
protein is directed to bind to specific, PS-rich sites within the membrane. These specific 
membrane patches could reside in the tape worm itself or in the membrane of a host cell. 
Too little is  known about  the localisation of annexin B1  in vivo to draw any further 
conclusions  regarding  the  utilisation  of  this  property.  An involvement  of  these  basic 
residues in membrane binding could be verified by employing mutagenesis studies. 
One could imagine that the calcium-independent membrane binding mechanism might 
assist the calcium-dependent mechanism in annexins where functional calcium binding 
sites  are  destroyed by mutation in  the  endonexin  sequence.  For  instance,  the  protist-
derived annexin -1 giardin has only one proposed intact type II calcium binding site in 
domain II whereas helminth annexin B1 has three in domains I, II and IV (see figure 3-3). 
Plant  annexins  generally possess two type II  calcium binding sites.  In  contrast,  most 
mammalian annexins possess four intact type II calcium binding sites. The development of 
four canonical calcium binding sites in certain annexins (predominantly later in evolution) 
might  have  made  the  calcium-independent  mechanisms  obsolete.  The  observation  of 
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calcium-independent  membrane binding by annexin B1 fits  well  with this  hypothesis, 
since one can anticipate a disrupted canonical calcium binding site in domain III of this 
protein. In future studies, membrane binding of -1 giardin will be assessed where a more 
calcium-independent  mechanism  is  hypothesized.  Outcome  of  this  study  will  help 
understand the evolution of calcium binding sites in annexins.
4.6.2 Lectin properties
Binding to carbohydrates of proteoglycans or glycosaminoglycans might be a crucial step 
in attachment, invasion and cytolysis of intestinal epithelium by parasites. As annexin B1 
has been demonstrated to be highly immunogenic [31] and is potentially present on the 
surface of C. cellulose. Results from this work show that annexin B1 binds to heparin in a 
calcium-dependent and cooperative manner.  The assumption of three calcium-dependent 
calcium binding sites in annexin B1 coincides with the fact that annexin B1 has three 
canonical type II calcium binding sites. It remains to be clarified whether all three binding 
sites  engage  in  calcium-dependent  glycosaminoglycan  binding.  A  model  for  heparin 
binding had been proposed for annexin A5 , where two main heparin binding sites engage 
in  recognition  and/  or  binding  of  heparin.  Only  one  of  the  heparin  binding  sites  is 
conserved in annexin B1 involving residues Lys38 and Arg39 but further basic surface-
exposed residues could be identified on the surface of the protein which could be involved 
in heparin binding.
Interestingly, several viruses and parasites are thought to have infection strategies based 
on binding to glycosaminoglycans in the extra-cellular matrix.  Prominent examples of 
proteins  with  lectin  properties  are  microbial  adhesions,  including  the  influenza 
hemaglutinin,  as  well  as  the  adhesins  from  Shiga toxin  and  Entamoeba  histolytica . 
Heparan sulphate binding has been found with -1 giardin, one annexin of the protozoan 
parasite G. lamblia. This protein has also been found to bind to epithelial cells of the small 
intestine,  mast  cells  and connective tissue. Annexin  B1 has  been demonstrated to  be 
highly immunogenic ,  and is potentially present on the surface of  C. cellulosae .  The 
binding  of  the  protein  to  glycosaminoglycans  such  as  heparin  may  therefore  be  a 
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mechanism used by C. cellulosae to attach to and invade host tissue. This finding opens 
possibilities for drug design at the heparin binding sites of the protein. Drugs designed to 
interfere with heparin binding are suitable as they might prevent parasite attachment and 
invasion of host tissue. Therefore, crystallisation of annexin B1 in complex with heparin 
tetrasaccharides is considered a goal for further studies in this area. Crystal structures of 
annexin B1 in complex with heparin tetrasaccharides could be used to investigate the 
heparin binding sites. 
4.6.3 Redox-dependent oligomer formation
Biophysical studies revealed that annexin B1 is present as a mixture of different oligomers 
in solution, and that their formation is Redox-dependent. Two of the four cysteines present 
in the protein are likely to be involved in this process, Cys210 (domain III) and Cys340 
(domain IV).  This led to the hypothesis that side-to-side oligomers are formed which 
could, on a lipid layer, result in formation of rod-like structures such as the ones found 
with plant annexins .  Coating of target membranes to establish and/or regulate lateral 
membrane domains is likely to be a key element of annexin function .  Formation of 2D 
crystals  of  annexins  on the surface  of  membranes  was first  observed in electron  and 
atomic force  microscopy experiments  for some mammalian annexins, including AnxA5 
and AnxA6 . In a later study, formation of elongated rods reminiscent of 2D crystals was 
also  observed  with  plant  annexins  Anx24(Ca32)  and  Anx(Gh1)  .  These  rods  were 
presumably made up by annexin dimers implying protein-protein interactions as a very 
important factor for formation of those structures. In that study, a hypothesis had been put 
forward, where an extended annexin oligomer would be able to provide interaction sites 
for two membranes at both ends. Those “connecting” rod-like structures would be able to 
initiate  and/or  assist  in  membrane-fusion  events  in  endo-  and  exocytosis.  The  same 
mechanism could also play a role in the cell’s attachment to other (extracellular) structures 
like infection of a host by a parasite. On the other hand, supra-molecular assembly of 
annexins on membrane surfaces might provide a platform for binding other proteins and 
thus carry out scaffolding functions for the cell. 
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Disulfide-dependent oligomer formation was shown to be responsible for activation and/or 
functionality  of  proteins  from  different  organisms  and  cellular  compartments  such 
membrane-bound transcription  factor  ATF6  and  prostanoid  IP  receptor  .  The  serum 
protein Acrp30/adiponectin activates different signal transduction pathways in its trimeric 
and hexameric form , and the activity of the cytosolic thimet oligopeptidase is dependent 
on the location of dimer forming disulfide bonds,  rather than their  existence  per se . 
Disulfide-dependent  oligomer  formation  might  have  implications  for  the  function  of 
annexin B1 in a cellular context. Results from this work suggest the formation of an intra-
molecular disulfide bridge between Cys130 and N-terminal Cys4 on the concave side of 
the  protein.  Reduction  of  the  disulfide  bridge  would  release  the  N-terminus  to  exert 
specific functions, e.g. in membrane binding, as has been found for annexins A3  and A1 . 
In the case of annexin A3, the local mobility of Trp5 is dependent on Ca2+ binding and 
membrane association of the protein. The N-terminal region of annexin A1 consists of an 
amphipathic -helix which is buried into the core domain and becomes solvent exposed 
upon calcium and membrane binding. Additionally, the N-terminal domain of annexin B1 
might also show secondary structure as had been found with annexin A1. The presence of 
a disulfide bond between Cys130 and Cys4 of annexin B1 needs to be validated in a 
crystal structure of the protein.
In future studies, the cysteine residues could be mutated to serine residues to study their 
effects on oligomer formation. Truncation of the N-terminal region might reveal insights 
into its function and might give clues to the protein’s function in the cell. Binding studies 
on lipid monolayers using a Langmuir balance and electron microscopy  could provide 
information  about  oligomer  formation  on  membranes  which  might  be  different  from 
findings in solution. 
4.6.4 Crystallisation
In initial trials, annexin B1 could be crystallised and yielded a crystal that diffracted up to 
3.8Å  but  the  data  set  could  not  be  indexed.  There  are  several  methods  by  which 
crystallisation  of  a  protein  could  be  improved  to  yield  a  crystal  suitable  for  X-ray 
diffraction and structure determination. Those methods include modification of the protein 
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on the DNA level and on the protein level. Annexin B1 possesses a 13 amino acid longer 
N-terminus as compared to annexin A5 which might be very flexible and hinder a defined 
arrangement of protein molecules in the crystal. Truncation of the N-terminus at the DNA-
level is currently underway, and the truncated protein will be subjected to crystallisation 
trials  as  soon  as  it  is  available.  Other  possible  modifications  of  the  protein  include 
mutation of surface-exposed cysteine residues to alanines. In this work, cysteine residues 
have  been  shown  to  be  involved  in  Redox-dependent  oligomer  formation,  and  their 
mutation might result in a protein that is mainly monomeric in solution. Modification of 
the  protein,  e.g.  methylation  of  surface-exposed  lysine  residues,  might  improve  the 
crystallisation  properties.  This  protein  engineering  approach  benefits  from  being 
conductible without  the necessity to re-clone the DNA and therefore being less time-
consuming.  Annexin  B1  possesses  a  total  of  20  lysines  which  could  potentially  be 
methylated.  Addition of  cross-linkers or  ligands  (DTT, HTS,  calcium) might  also aid 
packing of the protein into a crystal that diffracts to higher resolution. Co-crystallisation of 
annexin  B1  with  HTS  and  calcium  would  provide  valuable  information  about  the 
architecture of the heparin binding site and suggest ways for interfering with the binding. 
A three-dimensional structure would be the first step in structure based drug design for 
this protein.
The most interesting finding in this present study was that annexin B1 possesses features 
from both mammalian and plant annexins. It  binds to heparin in a calcium-dependent 
fashion which is reminiscent of mammalian annexins but binds to acidic phospholipids in 
a manner like plant annexins do. It is tempting to speculate that the ability to bind to 
heparin or to phospholipid membranes might have undergone a certain development in 
evolution which might have been intertwined with the development of calcium binding 
sites. In this scenario, the development of type II calcium binding sites, supposedly later in 
evolution,  might  have  made  a  calcium-independent  binding  mode  to  phospholipids 
obsolete. Heparin binding is promoted by type II calcium binding sites and was, so far, 
only  observed  for  mammalian  annexins  and  annexin  B1.  As  our  results  suggest 
cooperativity with respect to calcium, the number of type II calcium binding sites in the 
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protein might be important. Mammalian annexin A1 shows a stronger binding to heparin 
at lower calcium concentrations as compared to annexin B1, and it remains to be tested to 
which degree plant annexins and annexins from subfamily E would bind to heparin.
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5 Materials and Methods
5.1 General lab equipment, reagents and media
5.1.1 General lab equipment
Block heater QBT1, Grant Instruments, Cambridge, UK
MS1 Minishaker, IKA -Werke GmbH & CO. KG, Staufen, Germany
IKAMAG® Magnetic stirrer, IKA -Werke GmbH & CO. KG, Staufen, Germany
J2-21 centrifuge with rotor JA-20, Beckman Coulter Inc., High Wycombe, UK
J6-MC centrifuge with rotor TY.J5 4.2, Beckman Coulter Inc., High Wycombe, UK
Megafuge 1.0R with swing bucket rotor, Heraeus, Hanau, Germany
Biofuge fresco, Heraeus, Hanau, Germany
Biofuge pico, Heraeus, Hanau, Germany
Innova 4330 incubator, New Brunswick Scientific, Edison, USA
PE360 balance, Mettler-Toledo international inc., Columbus, USA
AB104 balance, Mettler-Toledo international inc., Columbus, USA
Microwave oven, Panasonic UK Ltd
PowerPac 300, Bio-Rad Laboratories, Inc, Hercules, California, USA
SDS-PAGE equipment: Hoefer Inc., 953 Indiana Street, San Francisco, California 94107
DNA-gel  equipment:  Orchard  House,  The  Square,  Hessle,  East  Riding  of  Yorkshire, 
HU13 0AE, UK
Stuart 3D rocking platform STR9, Barloworld Scientific, Stone, UK
U-100 UV/VIS Spectrophotometer, Hitachi High-Technologies Corp., Tokyo, Japan
Gel drying processor AE-3700, Atto, Tokyo, Japan 
UV transluminator UVT-28M, Herolab GmbH Laborgeräte, Wiesloch, Germany
Gene flash, Syngene Bio imaging, Cambridge, UK
Soniprep 140, MSE (UK) Ltd., Lower Sydenham, London, UK
pH meter 140, Corning Inc., Corning, New York, USA
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Scotsman ice machine, Scotsman Ice Systems, Vernon Hills, Illinois, USA
Puritec Select water purifier, Onedo Industrial Solutions, Vaucresson, France
Biocad® 700e Workstation (Applied Biosystems)
5.1.2 General Reagents
Purchased from Sigma-Aldrich   Company Ltd, Gillingham , Dorset, UK:  
Acetonitrile, NH4HCO3,  APS,  ampicillin,  L-Arginine,  benzamidinium  chloride, 
bromphenolblue, CaCl2, CHCA, Coomassie  Brillant  Blue  R,  deoxycholic  acid,  DTT, 
EDTA, NiSO4, NonidetP40, sorbitol, galactose, glycine, L-Histidine, HEPES, IAA, IPTG, 
isopropanol, lactate, Lysing enzyme, lysozyme, MnCl2, MOPS, PMSF, K2HPO4, KH2PO4, 
L-Serine, sinapinic acid, SDS, TEMED, TRIS, Triton X-100, xylene cyanol
Purchased from  Fisher Scientific UK Ltd, Loughborough, Leicestershire, UK:  
acetic acid (glacial), EtOH, glycerol, HCl, NaCl, NaOH, MgCl2, KCl, sucrose, urea, 
Purchased from   Promega 
trypsin
Purchased from   Invitrogen Corporation  ,  Paisley, UK:  
Agarose
Purchased from   VWR International Ltd, Ashbourne, Ireland:  
imidazole
Purchased from   Severn Biotech Limited Kidderminster, Worcestershire, UK  : 
Design a Gel Acrylamide Solution, 30% (w/v) acrylamide, acrylamide to bis-acrylamide 
ratio 37.5:1
Purchased from   Pierce, Rockford, Illinois, USA:  
Gelcode Blue Stain Reagent
Purchased from   Oxoid Ltd., Basingstoke, Hampshire, UK:  
tryptone, yeast extract
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5.1.3 Media
5.1.3.1 LB medium  
10g Tryptone (1%), 5g yeast extract (0.5%) and 5g NaCl were dissolved and made up to 1 
litre with water. The medium was autoclaved.
5.1.4 Other materials
Vivaspin concentration devices, VivaScience,  Unit 6, Stroud Business Centre, Oldends 
Lane Industrial Estate, Stonehouse, GL10 3RQ, Glouchestershire, UK
Centricon,  Amicon  Ultra,  Millipore,  112  Talavera  Road,  North  Ryde,  NSW  2113, 
Australia
Dialysis bags,  Spectrum Laboratories Inc, 18617 Broadwick street, Rancho Dominguez, 
CA 90220, USA
5.1.5 Crystallisation equipment
24-well plates, 22mm siliconized circular cover slides, high vacuum sealant and synthetic 




Plasmids are circular, double-stranded DNA (dsDNA) molecules that are separate from 
the  cell's  chromosomal  DNA.  Plasmid  vectors  contain  essential  nucleotide  sequences 
required  for  their  use  in  DNA  cloning:  a  replication  origin  and  a  region  in  which 
exogenous DNA fragments can be inserted. The plasmid also harbours a selective gene, 
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the  most  commonly  used  being  the  ampicillin-resistance  gene  (ampr),  encoding  β-
lactamase, which inactivates the antibiotic ampicillin. During cell division, at least one 
copy of the plasmid DNA is segregated to each daughter cell, and any DNA sequence 
inserted  into  such  a  plasmid  is  replicated  along  with  the  rest  of  the  plasmid  DNA. 
Expression  vectors  can produce protein  upon induction with  IPTG (isopropyl-beta-D-
thiogalactopyranoside).
List of plasmid vectors:
pETDuet-1 Novagen, EMD Biosciences, Inc, Darmstadt, Germany
pTrcHis_B Invitrogen Corporation, Paisley, UK
pRSET_6c Schoepfer, 1993 
pRSET_C Invitrogen Corporation, Paisley, UK
5.2.2 Molecular cloning
The essence of  recombinant  DNA technology is  the  preparation  of  large numbers  of 
identical DNA molecules through linkage of a DNA fragment with a vector. This way, 
identical copies of a DNA fragment can be produced (cloning). 
Rare specific  DNA sequences  can be directly  amplified  to  large  amounts through an 
alternative  to  cloning,  called  the  polymerase  chain  reaction  (PCR).  In  a  PCR,  two 
synthetic oligonucleotides (primers) complementary to the 3′ ends of the plus and minus 
strand of the target DNA segment are used as primers for DNA chain synthesis done by a 
temperature-resistant  DNA  polymerase  for  instance  from  Thermus  aquaticus  (Taq 
polymerase). Oligonucleotides, deoxynucleotides and DNA polymerase are mixed with 
the target DNA and subjected to repeated heating and cooling cycles. 
Prohibitin  truncation  mutants  were  generated  from  the  tandem  vector  His6-
BAP32:BAP37_pETDuet (a kind gift from T. Tatsuta) as template which was digested to 
gain the DNA for  the  respective proteins  which would serve as  templates  for  PCRs. 
BAP32 was originally cloned into the first multiple cloning site of pETDuet using the 
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restriction  sites  for  BamHI and  EcoRI,  BAP37  was  cloned  into  the  second  multiple 
cloning site via restriction sites for  NdeI and XhoI. Using suitable primers in the PCRs, 
truncated  versions  of  the  proteins  were  produced.  Each  PCR  was  optimised  in  its 
annealing temperature to give maximum yield of product.  The amplified product  was 
subsequently ligated into expression vectors pTrc_His_B (BAP32) or pRSET_C (BAP37). 
The different truncation mutant constructs, their respective PCR primers and annealing 
temperatures are summarised in table 5-1.
Following page: Table  -1:  Used primers and annealing temperatures for  cloning of  prohibitin 
truncation mutants
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List of primers
BAP32_1F coding, BAP32(1-30), BamHI
5’-C GCG GAT CCC GAT GCT GGA CAC AGA GCT GTC-3’
BAP32_1R non-coding, BAP32, EcoRI
5’-CCG GAA TTC TCA CTG GGG AAG CTG GAG AAG CAC GG-3’
BAP32_2R non-coding, BAP32(1-177), EcoRI
5’-CCG GAA TTC TCA CTT CCC GAA GGT CAG ATG TGT CAG-3’
BAP32_2F coding, BAP32(1-24), EcoRI
5’-C CGG AAT TCT GCT TTG TAT AAT GTG GAT GC-3’
BAP32_3R non-coding, BAP32, HindIII
5’-CCC AAG CTT  TCA CTG GGG AAG CTG GAG AAG CAC-3’
BAP37_1F coding, BAP37, NdeI
5’-GGG TTT CAT ATG GCA GAT CTC GCA GCC CAG AAC TTG-3’
BAP37_1R non-coding, BAP37, XhoI
5’-CCG CTC GAG GTC ATT TCT TAC CCT TAA TGA GGC TGT-3’
BAP37_2F coding, BAP37(1-40), NdeI
5’-GGG TTT CAT ATG CGC GAA TCC GTG TTC ACC GTG GAA GGC GG-3’
BAP37_2R non-coding, BAP(1-191), XhoI
5’-CCG CTC GAG TCA TCG GCT GAA GCT CAG CTC TGT GAT-3’
HIS6-FtsH-IMS region was generated from E. coli genomic DNA using suitable primers in 
a PCR reaction with an annealing temperature of 48ºC, followed by double digestion using 
EcoRI and XhoI and ligation into cut pRSET_C vector. The success of the ligation was 
analysed by analytical digestion of the ligated plasmid and sequencing.
List of primers
FtsH_1F N-terminal loop, extra-membrane domain, coding, XhoI
5’-CC GCT CGA GAT CAG AGC TTT GGG CCC AGC GAG-3’
FtsH_1R N-terminal loop, extra-membrane domain, non-coding, EcoRI
3’-GGC GGA CTT CTT GGT TCG ATC CTT AAG GCC-5’
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All primers were purchased from MWG, Ebersberg, Germany. Identity of each construct 
was verified by DNA sequencing. 
5.2.2.1 PCR  
The PCR is mostly dependent on the annealing temperature of the primers, the magnesium 
concentration and the amplifying system. PCR conditions were optimized in annealing 
temperature  whereas  the  magnesium concentration  was kept  constant  for  all  PCRs at 
4mM.
Amplifying system: Taq DNA polymerase, Promega UK Ltd., Southampton, UK
Taq DNA polymerase, Roche Diagnostics Ltd., Burgess Hill, UK
PCR machine: MJ research PTC-200, GMI Inc., Minnesota, USA
An example of the reaction mix and the used PCR protocol is stated below (see table 5-2). 
The reactions were analyzed  on a 1% agarose gel stained with SYBR Safe™ DNA gel 
stain (Invitrogen Corporation, Paisley, UK). The appropriate DNA bands were cut out and 
gel  extracted  using  the  gel  extraction  kit  from Qiagen  following  the  manufacturer’s 
protocol.
Table 5-2: Examples for a PCR mix and a PCR protocol
Mixture Protocol
 32µl sterile water Denaturation  94ºC for 5:00
   4µl 10x Thermo Pol buffer Denaturation  94ºC for 1:30 ╗
   4µl or 6.5µl 25mM MaCl2 Annealing      42ºC for 1:30 ╠ 30x
   1µl 100pmol Primer F Elongation     72ºC for 2:30 ╝
   1µl 100pmol Primer R Elongation     72ºC for 10:00
0.4µl 3.2pmol dNTPs (25mM)
0.5µl template DNA
   1µl Taq Polymerase
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5.2.2.2 Restriction digest  
To  clone  specific  DNA fragments  into  a  plasmid  vector,  the  PCR  products  and  an 
appropriate  vector  were  digested  using  restriction  enzymes.  In  this  reaction,  single-
stranded  regions  (“sticky  ends”)  of  complementary  sequences  were  created  at  the 
respective  restriction-sites. Pairing  of  matching  single-stranded  regions  from  a  DNA 
fragment with single-stranded regions from a cut vector in a ligation reaction leads to 
formation of a chimeric molecule, the new plasmid. 
Digests of PCR products or vectors were carried out as subsequent single (one restriction 
enzyme) or one double digest (two restriction enzymes at a time) by incubation of the 
DNA with the appropriate restriction enzymes and buffers at 37ºC for 2 to 4 hours. During 
digestion of a vector, 1/10 volume of CIP was added for the last 30 minutes to remove 
phosphates at the restriction sites which reduces re-ligation of the vector in the subsequent 
ligation reaction.  All  digests  were analysed on a  1% agarose gel  stained with SYBR 
Safe™ DNA gel stain (Invitrogen Corporation,  Paisley, UK). The DNA bands were cut 
out  and  extracted  using  the  gel  extraction  kit  from  Qiagen  and  following  the 
manufacturer’s protocol. 
List of enzymes:
restriction endonucleases:  NdeI,  EcoRI, HindIII, XhoI,  BamHI, all purchased from New 
England Biolabs, Ipswich, Massachusetts, USA
other enzymes: Calf  Intestinal  Alkaline  Phosphatase  (CIP)  purchased  from 
New England Biolabs, Ipswich, Massachusetts, USA
5.2.2.3 Ligation  
In recombinant DNA technology, purified DNA ligase is used to covalently join the ends 
of restriction fragments in an ATP dependent chemical reaction. 
The digested PCR products and vectors were evaporated at  50ºC in a heating block to 
increase their concentration. Ligation reactions were carried out in a total volume of 20µl 
at 16ºC at least overnight, and up to 4 days. The reaction set up included 4µl T4 ligase and 
Anja Winter                                                                                                                                     205  
Structural Biology of Prohibitins and Annexin B1
2l  10x T4 DNA ligase buffer, PCR product and vector. Success of the ligation was 
determined by transforming the ligation reaction mix into XL1Blue cells and incubating 
the plate overnight at 37ºC. Resulting colonies were used to inoculate 8-10ml LB media 
with  which  a  MINI  prep  (Qiagen)  was  carried  out  the  following  day  using  the 
manufacturer’s protocol. Analytical digest and sequencing of the gained plasmid DNA 
confirmed the success of the ligation and the identity of the construct. 
Enzme:T4 DNA Ligase, New England Biolabs, Ipswich, Massachusetts, USA
Cells: XL1Blue E.coli, Stratagene, La Jolla, California, USA
5.2.2.4 Sequencing  
A PCR reaction was set up using the plasmid, T7 sequencing primer and Big Dye Term 
Mix, and following the protocol stated in table 5-3. The Big Dye Terminator Mix (Applied 
Biosystems, Foster City, California, USA) contains a polymerase, unlabelled and labelled 
nucleotides in buffer. Whenever a labelled nucleotide is used by the polymerase in the 
elongation process, the chain terminates. Statistically, all terminated chains have different 
lengths with one labelled nucleotide at the end. The mix is the run on a gel and analysed 
by a software that detects intensity and identity of the fluorescently labelled nucleotides at 
the ends of the DNA oligomers. Sequencing was done by the DNA sequencing facility at 
the School of Biology, The University of Edinburgh.
Table 5-3: PCR mixture and temperature protocol used for sequencing.
T7 sequencing primer: 5’-TAA TAC GAC TCA CTA TAG GGA GA-3’
Mixture Protocol
4µl Big Dye Term Mix Denaturation   96ºC for 0:20
1-5µl DNA template Annealing       50ºC for 0:20
1µl T7 sequencing primer Elongation      60ºC for 4:00
sterile water to 20µl 25 repeats
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5.2.3 Generation of a BAP32 construct with an artificial N-terminal helix
The construct His-BAP32(1-24)_pTrc_His_B was generated in two steps: first, BAP32(
1-24) was amplified in a PCR using the primers BAP32_2F and BAP32_3R creating 
restriction sites for  EcoRI and  HindIII. The PCR product was digested and cloned into 
pTrc_His_B  to  create  the  intermediate  construct  His6-BAP32(1-24)_pTrcHis_B. 
Afterwards, the intermediate construct was cut with BamHI and EcoRI in two subsequent 
single digests to create sticky ends for ligation with the hybridized oligomers coding for 
the artificial helix. 1/10 volume CIP was added to the last 30 minutes of the second digest 
to remove phosphates at the restriction sites. 
The  artificial  helix  AKAAAAKAAAAKAAAA was translated  into a  DNA code and 
purchased from MWG (Ebersberg, Germany) as two oligomers of 54 nucleotides. For 
usage in the later ligation, the oligomers were designed with complementary sticky ends 
as  theoretically  gained  from  a  BamHI/  EcoRI  restriction  digest  of  the  intermediate 
construct, and a phosphate at both 5’ ends was introduced to enable ligation (see figure 5-
1). The lyophilised oligomers were dissolved in STE buffer (10 mM Tris pH 8.0, 50 mM 
NaCl, 1 mM EDTA) at a concentration of 8 OD260 units/ 100l. The two strands were 
mixed together in equal molar amounts (5l + 5l). After heating to 94oC in a heating 
block, the block was allowed to gradually cool down to room temperature enabling a slow 
annealing of both strands. The resulting product was a stable, double-stranded DNA that 
was used for ligation into the cut intermediate construct. The ligation and sequencing was 
carried out as stated above.
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Figure -1: Cloning strategy for generating HIS6-helix-BAP32(1-24)_pTrcHIS_B. The oligomers for 
the 16 residues long artificial  helix (pink) is cloned into the vector pTrc_His_B (blue) using a 
BamHI restriction site. BAP32(1-24) (purple) is inserted upstream of the helix via  EcoRI and 
HindIII sites. Oligomers for the artificial helix were designed including a phosphate residue at the 
5’end to enable ligation.
List of oligomers:
coding, synth. helix, BamHI/EcoRI
5’-pGATCCGGCTAAGGCCGCGGCAGCTAAAGCCGCGGCAGCTAAGGCAGCTGCCGCG-3’
non-coding, synth. helix, EcoRI/BamHI
5’-pAATTCGCGGCAGCTGCCTTAGCTGCCGCGGCTTTAGCTGCCGCGGCCTTAGCCG-3’
5.2.4 Transformation
Transformation describes a genetic alteration of a cell caused by the uptake and expression 
of foreign DNA regardless of the mechanism involved. The selective gene on the plasmid 
provides the transformed cell with a resistance against this antibiotic which is used to 
differentiate between successfully transformed and not transformed cells.
List of cell strains:
BL21(DE3) E.coli Invitrogen Corporation, Paisley, UK
DH5E.coli Invitrogen Corporation, Paisley, UK
XL1Blue E.coli Stratagene, La Jolla, California, USA
Rosetta 2(DE3) E.coli Novagene, Merck Pty., Kilsyth, Victoria, Australia
All  transformations  involved  in  this  work  were  done  either  by  heat  shock  or 
electroporation.  For transformation by heat shock, one aliquot of competent cells was 
thawed on ice and 1µl plasmid DNA was added. After incubation on ice for 10 minutes, 
the  cells  were  placed  in  a  heat  block  at  42ºC for  4  minutes  (heat  shock)  to  enable 
transformation. The cells were incubated on ice for further 10 minutes, afterwards mixed 
gently  with 800µl  LB media and incubated at  37ºC for  45 minutes.  Cells  were then 
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harvested by centrifugation at 3000 g for 5 minutes at room temperature in a Biofuge pico. 
Finally, the cell pellet was resuspended in a small volume of LB media and plated on an 
agar plate containing an antibiotic (e.g. ampicillin) as a selection tool. The plate was then 
incubated at 37ºC over night. 
Competent cells used for transformation by electroporation were washed three times with 
400µl glycerol in order to remove remaining salt surrounding the cells. After adding 1µl 
plasmid DNA, the cells were incubated on ice for 15 minutes. The cells were transferred 
to the precooled electroporation cuvette, and the cuvette was placed in the electroporator 
(Gene Pulser with Pulse Controller and Capacitance Extender, Bio-Rad Laboratories, Inc, 
Hercules, California, USA) and electroporated. If no sparks have appeared during pulsing 
the cells, the electroporation was considered successful. The cells were transferred into 
800µl LB warm media immediately. After incubating the cells for ca. 45 minutes at 37ºC 
while shaking, the cells were centrifuged at 3000rpm for 7 minutes in a Biofuge pico at 
room temperature. The cells were plated on an agar plate and incubated over night at 
37ºC.
5.2.5 Plasmid DNA preparation
Plasmid  preparations  were  carried  out  using  Qiagen  MINI  or  MIDI  plasmid  kits 
(QIAGEN Ltd., Crawley, West Sussex, UK), and following the manufacturers protocols.
For preparation of plasmid DNA, a single colony of transformed DH5 or XL1Blue cells 
was picked from an agarose plate to inoculate 7ml (MINI) or 100 ml (MIDI) LB media 
containing 100µg/ml ampicillin. After incubation over night at 37ºC in an orbital shaker, 
the cells were spun down at 3000g, 4ºC for 15 minutes in a Megafuge 1.0R. Plasmid DNA 
was isolated from the  cells  following the instructions  for  the plasmid purification kit 
(MINI or MIDI) by Qiagen. For convenience, step 13 and 14 of the MIDI prep protocol 
were altered as follows: after elution of the plasmid DNA from the column with buffer QF 
and subsequent addition of 3.5ml isopropanol, the solution was aliquoted into 6 Eppendorf 
tubes and spun for 45 minutes at 13.000 rpm using a Biofuge fresco. The pellets were 
washed with 200l 70% ethanol and pooled into one tube. This tube was spun again for 30 
minutes at 13.000 rpm. The ethanol was removed, and the tube was left to dry over night 
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to remove residual ethanol. Finally, the DNA was resolved as recommended in the Qiagen 
protocol.
5.2.6 Isolation of genomic DNA
For cloning of FtsH-IMS region into pRSET_C, genomic  E.coli DNA was isolated and 
used as a template in the PCR reaction. 20µl of untransformed DH5cells were used to 
inoculate 20ml LB media without an antibiotic. Bacteria were pelleted by centrifugation at 
3000g for 15 minutes in a Megafuge 1.0R, the supernatant was discarded and all liquid 
was completely removed. For purifying the genomic DNA, two QIAGEN protocols (for 
MIDI prep and for Isolation of genomic DNA) were combined as follows. The cell pellet 
was  resuspended in 3.5 ml Buffer  B1 with 10 µl  RNase A solution (100 mg/ml)  by 
vortexing.  100 µl  lysozyme stock solution (100 mg/ml)  was added,  and the mix was 
incubated at 37°C for 30 minutes. After adding 1.2 ml of Buffer B2, the tube was mixed 
by  inverting  the  tube  several  times  and by  vortexing  for  a  few seconds.  During  the 
following  incubation  at  50°C for  30  minutes,  the  QIAGEN MIDI  prep  column  was 
equilibrated with 10 ml of Buffer QBT. After the column was allowed to empty by gravity 
flow, the sample was vortexed for 10s at maximum speed and applied to the equilibrated 
column and allowed to enter the resin by gravity flow. The column was washed 2 times 
with 10 ml of Buffer QC, and the genomic DNA was eluted with 5 ml of Buffer QF. 
Afterwards, the DNA was precipitated by adding 3.5 ml (0.7 volumes) room-temperature 
isopropanol. The tube was inverted 10 to 20 times, and the DNA spooled using a curved 
glass rod. The end of the rod containing the DNA was immediately transferred into a 
microcentrifuge tube, and 300µl 10mM Tris-HCl, pH 8.5, was added. After dissolving the 
DNA overnight on a shaker at room temperature, the microcentrifuge tube was centrifuged 
at 13000rpm (Biofuge fresco) for 10 minutes at 4ºC. The dissolved DNA was transferred 
into a fresh microcentrifuge tube and stored at -20ºC.
Buffer compositions:
B1: 18.61g Na2EDTA·2H2O and 6.06g Tris base are dissolved in 800ml distilled water, 
and 50ml 10% Tween-20 solution and 50ml 10% Triton X-100 solution are added. 
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After the pH is adjusted to 8.0 with HCl, the volume is brought to 1L with distilled 
water.
B2: 286.59g guanidine HCl are dissolved in 700ml distilled water, and 200ml of 100% 
Tween-20 are added. The volume is adjusted to 1L with distilled water.
QBT: 43.83g NaCl and 10.46g MOPS (free acid) are dissolved in 800ml distilled water, 
and the pH is adjusted to 7.0 with NaOH. Afterwards, 150ml pure isopropanol and 
15ml 10% Triton X-100 solution (v/v) are added. The volume is brought to 1L 
with distilled water.
QC: 58.44g NaCl and 10.46g MOPS (free acid) are dissolved in 800ml distilled water 
and the pH adjusted to 7.0 with NaOH. 150ml pure isopropanol are added and the 
volume is brought to 1L with distilled water.
QF: 93.5g NaCl and 6.06g Tris base are dissolved in 800ml distilled water, and the pH 
is adjusted to 8.5 with HCl. 150ml pure isopropanol are added and the volume is 
brought to 1L with distilled water.
5.3 Protein production
5.3.1 Protein expression for FtsH-IMS region and annexin B1
A single colony of transformed BL21(DE3) was picked from a plate to inoculate the 
preculture of 1L LB media containing 100µg/ml ampicillin. After incubation over night at 
37ºC in an orbital shaker, the preculture was diluted into 7L fresh LB media (containing 
100µg/ml ampicillin) and grown at 37ºC while shaking until the OD600 exceeds 1. The 
cells were induced with 0.5mM IPTG (final concentration) and incubated overnight at 
37ºC in an orbital shaker incubator. After harvesting the cells at 3000g, 4ºC for 20 minutes 
(J6-MC centrifuge,  Beckman),  the cell  pellet was resuspended in buffer D1 (100 mM 
NaCl, 1.5 mM EDTA, 5 mM benzamidinium chloride, 1 mM PMSF, 0.1% Triton X-100, 
20 mM Tris, pH 8.0) and stored at -20ºC until further use.
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5.3.2 Protein expression for prohibitins
A single colony of transformed BL21(DE3) was picked from a plate to inoculate the 
preculture of 0.5-1L LB media containing 100µg/ml ampicillin.  After incubation over 
night at 37ºC in an orbital shaker, the preculture was diluted into 3L fresh LB media 
(containing 100µg/ml ampicillin) and grown at 37ºC until the OD600 exceeds 1. The cells 
were induced with 0.5mM IPTG (final concentration) and incubated for further 3 hours at 
37ºC.  The  cells  were  harvested  at  3000g,  4ºC  for  20  minutes  (J6-MC  centrifuge, 
Beckman).  The cell  pellet  was  resuspended in 20ml lysis  buffer  (25% sucrose,  1mM 
EDTA, 50mM Tris/HCl, pH 8.0, 1mM PMSF in isopropanol) and stored at -20ºC until 
inclusion bodies were prepared.
5.3.3 Preparation of inclusion bodies
The isolation of the inclusion bodies was carried out in accordance to a protocol provided 
by  C.  Rückert  (Institut  für  Immungenetik,  Universitätsklinikum  Charité,  Humboldt-
Universität zu Berlin, Germany) and as previously described in Garboczi et al., 1992 .
One  litre  frozen  cell  pellets  were  thawed,  resuspended  and  1ml  lysozyme  solution 
(10mg/ml lysozyme in lysis buffer) was added. After incubation on ice for 30 minutes, 
200µl 1M MgCl2 and 20µl 1M MnCl2 were added. The cells were then sonicated 5 times 
for 5 seconds each time at 35% amplitude, with 10 seconds break between the pulses to 
enhance the lysis process. The lysate was centrifuged for 10 minutes at 4°C, 10000 x g in 
a Beckman centrifuge J2-21,  to remove light cellular components and particles of the 
cytosole. The light brown pellet was then resuspended in 20 ml detergent buffer (200mM 
NaCl, 1% deoxycholic acid, 1% Nonidet-P40, 2mM EDTA, 20mM Tris, pH 8.0) with 
40µl 1M DTT. After another sonication step and centrifugation, the pellet was washed in 
20ml Triton buffer (100mM NaCl, 1mM EDTA, 0.5% TritonX-100, 50mM Tris, pH 7.5) 
with 40µl 1 M DTT and then sonicated again. Afterwards, the solution was incubated on 
ice for 10 minutes and centrifuged again. The washing step in Triton buffer followed by 
sonication and centrifugation was repeated two more times but without the incubation on 
ice. The last pellet (inclusion bodies) appeared to be white and was resuspended in 4ml 
inclusion bodies buffer (20mM Tris, 150mM NaCl, pH 7.5) with 40µl 1M DTT, aliquoted 
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to 1ml aliquots into microcentrifuge tubes and stored at -20°C. Stepwise  purification of 
the inclusion bodies was traced on SDS PAGE.
5.3.4 Refolding
Microcentrifuge tubes containing inclusion bodies were thawed, and centrifuged for 10 
minutes at 4°C, 10000 x g in a Biofuge fresco. The pellets were resuspended in 1ml urea 
buffer (8M urea, 50 mM NaCl, 20 mM Tris, pH 7.5) and incubated for 2 hours at room 
temperature while shaking. A centrifugation step in a Biofuge fresco for 20 minutes at 
10000 x g, 4°C, separates the supernatant containing BAP32 and BAP37 or their truncated 
forms from the inclusion body membrane. A refolding protocol was established according 
to the suggestions made by .  To avoid protein precipitation,  the protein solution was 
diluted with urea buffer to a concentration of ~1mg/ml protein. The proteins are refolded 
by  stepwise  dialysis  using  10  times  the  amount  of  refolding  buffer  compared to  the 
dialysis sample. The protein solution is transferred into a dialysis tube (heated 100mM 
EDTA for 10 minutes prior to use, MWCO 6000 – 8000Da) and dialysed against refolding 
buffer A (0.5M Tris, 20% glycerol, 1% Nonidet-P40, 150mM KCl, 1mM DTT, 0.113M L-
Arginine, 0.275M L-Serine, 11.86mM L-Histidine, pH is adjusted to 7.5) overnight at 4ºC. 
The  next  morning,  the  tube  is  transferred  into  fresh  refolding  buffer  A and  dialysis 
continues for at least another 8 hours at 4ºC. Finally, the dialysis tube is transferred into 
refolding  buffer  B  (150mM KCl,  100mM Tris,  10% glycerol,  1% Nonidet-P40,  pH 
adjusted to 8.0) and dialysed overnight at 4ºC. The content of the dialysis tube was applied 
to an equilibrated nickel column for protein purification (see section 5.4.1).
5.3.5 Protein expression in expression trials
A single colony of transformed BL21(DE3) was picked from a plate to inoculate the 
preculture of 20ml LB media containing 100µg/ml ampicillin. After incubation over night 
at 37ºC in an orbital shaker, 2ml of the preculture was diluted into 20ml fresh LB media 
(containing 100µg/ml ampicillin) and grown at 37ºC until the OD600 exceeds 1. A sample 
was taken (20µl) before the cells were induced. The cells were induced with varying final 
IPTG  concentrations:  0.125mM,  0.25mM,  0.375mM  and  0.5mM.  All  cultures  were 
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incubated for further 7 hours at 37ºC or 30ºC, and another sample was taken. The samples 
representing uninduced and induced cells were run on SDS-PAGE. After incubation over 
night at 37ºC or 30ºC, respectively, the cells were harvested for 15 minutes at 3000 x g, 
4ºC (J6-MC centrifuge, Beckman). The cell pellet was resuspended in 1ml lysis buffer 
(25% sucrose, 1mM EDTA, 50mM Tris/HCl, pH 8.0, 1mM PMSF in isopropanol) and 
subjected to three freeze-thaw cycles to lyse the cells. After centrifugation for 40 minutes 
at 13000rpm and 4ºC (Biofuge fresco), 20µl of supernatant and pellet were analysed on 
SDS-PAGE.
5.4 Protein purification and concentration
Annexin B1 and HisS6-FtsH-IMS were expressed as soluble proteins in the cell cytosol. 
Cells from expression experiments of both proteins were harvested and frozen at -20ºC. 
For purification, frozen cell pellets were thawed and refrozen three times to lyse the cells. 
Afterwards, the resuspended cell pellets were sonicated three times for 15 seconds on/ 15 
seconds  off  at  15  micron  amplitude.  High-speed  centrifugation  at  23000 rpm for  30 
minutes at 4ºC (Beckman centrifuge J2-21) separated the cell cytosol (supernatant) from 
insoluble  parts  of  the  cell  such  as  membranes  and  cell  organelles.  The  supernatants 
containing the proteins were subjected to individual purification protocols. Purification of 
annexin B1 included anion exchange and heparin affinity chromatography; whereas His6-
FtsH-IMS was purified employing immobilised metal affinity chromatography (IMAC) 
and anion exchange chromatography as a polishing step.
Prohibitins were subjected to immobilised nickel affinity chromatography after refolding 
of the proteins.
5.4.1 Immobilised metal affinity chromatography (IMAC)
IMAC is useful  for purifying histidine-tagged proteins, but generally applicable to most 
proteins with exposed histidine, cysteine, and tryptophan residues. The highly selective 
affinity depends upon the metal ion used such as Ni2+ and Co2+ which is bound to the 
chelating ligand nitrilotriacetic acid (NTA) on highly cross-linked agarose beads (Ni-NTA 
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Sepharose™ 6 Fast Flow, QIAGEN Ltd., Crawley, West Sussex, UK). Free coordination 
sites of the nickel ion interact with the imidazole rings of the histidine-tag thus binding the 
protein. Imidazole itself can also bind to the nickel ions, and can be used to elute the His6-
tagged protein. Other methods to elute the bound protein include reducing the pH to 4.5–
5.3 which will protonate the histidine residues or using reagents such as EDTA or EGTA 
to chelate the nickel ions, and this way removing them from the NTA groups including the 
protein. 
The  Ni-NTA resin  used  for  purifying  the  intermembrane  space  region  of  FtsH  was 
equilibrated with 20mM Tris, pH 7.5, 100mM NaCl. The supernatant from the high-speed 
centrifugation step was diluted 1:3 with 20mM tris, pH 7.5, 100mM NaCl and applied to 
the equilibrated column. The Ni-NTA resin was eluted with a step gradient of 20, 50, 100, 
150 and 250mM imidazole in 20mM Tris, pH 7.5, 100mM NaCl. 50ml imidazole solution 
was used for each step. Fractions were collected and proteins were detected using SDS-
PAGE. 
For purifying prohibitins, the Ni-NTA resin was equilibrated with refolding buffer B, and 
the contents  of the dialysis  bag after  refolding was applied onto the column. After a 
washing step with buffer B, the protein complex was eluted from the column with 50ml 
500mM imidazole in refolding buffer B. 
5.4.2 Anion exchange chromatography
In anion exchange chromatography, positively charged exchange groups are linked to a 
sepharose  resin  (Q-Sepharose,  Amersham Biosciences,  GE Healthcare  UK Ltd,  Little 
Chalfont, Buckinghamshire, UK) giving the resin an overall positive charge. Negatively 
charged patches in proteins can bind to the resin and thus attach the protein to the resin. 
Proteins can then be eluted with high salt solution such as 1M NaCl or a change in pH.
Anion exchange chromatography was employed as a second purification step for His6-
FtsH-IMS. Pooled fractions from the nickel affinity step were dialysed 1:10 over night at 
4ºC in 20mM tris, pH 9.0. After application onto the equilibrated column and washing, the 
protein was eluted using a linear gradient  from 0M to 1M NaCl in  20mM Tris, pH 9.0 
with a total volume of 400ml.
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Supernatant containing annexin B1 was dialysed 1:10 in equilibration buffer (20 mM Tris, 
pH 9.0) over night at 4 ºC. After applying the supernatant to the equilibrated column, the 
column was washed extensively with equilibration buffer. To elute the protein, 500ml of a 
linear  gradient  from 20mM to 1M NaCl  in  equilibration buffer  was  applied,  and the 
protein eluted from 150mM to 300mM NaCl. After  detecting the proteins using SDS-
PAGE, the protein containing fractions were pooled and dialysed against the equilibration 
buffer for heparin affinity chromatography as the next purification step.
5.4.3 Heparin affinity chromatography
Heparin Sepharose™ 6 Fast flow (Amersham Biosciences,  GE Healthcare UK Ltd, Little 
Chalfont, Buckinghamshire, UK) allows separation of biomolecules with an affinity for 
heparin, a naturally occurring glycosaminoglycan with a molecular weight distribution 
from 5kDa to 30kDa. 
Purification by heparin affinity chromatography was used as the second purification step 
in purifying wild type annexin B1. The pooled fractions obtained from the anion exchange 
step  were  dialysed  over  night  against the  equilibration  buffer  for  heparin  affinity 
chromatography (5mM CaCl2,  250mM NaCl,  50mM Tris,  pH 9.0) and loaded onto a 
heparin sepharose column. After extensive washing, the protein was eluted by applying 
buffer containing EDTA (10mM EDTA, 250mM NaCl, 50mM Tris, pH 9.0). Fractions 
were analysed on SDS-PAGE,  and annexin B1 containing  fractions  were pooled  and 
concentrated.
5.4.4 Nickel affinity chromatography batch experiment
Batch experiments were carried out to detect His6-tagged prohibitin proteins in a protein 
mixture.  700μl  of  Ni-NTA  resin  (Amersham  Biosciences)  was  transferred  to  a 
microcentrifuge tube and spun down for 3 minutes at 3000 x g, 4ºC in a Biofuge fresco. 
The supernatant was then removed, and the resin was washed 3 times with 500μl refolding 
buffer B. After the protein solution was applied onto the resin, the microcentrifuge tube 
was centrifuged  for 3 minutes at 3000 x g,  4ºC, and the first supernatant was kept as 
fraction  F.  Afterwards,  the  resin  was  washed  again  with  500μl  refolding  buffer  B. 
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Centrifuging the tube produced a second supernatant kept as fraction W. The proteins 
were  eluted  from  the  resin  by  adding  500μl  of  500mM  imidazole,  and  the  third 
supernatant after centrifugation was kept as fraction E. All fractions were analysed using 
SDS-PAGE.
5.4.5 Concentrating protein
Different methods can be employed to concentrate a protein sample such as ultra filtration 
or dialysis. Ultra filtration using Vivaspin (Vivascience) or Centricon (Millipore) devices 
removes species  smaller  than the molecular  weight  cut  off  of  the filtering device  by 
centrifugal force. Concentration using a dialysis tube in a bed of PEG, MW 20000, or in a 
highly concentrated sucrose solution might be preferred when the protein sample tends to 
stick  to  the  membranes  of  centrifugation  devices.  Here,  molecules  smaller  than  the 
molecular weight cut off of the dialysis membrane and water pass through the membrane 
driven  by  the  force  to  generate  a  concentration  equilibrium  with  the  surrounding 
environment.  On  the  other  hand,  small  molecules  present  in  PEG20K  or  sucrose 
molecules might pass through the dialysis bag in the other direction. In some cases, this 
might aid protein stability or solubility, but it is considered a contamination.
5.4.6 Determination of protein concentration
Concentrations of proteins were determined using UV spectroscopy and employing the 
Lambert-Beer-law. It describes the relationship between UV absorption of a sample with 
its concentration via the extinction coefficient: 
A = ε · c · d [1] 
The absorption, A, is the product of the extinction coefficient ε, the concentration c and 
the path length d. 
A  UV-spectrum of  the  protein  was  recorded  from 500nm to  210nm.  After  baseline 
correction, the absorption value was used to calculate the protein concentration.
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5.5 Gel electrophoresis
5.5.1 DNA gel electrophoresis
Mixtures  of  DNA fragments  can  be  separated  by  agarose  gel  electrophoresis.  When 
applying an electric field to a DNA mixture, the negatively charged DNA molecules will 
separate according to their size only because it is proportional to their charge. For 100ml 
of 1% agarose gel, 1g agarose was mixed with 100ml TAE buffer (40 mM Tris, 20 mM 
acetic acid (glacial),  1 mM EDTA, pH= 8.4) and heated in a microwave until  it  was 
dissolved. 8µl  SYBR Safe™ DNA gel stain (Invitrogen Corporation,  Paisley, UK) was 
added to the melted agarose in order to stain the DNA fragments for visualisation. The 
solution was poured into a horizontal gel chamber (SciePlas, Gentaur, Av. de l’Armèe 68, 
B-1040 Brussels, Belgium) and left to harden. After cooling, the comb is removed and the 
gel  placed  in  the  electrophoresis  apparatus.  Samples  were  mixed with  6  times  DNA 
loading dye (30% (v/v) glycerol, 0.25% (w/v) bromphenolblue, 0.25% (w/v) 0.1 g xylene 
cyanol), loaded onto the gel and subjected to electrophoresis. The gel was run in TAE 
buffer at 140V for 20 to 30 minutes using a Bio-Rad PowerPac. DNA was visualized 
using a UV transluminator and could be photographed using the gene flash imager. DNA 
that was used for further experiments could be excised and extracted from the agarose gel 
using  a  Qiagen  gel  extraction  kit  and  following  the  instructions  as  stated  in  the 
manufacturer’s protocol.
5.5.2 Reducing SDS-Polyacrylamid gel electrophoresis (SDS-PAGE)
In SDS-PAGE, proteins are separated according to their molecular weights. The protein 
samples are mixed with loading dye  (100mM Tris (pH= 6.8), 200mM DTT, 4% (w/v) 
SDS, 0.2% (w/v) bromphenolblue, 20% (w/v) glycerine ad 50ml H2O) that contains SDS 
and DTT. The negatively charged anionic detergent SDS denatures secondary and non–
disulfide–linked tertiary structures and thus applies a negative charge to each protein in 
proportion to its mass. This way, the distance of migration through the gel can be assumed 
to be directly related to the size of the protein. DTT reduces disulfide bonds, and heating 
of the samples for 5 minutes at 95ºC unfolds the proteins completely. Usage of a protein 
Anja Winter                                                                                                                                     218  
Structural Biology of Prohibitins and Annexin B1
size marker allows an estimation of the molecular weight of the proteins in question. 8 
SDS-PA gels were prepared in a caster using the following recipe:
Table 5-4: Recipe for reducing and denaturing SDS-PAGE
Separation gel Stacking gel
Ingredient 16% 14% 12% 5%
H2O 24ml 30ml 36ml 41.6
2M TRIS (pH 8.8) 17ml 17ml 17ml -
1M TRIS (pH 6.8) - - - 7.5 ml
SDS (10%) 0.9ml 0.9 ml 0.9 ml 0.6 ml
AA / Bis-AA 48 ml 42 ml 36 ml 10 ml
APS 200µl 200µl 200µl 200µl
TEMED 100µl 100µl 100µl 100µl
First, the separation gel was prepared. When polymerised, the stacking gel was poured on 
top  of  the  separation  gel,  and  the  combs  were  placed.  After  the  stacking  gel  was 
polymerised, the comb could be removed leaving wells for loading the samples. The gel is 
placed  vertically  in  the  electrophoresis  apparatus,  and  both  chambers  are  filled  with 
running buffer (25mM Tris, 250mM glycine, 0.1% (w/v) SDS). An electric field of 140V 
was applied for 1 hour causing the negatively-charged proteins to migrate across the gel 
towards  the anode.  All  gel  equipment  was  from Hoefer Inc,  953 Indiana  Street,  San 
Francisco, CA 94107, USA. SDS-PAGEs were stained with Coomassie solution (2.5 g 
Coomassie Brilliant Blue R250, 100 ml HAc (glacial), 450 ml MeOH, 450 ml H2O) for 20 
minutes and destained with destaining solution (250ml methanol, 80ml acetic acid brought 
up to 1L with water) over night. 
Prohibitins and annexin B1 were mostly run on a 12% or a 14% gel, whereas FtsH-IMS 
was run on 16% SDS PAGEs. 
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5.5.3 Non-reducing SDS-PAGE
Non-reducing SDS-PA gel was used to investigate DTT dependent oligomer formation of 
annexin B1. The gel was prepared like a reducing SDS-PA gel but no DTT was used in 
the protein loading dye. The samples were denatured using SDS in the gel and in the 
loading dye. Furthermore, the samples were also heated prior to use. The gels were run in 
running buffer (25mM Tris, 250mM glycine, 0.1% (w/v) SDS) at 140V for 1 hour and 
treated as stated above.
5.5.4 Native gel electrophoresis
In native gels, proteins separate according to their size, shape and natural charge. Native 
gals were prepared as stated for SDS-PAGEs (see section 5.5.2.) but SDS was replaced by 
the respective amount  of  water.  Protein samples were mixed with native loading dye 
(100mM TRIS (pH= 6.8),  0.2% (w/v) bromphenolblue,  20% (w/v) glycerine ad 50ml 
H2O), and the samples were not heated. After assembling the gel in the electrophoresis 
apparatus, the gel was run in native running buffer (25mM Tris, 250mM glycine) for up to 
6 hours at 80V and room temperature. Gels were stained with Coomassie solution for 20 
minutes and destained with destaining solution.
5.6 Biochemical assays
5.6.1 Western Blot
The SDS-PAGE was blotted onto a PVDF membrane using a current of 30mA for 60 
minutes. The PVDF membrane was stained with Coomassie solution for a few seconds 
and destained extensively with destaining solution.
5.6.2 Co-pelleting assay
To assess  the  membrane  binding  behaviour  of  annexin  B1,  a  co-pelleting  assay  was 
conducted in accordance to a protocol established by Hofmann & Huber in 2003. In this 
assay, the protein is co-pelleted with lipid vesicles by centrifugation at ultra-high speed, 
and the amount of protein copelleted with liposomes can be quantified directly using 
densitometric analysis of a SDS-PAGE. Phospholipid vesicles were prepared from 1,2-
Anja Winter                                                                                                                                     220  
Structural Biology of Prohibitins and Annexin B1
dioleoyl-sn-glycero-3-phosphoserine  (PS)  and 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(PC) (both from Avanti Polar Lipids Inc.,  Alabaster, Alabama, USA) according to the 
protocol  by  Reeves  & Dowben .  The  vesicles  were  converted  into  large  unilamellar 
vesicles (LUVs) by five freeze-thaw cycles and subsequent extrusion (11 times) through 
0.1 µm filter membranes using an extruder (Avanti Polar Lipids Inc., Alabaster, Alabama, 
USA) at 37°C. A total of 0.2µmol phospholipids for each individual sample (500µl) was 
mixed with protein buffer with varying calcium concentrations (0, 1, 2, 10 and 20mM). 
Afterwards, 0.5nmol protein in liposome buffer is added to each sample. It binds to the 
liposomes according to the calcium concentration in the buffer. As a control, a sample of 
0.1nmol protein in 100µl of 10% SDS was prepared at this stage (master sample). All 
samples were incubated for 10 minutes and centrifuged for 45min and 13000rpm at 4°C to 
remove unbound protein from the liposome suspension.  The pellets were resuspended 
with 50µl of 10% SDS and subjected to SDS-PAGE to detect the remaining protein (see 
figure 5-2). 
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Figure  -2:  Co-pelleting assay.  Top panel-  Microtest tubes containing liposomes and protein at 
different calcium concentrations. Middle panel – Calcium-dependent binding to liposomes. Bottom 
panel – Detection of liposome-bound protein using SDS PAGE. Figure prepared by N.-J. Hu.
Gels were stained with Coomassie solution, destained with destain solution and analysed 
densitometrically using the programme ImageJ . Each calcium concentration was assessed 
three times independently. Curve fitting was performed with SigmaPlot .
5.6.3 Heparin binding assay
For assessing calcium-dependent binding of annexin B1 to heparin, a centrifugation assay 
using heparin sepharose was developed. 1 ml suspension of  heparin Sepharose™ 6 Fast 
flow (Amersham Biosciences, GE Healthcare UK Ltd, Little Chalfont, Buckinghamshire, 
UK) was equilibrated by washing three times with 3.5 ml protein buffer (100mM NaCl, 
20mM Tris, pH 8.0) and subsequent centrifugation at 3000rpm and 3min, at  4°C. The 
resin  was  resuspended in  4  ml  protein  buffer  and  distributed into  six  aliquots.  After 
centrifugation,  the supernatant  was removed,  and the resin was resuspended in 390µl 
protein buffer containing varying concentrations of calcium (0, 0.5, 1, 2, 5 and 10mM). 
Finally,  10μl  of  the protein (1mg/ml – 5mg/ml)  was added to each aliquot.  After  10 
minutes incubation at room temperature, the samples were subjected to centrifugation and 
the supernatant removed. The pellets were then washed with 400µl protein buffer with the 
appropriate calcium concentration and the samples were centrifuged again.  The protein 
was eluted from the resin with 400μl of protein buffer containing 30mM EDTA. The 
amount of reversibly bound annexin could be determined by running the supernatant from 
the EDTA elution on SDS-PAGE (see figure 5-3) and analysing the protein bands by 
densitometric analysis using the programme ImageJ .  Each calcium concentration was 
assessed three times independently. Curve fitting was performed with SigmaPlot .
Figure  -3: Example of an SDS PAGE for Heparin binding assay. Shown are supernatants from 
EDTA elutions.
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5.6.4 Chemical cross linking
Cross-linking reagents contain reactive ends that  are able to form a covalent  bond to 
specific functional groups (primary amines, sulfhydryls, etc.) on proteins. Using analytical 
methods such as trypsin digest and mass spectrometry on the covalently linked protein 
molecules, protein interfaces can be determined. Annexin B1 was cross-linked using the 
reagents listed in table 5-5 also stating their specificity and reaction conditions.






Bissulfosuccinimidyl (BS3) lysine 8 PBS pH 8.0 1M TRIS pH 7.5
Dimethyl suberimidate (DMS) Primary amines 35.7 PBS pH 8.0 1M TRIS pH 7.5
Dithiobis[succinimidylproprionate] 
(DSP)



















10 MES pH 6.0 1M TRIS pH 7.5
Glutaraldehyde (GA) Non specific 100% PBS pH 8.0 1M TRIS pH 7.5
Reactions of all cross-linkers except glutaraldehyde were set up with 4mM cross-linker, 
0.04mM protein and the appropriate amount of buffer giving a total volume of 20µl. The 
samples  were incubated at  room temperature or  at  4ºC for  varying amounts of  time. 
Glutaraldehyde was used as 0.1% of the total reaction volume. Reactions were quenched 
with either 1µl of 1M TRIS pH 7.5 or 0.28µl of 10%  -mercaptoethanol. All samples 
were analysed on a  denaturing SDS-PAGE under  reducing conditions except  samples 
cross-linked with DSP which would be cleaved by DTT.
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5.7 Biophysical experiments
5.7.1 Mass spectrometry
Mass  spectrometry  is  an  analytical  tool  used  for  determining  the  molecular  mass  of 
peptides or proteins in a sample to a great accuracy. Mass spectrometers can be divided 
into three fundamental parts, namely the ionisation source, the analyser, and the detector. 
In  electrospray  ionisation  mass  spectrometry  (ESI-MS),  the  liquid  protein  sample  is 
ionised  when  it  is  forced  through  a  small  capillary  and  evaporates  into  a  gas-filled 
chamber. When the protein exists as a lone ion, it moves to the analyser. This method is 
used to determine the full-length mass of the protein by obtaining mass spectra. In the case 
of peptide analysis by Matrix Assisted Laser Desorption Ionisation (MALDI), molecules 
in  the  sample  are  ionised  due  to  bombardment  with  a  pulsed  nitrogen  laser  with  a 
wavelength  of  337nm producing  mostly  single  protonated  molecules.  This  method is 
mainly  used  to  analyse  proteins  and  peptide  fragments.  All  mass  spectrometry 
experiments were carried out at the COIL facility, University of Edinburgh where a time-
of-flight analyser (TOF) measured the time it took for the peptide ions to travel through a 
field free region known as the flight, or drift, tube under high vacuum.  Here, particles 
were separated according to their mass-to-charge (m/z) ratios. After inserting the plate in 
the mass spectrometer, the laser was fired, the energy arriving at the sample/matrix surface 
optimised, and data accumulated until an m/z spectrum of good intensity and signal-to-
noise-ratio had been amassed as judged by eye. The m/z scale of the mass spectrometer 
was calibrated with either myoglobulin (full-length protein analysis) or trypsin digested 
trypsin (peptide analysis).  Trypsin calibration was done either independently (external 
calibration) or pre-mixed with the sample (internal calibration). The spectra were analysed 
using  the  software  Data  explorer   and  compared  to  the  peptide  data  base  SwissProt 
(www.expasy.org).
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5.7.1.1 ESI-MS  
Full-length of annexin B1 was analysed by Sam Clokie in the COIL facility, University of 
Edinburgh, and the result was presented as a spectrogram including mass values for the 
respective peak.
5.7.1.2 MALDI-MS  
Full-length protein analysis  of HIS6-FtsH-IMS was done using MALDI-MS. Different 
dilutions of sample were used in the experiment, the highest being 3µl of 10mg/ml protein 
mixed with 27µl of 50mM ammonium bicarbonate (ABC). After spotting 0.5µl of the 
protein sample onto the plate, it was covered with 0.5µl of sinapinic acid serving as a 
matrix. The sample was allowed to dry prior to insertion into the mass spectrometer. 
For  analysing  peptides,  the  protein  was  digested  with  trypsin,  a  serine  protease  that 
specifically cleaves at the carboxylic side of lysine and arginine residues with stringent 
specificity.  The  peptides  gained  from in-solution  or  in-gel  digestion  are  purified  and 
concentrated, then analyzed by mass spectrometry to determine their molecular masses. 
The  list  of  peptide  masses  obtained  from  the  experiment  was  analysed  using  the 
programme Data Explorer ,  and peaks were compared to the Mascot database  or the 
peptide data base SwissProt (www.expasy.org). Protein samples were digested using three 
different protocols depending on digestion in-solution or in-gel and the sample quality. 
After  digestion  over  night,  0.5µl  of  the  reaction  mix  and  0.5µl  of  -cyano-4-
hydroxycinnamic acid (CHCA) were spotted on a gold plate, left to dry and inserted into 
the mass spectrometer.
For basic in-solution digestion, 1µl porcine trypsin (Roche) was added to 3µl of 10mg/ml 
protein premixed with 27µl of 50mM ammonium bicarbonate and incubated over night at 
32ºC. For better resolution in the mass spectrogram, beneficial in case of a low quality 
sample, 3µl of 10mg/ml protein was mixed with 27µl of 50mM ammonium bicarbonate. 
DTT was added to a final concentration of 5mM and the sample was heated to 60ºC for 30 
minutes. After cooling down to room temperature, iodoacetamide was added to a final 
concentration of 15mM, and the sample was incubated for 30 minutes in the dark at room 
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temperature. Afterwards, 1µl trypsin was added and the sample was either incubated at 
37ºC for 2 hours or at 32ºC overnight to gain the desired peptides.
For in-gel digestion, a SDS-PAGE was run, stained with GelCode Blue Stain Reagent and 
destained with water. The protein bands were cut out tight and placed in a microcentrifuge 
tube. 300µl buffer1 (200mM ammonium bicarbonate in 50% acetonitrile) were added to 
the samples and left to incubate at room temperature for 30 minutes. This was repeated 
twice to remove all SDS in the gel. The gel was incubated in 300µl buffer 2 (200mM 
DTT,  200mM ammonium bicarbonate,  50% acetonitrile)  for  one  hour  to  reduce  the 
protein. The gel was washed three times in 300µl buffer 1 before alkylating the cysteines 
in  100µl  buffer  3  (50mM  iodoacetamide,  200mM  ammonium  bicarbonate  in  50% 
acetonitrile) at room temperature in the dark for 20 minutes. The gel pieces were washed 
three  times  with  500µl  buffer  4  (20mM ammonium bicarbonate  in  50% acetonitrile) 
before cut into 2mm x 1mm big pieces. After spinning down at 13000rpm and 4ºC using a 
bench top centrifuge, the supernatant was removed and the gel pieces covered with 100% 
acetonitrile. The gel pieces shrink and turn white from dehydration. The acetonitrile is 
then removed, and the gel pieces are allowed to dry. Gel pieces are swollen in trypsin 
solution (1µl  trypsin  stock  solution and 29µl  50mM ammonium bicarbonate)  at  4ºC. 
Finally,  the  samples  are  incubated  at  32ºC for  22  hours.  The  next  day,  samples  are 
sonicated shortly prior to spotting onto the plate.
Results were analysed using the probability based Mowse score, -10*log(P), where P is 
the probability that the observed match is a random event. Scores greater than 67 are 
considered  significant  (p<0.05)  and  indicate  that  the  protein  is  the  most  probable 
identification.
5.7.2 Circular dichroism spectroscopy
Circular  dichroism (CD)  is  a  phenomenon  resulting  from  the  interaction  of  circular 
polarised light with chiral molecules such as amino acids. The amide groups of the peptide 
bonds are the actual chromophors in CD. The chiral centres of the protein molecules affect 
the velocity of the right- and left-handed component of the circular polarised light leading 
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to  a  difference  in  absorption  of  both  components  which  is  measured.  The  restricted 
arrangement of the amino acids/ peptide bonds in secondary structure elements in proteins 
is also an influential factor in CD causing coupling of absorption effects by the peptide 
bonds. Consequently, the shape of the resulting CD spectrum allows conclusions towards 
the  presence  of  a  secondary  structure  element  such  as  -helix  and  -sheet.  Proteins 
containing multiple secondary structure elements show a superposition of their respective 
spectra.
A CD cuvette with a light path of 1mm (Hellma GmbH & Co. KG, Müllheim, Baden, 
Germany) and a Jasco J-810 spectropolarimeter equipped with a Peltier element were used 
for all experiments. The data collected in CD experiments were deconvoluted using the 
programme ACDP  to calculate mean residue ellipticity, mean , thus normalising the data 
against path length, protein concentration and extinction coefficient of the protein.
5.7.2.1 Wavelength scan  
Wavelength scans were performed by measuring the CD signal in the wavelength range 
from 260nm to 190nm or 200nm at a set temperature, e.g. 20ºC. After transformation of 
the data into mean residue ellipticity using the programme ACDP , the secondary structure 
was predicted using implementations of the K2D algorithm and Fasman deconvolution in 
the programme.
CD wavelength spectra of annexin B1 (1.8 µM) were recorded either in buffer 1 (50 mM 
NaCl, 5 mM Tris, pH 8.0) or in buffer 2 (20mM NaCl, 5mM Hepes, pH 7.5). Experiments 
in the presence of calcium or DTT were carried out with the addition of 5mM CaCl2 or 
1mM DTT in the buffer, respectively. 
Wavelength spectra of His6-BAP32(1-30):BAP37(1-40) were recorded in 100mM Tris, 
pH 7.5, 100mM KCl at a protein concentration of 0.054mg/ml.
CD  signals  of  His6-FtsH-IMS  region  were  monitored  at  a  protein  concentration  of 
0.04mg/ml in 5mM Hepes, pH 7.5, 20mM NaCl.
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5.7.2.2 Temperature scan  
Denaturation  curves  provide  valuable  information  about  the  protein,  its  fold  and 
conformational stability. They are very helpful in measuring differences in conformational 
stability between folded and unfolded protein and how modifications of the protein might 
influence both conformational states. Even though equilibrium measurements are made, 
conclusions about the mechanism of the folding of the protein can be drawn, e.g. how 
many separate folding units are present in the protein and how stable they are in relation to 
each other. And finally, unexpected results may provide valuable information about the 
protein  such  as  a  possible  influence  of  disulphide  bonds  on  the  protein  stability.  In 
general, the greater the change in a physical property of a protein is when it unfolds, the 
more usable is the technique for following unfolding. 
A folded protein can be unfolded either by heating (thermal unfolding) or by adding a 
denaturant such as urea (chemical unfolding). Secondary structure elements show spectra 
with specific minima, 208nm and 222nm for  -helices, and 216nmforsheets which 
can be used to monitor unfolding. The wavelength for recording the temperature scan was 
chosen by the criterion of a large difference between thre CD signal of the protein at low 
temperature  (10ºC)  compared  to  the  CD  signal  at  high  temperature  (90ºC).  The 
temperature scan was performed by measuring the CD signal at that specific wavelength 
in  the  temperature  range  from 10ºC or  20ºC to  80ºC.  Data  were  recorded using  the 
following parameters: temperature slope 1K/minute or 20 K/hour and a data pitch of 0.5 or 
0.2. For investigation of the thermal denaturation of FtsH-IMS region and annexin B1, the 
CD signal at 222nm was recorded whereas the unfolding behaviour of the BAP complex 
was  monitored  at  216nm.  Unfolding  experiments  were  performed  three  times 
independently. Changes in the CD signal were used to construct an unfolding curve which 
was fitted with SigmaPlot  using a sigmoidal equation. 
5.7.3 Fluorescence spectroscopy
Absorption of light with a wavelength in the range of ultra violet or visible light leads to 
excitation  of  electrons  in  a  protein  molecule.  Fluorophores  in  a  protein  are  tyrosine, 
phenylalanine and tryptophane side chains. When the molecule returns to its ground state, 
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fluorescence might occur. Fluorescence is characterised by a) an independence of emitted 
light with regards to the excitation wavelength, b) a shift towards higher wavelengths of 
the  emitted  spectrum  as  compared  to  the  absorption  spectrum  and  c)  a  mirrored 
progression of both spectra when because the excited state and the ground state show 
similar vibration structures.
Changes  in  the intrinsic  protein fluorescence that  occurred during  chemical  unfolding 
were  monitored  by  fluorescence  spectroscopy  using  urea  as  denaturant  at  various 
concentrations. 2µl of 1.3mg/ml annexin B1 were added to 298µl buffer containing urea at 
concentrations from 0 to 8M in 0.5M increments and incubated for 1.5 hours at room 
temperature to reach equilibrium. Samples were measured in a Fluoromax spectrometer by 
Jobin Yvon using a quartz cuvette (Starna). Unfolding experiments under 1mM DTT or 
5mM CaCl2 were carried out by adding 1µl 300mM DTT or 1.5µl 1M CaCl2 to the sample 
tubes.  Samples  were  incubated with the respective  agent  and urea 1.5 hours  prior  to 
measurement  to  reach  equilibrium,  and  measured  with  two  different  excitation 
wavelengths, at 280nm and at 295nm. Emission was monitored from 300nm to 400nm for 
the excitation wavelength at 280nm (experimental setup A), and from 310nm to 400nm 
for excitation at 295nm (experimental setup B). Experiments were repeated three times 
independently. In order to determine changes in fluorescence intensity and the spectrum 
itself,  the quotient  of fluorescence intensities at  the respective wavelength maxima of 
folded (0M urea) and unfolded (8M urea) protein was used. All curves were generated and 
fitted  with  SigmaPlot   using  a  sigmoidal  equation  to  determine  c1/2(urea),  the  urea 
concentration at which half of the protein is denatured. 
5.7.4 Gel filtration analysis
A Superose® 12 HR 10/30 column (Amersham Biosciences, GE Healthcare UK Ltd, Little 
Chalfont, Buckinghamshire, UK) was run on a Biocad® 700e Workstation or a BioLogic® 
HPLC syatem (Biorad)  allowing a  separation in  the range of 1kDa-3kDa.  The cross-
linked,  agarose-based  Superose  resin  consists  of  beads  of  a  narrow  particle-size 
distribution of 8-12µm in diameter. Separation is achieved by filtering the sample through 
a tightly packed network of beads, allowing large particles to leave the column quickly, 
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whereas small particles remain longer on the column, and thus are eluted with longer 
separation times.
Gel filtration experiments were carried out to investigate dimer formation of annexin B1 
under different buffer conditions. Gel filtration buffers consisted of 20mM Hepes, pH 7.5 
and 100mM NaCl completed with 1mM DTT,  5mM, 15mM calcium chloride,  20mM 
EDTA, or 0.8mM H2O2 depending on the experiment carried out. His6-FtsH-IMS region 
was  run  in  20mM  HEPES,  pH  7.5  and  100mM  NaCl.  Preparative  size  exclusion 
chromatography  was  used  to  separate  refolded  His6-BAP32(1-30):BAP37(1-40) 
complex from His6-BAP32(1-30) or BAP37(1-40) monomers using their different size 
and shape. The running buffer consisted of 20mM TRIS, pH 7.5 and 100mM KCl. All 
buffers were filtered through a 0.22m filter (Whatman) and degased before use.
Gel filtration experiments were performed at a flow rate of 0.5ml/min. After equilibrating 
the column with up to three column volumes of buffer (~ 75ml), 1ml of sample was 
loaded. Proteins were separated on the column for 2 column volumes, and their absorption 
was monitored at 280nm. All sample runs were analyzed using the programme PeakFit 
version 4.0  to determine the maximum of the elution peak.
5.7.4.1 Relating elution volumes to molecular weight values  
In  order  to  estimate the sizes  of  molecules  eluted from the column,  the column was 
calibrated with Dextran Blue (2MDa), albumin (62kDa) and chymotrypsinogen A (25kDa) 
or  Dextran  Blue  (2MDa),  aldolase  (160kDa),  BSA (68kDa),  myoglobin  (17kDa)  and 
cytochrome C (12.4kDa) using the same general setups of the runs. In different calibration 
experiments, Dextran Blue eluted with 7.82 ml to 8.14ml in different calibration runs 
which represents the void volume of the column (1st peak, figure 5-4, A). All calibration 
proteins are of globular shape, and therefore the experimentally determined relationship 
between molecular weight of the protein and its retention time from the column is only 
valid for globular proteins.
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Figure -4: Calibration of Superose 12 HR 10/30 column using known protein standards.
The elution volumes of the proteins were used to calculate  the gel  phase distribution 
coefficient, Kav, values using the formula:
Kav=(Ve-Vo)/(Vt-Vo) [2]
where Ve is the volume at which the protein elutes, Vo is the void volume and Vt the total 
column volume (bed volume). Kav values were plotted against the respective molecular 
weights  on  a  logarithmic  scale.  The  data  were  fitted  with  Excel  using a  logarithmic 
regression (see figure 5-4, B). The equation of the trend line was subsequently used to 
determine the molecular weight of proteins in question.
5.7.4.2 Relating elution volume to Stokes’ radius  
In  cases  of  elongated proteins  or  denatured proteins  where calibration using globular 
shaped proteins fails, it can be useful to relate the elution volume to another molecular 
parameter,  the Stokes’ radius Rs.  For  elongated proteins,  the Stokes’ radius would be 
higher than the radius of a globular protein of the same molecular mass. 
The Stokes’ radius for albumin and chymotrypsinogen are known to be 35.5Å and 20.9Å, 
respectively, and can be used to create a plot of Rs vs. (-log(Kav))1/2 (Figure 5-5). The data 
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points  were fitted in Excel using a linear regression.  Stokes’ radius of  the protein in 
question can be calculated from the respective equation. 
Figure -5: Plot for calculating Stokes’ radii.
5.7.5 Small angle X-ray scattering (SAXS)
SAXS experiments were carried out by our collaborator, Jan Skov Pedersen at University 
of  Aarhus  in  Denmark.  It  is  a  technique  where  X-rays  (wavelength  0.1  to  0.2nm) 
experience elastic  scattering by a  non-crystalline sample that  is  recorded at  very low 
angles  (typically  0.1°  -  10°).  This  way,  structural  information  on  the  order  of 
submicrometers (50Å to 250Å) can be obtained allowing conclusions about the shape and 
size of macromolecules such as proteins. His6-FtsH-IMS region was subjected to SAXS at 
concentrations of 10mg/ml, 5mg/ml and 2.5mg/ml. Data showing least aggregation were 
obtained at 5mg/ml. They were improved by excluding some data points at the beginning 
of the scattering curve eliminating contributions from aggregates and higher oligomers, 
and were analysed by the collaborators using the programme Gnom . From the data, a 
reference  model  could be created employing the dummy bead programme Dammin . 
Using the information of the protein sequence, the dummy residue programe Gasbor was 
used to create the most probable model of an His6-FtsH-IMS region dimer. The results 
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were presented by the collaborator as a report showing both the data curves and calculated 
models. 
5.8 Crystallography
Crystallography is the experimental science of determining the arrangement of atoms in 
solids (crystals). In a protein crystal, X-rays are scattered by the electrons of all atoms 
leading to an overall scattering pattern as waves will add constructively or destructively to 
varying degrees. This diffraction of the unit cell is repeated on a lattice that determines the 
space group. The combination of the diffraction pattern resulting from the unit cell and the 
diffraction pattern resulting from the lattice gives the diffraction pattern of the complete 
crystal. The diffraction pattern of a crystal can be expressed mathematically, and an image 
of the crystal structure can be calculated. In X-ray experiments, only the structure factor 
amplitudes can be measured directly whereas the phases remain to be determined by other 
methods (phase problem). Methods used in macromolecular crystallography include use of 
anomalous  dispersion  (MAD),  isomorphous  replacement  (SAD)  and  molecular 
replacement.
5.8.1 Crystal growth using the hanging drop method
The hanging drop method is based on vapour diffusion, where water diffuses from a mix 
of protein solution and screening solution into a solution with higher concentration. As the 
protein concentration in the drop increases, a precipitant in the screening solution induces 
formation of the protein crystal.
The protein solution was mixed with a screening solution forming a drop that is placed on 
a glass slide. In a usual setup, the ratio between protein solution and screening solution 
was 1:1. The glass slide was turned upside down and used to seal a well containing 300l 
of  the screening solution (hanging drop).  Crystallisation trials  were set  up in 24-well 
plates  (Hampton  Research)  using  high  vacuum  grease  as  sealant.  The  plates  were 
incubated at 16ºC and evaluated under the microscope for crystal growth. Annexin B1 was 
the only protein within this work from which a crystal could be obtained.
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5.8.2 Crystal mounting and data collection
Once a crystal was produced, it was placed on a synthetic CryoLoop (fishing), soaked 
shortly in cryo-protectant (70l  screening solution and 30l  75% glycerol),  and shock 
frozen in liquid nitrogen. Crystals were mounted onto the goniometer head of the in-house 
diffractometer (Rigaku generator, MAR Research Image Plate) under a constant flow of 
liquid nitrogen, and X-rays of 1.5418nm were applied (screening). Crystals showing a 
protein diffraction pattern (multiple ordered spots) were dismounted, and a data set was 
collected at a synchrotron facility. The dataset of annexin B1 with the highest resolution 
was recorded at the ESRF in Grenoble at beam line BM14 with a wavelength of 0.978nm.
5.8.3 Data analysis
Datasets  were  analysed  by  Mosfilm   to  index  the  spots,  predict  a  space  group  and 
determine the unit cell parameters. 
5.9 Computational methods
5.9.1 Alignments and secondary structure prediction 
Multiple sequence alignments were generated using ClustalW . The multiple sequence 
alignment of the PHB domains of BAP32,  BAP37 and flotillin-2 was generated with 
MUSCLE   and  slightly  adjusted  to  match  conserved  secondary  structure  elements 
especially in the PHB domain. The secondary structures were predicted using PSIPRED .
5.9.2 Homology modelling and refinement
PHB domains of BAP32 and BAP37 were modelled on the NMR structure of the PHB 
domain of mouse flotillin-2 PDB accession number  1WIN)  whereas annexin B1 was 
modelled to the crystal structure of annexin A5 (PDB accession number 1AVR). Twenty 
independent  homology models were calculated with the programme Modeller  4 ,  and 
models with the lowest energy were selected, visually inspected with O  and subjected to 
further energy minimization using CNS .  The overall  geometry was scrutinized using 
PROCHECK  .  Angles   and   of  amino  acids  were  analysed  by  drawing  a 
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Ramachandran plot using PROCHECK  in order to expose any tension in the protein main 
chain which would indicate a bad model in this area of the protein. Models of BAP32(49-
194),  BAP37(59-207),  annexin  B1(24-347)  were  generated.  Surface  properties  and 
electrostatic characteristics were analysed using PyMol . 
5.9.3 Modelling of protein:protein interactions
The  modelled  structures  of  BAP32  and  BAP37  were  subjected  to  an  automated 
macromolecular docking calculation with the programme Hex  in order  to investigate 
potential interaction sites. Hex differs from other macromolecular docking programs in its 
use of polar Fourier correlations to accelerate docking calculations. Hex was run with its 
default  settings  and taking surface electrostatics  into account.  BAP32 was defined as 
protein, BAP37 was defined as ligand. 
Models  for  BAP32:BAP37 complexes  were  also  constructed  manually  by  rigid  body 
movements using the graphics programme O  based on the crosslinking study by Back and 
colleagues  .  The  initial  model  was  subjected  to  molecular  dynamics  simulations  in 
GROMACS . The simulations (50 ps, 500 ps) were carried out using a model with explicit 
solvation and without superimposing any user-defined distance restraints.
The dimer of the N-terminal BAP helices was constructed using -helices generated with 
GARLIC  which were oriented as rigid bodies in  the programme O  to yield a first 
approximation of a helix dimer. The raw model was then subjected to molecular dynamics 
simulations in GROMACS .  No user-defined distance restraints  were applied and the 
simulations were carried out  in vacuo  for 50ps and 500ps, respectively. The molecular 
dynamics simulations were analysed using the tools included in GROMACS , as well as 
VMD  and O . Surface properties and electrostatic characteristics were analysed using 
PyMol .
5.9.4 Modelling of protein - ligand interactions
An automated docking approach was employed to investigate the interaction between 
BAP32  and  its  ligand  melanogenin  using  the  programme  FlexX .  First,  the  BAP32 
homology model was visually inspected and potential binding sites were identified by 
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surface  analysis.  Then,  the  three-dimensional  molecule  structure  of  melanogenin  was 
created and subsequently optimized by energy minimisation with Sybyl . After site point 
generation within the docking programmes, the ligand was fitted into the binding pockets 
based on chemical and shape complementation. The resulting models were analysed with 
Sybyl . 
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6 Appendix
6.1 Ramachandran Plots
Ramachandran  plots  of  homology  models  of  BAP32(49-194),  BAP37(59-207)  and 
annexin B1(24-347)
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Annexins are water-soluble, calcium-dependent phos-
pholipid-binding proteins. Members of the annexin
family are ubiquitously distributed in different tissues
and cell types of higher and lower eukaryotes. To date,
over 160 unique annexin proteins have been found in
more than 65 different species ranging from fungi and
plants to nonvertebrates and higher vertebrates [1].
Their abundance, as well as their calcium-regulated
presence at cell membranes, makes members of this
family versatile adapter and regulator proteins in
membrane-associated processes. Accordingly, a role in
endo- and exocytosis has been assigned to many ann-
exin proteins [2,3]. Despite being intracellular proteins,
extracellular functions have been described for several
annexins. Whereas annexin A2 is known to act as a
coreceptor for plasminogen and tissue plasminogen
activator on the surface of endothelial cells [4], annex-
in A1 has been observed to bind to an extracellular
domain of b2 integrin [5]. Annexin A5 was found to
bind to the intracellular part of the b5 integrin receptor
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Annexin B1 from Cysticercus cellulosae has recently been identified using
immunological screening in an attempt to find novel antigens for vaccine
development against cysticercosis. The protein possesses anticoagulant
activity and carries significant therapeutic potential due to its thrombus-
targeting and thrombolytic properties. We investigated the biochemical
properties of annexin B1 using liposome and heparin Sepharose copelleting
assays, as well as CD spectroscopy. The calcium-dependent binding to aci-
dic phospholipid membranes is reminiscent of other mammalian annexins
with a clear preference for high phosphatidylserine content. A unique prop-
erty of annexin B1 is its ability to bind to liposomes with high phosphat-
idylserine content in the absence of calcium, which might be due to the
presence of several basic residues on the convex protein surface that har-
bours the membrane-binding loops. Annexin B1 demonstrates lectin prop-
erties and binds to heparin Sepharose in a cooperative, calcium-dependent
manner. Although this binding is reversible to a large extent, a small frac-
tion of the protein remains bound to the glycosaminoglycan even in the
presence of high concentrations of EDTA. Analogous to annexin A5, we
propose a model of heparin wrapped around the protein thereby engaging
in calcium-dependent and calcium-independent interactions. Although the
calcium-independent heparin-binding sites identified in annexin A5 are not
conserved, we hypothesize three possible sites in annexin B1. Results from
CD spectroscopy and thermal denaturation indicate that, in solution, the
protein binds calcium with a low affinity that leads to a slight increase in
folding stability.
Abbreviations
LUV, large unilamellar vesicle; PtdCho, phosphatidylcholine; PtdSer, phosphatidylserine.
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subunit [6]. Annexins A2 and A5 have repeatedly been
reported to act as cellular receptors for cytomegalo-
virus and hepatitis B virus [7–9], although this is still
a matter for discussion within the community. Fre-
quently, annexins are found to interact with cytoskele-
tal proteins. Annexins A1 [10] and A2 [11], as well as
the plant annexins p34 and p35 from tomato [12], exhi-
bit binding to F-actin, and others, for example plant
annexins from corn [13], bell pepper [14] and cotton
[15], tested negative in this context. Interactions
between annexin A1 and profilin have also been dem-
onstrated [16].
The glycosaminoglycan heparan sulfate is ubiqui-
tously distributed on the surface of cells and acts as a
regulator of ligand–receptor encounters [17], promotes
protein assembly [18] and thus coordinates a variety of
cellular functions. Heparan sulfate has a variable hep-
arin-like structure but more N-acetylated and fewer
N- or O-sulfonated groups than heparin. Heparin itself
is a highly potent anticoagulant due to its ability to
activate serine protease inhibitors such as antithrombin
[19].
Several annexins, including annexins A1 [16], A2
[20], A4 [21], A5 [21–24], A6 [21] and Nex1 [25], are
known to possess glycosaminoglycan-binding proper-
ties. The crystal structure of annexin A5 in complex
with heparin-derived tetrasaccharides revealed two
binding sites, a calcium-mediated one residing on the
convex side and a calcium-independent one on the
concave side of the protein [24]. In that study, Capila
et al. presented a model in which the heparin chain is
wrapped around the annexin molecule occupying both
binding sites. Whereas binding of the carbohydrate to
the site on the concave surface of the protein most
likely does not interfere with the essential annexin–
membrane association, the site on the convex surface
would be affected by membrane binding. However,
in vitro studies showed that heparin binding cannot
compete effectively with phospholipid membrane bind-
ing to annexin A5 [21,26]. Therefore, heparin might be
displaced from the binding site on the convex surface
of annexin A5 upon competition by phospholipid mol-
ecules, e.g. when membrane binding occurs. In the sol-
uble state, calcium binding contributes to the overall
affinity of the annexin A5–heparin interaction. Thus,
the annexin A5–heparin interaction is calcium-depend-
ent in vitro, but is thought to carry less significance
in vivo [24].
The implications of annexin proteins in health and
disease are increasingly being appreciated and the term
‘annexinopathies’ has been put forward for annexin-
related diseases. In particular, the importance of
annexin A1 in inflammation [27] and annexin A2 in
plasminogen-dependent fibrinolysis [28] has long been
appreciated. In recent years, the role of membrane-
bound annexin A5 as a protective shield has clarified the
molecular mechanisms of its anticoagulant properties
[29]. Altered gene regulation and ⁄or distribution of
annexins have been observed for a variety of conditions.
Cysticercosis is an infection by Cysticercus cellulo-
sae, the larva of the pig tapeworm Taenia solium. The
condition seriously affects human health and also leads
to economic losses in some developing countries. Infec-
tion occurs mostly in the CNS, muscles, subcutaneous
tissue and the globe of the eye [30]. In an attempt to
find novel antigens for vaccine development, annex-
in B1 was identified by immunological screening of a
C. cellulosae library [31]. The ability of annexin B1 to
displace phospholipid-dependent coagulation factors
and to prolong clotting times of human serum empha-
sizes its potential for antithrombotic treatments. The
combination of thrombus-targeting and thrombolytic
properties has also been suggested for the protein [32].
To date, there has been no systematic characterization
of the molecular properties of annexin B1. All the
literature reports have mainly concentrated on identifi-
cation and probable functions of the protein.
Similar to other annexins, annexin B1 comprises a
tetrad repeat of  70 amino acids and possesses all the
highly conserved residues generally found in other
annexins involved in salt bridge interactions. The land-
mark feature of annexins is their ability to bind to
acidic phospholipid membranes in the presence of
calcium, which is facilitated by calcium ions coordina-
ted within the AB and DE loop areas. Accordingly,
this feature has also been observed with annexin B1
[32,33] although the primary structure (Fig. 1) suggests
that the calcium-binding site in the third domain is dis-
rupted due to a lysine (K254). This lysine occupies the
position of the bidentate residue in the DE loop
required for calcium coordination by the endonexin
sequence [34]. Annexin B1 shares 35% amino acid
identity with hydra annexin B12 and human annex-
in A5. Further distinct features of annexin B1 include
the slightly longer N-terminal domain ( 30 amino
acids), as well as a connector region between domains
II and III. The connector region of this protein com-
prises of 30 amino acids compared with annexins A5
and B12, which have an insertion of 14 residues.
To learn more about the molecular evolution of
annexins, as well as to characterize the molecular
properties of annexin B1, we set out to characterize
the protein biochemically and biophysically.
In this study, we investigated the binding behaviour
of annexin B1 to heparin and phospholipid vesicles
in a calcium-dependent manner. Although the protein
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shares the feature of binding membranes calcium-inde-
pendently with its plant relatives, the ability to bind
heparin is reminiscent of mammalian annexins. Fur-
thermore, we developed an inexpensive purification
procedure that produces protein amounts comparable
with other protocols.
Results
Production of native annexin B1
Whereas recombinant annexin B1 has previously been
purified either by ion-exchange chromatography [32]
or liposome-affinity using proteoliposomes formed
from disintegrated cell membranes [33], we explored
the possibility of obtaining the protein by heparin-
affinity chromatography [35]. After an initial anion-
exchange chromatography step, annexin B1 was bound
to heparin-Sepharose in the presence of 5 mm calcium
and eluted, after extensive washing, by the application
of an EDTA-containing buffer (Fig. 2). In SDS ⁄
PAGE, the protein migrates at an apparent molecular
mass of 38 kDa.
This protocol yields up to 10 mg proteinÆL)1 bacter-
ial culture with a purity of >95%, as determined by
MS. As such, this procedure results in comparable
quantity and quality of protein as other methods.
However, it is more convenient than the protocol
based on liposome-affinity, due to utilization of
re-usable affinity chromatography resin.
Protein fold and folding stability
The CD spectra of recombinant annexin B1 in the
absence and presence of 5 mm calcium did not show a
significant difference (Fig. 3A). Therefore, in solution,
the secondary structure of the protein is not affected
by calcium, an observation also seen in many other
annexins.
Denaturation studies as monitored by CD indicate
that there is one transition in heat-induced unfolding
and that the presence of 5 mm calcium shifts the trans-
ition temperature by 6 K (Fig. 3B, Table 1). This situ-
ation is also seen in mammalian annexins such as
annexin A5. Annexin B1 thus unfolds as one folding
unit and the presence of calcium slightly stabilizes the
protein.
Heparin binding
Calcium-dependent binding of annexin B1 to heparin
was investigated using a centrifugation assay with hep-
arin Sepharose beads. After binding the protein onto
the beads in the presence of various calcium concentra-
tions, the beads were washed once while maintaining
the calcium concentrations. A washing step with cal-
cium was performed to exclude possible artefacts from
unspecific binding to the heparin matrix, and the
amount of (reversibly) bound protein was determined
from the EDTA eluate. As seen from Fig. 4B, the data
for annexin B1 suggests a cooperative binding beha-
Fig. 1. Amino acid alignment of annexin B1
from C. cellulosae (GenBank accession nu-
mber AF147955), annexin B12 from Hydra
vulgaris (GenBank accession number P2625-
6) and human annexin A5 (GenBank acces-
sion number P08758). The endonexin
sequence in all four domains is highlighted.
The heparin binding sites HTS-1 (Arg207)
and HTS-3 (Arg25) [24] are highlighted in
bold. The predicted heparin binding site
HTS-2 including Arg289 [45] is underlined.
The potential heparin binding sites in annex-
in B1 are highlighted by bold italics. Align-
ment was calculated with the program
MUSCLE [46].
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viour with respect to calcium that can be fitted with a
Hill equation using a Hill coefficient of n ¼ 3. For
comparison, annexin A1 displays a binding behaviour
with less cooperativity (n ¼ 1.7; Fig. 4C). Comparing
the binding curves of the two proteins, we can thus
rule out the possibility that the lag phase observed
with annexin B1 is due to an artefact within the assay.
For both proteins, the maximal binding degree, as
determined from the supernatant of the EDTA elution
step, is only  60–70%. We therefore analysed the
heparin Sepharose resin pellet in the EDTA elution
step and found that not all of the protein could be
released from the resin. The amount of irreversibly
bound protein increases with higher calcium concentra-
tions and reaches between 10 and 20% at 10 mm cal-
cium for both annexins. Importantly, no annexin B1
1 2 3 4 5 6 7 8 9 10























Fig. 2. Purification of native annexin B1. Fractions of the chroma-
tography purification subjected to SDS ⁄ PAGE and stained with
Coomassie Brilliant Blue. (A) After harvesting and lysing the cells,
the cell lysate was applied to anion-exchange chromatography
using Q-Sepharose. Shown are the molecular mass marker (lane 1),
cell lysate (lane 2), flow-through (lane 3), wash (lane 4), elution frac-
tions from 120 to 300 mM NaCl (lanes 5–10). (B) Affinity chroma-
tography using heparin Sepharose. Protein-containing fractions from
the anion-exchange chromatography were pooled, dialysed against
a buffer containing 5 mM CaCl2 and applied to the heparin column.
Shown are the molecular mass marker (lane 1), flow-through from
the loading step (lane 2), wash (lane 3), and elution fractions after
applying 10 mM EDTA (lanes 4–10).
Fig. 3. Protein fold and folding stability. (A) Far-UV CD spectra of
annexin B1 in the absence (dashed line) and presence (solid line) of
5 mM CaCl2. (B) Thermal unfolding of annexin B1 in the absence
(open circles, dashed line) and presence (closed diamonds, solid
line) of 5 mM CaCl2. The CD at 222 nm was monitored as des-
cribed in Experimental procedures. The fit of the average of three
independent experiments in the absence and presence of CaCl2 is
represented by the dashed and solid line, respectively.
Table 1. Thermal denaturation of annexin B1. The values for AnxA5








AnxB1 52 58 +6
AnxA5 [38] 52 59 +7
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was found to bind to the resin at low levels of calcium
(0–1 mm). Results from a precipitation assay show that
only insignificant amounts of annexin B1 precipitate in
the range of 0–10 mm calcium (data not shown).
Membrane binding
The calcium-dependent membrane binding of annex-
in B1 was assessed using large unilamellar vesicles
(LUVs) with two different phosphatidylserine (PtdSer)
contents (Fig. 5 and Table 2). The protein displays a
calcium-dependent binding behaviour to PtdSer ⁄phos-
phatidylcholine (PtdCho) (1 : 3) vesicles, albeit only to
a moderate extent with a maximal binding of 30%
at 10 mm calcium. In contrast, the binding is more
enhanced with PtdSer ⁄PtdCho (3 : 1) vesicles. Here,
the maximal binding degree at 10 mm calcium is 90%
and the half-maximal calcium concentration of 0.1 mm
is at the lower end of the range observed with several
plant annexins [36].
More interestingly, using PtdSer ⁄PtdCho (3 : 1) lipo-
somes, annexin B1 exhibits calcium-independent bind-
ing with a binding degree of  50%. This behaviour is




Fig. 4. Calcium-dependent binding of annexin B1 to heparin resin.
(A) A representative SDS ⁄ PAGE of calcium-dependent annexin B1
binding to heparin Sepharose. Lane 1 is the amount of 100% pro-
tein (‘Master sample’). Lanes 2–7 are the EDTA-elicited superna-
tants of samples with varying calcium concentrations (0, 0.5, 1, 2,
5, 10 mM). (B) Calcium-dependent binding of annexin B1 to heparin
Sepharose displays a cooperative behaviour with respect to cal-
cium. The degree of reversibly (closed circles) and irreversibly
(open circles) bound annexin B1 was determined as outlined in
Experimental procedures. Each data point represents the average
of at least three independent experiments. The solid lines represent
the fit of data to binding equations with a Hill coefficient of n ¼ 3.
(C) Annexin A1 binds to heparin Sepharose in a calcium-dependent
manner with lower cooperativity (n ¼ 1.7) than annexin B1. The
degree of reversibly and irreversibly bound protein is shown as
closed and open triangles, respectively. Each data point represents
the average of at least three independent experiments. The solid
lines represent the fit of data to binding equations.
Fig. 5. Membrane binding of annexin B1 to liposomes. Membrane-
binding of annexin B1 to PtdSer ⁄ PtdCho (1 : 3) (d to solid line) and
PtdSer ⁄ PtdCho (3 : 1) (s to dashed line) liposomes. The lines rep-
resent the fit of a standard binding equation to the data (one bind-
ing site). The data points are the average of at least three
independent measurements.
Table 2. Calcium-dependent phospholipid binding of annexin B1.
Liposome
composition










PtdSer ⁄ PtdCho (1 : 3) – 0 30
PtdSer ⁄ PtdCho (3 : 1) 0.13 50 90
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akin to that seen from bell pepper and cotton annex-
ins, although the latter proteins have a less stringent
requirement for PtdSer in this context [36].
Discussion
Denaturation studies
As seen from thermal denaturation, annexin B1
unfolds as one folding unit similar to most of its mam-
malian relatives. The only notable exception is annexin
A3 where the N-terminal domain acts as a second
unfolding unit due to the Trp5-mediated anchorage of
the N-terminal tail to the core of the protein [37].
Although the calcium affinity of annexin proteins in
the absence of phospholipids is rather low with micro-
molar and millimolar dissociation constants, a stabil-
ization effect has been observed with mammalian
annexins, in particular annexin A5, in the presence of
calcium [38]. We report the same effect with annexin
B1 which displays a higher folding stability in the pres-
ence of calcium as indicated by an increase of 6 K in
its transition temperature. This increase is comparable
with that observed with annexin A5.
Membrane binding
Annexin B1 exhibits the landmark feature of calcium-
dependent binding to acidic phospholipid membranes
shared by all annexins studied to date. A comparison
of low and high PtdSer containing LUVs yields only
poor annexin binding to PtdSer ⁄PtdCho (1 : 3) vesi-
cles, but enhanced binding to PtdSer ⁄PtdCho (3 : 1)
vesicles. Intriguingly, calcium-independent binding up
to  50% is observed with the latter vesicles. This
behaviour deviates from that of mammalian annexins
which rely almost entirely on a calcium-mediated bind-
ing mode regardless of the vesicle composition. In con-
trast, recent results demonstrate that some plant
annexins employ a second, calcium-independent mech-
anism that utilizes conserved exposed surface residues,
including Trp35, Trp107 and Lys190 [annexin 24
(Ca32) numbering] [36]. One can therefore speculate
that annexin B1 employs a similar mechanism whereby
exposed residues on the convex surface engage in
direct interactions with the membrane. From the three
identified residues in plant annexins, only Lys190 is
semiconserved in annexin B1 by Arg214. However, it
is possible to identify a number of exposed basic resi-
dues on the convex surface of the protein. The involve-
ment of these basic residues would help to explain the
observation that a high PtdSer content in the mem-
brane is required in order to bind annexin B1.
It is worth noting that, in contrast to mammalian
annexins, plant annexins apparently have fewer than
four canonical type II calcium binding sites. One could
imagine that the calcium-independent membrane bind-
ing mechanism assists the calcium-driven membrane-
binding process which might be less efficient, in case of
dysfunctional calcium binding sites. The development
of four canonical calcium-binding sites in certain
annexins (predominantly later in evolution) might have
made the calcium-independent mechanisms obsolete.
The observation of calcium-independent membrane
binding by annexin B1 fits well with this hypothesis,
because one can anticipate a disrupted canonical cal-
cium-binding site in domain III of this protein.
Heparin binding
Results from the heparin-binding assay show that ann-
exin B1 possesses lectin properties. The protein binds
to glycosaminoglycan in a calcium-dependent manner
and displays cooperativity with respect to calcium.
This latter feature is less pronounced in annexin A1,
which was used as a control in this study. The binding
data can be fitted assuming the presence of three bind-
ing sites which coincides with the fact that annexin
B1 only has three canonical type II binding sites.
It remains to be clarified whether all three binding
sites engage in calcium-dependent glycosaminoglycan
binding.
Interestingly, between 10 and 20% of both annexins
remain bound to the glycosaminoglycan even after
extraction with high concentrations of a chelating
agent. Unspecific binding to the heparin matrix can be
excluded due to an intermediate washing step and the
fact that no protein was found to bind to the glycos-
aminoglycan in the absence of calcium. Based on
results from precipitation assays, we can also rule out
artefacts caused by calcium-mediated protein aggrega-
tion. Apparently, the protein is dependent on calcium
ions to initially form interactions with heparin. Once
bound, a fraction of the protein undergoes a shift in
binding mode which ‘irreversibly’ attaches it to the
glycosaminoglycan.
For annexin A5, a model of heparin binding has
been put forward in which recognition and binding of
heparin occurs on the concave side of the protein via
the two binding sites HTS-1 (Arg207–Lys208) and
HTS-2 (Arg285–Lys286–X–X–Arg289–Lys290) [24].
However, the HTS-3 (Arg25–Lys26) site on the convex
surface is not involved in the recognition process but
significantly increases the affinity of the interaction
with heparin. Subsequent binding of annexin A5 to the
membrane surface releases the glycosaminoglycan from
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the HTS-3 site because its affinity for the phospholipid
membrane is considerably higher [26]. In this latter
state, the protein is attached to the membrane surface
via its convex site and the heparin is bound with the
binding sites only on the concave side. One could envi-
sion a similar mechanism with annexin B1, in which
the calcium-dependent binding step occurs through the
calcium-binding sites on the convex domain. Assuming
the presence of further heparin-binding sites elsewhere
on the protein surface, annexin B1 can remain bound
to the glycosaminoglycan even in the absence of cal-
cium ions. In this context, the amino acid sequence
alignment of annexins A5 and B1 reveals that only the
HTS-3 site of annexin A5 (Arg25–Lys26) is conserved
in annexin B1 (Lys38–Arg39), which may thus act in
the same manner as in its mammalian relative. The
binding sites on the concave surface (HTS-1 and HTS-
2) are not observed with annexin B1, although a K-E-
K motif is present instead of the R-K-X-X-R-K motif
of HTS-1. However, two other sites in annexin B1
merit attention. The motifs Arg91–Arg92 and Lys139–
Lys140 on the concave sides of domains I and II,
respectively, could be potential calcium-independent
heparin binding sites. A further possible motif,
Lys254–Lys255 is found in the DE loop of domain III,
which is located in the anticipated dysfunctional
canonical calcium binding site. Nevertheless, occupa-
tion of this site by heparin would compete with bind-
ing to the membrane surface. Further studies to test
these hypotheses are currently under way.
Several viruses and parasites have infection strat-
egies based on binding to proteoglycans in the extra-
cellular matrix. Binding to the carbohydrates of
proteoglycans is a crucial step in attachment, inva-
sion and cytolysis of intestinal epithelium by para-
sites. Obviously, this requires the invader to have
glycosaminoglycan-binding proteins. Prominent exam-
ples are microbial adhesions, including the influenza
haemagglutinin, as well as the adhesins from Shiga
toxin and Entamoeba histolytica [39]. Annexin B1 has
been shown to be highly immunogenic [31], and is
potentially present on the surface of C. cellulosae.
The binding behaviour of the protein to heparin as
determined in this study may therefore be a mechan-
ism used by C. cellulosae to attach and invade host
tissue.
Experimental procedures
Production of native annexin B1
Annexin B1 cDNA was cloned into the bacterial expression
vector pRSET_6c [40] using PCR amplification to engineer
NdeI and XhoI restriction sites. The construct was obtained
with a P346H mutation.
The construct was expressed in Escherichia coli strain
BL21(DE3). A total of 8 L of Luria–Bertani medium
(50 mgÆL)1 ampicillin) was inoculated with an overnight
culture of 1 L. The cells were grown at 37 C until the
absorbance at 600 nm exceeded 1.0. Induction was carried
out with 0.5 mm isopropyl thio-b-d-galactoside. Cell
growth was then continued for 14–16 h before being har-
vested. The cell pellets were resuspended (100 mm NaCl,
1.5 mm EDTA, 5 mm benzamidinium chloride, 1 mm phe-
nylmethylsulfonyl fluoride, 0.1% Triton X-100, 20 mm Tris,
pH 8.0) and lysed by freeze–thaw and sonication. Cell deb-
ris was separated by centrifugation for 45 min, 60 000 g,
and 4 C.
The protein was purified in two steps, anion exchange
chromatography using Q-Sepharose resin, and heparin
affinity chromatography. The anion-exchange column was
equilibrated with 20 mm Tris, pH 9.0 and the supernatant
from the centrifugation step was applied. After extensive
washing with equilibration buffer, a linear NaCl gradient
was applied and the protein eluted from 150 to 300 mm
NaCl. The pooled fractions obtained from this step were
dialysed against the equilibration buffer for heparin-affinity
chromatography (5 mm CaCl2, 250 mm NaCl, 50 mm Tris,
pH 9.0) and loaded onto a heparin Sepharose column.
After extensive washing, the protein was eluted by applying
buffer containing EDTA (10 mm EDTA, 250 mm NaCl,
50 mm Tris, pH 9.0). Fractions containing annexin B1 were
pooled and concentrated using 10 kDa molecular mass cut-
off Vivaspin concentrators (Vivascience, Fisher Scientific,
Loughborough, UK). SDS ⁄PAGE analysis was performed
throughout the purification process. The identity and purity
of annexin B1 was confirmed using MALDI-TOF. The
whole procedure yields  8 mg proteinÆL)1 of cell culture.
Heparin-binding assay
Calcium-dependent binding of annexin B1 to heparin was
studied by a centrifugation assay using heparin Sepharose.
For the assay, 1 mL suspension of heparin Sepharose
(Amersham Pharmacia Biotech, Piscataway, NJ) was equili-
brated by washing three times with 3.5 mL buffer (100 mm
NaCl, 20 mm Tris, pH 8.0). All centrifugation steps were
carried out for 3 min, 3000 r.p.m., 4 C. The resin was
finally resuspended in 4 mL protein buffer and distributed
into six aliquots. After centrifugation, the supernatant was
removed and CaCl2 was added to the protein buffer (total
volume 390 lL) to yield varying concentrations of calcium
(0, 0.5, 1, 2, 5 and 10 mm). Finally, 10 lL of annexin B1
(1–5 mgÆmL)1) was added to each aliquot. After 10 min
incubation at room temperature, the samples were subjected
to centrifugation. The pellets were then washed with
400 lL protein buffer with the appropriate calcium concen-
tration and the samples were centrifuged again. The protein
Biochemical characterization of annexin B1 A. Winter et al.
3244 FEBS Journal 273 (2006) 3238–3247 ª 2006 The Authors Journal compilation ª 2006 FEBS
was eluted with 400 lL of protein buffer containing 30 mm
EDTA. After centrifugation, the supernatant was run on
SDS ⁄PAGE (Fig. 4A). The amount of reversibly bound
annexin was determined by densitometric analysis of the
Coomassie Brilliant Blue-stained gels using the program
imagej [41].
Liposome-based copelleting assay
Phospholipid vesicles were prepared from 1,2-dioleoyl-sn-
glycero-3-phosphoserine and 1,2-dioleoyl-sn-glycero-3-phos-
phocholine (Avanti Polar Lipids, Alabaster, AL, USA)
according to the protocol of Reeves & Dowben [42]. The
vesicles were converted into LUVs using five freeze–thaw
cycles and subsequent extrusion (11 times) through 0.1 lm
filter membranes using an extruder (Avanti Polar Lipids) at
37 C. To assess the annexin–membrane binding behaviour,
a copelleting assay was conducted [43]. A total of 0.2 lmol
phospholipids was used for each individual sample
(500 lL), composed of 0.5 nmol protein in liposome buffer
and varying amounts of calcium (0, 1, 2, 10 and 20 mm).
As a control, a sample of 0.1 nmol protein in 100 lL of
10% SDS was prepared at this stage. All samples were cen-
trifuged (45 min, 13000 r.p.m., 4 C), the pellets resuspend-
ed with 50 lL of 10% SDS and subjected to SDS ⁄PAGE.
Gels were stained with Coomassie Brilliant Blue and ana-
lysed densitometrically using the program imagej [41]. Each
calcium concentration was assessed three times independ-
ently. Curve fitting was performed with sigmaplot.
Calcium-dependent aggregation ⁄precipitation
assay
Calcium-induced precipitation of annexins B1 and A1 was
performed as a control for the heparin binding and lipo-
some copelleting assays. 10 lL of 2 mgÆmL)1 protein in
standard buffer (100 mm NaCl, 20 mm Tris, pH 8.0) or
liposome buffer was added to 390 lL of standard buffer
containing different concentrations of calcium (0, 0.5, 1, 2,
3.5, 7 and 10 mm) and incubated for 10 min at room tem-
perature. After centrifugation (30 min, 16 000 g, 4 C), the
supernatant were carefully removed. The tubes were washed
with 20 lL of 10% SDS and the samples subjected to
SDS ⁄PAGE. Gels were stained with Coomassie Brilliant
Blue and analysed densitometrically using the program
imagej [41].
CD spectroscopy
CD spectra of protein samples (1.8 lm) were recorded in
50 mm NaCl, 5 mm Tris, pH 8.0 at 20 C using a Jasco J-
810 spectropolarimeter equipped with a Peltier element.
Experiments in the presence of calcium were carried out
with the addition of 5 mm CaCl2 in the buffer. For investi-
gation of the thermal denaturation of annexin B1, the CD
signal at 222 nm was monitored from 20 to 80 C with a
heating rate of 1 KÆmin)1. Data were recorded at 0.5 K
increments. Unfolding experiments were performed three
times independently. All spectra were corrected against the
baseline and the data were transformed into mean residue
ellipticity using the program acdp [44]. Changes in the
mean residue ellipticity at 222 nm were used to construct
an unfolding curve. Curve fitting was done with sigmaplot
using a sigmoidal equation.
Acknowledgements
AW gratefully acknowledges a scholarship from the
Darwin Trust of Edinburgh.
References
1 Fernandez MP & Morgan RO (2003) Structure, func-
tion and evolution of the annexin gene superfamily. In
Annexins: Biological Importance and Annexin-Related
Pathologies (Bandorowicz-Pikula J, ed.), pp. 21–36.
Landes Bioscience, Georgetown, TX.
2 Goldberg M, Feinberg J, Rainteau D, Lecolle S, Kaet-
zel MA, Dedman JR & Weinman S (1990) Annexins
I–VI in secretory ameloblasts and odontoblasts of rat
incisor. J Biol Buccale 18, 289–298.
3 Fiedler K, Lafont F, Parton RG & Simons K (1995)
Annexin XIIIb: a novel epithelial-specific annexin is
implicated in vesicular traffic to the apical plasma mem-
brane. J Cell Biol 128, 1043–1053.
4 Hajjar KA, Guevara CA, Lev E, Dowling K & Chacko
J (1996) Interaction of the fibrinolytic receptor, annexin
II, with the endothelial cell surface. Essential role of
endonexin repeat 2. J Biol Chem 271, 21652–21659.
5 Liu J, Zhu X, Myo S, Lambertino AT, Xu C, Boetti-
cher E, Munoz NM, Sano M, Cordoba M, Learoyd J
et al. (2005) Glucocorticoid-induced surface expression
of annexin 1 blocks beta2-integrin adhesion of human
eosinophils to intercellular adhesion molecule 1 surro-
gate protein. J Allergy Clin Immunol 115, 493–500.
6 Andersen MH, Berglund L, Petersen TE & Rasmussen
JT (2002) Annexin V binds to the intracellular part of
the beta(5) integrin receptor subunit. Biochem Biophys
Res Commun 292, 550–557.
7 Pietropaolo RL & Compton T (1991) Direct interaction
between cytomegalovirus glycoprotein B and cellular
annexin II. J Virol 71, 9803–9807.
8 Neurath AR & Strick N (1994) The putative cell
receptors for hepatitis B virus (HBV), annexin V, and
apolipoprotein H, bind to lipid components of HBV.
Virology 204, 475–477.
9 Otto M, Gunther A, Fan H, Rick O & Huang RT
(1994) Identification of annexin 33 kDa in cultured cells
A. Winter et al. Biochemical characterization of annexin B1
FEBS Journal 273 (2006) 3238–3247 ª 2006 The Authors Journal compilation ª 2006 FEBS 3245
as a binding protein of influenza viruses. FEBS Lett
356, 125–129.
10 Ikebuchi NW & Waisman DM (1990) Calcium-depen-
dent regulation of actin filament bundling by lipocortin-
85. J Biol Chem 265, 3392–3400.
11 Ma ASP, Bystol ME & Tranvan A (1994) In vitro
modulation of filament bundling in F-actin and keratins
by annexin II and calcium. In Vitro Cell Dev Biol 30A,
329–335.
12 Calvert CM, Gant SJ & Bowles DJ (1996) Tomato
annexins p34 and p35 bind to F-actin and display
nucleotide phosphodiesterase activity inhibited by phos-
pholipid binding. Plant Cell 8, 333–342.
13 Blackbourn HD, Barker PJ, Huskisson NS & Battey
NH (1992) Properties and partial protein sequence of
plant annexins. Plant Physiol 99, 864–871.
14 Hoshino T, Mizutani A, Chida M, Hidaka H &
Mizutani J (1995) Plant annexins form homodimer dur-
ing Ca2+-dependent liposome aggregation. Biochem
Mol Biol Int 35, 749–755.
15 Delmer DP & Potikha TS (1997) Structures and functions
of annexins in plants. Cell Mol Life Sci 53, 546–553.
16 Alvarez-Martinez MT, Mani JC, Porte F, Faivre-
Sarrailh C, Liautard JP & Sri Widada J (1996) Charac-
terisation of the interaction between annexin I and
profilin. Eur J Biochem 238, 777–784.
17 Park PW, Reizes O & Bernfield M (2000) Cell surface
heparan sulfate proteoglycans: selective regulators of
ligand–receptor encounters. J Biol Chem 275, 29923–
29936.
18 Plotnikov AN, Hubbard SR, Schlessinger J & Moham-
madi M (2000) Crystal structures of two FGF–FGFR
complexes reveal the determinants of ligand–receptor
specificity. Cell 101, 413–424.
19 Olson ST & Bjork I (1991) Predominant contribution of
surface approximation to the mechanism of heparin
acceleration of the antithrombin–thrombin reaction.
Elucidation from salt concentration effects. J Biol Chem
266, 6353–6364.
20 Kassam G, Manro A, Braat CE, Louie P, Fitzpatrick
SL & Waisman DM (1997) Characterisation of the
heparin binding properties of annexin II tetramer. J Biol
Chem 272, 15093–15100.
21 Ishitsuka R, Kojima K, Utsumi H, Ogawa H &
Matsumoto I (1998) Glycosaminoglycan binding prop-
erties of annexin IV, V, and VI. J Biol Chem 273, 9935–
9941.
22 Römisch J & Heimburger N (1990) Purification and
characterization of six annexins from human placenta.
Biol Chem (Hoppe-Seyler) 371, 383–388.
23 Capila I, VanderNoot VA, Mealy TR, Seaton BA &
Linhardt RJ (1999) Interaction of heparin with annexin
V. FEBS Lett 446, 327–330.
24 Capila I, Hernaiz MJ, Mo YD, Mealy TR, Campos B,
Dedman JR, Linhardt RJ & Seaton BA (2001) Annexin
V–heparin oligosaccharide complex suggests heparan
sulfate-mediated assembly on cell surface. Structure 9,
57–64.
25 Satoh A, Hazuki M, Kojima K, Hirabayashi J &
Matsumoto I (2000) Ligand-binding properties of
annexin from Caenorhabditis elegans (Annexin XVI,
Nex-1). J Biochem (Tokyo) 128, 377–381.
26 Tait JF, Gibson DF & Fujikawa K (1989) Phospholipid
binding properties of the lipocortin family. J Biol Chem
264, 7944–7949.
27 Kamal AM, Flower RJ & Perretti M (2005) An over-
view of the effects of annexin 1 on cells involved in
the inflammatory process. Mem Inst Oswaldo Cruz 100,
39–48.
28 Cesarman-Maus G & Hajjar KA (2005) Molecular
mechanisms of fibrinolysis. Br J Haematol 129, 307–
321.
29 Rand JH, Wu XX, Quinn AS, Chen PP, McCrae KR,
Bovill EG & Taatjes DJ (2003) Human monoclonal
antiphospholipid antibodies disrupt the annexin A5
anticoagulant crystal shield on phospholipid bilayers:
evidence from atomic force microscopy and functional
assay. Am J Pathol 163, 1193–1200.
30 Baron S (1996) Medical Microbiology, 4th edn. Univer-
sity of Texas at Galveston, Galveston.
31 Yan H, Song Y, Fan L, Chen R & Guo Y (2002)
Cloning and functional identification of a novel annexin
subfamily in Cysticercus cellulosae. Mol Biochem Parasi-
tol 119, 1–5.
32 Zhang Y, Guo YJ, Sun SH, Yan HL & He Y (2004)
Non-fusion expression in Escherichia coli, purification,
and characterization of a novel Ca2+- and phospholi-
pid-binding protein annexin B1. Protein Expr Purif 34,
68–74.
33 Gao YJ, Zhang Y, Yan HL, He Y, Wang F & Sun SH
(2005) Preparation and purification of recombinant
annexin B1 by Ca2+-triggered precipitation. Annexins 2,
18–20.
34 Geisow M, Fritsche U, Hexham J, Dash B & Johnson
T (1986) A consensus amino acid sequence repeat in
Torpedo and mammalian calcium-dependent membrane
binding proteins. Nature 320, 636–638.
35 Alvarez-Martinez MT, Mani JC, Porte F, Faivre-
Sarrailh C, Liautard JP & Sri Widada J (1996) Charac-
terisation of the interaction between annexin I and
profilin. Eur J Biochem 238, 777–784.
36 Dabitz N, Hu NJ, Yusof AM, Tranter N, Winter A,
Daley M, Zschörnig O, Brisson A & Hofmann A (2005)
Structural determinants for plant annexin–membrane
interactions. Biochemistry 44, 16292–16300.
37 Hofmann A, Raguenes-Nicol C, Favier-Perron B,
Mesonero J, Huber R, Russo-Marie F & Lewit-Bentley
A (2000) The annexin A3–membrane interaction is
modulated by an N-terminal tryptophan. Biochemistry
39, 7712–7721.
Biochemical characterization of annexin B1 A. Winter et al.
3246 FEBS Journal 273 (2006) 3238–3247 ª 2006 The Authors Journal compilation ª 2006 FEBS
38 Jatzke C (1999) Untersuchungen zur Calcium- und
Phospholipid bindung von Annexin V, PhD thesis,
Westfälische Wilhelms-Universität Münster, Germany.
39 Esko JD (1999) Proteins that recognise glycans. Micro-
bial carbohydrate-binding proteins. In Essentials of
Glycobiology (Varki A, Cummings R, Esko J, Freeze H,
Hart G & Marth J, eds). Cold Spring Harbor Laborat-
ory Press, Cold Spring Harbor, New York.
40 Schoepfer R (1993) The pRSET family of T7 promo-
ter expression vectors for Escherichia coli. Gene 124,
83–85.
41 Rasband W. Imagej 1.30v. National Institutes of Health.
http://rsb.info.nih.gov/ij/.
42 Reeves JP & Dowben RM (1969) Formation and prop-
erties of thin-walled phospholipid vesicles. J Cell Physiol
73, 49–60.
43 Hofmann A & Huber R (2003) Liposomes in assessment
of annexin–membrane interactions. Methods Enzymol
372, 186–216.
44 Hu N-J, Currid M, Daley M & Hofmann A (2005) Two
new software applications for automated processing of
circular dichroism and fluorescence data. Appl Spectrosc
59, 68A.
45 Hileman RE, Fromm JF, Weiler JM & Linhardt RJ
(1998) Glycosaminoglycan–protein interactions: defini-
tion of consensus sites in glycosaminoglycan binding
proteins. Bioessays 20, 156–167.
46 Edgar RC (2004) MUSCLE: multiple sequence align-
ment with high accuracy and high throughput. Nucleic
Acids Res 32, 1792–1797.
A. Winter et al. Biochemical characterization of annexin B1
FEBS Journal 273 (2006) 3238–3247 ª 2006 The Authors Journal compilation ª 2006 FEBS 3247
Molecular Modeling of Prohibitin Domains
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ABSTRACT Prohibitins comprise a family of
highly conserved ubiquitous eukaryotic proteins
that mainly localize to the mitochondria. They
have been implicated in important cellular pro-
cesses such as cellular signaling and transcrip-
tional control, apoptosis, cellular senescence, and
mitochondrial biogenesis. Using molecular model-
ing techniques, we have generated structural mod-
els of human prohibitins BAP32 and BAP37, which
have previously been shown to exist as large ring-
like oligomers in the membrane-bound state. The
middle domain of prohibitins is evolutionary con-
served in the family of SPFH (PHB) domain pro-
teins. On the basis of the known structure of flotil-
lin-2, another member of the SPFH-domain family,
we have generated homology models for BAP32
and BAP37, and elucidated the implications for
formation of high molecular weight oligomers. A
model for the dimeric-building block of BAP32:
BAP37 for such assemblies was generated and its
stability scrutinized by molecular dynamics simu-
lations. The model of BAP32 was also analyzed as
to potential ligand-binding sites and the previ-
ously identified ligand melanogenin was docked
into a membrane-proximal cavity. The results are
discussed in the context of prohibitin interactions
with mitochondrial AAA-proteases and we suggest
two possible interaction interfaces between the
BAP32:BAP37 building block and the protease.
Proteins 2007;68:353–362. VC 2007 Wiley-Liss, Inc.




Flotillins and prohibitins belong to a larger family of
proteins that share an evolutionarily conserved stoma-
tin/prohibitin/flotillin/HflK/C (SPFH) domain with signif-
icant homology to several eukaryotic and prokaryotic
proteins. Members of this protein family are membrane-
associated and implicated in cellular processes concerned
with protein turnover,1 senescence,2 and proliferation
control.2–4 The integral membrane protein stomatin is
an important component of the red blood cell membrane
but can also be found in abundance in different tissues
and cell lines. A possible structural role for this protein
in the formation of membrane protrusions and anchor-
age to the actin cytoskeleton has been suggested.5 In
plants, stomatin has been implicated in ion-channel reg-
ulation and might play a role in resistance to pathogen
attack via hypersensitive reactions culminating in cell
death.6 Prohibitins are thought to be involved in cell pro-
liferation and senescence7,8 being located both in the nu-
cleus9 and the mitochondrion.10,11 Recent studies suggest
that they can also act as cell surface bound recep-
tors.12,13 Flotillins are upregulated in the retinal gan-
glion cells and retinal axons of regenerating neurons.14
The N-terminal membrane-associating region of both
mouse flotillin-1 and flotillin-2 was either identified as a
conserved prohibitin homology (PHB) by the Simple
Modular Architecture Research Tool (SMART)15 or as a
SPFH domain using PSI-BLAST mapping the region
amino acids 4-211 of mouse flotillin-1.1 However, it
appears that regardless of the variation in boundaries
described by the different data mining tools, the SPFH
and PHB are essentially describing the same domain.16
Members of the PHB domain family can be found in di-
vergent species; they are present in higher eukaryotes
(prohibitin, stomatin, and podocin), as well as in lower
eukaryotes and prokaryotes (vacuolin A and vacuolin B,
HflK and HflC, unc-1, unc-24, and mec-2). The PHB do-
main is conserved in proteins that are ubiquitously
expressed like flotillin, as well as in proteins that show
extremely restricted expression like the stomatin-related
olfactory protein (SROP), whose expression is con-
strained to olfactory sensory neurons.17 The evolutionary
significance of this domain is unclear but its prokaryotic
conservation suggests that it is indeed a primordial
motif. As there are more than 700 nonredundant sequen-
ces containing the PHB domain throughout all king-
doms, it is clear that this domain is likely to perform an
important cellular function and worthy of further exami-
nation.16
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Prohibitin, the archetypal PHB domain-containing
protein, is a mitochondrial inner-membrane protein that
has been proposed to act as a chaperone for the stabiliza-
tion of mitochondrial proteins.18–20
Two homologs of the protein are known and both are
membrane associated via an N-terminal membrane
anchor. Bacterial overexpression leads to formation of
inclusion bodies, which make structural work difficult
because of a limited amount of available protein. Human
prohibitin (BAP32) forms a large hetero-oligomeric com-
plex with its closely related PHB domain-carrying homo-
log, B-cell receptor-associated protein (BAP37; also called
prohibitone), and this complex is thought to protect non-
assembled mitochondrial membrane proteins against
proteolysis by the m-AAA protease.19,21–23 Electron
micrographs from yeast prohibitins Phb1 and Phb2
reveal large ringlike oligomers comprising 16–20 individ-
ual prohibitin molecules, and the C-terminal coiled-coil
regions are thought to be involved in formation of these
large oligomers.24 Furthermore, prohibitins are thought
to form a supercomplex with the m-AAA-protease whose
catalytic domains are located in the mitochondrial
matrix.25
Studies of the prohibitin homologs in yeast, Phb1, and
Phb2, suggest that these proteins may be involved in se-
nescence, as deletion of these genes results in a
decreased replicative lifespan.22 Interestingly, prohibitin
was originally described as a tumor-suppressor gene,7
but more recent studies suggest that this is only true for
the 30-untranslated region (30-UTR).26 The prohibitin
proteins have been found to be localized to various com-
partments in the cell suggesting a multiple function in
the cell. Its localization to the nucleus and its ability to
prevent cell proliferation has been attributed to its inter-
action with E2F transcription factors in addition to Rb
proteins (suppressors of E2F-mediated transcription)9 in
human cells. Despite contrary statements about whether
prohibitin and BAP37 localize to the plasma membrane,
there are also reports describing the presence of a sur-
face-bound prohibitin complex,12,13 which acts as a re-
ceptor for extracellular ligands.
In the recent years, the focus in prohibitin research
has been the prohibitin-ligand interactions, including
protein–protein interactions, and interactions with pepti-
des, sugars, and organic molecules. In 1999, Wang et al.
found that prohibitin could effectively interact with Rb,
p107, and p130. It was also found to repress the activity
of all of the five E2Fs through MAPK pathway.9 Yeast
two-hybrid screens identified a-actinin and annexin A2
as new binding partners for the prohibitin family27 in
the cell. Prohibitin was reported to be a marker of adi-
pose tissue and found to be a target for the peptide motif
CKGGRAKDC. The fusion of a proapoptotic peptide to
that peptide sequence led to ablation of white fat tissue
and thus reversal of obesity in a mouse model.12 Fur-
thermore, an interaction of cells and the Vi capsular
polysaccharide, a virulent antigen of Salmonella typhi
was shown to be mediated through a cell-surface-associ-
ated recognition complex containing prohibitins.13
The prohibitin complex has also been found to act as
an intracellular receptor. With a chemical genetics
approach searching for pigment-enhancing chemicals,
melanogenin has been found to enhance melanin produc-
tion in melanocytes and to bind specifically to prohibi-
tin.28 A sufficient pigment production in melanocytes is
important to the organism, as UV irradiation can cause
severe damage to the cell and finally induce apoptosis
through activation of the mitochondrial permeability
transition. Based on further RNA interference experi-
ments, these authors propose that prohibitin plays a
functional role in melanin induction since neither the
melanin induction agent isobutylmethylxanthine nor
melanogenin were able to induce melanin production
when prohibitin expression was silenced.28
In the absence of atomic details of prohibitin struc-
tures, we present structural models for BAP32 and
BAP37 based on secondary structure prediction and
homology modeling using the NMR structure of the band
7 domain of mouse flotillin-2, another member of the
PHB domain protein family. We also elucidate possible
interactions between BAP32 and melanogenin and dis-
cuss implications for protein–protein and protein–ligand
interactions.
MATERIALS AND METHODS
Secondary Structure Prediction and
Homology Modeling
Multiple sequence alignment of the PHB domains of
BAP32 (GenBank accession no. BC083354), BAP37 (Gen-
Bank accession no. NM_007531) and flotillin-2 (GenBank
accession no. NM_008028) generated with MUSCLE.29
The secondary structures of BAP32 and BAP37 were
predicted using PSIPRED,30 and compared to the NMR
structure of the PHB domain of mouse flotillin-2 (PDB
accession no. 1win). Thereafter, the multiple sequence
alignment was slightly adjusted to satisfy the secondary
structure elements. The flotillin-2 structure was then
used as template for homology modeling. Twenty inde-
pendent homology models of BAP32 and BAP37 were
calculated with the programme Modeller 431 and those
with the lowest energy were selected. The selected mod-
els were visually inspected with O32 and subjected to
further energy minimization using CNS.33 The overall
geometry was scrutinized using PROCHECK.34 Surface
properties and electrostatic characteristics were ana-
lyzed using GRASP.35 Root mean square (rms) distances
of structures were calculated using ALIGN.36
Modeling of Interactions Between BAP32
and BAP37
The modeled structures of BAP32 and BAP37 were
subjected to an automated macromolecular docking cal-
culation with the programme Hex37 to investigate poten-
tial interaction sites. In the programme, one of the pro-
teins was set as a receptor, and the other was set as a
ligand. The programme was run using the default set-
tings.
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Models for BAP32:BAP37 complexes were also con-
structed manually by rigid body movements using the
graphics programme O32 and considering a spatial vicin-
ity of residues Pro72 (BAP32) and Arg86 (BAP37),
Asp152 (BAP32) and Arg86 (BAP37), and Val149
(BAP32) and Gln159 (BAP37). The residues in those
positions have been found to interact, as identified in a
crosslinking study, using the yeast prohibitin complex.38
The initial model was subjected to molecular dynamics
simulations in GROMACS.39 The simulations (50 and
500 ps) were carried out using a model with explicit sol-
vation and without superimposing any user-defined dis-
tance restraints.
The dimer of the N-terminal BAP helices was con-
structed using a-helices generated with GARLIC,40
which were oriented as rigid bodies in O to yield a first
approximation of a helix dimer. The raw model was then
subjected to molecular dynamics simulations in GRO-
MACS. No user-defined distance restraints were applied
and the simulations were carried out in vacuo for 50 and
500 ps, respectively.
The molecular dynamics simulations were analyzed
using the tools included in GROMACS, as well as
VMD41 and O32.
Modeling of Interactions Between BAP32
and Melanogenin
An automated docking approach was employed to
investigate the interaction between BAP32 and its
ligand melanogenin using the programme FlexX42 to per-
form flexible ligand fitting. First, the BAP32 homology
model was visually inspected and potential binding sites
were identified by surface analysis. Then, the three-
dimensional molecule structure of melanogenin was cre-
ated and subsequently optimized by energy minimization
with Sybyl (Tripos). After site point generation within
the docking programme, the ligand was fitted into the
binding pockets based on chemical and shape comple-
mentation. The models with highest scores were ana-
lyzed with Sybyl.
RESULTS AND DISCUSSION
Homology in the PHB Superfamily
So far, the grouping of prohibitins, flotillins, stomatins,
and HflC/K into the PHB superfamily was mainly based
on amino acid sequence homology with rather poor
matches. Although alignment of BAP32 and BAP37
reveals a sequence similarity of 60% and an identity of
47%, the similarity of both proteins to mouse flotillin-2
is only 4 and 7%, respectively. Phylogenetic analyses of
PHB domains from different proteins revealed only am-
biguous relationships within this superfamily, indicating
independent origins for the individual members and con-
vergent evolution of the PHB domain.43 Several hall-
mark features are shared among the members of PHB
domain proteins: the association with the plasma or mi-
tochondrial membrane is due to the hydrophobic N-ter-
minal domain, which is fused to the PHB domain and
assumed to adopt a horseshoelike structure in the case
of reggies, stomatin, and podocin. Prohibitins, in con-
trast, possess transmembrane helices. The C-terminal
region of the PHB domain contains a stretch of EA
repeats. PHB domain proteins tend to form oligomers, as
shown for stomatin,44 podocin,45 prohibitin,24,38 and reg-
gies.46 In the case of stomatin, the first EA repeat was
proven to be essential for oligomerization of the pro-
tein.44 Accordingly, BAP32 and BAP37 topologically com-
prise an N-terminal hydrophobic transmembrane do-
main, followed by the well-conserved PHB domain, and a
C-terminal coiled-coil region (Fig. 1).
Secondary Structure Prediction of BAP32
and BAP37
The only experimentally obtained structure for any
member of the PHB superfamily is the NMR structure of
the band 7 domain of mouse flotillin-2 (PDB accession
no. 1win). Using fold recognition, a theoretical model for
the three-dimensional structure of BAP32 has been de-
posited in the PDB (PDB accession no. 1lu7). However,
while the theoretical model shares a very similar shape
with the flotillin-2 structure, the fold differs in the posi-
tion and orientation of secondary structure elements (see
also Ref. 43).
Fig. 1. Domain topology of human BAP32 and BAP37. The N-terminal transmembrane domain of BAP32 extends from residue 1 to 24, followed
by the predicted PHB domain (residues 55–172) and the C-terminal coiled-coil domain (residues 175–252). BAP37 is divided into its N-terminal do-
main (residues 2–36), the PHB domain (residues 68–185), and the C-terminal domain from residue 190 to 264. [Color figure can be viewed in the
online issue, which is available at www.interscience.wiley.com.]
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We have predicted the secondary structure of BAP32
and BAP37 using the PSIPRED server30 and compared
the results to the NMR structure of flotillin-2. As seen in
Figure 2, the PSIPRED-predicted secondary structure
for the PHB domain of both human prohibitins is in rea-
sonable agreement with the flotillin-2 structure. In the
N-terminal region, four b-strands are predicted for
BAP32 (b1, b2, b3, and b4); however, their positions are
slightly different from those in the flotillin-2 structure.
For BAP37, only three b-strands are predicted (b1, b2,
and b4) and almost identically positioned when com-
pared with BAP32. In the flotillin-2 structure, the b-
strands are followed by two a-helices whose extents coin-
cide nicely with the predicted three a-helices of BAP32
and BAP37 (a1, a2, and a3). The second a-helix of the
flotillin-2 structure is broken into two helices (a2 and
a3) of almost equal length in case of the prohibitins. The
helical segment of flotillin-2 is connected to two b-
strands, which are merged into one (b5) in both human
prohibitins extending over almost the same area. A short
a-helix in flotillin-2 marks the start of the coiled-coil
region and is resembled by helix a4 in BAP32 and
BAP37. As seen from Figure 2, the coiled-coil region is
predicted continuously helical for BAP32, but divided
into two helical segments in BAP37. However, the proba-
bility for helical geometry around residues 228/229 is
less than 0.5 for BAP32 and thus it is quite likely that
a4 might also be divided into two segments in BAP32. It
is worth noting that neither of the two human prohibi-
tins possesses the hepta-peptide repeat pattern (abc-
defg)n characteristic for coiled-coil motifs where a and d
are mostly hydrophobic residues and e and g are pre-
dominantly charged residues. Intriguingly, the N-termi-
nal region of helix a4 already comprises EA repeat areas
in both prohibitins, whereas the stretch of EA-repeats in
flotillin-2 occurs only C-terminal of the PHB domain.
The N-Terminal Domain of BAP32 and BAP37
Results from the secondary structure predictions are
well in agreement with the current state of knowledge
whereby the N-terminal domains of prohibitins either
form a membrane-anchoring a-helix (BAP32) or a trans-
membrane a-helix (BAP37). With a length of 36 Å, the
N-terminal a-helix in BAP32 would just be able to span
the lipid bilayer. For BAP37, the N-terminal helical seg-
ment has an expected length of 56 Å and is thus long
enough to reach well into the mitochondrial interior. As
seen from the helical wheel representations (Fig. 3), the
helical arrangements of amino acid residue stretches 1–
24 (BAP32) and 1–37 (BAP37) result in mainly hydro-
phobic helices with a fraction of polar and charged resi-
Fig. 3. Helical wheel representations for the N-terminal a-helices of
human BAP32(1–24) and BAP37(1–37). Polar residues are highlighted
in bold italic, basic and acidic residues are bold and underlined.
Fig. 2. Alignment of BAP32 and BAP37 with the flotillin-2 PHB domain. a-Helices are displayed by cylinders and b-strands are shown as arrows.
The secondary structure of flotillin-2 as seen in the NMR structure (PDB accession no. 1win) is shown by striped arrows/cylinders. The secondary
structure obtained from the prohibitin fold prediction model (PDB accession no. 1lu7) is shown in light gray. Secondary structure elements for BAP32
and BAP37 are drawn in dark gray and have been obtained by prediction with PSIPRED.30 Residues identified by an earlier crosslinking study38 are
highlighted.
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dues of about 20%. Intriguingly, the few polar and
charged residues are all positioned on one side of the
helix.
For Phb2, the yeast homolog of BAP37, the N-terminal
segment shows a much higher enrichment of basic resi-
dues giving rise to a truly amphipathic a-helical seg-
ment, which is characteristic for mitochondrial sorting
sequences. Mitochondrial import studies by Tatsuta
et al. demonstrated that it is the bipartite feature of the
N-terminal domain of Phb2, comprising the positively
charged leader sequence and the hydrophobic a-helix,
that is responsible for mitochondrial targeting of this
protein.24 With the yeast homolog of BAP32, Phb1, these
authors have also been able to show that the presence of
the N-terminal domain is required for mitochondrial tar-
geting. Although the topology of residues on the helical
wheel is very similar for Phb1 and BAP32, the charac-
teristic bipartite feature of Phb2 is not present in
BAP37. It therefore appears as if both human prohibi-
tins utilize the same unconventional N-terminal
sequence that is neither a fully hydrophobic nor a true
amphipathic a-helix.
We thus investigated, whether the energetically unfav-
orable exposure of polar/charged residues of the mem-
brane-inserted N-terminal helices of BAP32 and BAP37 to
hydrophobic environment might be avoided by masking of
the polar patches within a BAP32:BAP37 dimer. Homo-
dimerization was not considered as there is no experimen-
tal evidence for homo-oligomers.24 Inspection of a man-
ually generated model of BAP32(1-24):BAP37(1-39) shows
that some, but not all polar/charged residues could lie
within the dimer interface (Fig. 4). The model of the helix
dimer was further tested and its conformation improved
by subjecting it to molecular dynamics simulations with
GROMACS. Throughout the simulated time of 500 ps, the
two helices stayed in contact with each other and the
simulated complex equilibrated as judged by analysis of
rms distances and energies. However, several polar/
charged residues remained on the outside surface of the
helix dimer. Lys4 and Glu7 from BAP32 and Asp3, Gln7,
Lys10, Arg15, and Arg21 from BAP37 would still be in
contact with the hydrophobic interior of the mitochondrial
inner membrane (Fig. 4). One could therefore speculate
that these residues engage in interactions with trans-
membrane segments ofm-AAA protease subunits.
The C-Terminal Coiled-Coil Domain of BAP32
and BAP37
As anticipated from the predicted secondary structure,
the C-terminal domain of both prohibitins presumably
adopts a coiled-coil structure.24 Further analysis with
MultiCoil49 reveals that BAP32 shows a probability of
about 30% to form a two-stranded coiled coil. BAP37, in
contrast, is predicted to form a three-stranded coiled coil
with a probability of almost 60% (data not shown).
Generally, it is possible that the different strands of a
multistranded coiled coil are provided by the same mole-
cule or a neighboring molecule. Especially, if the coiled-
coil region is divided into two segments like in BAP37, it
is quite possible that the second segment adopts an anti-
parallel orientation with respect to the first one and
thus forms the second strand of a two-stranded coiled
coil. As there is no further structural information avail-
able, further predictions remain pure speculation and we
have thus decided not to propose any detailed model for
the C-terminal domains of prohibitins.
The Middle (PHB) Domain of BAP32 and BAP37
On the basis of the agreement between the predicted
secondary structures of BAP32/BAP37 and the experi-
mentally determined structure of flotillin-2, we generated
homology models for the PHB domains of both human
prohibitins using the NMR structure of flotillin-2. The do-
main adopts a slightly elongated globular shape where
the two antiparallel helices a2 and a3 pack against the
three-stranded antiparallel b-sheet formed by b1/b2, b3/
b4, and b5 [Fig. 5(A,B)]. The predicted helical segment a1
at the ‘‘bottom’’ (N-terminal) side of the protein appears
like an extended loop and probably an area of the model
where the structure can be predicted with less confidence.
The generated homology models have positional rms dis-
tances to the experimental flotillin-2 structure of 10.5 Å
(BAP32) and 10.0 Å (BAP37). The two models among
each other differ by an rms distance of 3.1 Å.
Although there are some similarities between the
homology model presented in this study and the pre-
dicted BAP32 model by Khurshid and coworkers (PDB
accession no. 1lu7), the latter shows a much less globu-
lar fold [Fig. 5(D)]. A b-sheet feature is present in the
predicted model, but it is exclusively built by the N-ter-
minal b-strands and there are no packing interactions to
the two antiparallel helices.
A comparison of the surface properties of the prohibi-
tin models and flotillin-2 reveal interesting differences
(Fig. 6). Although the PHB domain of flotillin-2 is pre-
dominantly negatively charged with only few isolated
positive areas and very little hydrophobic regions, the
two prohibitins appear to have gradually more hydro-
phobic character. The surface of BAP32 presents a mixed
arrangement of electropositive and electronegative
patches all over the PHB domain. BAP37, in contrast,
exposes predominantly electropositive groups and pos-
sesses only one acidic area at the ‘‘bottom’’ side of the
protein around and the N-terminal region.
The BAP32:BAP37 Oligomer
On the basis of the finding that prohibitins exist as
high molecular weight oligomers,19,20,50 as well as
results from crosslinking experiments,38 a ringlike as-
sembly of alternating prohibitin homologs has been pro-
posed. This model is supported by recent electron micro-
graphs of purified yeast prohibitin complexes revealing
large ring-shaped structures consisting of about 16–20
individual prohibitin molecules.24 So far, no experimen-
tal evidence has been obtained that would suggest for-
mation of homo-oligomers.24
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Protein docking calculations using the programme
Hex37 and the homology models of the middle domains of
BAP32 and BAP37 resulted in a model where a2 and a3
from BAP37 pack against b1 and a2 of BAP32 [see Fig.
7(A), left]. Overall, this leads to an orientation where both
molecules are positioned next to each other with a tilt
angle of about 1208 between their long axes. Thus, they are
aligned in an almost antiparallel fashion, which is not a
Fig. 4. Model of a putative hetero-dimer of the N-terminal membrane-anchoring helices of BAP32 and BAP37.
Human prohibitins utilise unconventional N-terminal sequences as membrane-anchoring helix elements. Several
polar and charged residues remain at the surface of the helical dimer and would thus be in contact with the hydropho-
bic interior of the mitochondrial inner membrane. A: A dimer model assuming parallel arrangement of N-terminal
a-helical segments of human prohibitins. The manually constructed model was subjected to a molecular dynamics
simulation with GROMACS.39 The four panels show successive rotations of 908 of the simulated model around the
vertical axis. The C-terminal end projects into the inter-membrane space. Figure prepared with BOBSCRIPT47 and
rendered with PovRay.48 B: Analysis of the molecular dynamics simulation. The potential energy of the dimer (top
panel) and the rms distance of backbone atoms (middle panel) suggests an equilibrated structure from 300 to 500
ps. The bottom panel shows the distance between both PHB domains and reveals an optimised orientation of both
domains at around 500 ps.
Fig. 5. Three-dimensional homology models of the PHB domains of
BAP32 (red) and BAP37 (blue) based on the structure of the flotillin-2
PHB domain (purple, PDB accession no. 1win). The predicted fold by
Khurshid and coworkers (PDB accession no. 1lu7) is shown in green
for comparison. Figure prepared with BOBSCRIPT47 and rendered with
PovRay.48
Fig. 6.
Fig. 7. The building block for ring-like prohibitin oligomers. Forma-
tion of prohibitin high-molecular weight complexes necessitates contacts
between the BAP32 (red) and BAP37 (blue) PHB domains. Left : The
dimer model as suggested by the programme HEX37 with an almost
antiparallel arrangement of the two PHB domains. Middle: A dimer
model considering the criteria of parallel arrangement and distance
restraints based on an earlier crosslinking study.38 The manually con-
structed model was subjected to a molecular dynamics simulation with
GROMACS.39 Right : Analysis of the molecular dynamics simulation.
The potential energy of the dimer (top panel) and the rms distance of
backbone atoms (middle panel) suggests an equilibrated structure from
300 to 500 ps. The bottom panel shows the distance between both
PHB domains and reveals an optimised orientation of both domains at
around 500 ps. Left and middle panels prepared with BOBSCRIPT47
and rendered with PovRay48.
Fig. 6. GRASP35 surface representations of the BAP32 (top panel)
and BAP37 (middle panel) homology models; the PHB domain of flotil-
lin-2 is shown for comparison (bottom panel). The surfaces are colored
according to electrostatic potential with blue indicating positive and red
indicating negative charge. The four pictures within one panel show
successive 908 rorations around the vertical axis.
preferable position considering that both N-termini carry
membrane-anchoring helices and therefore should be on
the same side of the prohibitin complex. The dimer is held
together mainly by van der Waals interactions, and only
one hydrogen bond between Thr124 (BAP32) and Glu139
(BAP37) can be identified. The buried surface area is about
2700 Å2 corresponding to 13% of the surface of each mono-
mer. However, the Hex-derived model does not agree with
the results from the earlier crosslinking study with yeast
prohibitin,38 where residues 72 and 152 (BAP32) were
found to be crosslinked with residue 86 (BAP37), and resi-
due 149 (BAP32) was linked to residue 159 (BAP37).
To elucidate possible models fitting these criteria, we
set out to manually create BAP32:BAP37 oligomers that
would satisfy the anticipated parallel orientation of the
two protein molecules, as well as the spatial closeness of
the residues identified from crosslinking of yeast prohibi-
tins.38 Inevitably, this leads to a model where helices a2
and a3 from both molecules form a four-helix bundle
[Fig. 7(A), right]. The starting model was subjected to a
molecular dynamics simulation in order to test the sta-
bility of the complex and improve the conformations as
to maximise the interactions between both monomers
[Fig. 7(B)]. The interaction interface covers about 1150
Å2 (6% surface of each individual protein molecule). Two
hydrogen bonds can be identified, one between Glu90
(BAP32) and Arg174 (BAP37) and another between
Asp104 (BAP32) and Ser231 (BAP37). The complex pos-
sesses pseudo-twofold symmetry, which establishes a
prohibitin dimer as building block for the ring-shaped
high molecular weight complex and requires a different
type of protein–protein interaction with the neighboring
prohibitin molecules in the ring. It is tempting to specu-
late that these interactions are provided by coiled-coil
interactions between neighboring BAP32 and BAP37
molecules. This speculation is in agreement with the
report by Tatsuta and colleagues showing that C-termi-
nally truncated yeast Phb1 is unable to form large
assemblies,24 as well as with a number of important resi-
dues in the coiled-coil region identified in the cross-
linking study by Back and coworkers.38 Intriguingly, all
previous studies in this context agree that there is no
prohibitin dimer detected in physiological environment.
One might therefore speculate that a cooperative effect
enables BAP32-BAP37 interactions by coiled-coil strand
exchange and four-helix-bundle formation, which ulti-
mately results in the formation of large ring-shaped com-
plexes. The fact that both proteins are membrane-bound
through their N-terminal helices will most likely lower
the activation energy for these interactions.
Binding of Melanogenin to BAP32
Melanogenin has been found to enhance melanin pro-
duction in melanocytes and to bind specifically to prohib-
itin,28 proposing a functional role for prohibitin in mela-
nin induction. A priori, it is not clear whether the role of
prohibitin in these processes involves an individual pro-
tein or the assembly of prohibitin with other proteins,
especially the prohibitin high molecular weight com-
plexes. Snyder and coworkers28 identified prohibitin as a
specific target for melanogenin by affinity chromatogra-
phy with immobilized ligand. Bound proteins were iden-
tified by digestion with trypsin and subsequent sequenc-
ing using mass spectrometry. BAP32 was identified
exclusively and unambiguously and we thus focused our
Fig. 8. Docking of melanogenin to two predicted pockets on BAP32.
The melanogenin molecule was docked into pocket 1 (A) and pocket 2
(B), shown as blue areas. The potential binding pockets are displayed
on the left side. The position and conformation of melanogenin in the
respective pockets is shown on the right. Interacting side chains of the
protein are colored in blue, the melanogenin molecule is colored by its
elements. Figure prepared with PyMOL.51
Fig. 9. Suggested model of membrane-bound prohibitin. Although
BAP32 (red) and BAP37 (blue) membrane helices might interact with the
m-AAA transmembrane helices (cyan), the PHB domains could interact
with the m-AAA IMS region (turquoise) exposed to the intermembrane
space of mitochondria. The ATPase domain and the protease domain of
m-AAA-protease are shown in yellow and green, respectively.
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further analysis on BAP32. We further assume that
binding of the ligand would occur at a globular domain,
that is, the PHB domain of the protein.
Melanogenin possesses three substituents at the central
triazine ring, a polyether/amine chain, a mono-fluoro-ben-
zyl group, and an ether-bonded penta-fluoro-hydroxy-ben-
zol. By visual inspection and surface analysis of our
BAP32 homology model, we have identified two potential
binding pockets within the PHB domain. One pocket
[pocket 1; Fig. 8(A)] is located at the membrane-proximal
side of BAP32 and constituted by helix a1 at the bottom,
strands b5 and b4 at the side and the linker region
between the N-terminal membrane helix and the PHB do-
main at the back. A slightly smaller pocket [pocket 2;
Fig. 8(B)] is located in a groove between helices a2 and a3
in between residues Thr124 and Phe134. Both pockets are
lined with hydrophobic residues in the cavities and polar/
charged residues at the protein surface.
Attempts to fit the ligand into the latter pocket yielded a
conformation where the two aromatic rings of the organic
molecule are sticking out from the protein surface and the
triazine ring, as well as the polyether/amine chain are
neatly accommodated in the groove. This binding mode
with a buried surface of 737 Å2 is stabilized by hydrogen
bonds provided by Ser129, Arg133, Gln149, and Asp153.
Docking of melanogenin into pocket 1 yields conforma-
tions with much larger buried surface areas (839 Å2)
when compared with pocket 2. Here, the polyether/amine
branch of the ligand protrudes into the cavity at the
membrane-proximal side of the protein. The side chain
amine group of Gln102 provides hydrogen bonds to inter-
act with the two ether groups and the most extreme
amine group of the ligand is held in position by hydro-
gen bonds with the backbone carbonyl groups of Phe161,
Gln102, and Val99. At the protein surface, Thr160 and
Arg157 provide hydrogen bonds to two nitrogen atoms of
the triazine ring system, which is further held in place
by van der Waals interactions with Ile122. The fluorine
of the mono-fluoro-phenyl group is hydrogen bonded by
the side chains of Ser121 and Glu125, and the penta-flu-
oro-substituted ring system is only loosely held in place
by van der Waals interactions with Thr160. An alterna-
tive binding mode where the two aromatic ring systems
have switched places has also been obtained with
slightly lesser scoring values. It thus remains unclear
which binding mode might be preferred. For both pock-
ets, a common observation is the fact that the penta-flu-
oro-substituted ring system is not fully coordinated by
protein residues, sticking out of the protein surface, and
available for external interactions. This is contrasted to
a certain extent by a finding by Snyder and coworkers
who found a melanogenin derivative with a 2,3,6-tri-flu-
oro-hydroxybenzol group to bind less well to prohibitin.28
CONCLUSIONS
In the absence of experimentally determined three-
dimensional structures, the field is still far from a com-
plete understanding of prohibitins at the molecular level.
However, dissecting the proteins into the three domains
allows some structural predictions. Using homology mod-
eling, molecular dynamics simulations and the currently
available information about prohibitins, one can suggest
a model whereby the N-terminal transmembrane helices
as well as the middle (PHB) domains are engaged in
direct interactions thus constituting a dimeric-building
block for the high molecular weight assemblies.
Although the C-terminal coiled-coil domains will most
likely be involved in intermolecular interactions as
well,52 it is not clear at this point, whether these interac-
tions occur within the dimeric-building block or between
two of these building blocks.
Given the results from an earlier crosslinking study of
the yeast prohibitin complex,38 it seems that the main
interactions between the globular PHB domains of
BAP32 and BAP37 occur only on one side. The formation
of ringlike assemblies would require interactions be-
tween the dimeric-building blocks, most probably between
either the N-terminal helices (within the membrane) or
the C-terminal coiled-coil domains. Alternatively, the
ringlike assembly could also be promoted by an external
factor such as the m-AAA protease.
The m-AAA-protease is anchored to the inner mito-
chondrial membrane by the N-terminal domain of its
subunits, while the C-terminal ATPase and metallopepti-
dase domains protrude into the mitochondrial matrix.53
Although the X-ray structure of the ATPase domain of
the E. coli AAA-protease FtsH has been solved,54 only
little structural information is available about the N-ter-
minal domain. In yeast, it is thought that both subunits,
Yta10 and Yta12, anchor the m-AAA-protease to the
inner mitochondrial membrane with two transmembrane
helices.55 Both transmembrane helices are connected via
a structurally well conserved N-terminal loop. Thus,
interactions of the dimeric-building blocks of BAP32:
BAP37 with the m-AAA-protease could happen at two
possible interfaces (Fig. 9). The N-terminal trans-
membrane helices interact with each other inside the
membrane, which would satisfy the need to mask the
remaining exposed polar residues of the two BAP trans-
membrane helices. Alternatively, the N-terminal loop of
m-AAA-protease, which is exposed at the inter-mem-
brane space interacts with the PHB domains of the
BAP32:BAP37 building blocks.
The immense difficulties in the crystallization of pro-
hibitins and their domains (Winter and Hofmann,
unpublished) might be overcome by focussing on prohibi-
tin complexed with other proteins or ligands rather than
the individual prohibitin proteins. However, interactions
of prohibitins with other proteins such as Rb, p107,
p130, a-actinin, and annexin A2 are complex and might
involve further participants that have not yet been iden-
tified. The putative interaction with the N-terminal loop
of m-AAA proteases concluded in this study adds a new
target in this context and might well turn out to be of
high interest because of its potential significance for
membrane protein turnover and mitochondria-born dis-
eases as well as its technical feasibility.
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On the basis of our results from the docking studies,
we believe that the larger pocket in BAP32 constituted by
helix a1 and strands b5 and b4 is a likely binding pocket
for melanogenin. The model obtained from our docking
results does not explain the apparent discriminating effect
of the fluoro-substituents in position 4 and 5 of the penta-
fluoro-hydroxy-benzol group of melanogenin, but this
might well be because of shortcomings of the homology
model of the BAP32 PHB domain. A different conformation
of amino acid residues in the area of the binding pocket
might easily lead to a different conformation of the bound
ligand, for example, a change of positions between the
penta- and mono-fluoro-substituted ring systems.
Further experiments aiming at targeted design of lead
compounds will most likely involve database-mining
approaches. However, even this line of investigation put
further weight on the demand for experimental struc-
tures of prohibitin proteins and their complexes.
Structural information about the prohibitin complex at
atomic detail will undoubtedly be useful in understand-
ing the molecular mechanisms of protein turnover in mi-
tochondria as well as in structure-based lead compound
discovery for novel drugs in a variety of diseases. Fur-
ther efforts are currently being undertaken in our labo-
ratory to aid in elucidation of the structural chemistry of
these highly conserved proteins.
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Structure 2002;10:1073–1083.
55. Langer T. AAA proteases: cellular machines for degrading mem-
brane proteins. Trends Biochem Sci 2000;25:247–251.
362 A. WINTER ET AL.





Towards understanding the roles of prohibitins, multi-
functional regulator proteins 
 
 
Anja Winter1,2 & Andreas Hofmann2* 
 
 
1ISMB, School of Biological Sciences, The University of Edinburgh, Scotland, UK 




*Correspondence to Andreas Hofmann, Structural Chemistry Program, Eskitis Institute for Cell &  
Molecular Therapies, Griffith University, Brisbane Innovation Park,  
Don Young Road, Brisbane, Qld 4111, Australia. 








Revised version, 25.05.07 
 
Winter & Hofmann Prohibitins, multi-functional regulator proteins 2 
p_5.doc, 25.05.2007 
Abstract 
Prohibitins comprise a family of highly conserved ubiquitous eukaryotic proteins that localise to different 
compartments of the cell. They have been implicated in important cellular processes such as cellular 
signalling and transcriptional control, apoptosis, cellular senescence, early development of 
Caenorhabditis elegans and mitochondrial biogenesis. 
 
In yeast, mammals and C. elegans there exist at least two homologous prohibitin proteins (yeast: PHB1, 
PHB2; human: BAP32, BAP37), which assemble into high molecular weight complexes of about 1.2 
MDa in the inner mitochondrial membrane. Experimentally determined structural information about 
these proteins has been elusive for a long time. Recently, however, the biogenesis and architecture of 
the yeast prohibitin complex has been analysed and yielded ring-shaped structures as visualised by 
single particle electron microscopy. 
Structural details at atomic level remain to be determined, but a first step into this direction is provided 
by modelling approaches. Prohibitins consist of three domains, an N-terminal transmembrane helix, a 
middle (PHB) domain and a C-terminal coiled coil domain. The PHB domain is the landmark feature 
within the super-family of SPFH (stomatin / prohibitin / flotillin / HflK/C) domain proteins. The recently 
determined NMR structure of mouse flotillin-2 provides a first access to structural details of prohibitins. 
 
While the first functional role attributed to prohibitins was the regulation of cellular senescence, DNA 
transcription and tumour cell growth, there is recent evidence that they also can act as markers for 
adipose tissue. In a mouse model, an apoptotic peptide targeted at prohibitin was successful in 
reversing obesity. An extracellular complex containing both BAP32 and BAP37 was found to bind to the 
Vi capsular polysaccharide, first identified as a virulence antigen of Salmonella typhi, suggesting a key 
role for both proteins in infection with S. typhi. Furthermore, the interaction of prohibitin with 
compounds activating melanin production has placed these proteins at a central position in 
melanogenesis, and further implicates mitochondria in signalling pathways of the pigmentation process. 
Accumulating evidence suggests that prohibitins are implicated in mitochondrial, age and oxidative 
stress -related diseases, as well as in immunity and inflammation, cancer and cancer-like diseases, 
obesity, and drug resistance. 
 
The complementary interplay between structural and chemical biology will provide important insights 
into the molecular mechanisms of prohibitins and, more generally, the functions of mitochondria in 
living cells. 
This review discusses the current state of knowledge about prohibitins, and provides a vision for further 
developments in the field of these eminently important proteins. 
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Introduction 
Prohibitins comprise a family of conserved ubiquitous eukaryotic proteins [1]. They have been 
implicated in important cellular processes and have been found in different cellular compartments, 
including mitochondria. Prohibitin 1 cDNA was first isolated by hybridisation to RNA in rat liver and the 
protein was proposed to be an inhibitor of cellular proliferation [2]. Inhibition of DNA synthesis was 
observed upon microinjection of prohibitin 1 mRNA into human fibroblasts [3], an effect that was 
subsequently found to be a feature of the 3’-untranslated region of prohibitin 1 [4].  
While prohibitin 1 is usually referred to as Phb1, its human orthologue is known as B-cell receptor 
associated protein 32 (BAP32). The related protein prohibitin 2 (Phb2) is also known as prohibitone [5], 
and the human orthologue is known as BAP37 which is identical to a protein earlier identified as 
repressor of estrogen receptor action (REA) [6]. Prohibitin orthologues have also been identified in other 
mammals, Drosophila, plants and yeast. In yeast, prohibitin 1 is referred to as PHB1, whereas 
prohibitone is called PHB2. 
Prohibitins belong to a larger super family of proteins, called the stomatin/prohibitin/flotillin/HflK/C 
(SPFH) super family, that share an evolutionary conserved domain, the SPFH, or PHB domain. Members 
of this protein family are membrane-associated and implicated in cellular processes concerned with 
protein turnover [7], senescence [2] and proliferation control [2, 8, 9]. They can be found in higher 
eukaryotes (prohibitin, stomatin, podocin), as well as in lower eukaryotes and prokaryotes (vacuolin A, 
vacuolin B, HflK, HflC, unc-1, unc-24, mec-2). The PHB domain is conserved in proteins that are 
ubiquitously expressed such as flotillin, as well as in proteins that show extremely restricted expression 
like the stomatin-related olfactory protein (SROP) whose expression is constrained to olfactory sensory 
neurons [10]. The evolutionary significance of this domain is unclear but its prokaryotic conservation 
suggests that it is indeed a primordial motif likely to perform an important cellular function. 
 
Cellular localisation of prohibitins 
Prohibitins have been found in several intra- as well as extra-cellular locations. In early studies, 
prohibitins were nearly exclusively found to localise to mitochondria, but later studies reported 
prohibitins to be localised also in the nucleus and the cytosol, as well as at the cell surface. While it has 
been suggested that the N-terminal sequences of PHB-domain containing proteins are responsible for 
subcellular targeting [11], it remains unclear which mechanisms and what signals are used to transport 
prohibitins to different cell compartments. 
With immunohistochemical methods and subcellular fractionation, prohibitins have been found most 
abundantly in mitochondria [12-15], where they form ring-shaped high molecular weight complexes in 
the inner mitochondrial membrane [16]. 
Using differential immunisation, BAP32 and BAP37 have been detected in the human circulation 
system, with considerably higher levels in cancer patients [17]. The implications of extra-cellular 
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prohibitins remain to be elucidated, but BAP32 has recently been linked to complement activation since 
it interacts with complement component C3 [18]. Most likely, the externalisation of prohibitins happens 
by release from lipid vesicles rather than protein translocation using signal peptides [19] which might 
also be the mechanism of prohibitin transport to the endothelium. 
Using mouse and human tissues, an immunohistochemical study revealed that prohibitin 1/BAP32 is 
present in the vasculature of white adipose tissue [20], and may therefore be used as a target for 
apoptosis inducing drugs to fight obesity. Cell surface –associated BAP32 and BAP37 have also been 
shown to interact with Vi capsular polysaccharide of Salmonella typhi [21] in the intestinal epithelium.  
Phb1/BAP32 [22-25] and Phb2/BAP37 [26, 27] were repeatedly shown to be present in the nucleus. 
BAP32 possesses a nuclear export signal and, in breast cancer cells, translocates to the cytoplasm upon 
apoptotic stimulation [24, 28, 29]. Recently, prohibitin 2 has been shown to translocate from the 
mitochondria to the nucleus in the presence of estrogen receptor alpha and estradiol, suggesting a role 
of this protein in coupling of mitochondrial-nuclear interactions [30].  
Both proteins were also found to be associated with cytoskeletal proteins [31], and the association with 
annexin A2 provides a link of prohibitins to lipid rafts. This notion is further supported by the discovery 
of the PHB-domain containing proteins erlin-1 and erlin-2 in lipid rafts of the endoplasmic reticulum 
[11], and the association of lipid rafts with BAP32 and BAP37 on the cell surface [21]. Notably, for 
podocin and mec-2, the palmitoylated PHB domains have been proven to be essential for the ability to 
bind cholesterol [32]. 
 
Topology and structure of prohibitins 
Topologically, prohibitins can be dissected into three domains: an N-terminal membrane-anchoring α-
helix, the middle or prohibitin homology (PHB) domain, and the C-terminal coiled coil region. In the 
absence of atomic details of prohibitin structures, homology models for the PHB domains of both 
human prohibitins have been generated [33] based on the NMR structure of the related flotillin-2 (PDB 
accession number 1win). The domain adopts a slightly elongated globular shape where the two anti-
parallel α-helices pack against a three-stranded anti-parallel β-sheet. A comparison of the surface 
properties of the prohibitin models and flotillin-2 reveals interesting differences with the PHB domain of 
flotillin-2 being predominantly negatively charged. The surface of BAP32, in contrast, presents a mixed 
arrangement of electropositive and electronegative patches all over the PHB domain, and with BAP37 
an almost exclusively electropositive surface potential is observed in the PHB domain. Figure 1 shows 
representations of the secondary structure elements and surfaces of the modelled PHB domains of 
BAP32 and BAP37 in combination with their modelled N-terminal helices [33] embedded in the inner 
mitochondrial membrane. 
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Prohibitins show a limited sequence similarity to chaperonins of the GroEL/Hsp60-class. Since 
prohibitins were found to interact with newly synthesised mitochondrial translation products such as 
cytochrome c oxidase, they have been proposed to function as a chaperoning "holdase" during the 
assembly of the respiratory chain [12]. Incidentally, the architecture of the membrane-bound yeast 
prohibitin complex that has been analysed recently by single particle electron microscopy yielded ring-
shaped structures with outer dimensions of about 270 x 200 Å [16] and is thus reminiscent of 
chaperonins that provide a sequestered environment within cylindrical structures. However, compared to 
GroEL with a diameter of 150 Å, the prohibitin ring is substantially larger. This prompted Langer and 
colleagues to suggest a scaffolding function of the prohibitin complex that may ensure the organisation 
and integrity of the inner mitochondrial membrane. This role would also agree with the functional 
interaction of prohibitins with various mitochondrial proteins reflecting the proposed role of prohibitins 
for the maintenance of mitochondrial morphology [16]. 
The ring-like structures of membrane-bound prohibitins imply a topology where prohibitin 1 and 2 
associate by an interaction interface that may be formed by the PHB domain. A model of the PHB 
domain dimer of BAP32:BAP37 has been constructed based on earlier crosslinking experiments [33, 
34]. While molecular details remain to be clarified, the ring-like structures of both prohibitins confirm 
earlier findings of both proteins forming a tight complex and thus stabilising each other [12, 35, 36].  
In contrast, Bacher and coworkers reported that both isolated prohibitins, BAP32 and BAP37, preferably 
form homotetramers as well as calcium-independent heteromeric complexes with affinities of 10-7 M 
[31]. Potentially, BAP32 could form dithioether-based dimers via its cysteine residue in position 69 (see 
Figure 2) and, intriguingly, is substrate of the transglutaminase 2, a disulphide isomerase [37]. This 
finding also poses the question of the importance of prohibitin disulphide RedOx chemistry and fold 
stability for its function. However, since BAP37 does not have any cysteine residue, the BAP32:BAP37 
interactions cannot involve dithioether functionalities.  
 
Apart from their oligomeric species, prohibitins 1 and 2 have also been found to interact with target 
proteins in their monomeric states. In the nucleus, for instance, prohibitin 1 (BAP32) was found to 
interact with p53 [24], Rb [23, 38], and E2F [39]. Prohibitin 2 (BAP37) was reported to bind to estrogen 
receptor (ER) [6, 30] and Akt [27]. It remains to be clarified under which circumstances the proteins exist 
in the respective oligomeric states. Most likely, occurrence of the monomeric state in non-membrane-
bound states would require binding of stabilising proteins to mask the hydrophobic N-terminal domains 
[33].  
 
The wide range of interactions of prohibitins with other proteins might not only result from different 
quaternary structures, but also post-translational modifications of the proteins enabling them to carry 
out various functions in the cell. Phosphorylated species of prohibitins were found in 2D-gel 
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electrophoresis experiments in plants [40], and it was also shown that purified JNK1 successfully 
phosphorylates prohibitin in vitro [39]. While phosphorylation of yeast prohibitin 2 by Akt could not be 
confirmed despite the presence of a consensus Akt phosphorylation site in prohibitin 2 (86-RPRKIS-91), 
an interaction of both proteins could be verified in co-immunoprecipitation assays and yeast two-hybrid 
screens [27]. Residues 120-232 on prohibitin 2 were identified as interaction interface (see figure 2), 
indicating that it might belong to the class of Akt-binding proteins that are not substrates for the kinase 
(see next section). 
Examination of our proposed PHB domain dimer model of BAP32 and BAP37 [33] shows that most of 
the three predicted phosphorylation sites (ExPASy proteomics server, www.expasy.ch) in BAP32 (T108, 
S109, T141) and BAP37 (T194, S190, S110) are surface-accessible (Figure 2). Importantly, some 
phosphorylation sites are positioned in interaction interfaces to other proteins and might thus be 
involved in modulation of binding properties to target proteins. 
Another post-translational modification might happen by lipo-conjugation of the PHB domain as 
observed with podocin and mec-2, two PHB domain -containing proteins [32]. As palmitoylation occurs 
at accessible cysteine residues, only BAP32 (one cysteine at position 69; see Figure 2), but not BAP37 
(no cysteine) is anticipated to possess this feature. Based on a preliminary secondary structure alignment 
of BAP32 with podocin and mec-2, Cys69 seems to be located in a similar position like the conjugated 
cysteine in podocin/mec-2. 
 
Prohibitins as regulators of gene expression 
Several studies have identified prohibitins as cell cycle regulators, although the detailed mechanisms 
remain to be clarified [18, 41]. There is accumulative evidence of prohibitins acting as transcription 
regulators. Prohibitin 1 interacts with checkpoint molecules of the cell cycle, such as p53 [24] and Rb 
[23, 38], and with the transcription factor E2F [39]. The reported interaction sites of Rb and E2F with 
prohibitin 1/BAP32 can be mapped on the modelled BAP32:BAP37 dimer unit as illustrated in Figure 2. 
The region on prohibitin 1 C-terminal to the PHB domain (residues 185 to 214) is required for 
repression of E2F activity in addition to the Rb-binding domain [39]. The transcription of multiple genes 
has been found to be modulated by increased cellular levels of prohibitin in transfection experiments, 
and, accordingly, prohibitin has been implicated in cell cycle regulation [23, 24, 39].  
The repressor function of BAP32 with respect to E2F-mediated transcription appears to utilise molecular 
mediators and signalling pathways different from the Rb pathway [41]. BAP32 recruits co-repressors 
HP1γ and Brg1/Brm to repress E2F-mediated transcriptional activity [42-44]. Breast cancer cells treated 
with estrogen antagonist showed an enhanced association between Brg1/Brm and prohibitin [43, 44].  
A similar observation has been reported for the anti-proliferative actions of vitamin D [45]. Cellular 
levels of BAP32 were found to be increased by vitamin D treatment of breast cancer cell lines 
subsequently leading to growth inhibition. While a binding site for the vitamin D receptor/retinoid X 
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receptor has been predicted in the promoter region of BAP32, direct interactions at protein level remain 
to be clarified.  
The Rb binding region on BAP32 spans residues 74-116, where three of four point mutations of 
prohibitin are found in sporadic breast cancer cells [38, 46, 47]. Interestingly, those residues span the 
anti-parallel β-sheet of BAP32, which is proposed not to interact with its homologue, BAP37, and would 
thus be potentially available for interactions with other target proteins. Further research in this area 
might give clues to the nature of this interaction and thus provide insights in the mechanism responsible 
for E2F repression.  
BAP37, originally known as REA, is a repressor of estradiol-dependent transcription [6, 30] and binds 
directly to the estrogen receptor (ER) in the presence of its ligand estradiol. While BAP37 possesses the 
common ER-binding motif L-X-X-L-L N-terminal of its PHB domain, residues 175-198 are required for 
binding to ER [48] (see Figure 2). The L-X-X-L-L motif is suggested to be required for its repressive 
activity due to inhibiting ER co-activation by SRC-1. 
Interestingly, BAP32 was also shown to have a repressive effect on androgen receptor (AR)–mediated 
transcription and androgen-dependent cell growth without an apparent direct interaction with AR [49]. 
In the nucleus, Akt has been shown to stimulate the transcription factor families of MyoD and MEF2 
indirectly during muscle differentiation. This action was specifically repressed by prohibitin 2, possibly 
with the help of co-activators such as histone deacetylases. Prohibitin 2 might thus act as a miogenic 
repressor by competing with Akt to prevent its interaction with MyoD and MEF2 [27].  
One can thus speculate that a complex consisting of both prohibitins acts as a mediator between Rb 
and E2F (interacting with BAP32) on the one hand, and ER receptor (interacting with BAP37) on the 
other. Furthermore, these functions might be activated by phosphorylation since some phosphorylation 
sites are situated in the proposed binding sites of Rb/E2F (see Figure 2). 
 
Prohibitins in cancer 
Early work on BAP32 suggested that the protein is a tumour suppressor, because a growth arrest was 
found in HeLa cells after microinjection of prohibitin transcripts [3]. It was shown later that this property 
actually resides in the 3’-UTR of BAP32 mRNA and the ability to inhibit cell cycle activity is restricted to 
normal cells and cells of the so-called group B immortal complementation group [12]. A polymorphism 
in the 3’-UTR of BAP32 has been identified as a risk modifier in breast cancer in the presence of BRCA1 
mutation [12]. In a screening for somatic mutations in 23 breast cancers, four mutations leading to 
amino acid changes at positions 88 (Val Ala) and 105 (Arg His), as well as a frame shift mutation 
leading to a truncation at position 53 [46]. Within an intron, a C T change was observed which may 
interfere with the splicing process. Interestingly, almost all mutations reported in sporadic breast cancer 
lie within the Rb-binding domain of prohibitin [46]. 
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BAP32 has also been localised to the nuclei of breast cancer cells [24] and the cellular expression of 
the non-mutated protein is generally up-regulated in tumour cells as compared to normal cells [12, 50-
53]. BAP32/BAP37 was also found at the cell surface of cultured colorectal tumour cells, and, notably, 
significant levels of both proteins were found in the serum [17]. It is not entirely clear whether 
BAP32/BAP37 are intentionally released into the blood or whether this is a direct consequence of the 
necrosis of tumour cells. In any case, these observations support a probable usability of prohibitins as 
tumour markers (see also [50]). 
The involvement of BAP32 in repression of estrogen-dependent transcription has brought the prohibitin 
proteins back into focus as potential targets for breast cancer therapy. Estrogen antagonists are the 
commonly used endocrine therapy in breast cancer, but application is limited due to development of 
cellular resistance [44]. Further investigation of the prohibitin-E2F interactions and the involvement of 
estrogen antagonists at the molecular level might lead to development of new drugs in breast cancer 
therapy. The re-gained attention as potential cancer targets is further deserved because BAP32 was 
identified as a novel target gene of vitamin D, leading to downregulation of proliferation by activation 
of the vitamin D receptor. The clinical use of vitamin D in cancer therapy and prevention is restricted by 
its toxic effects at higher concentrations. Recently, BAP32 has been shown to enhance the anti-
proliferative effects of vitamin D in breast cancer cells [45].  
The re-gained interest in prohibitin for cancer treatment is also supported by the observation that 
interaction of BAP32 with the signalling kinase cRaf is crucial for Ras-mediated activation, as well as 
membrane targeting of cRaf [54]. BAP32 directly interacts with the kinase and is indispensable for the 
replacement of 14-3-3 from cRaf by Ras-GTP. Because Ras mutants activating Raf kinases are 
frequently found in tumours, and BAP32 is a crucial facilitator of this signalling pathway, prohibitin has 
again become a possible target for therapeutic applications. 
Interestingly, a recent study elucidating the mechanisms for occurrence of multidrug resistance in a 
Caenorhabditis elegans model identified the E130K mutation in prohibitin 2 to be responsible for drug 
resistance of drugs binding to tubulin and camptothecin [55]. The location of Glu130 in the region of 
prohibitin 2 binding to Akt, MyoD and α-actinin (see table 1) might indicate the direction of further 
studies to elucidate the molecular mechanism. 
 
The role of prohibitins in apoptosis 
Very early on, the implications of prohibitins for cellular senescence have been emphasised by a 
number of studies, mainly fuelled by the observation of a shortened replicative life span of an yeast 
phenotype with disrupted prohibitin [35, 36]. While disruption of prohibitin genes in S. cerevisiae does 
not result in a lethal phenotype [35], the deletion of a prohibitin homologue in D. melanogaster [56] 
and C. elegans [57] is lethal during larval development. In a quest for finding drug-regulated genes in 
osteosarcoma cells, the cytotoxic chemicals cis-platin, methotrexate and doxorubicin were found to 
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increase cellular expression of eight genes mainly coding for electron transfer proteins, but to 
significantly decrease the expression of prohibitin and α-actinin [58]. The role of prohibitin in 
modulation of drug-induced apoptosis was further confirmed by the finding that its overexpression 
reduced chemosensitivity of the cells by about 50%. 
Similar observations have been made with granulosa cells [59] and plant prohibitins. After inducing 
defense responses with the protein phosphatase inhibitor calyculin A, rice prohibitin 1 becomes hyper-
phosphorylated in a lesion-mimic mutant that exhibits spontaneous cell death in the leaf [40, 60]. The 
down-regulation of expression of petunia prohibitin 1 by virus-induced gene silencing resulted in an 
acceleration of senescence of the flower [61]. While the same observation was made for prohibitin 1 in 
tobacco, the suppression of prohibitin 2 resulted in even more severe growth inhibition and apoptosis 
[62]. 
The senescent and apoptotic effects of prohibitin downregulation have always been observed to be 
accompanied by mitochondrial effects. In normal prostate epithelium, the transforming growth factor-β 
(TGF-β) acts as a tumor suppressor via induction of apoptosis and inhibition of cell proliferation. 
However, in advanced cancer, TGF-β signaling is deregulated which leads to promotion of tumor 
progression and metastasis acquiring anti-apoptotic pathways. Upon treatment with TGF-β, prohibitin 
translocates from the nucleus to the cell cytosol and was found strongly associated with the 
mitochondrial apoptosis-suppressor Bcl-2 [29]. In the yeast phenotype, a defect of the mitochondrial 
membrane potential has been observed [35], and the mitochondrial segregation from the mother to the 
daughter cells seems to be the reason for the shortened lifespan [63]. A disruption of mitochondrial 
biogenesis has also been found in C. elegans mutants [57]. Recent studies in tobacco show that a 
depletion of both prohibitins leads to a loss of mitochondrial integrity, excessive production of reactive 
oxygen species, and, subsequently, over-sensitivity to various stresses [62]. 
As for possible mechanisms, it has been suggested that the downregulation of prohibitin increases E2F 
acitvity, and thus E2F-mediated transcription which then triggers the apoptotic processes during the cell 
cycle at the entry into the S-phase [41]. Very recently, BAP37 has been reported to interact with the anti-
apoptotic protein Hax-1 [30], an integral membrane protein of the outer mitochondrial membrane that 
is exposed to the intermembrane space. A model has been postulated where Hax-1 is being protected 
from proteolytic degradation through association with BAP37. Notably, the authors report indications 
that the interaction of BAP37 with Hax-1 is stronger than the BAP32-BAP37 interaction [30]. It will be 
interesting to see in future experiments whether specific, individual target proteins exist for both 
prohibitins. 
 
Implications for mitochondrial functions 
Different stimuli such as UV irradiation, reactive oxygen species, hormones and growth factors can 
induce apoptosis which is a well-characterised form of programmed cell death [64] that requires the 
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action of caspases. Mitochondria play a pivotal role in the signal transduction of apoptosis, since they 
trigger the activation of caspases by release of cytochrome c, apoptosis-inducing factor and 
Smac/Diablo in a process called mitochondrial permeability transition which is the main pathway of 
programmed cell death in animal cells [65-68].  
To date, it is known that prohibitin 1 and 2 assemble into hetero-oligomers to yield high-molecular 
weight complexes of about 1.2 MDa as shown for yeast [69], mammals [12] and C. elegans [57]. For 
most interactions with prohibitin target proteins, it is not clear whether this requires reorganisation or 
indeed disassembly of the prohibitin hetero-oligomers. However, prohibitins seem to be able to interact 
with several target proteins simultaneously [31]. 
Further weight was put on the notion that high-molecular weight prohibitin complexes play an important 
role for the integrity of mitochondrial membranes [36] by the finding that prohibitin mutations in yeast 
are lethal when combined with disruption of the phosphatidylethanolamine (a major component of 
mitochondrial membranes) biosynthetic pathway [70]. This hypothesis is further supported by the first 
structural characterisation of membrane-bound prohibitin ring complexes. The findings by Langer’s 
group indicate a direct effect of the complexes on the ultrastructure of the inner mitochondrial 
membrane, since the ring-like structures have a similar diameter to cristae junctions [16]. In tobacco, 
prohibitin depletion causes abnormal mitochondria that lack inner cristae and contain fibre-like 
structures that probably represent disintegrated inner membrane [62]. The phenotype is further 
characterised by disrupted mitochondrial biogenesis or stimulated mitochondrial degeneration, and a 
reduction in number and mass of mitochondria in the cell. Aberrant mitochondria lacking the 
mitochondrial genome  were found to accumulate in S. cerevisae when the function of either prohibitin 
was lost [36, 63]. A lack of prohibitins was shown to affect mitochondrial distribution and morphology 
during development of body wall muscle cells of C. elegans [57]. In this context, RNAi-mediated 
elimination of prohibitin 2 was found to lead to mitochondrial fragmentation in HeLa cells [30]. 
The importance of prohibitins for programmed cell death might thus be due to their crucial role for 
mitochondrial integrity as suggested by recent studies in plants [40, 60]. Since prohibitins seem to 
protect inner membrane proteins, modifications such as phosphorylation (of BAP32) might change their 
functional properties or interactions with other proteins and finally lead to cell death. Accordingly, the 
high-molecular weight complexes of prohibitins with m-AAA protease are of particular interest. AAA 
protease, as well as the bacterial orthologue FtsH and other FtsH-like proteases from plants [71, 72], 
degrades membrane proteins in mitochondria [73] and seems to be regulated by prohibitins. Recently, 
the PHB domain –containing protein QmcA was identified in E. coli as a factor involved in membrane 
protein quality control [74]. As concluded from pulldown assays, QmcA interacts with FtsH to form 
oligomers. Based on findings from proteolytic accessibility experiments, these authors also suggested 
that PHB domains might be present on both sides of the membrane. 
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Generally, mitochondrial disorders can give rise to a broad spectrum of diseases such as myopathies, 
loss of hearing and optic neuropathy [75]. Mitochondrial dysfunction has also been implied in 
inflammatory diseases such as ulcerative colitis, a disorder characterised by chronic inflammation of the 
colon mucosa [76]. With a proteomics approach, several mitochondrial proteins have been found to be 
down-regulated in colon mucosa from patients with ulcerative colitis. This phenomenon is accompanied 
by pathological alterations of the mitochondrial ultrastructure [76].  
Metabolic stress caused by imbalances of mitochondrial and nuclear encoded proteins leads to up-
regulation of BAP32 and BAP37 expression levels [75]. The mitochondrial prohibitin complex was found 
to bind to mitochondrial translation products of the respiratory chain such as cytochrome c oxidase 
(COX). Here, it acts as a chaperone to assemble the COX complex [12], thus exerting important 
functions in maintaining a healthy protein population in mitochondria.  
Disturbances in mitochondrial function might be common in aged population and probably contribute 
to age-related diseases, such as Type 2 Diabetes [41]. In ageing mitochondria, oxidative stress leads to 
accumulation of superoxide, which could lead to the promotion of type 2 diabetes [77]. One might 
speculate that prohibitins could play a role in this process, especially when considering that prohibitin 
depletion leads to an excessive production of reactive oxygen species in plants [62]. Furthermore, 
overexpression of prohibitin increases the expression of glutathione-S-transferase π and protects from 
accumulation of reactive oxygen metabolites, as well as increased permeability induced by oxidative 
stress in intestinal epithelial cells. As such, prohibitin might act as a cellular defense against oxidant 
injury and thus be an interesting target for tissue injury and inflammatory diseases such as bowel and 
Crohn’s disease [78]. 
This link deserves further attention, since the addition of BAP32 to cultured adipocytes has been 
reported to result in inhibition of mitochondrial pyruvate carboxylase and subsequent suppression of 
glucose and fatty acid oxidation [79].  
 
With a chemical genetics approach searching for pigment-enhancing chemicals, melanogenin has been 
found to enhance melanin production in melanocytes and to bind specifically to prohibitin [80]. A 
sufficient pigment production in melanocytes is important for the organism, since UV irradiation can 
cause severe damage to the cell and finally induce apoptosis through activation of the mitochondrial 
permeability transition. The damage is possibly caused by favouring the opening of the mitochondrial 
permeability transition pore. Based on further RNA interference experiments, it has been proposed that 
prohibitin plays a functional role in melanin induction, since neither the melanin induction agent 
isobutylmethylxanthine nor melanogenin were able to induce melanin production when prohibitin 
expression was silenced [80]. Not only opens this finding another avenue for potential therapeutic 
applications of compounds targeting prohibitin, but it also demonstrates the possibilities of chemical 
biology approaches to probe organelle functions. 
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Prohibitin interactions with cytoskeletal proteins  
Employing an yeast two-hybrid screen, annexin A2 and α-actinin have been identified as binding 
partners for BAP32 and BAP37 [31]. Both proteins are able to bind to various target proteins in a 
calcium-dependent or a calcium-independent fashion. Annexin A2 is also able to bind to acidic 
phospholipid membranes in a calcium-regulated fashion.  
Truncation experiments by Bacher and colleagues [31] show that for binding to annexin A2, full-length 
BAP32 or BAP37 is required. The first 100 N-terminal residues of BAP32 displayed a strong binding to 
α-actinin, but in BAP37 the binding site for α-actinin seems to reside in the C-terminal domain. While 
each prohibitin was able to bind to each target protein, the stronger affinities were observed between 
BAP32 and annexin A2, and BAP37 and α-actinin, respectively [31]. The fact that these interactions are 
calcium-mediated does not automatically suggest a ‘sandwich’ role for the metal ion, since both target 
proteins are known to possess calcium-dependent allosteric mechanisms [81].  
Notably, prohibitins can interact with several target proteins simultaneously which might also explain the 
rather moderate in vitro binding affinities determined so far. Homo- and hetero-oligomerisation, as well 
as ligand interactions probably stabilise the overall complex and thus would increase the affinity 
constants. 
 
Extra-cellular functions of prohibitins 
In an attempt to find peptide motifs that specifically target white tissue, the motif CKGGRAKDC was 
specifically localised to and internalised by blood vessels of subcutaneous and peritoneal white fat in 
mice [20]. The peptide interacts with prohibitin 1 at the protein level which further supports the notion 
that prohibitins, probably as part of higher order complexes, are present as surface receptors of certain 
cell types, specifically in endothelial white adipose tissue. The study by these authors [20] went even 
further in showing that conjugation of a pro-apoptotic peptide to the CKGGRAKDC motif was 
successful in reversing obesity in the mouse model. 
 
Salmonella typhi is a pathogen that enters the human body by intake of contaminated food or water 
causing typhoid fever [82]. After intake, the bacterium is translocated to the intestine and subsequently 
distributed through the reticuloendothelial system. To date, the host-pathogen interactions of Salmonella 
remain incompletely characterised, but the Vi capsular polysaccharide had been identified as a major 
virulence factor [83]. Vi is currently one of the most efficient available vaccines for use in humans [84]. 
Using a human model intestinal epithelium cell line, the polysaccharide has been shown to interact with 
a specific cell surface -associated recognition complex that contains BAP32 and BAP37 [21]. Possibly by 
activating the MAP kinase pathway through the BAP32/BAP37 cell surface complex, Vi reduces an early 
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inflammatory response of the host organism [39, 85]. The role of prohibitins in this context could go 
beyond extra-cellular recognition, and include a possible participation in intracellular signalling.  
 
Recently, BAP32, but not BAP37, has been shown to circulate in the serum and to exist in a complex 
with C3, thus being able to enhance complement activation [86]. This ability assigns a potential role to 
prohibitin in innate immunity which is in agreement with the findings that prohibitins localise to the 
plasma membrane of human intestinal epithelial cells [21] and lymphocytes [87]. Intriguingly, during 
infection with S. typhi, serum complement activation is inhibited, if the strains carry the Vi antigen [88]. 
A link between both findings could be provided by prohibitins, circulating in the serum on the one hand 
and residing in a cell-surface complex on the other.  
 
Conclusion: Chemical biology of prohibitins 
Prohibitins have first been characterised about 18 years ago, but research on these highly conserved 
and important proteins has been intensified only in the last six to seven years. By now, the initial focus of 
prohibitins as new tumour suppressors has been shifted towards detecting intra- and extra-cellular 
interaction partners, which also diversified the significance of these proteins. The wide range of 
interaction partners shows that the anticipated fundamental role of prohibitins within the cell has not 
only been confirmed, but broadened. The involvement in pivotal cellular processes places prohibitins in 
the context of mitochondrial, age and oxidative stress -related diseases, as well as in immunity and 
inflammation, cancer and cancer-like diseases, obesity, and drug resistance. While a wealth of 
information on prohibitin implications in cellular processes has become available, structurally, these 
proteins are poorly understood. A major breakthrough in this context was achieved by Langer and 
colleagues who obtained the first visualisation of a low-resolution structure of membrane-bound 
prohibitins.  
Further efforts will now have to be undertaken to obtain more detailed, atomic structure information 
about the various molecular states of prohibitins. Structural information and their correlation with 
available functional data will lead to a deeper understanding of the molecular mechanisms of this 
protein system and reveal their roles in cellular processes. 
Chemical biology and structural chemistry will be able to provide this information. The use of small 
molecules or protein ligands in these studies will not only lend aid in stabilising this protein system in 
vitro, but will also allow insights into protein-ligand binding. Moreover, this approach will yield valuable 
data for evaluation of drug interference with the functions of these proteins. Since prohibitins are 
implicated in a variety of disorders, this will certainly be a highly beneficial undertaking for finding new 
drugs to fight those diseases. 
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Model of a putative membrane-anchored hetero-dimer of BAP32 and BAP37 [33]. The hetero-dimer 
would be part of a larger oligomer forming ring-like structures in the mitochondrial inner membrane as 
observed by Langer and colleagues [16]. The dimer model of the N-terminal and PHB domains of 
BAP32 (orange) and BAP37 (blue) assumes a parallel arrangement of both proteins in the membrane-
bound state. Figure prepared with PyMOL [89]. 
 
Figure 2 
Visualisation of functionally important sites on prohibitins. Interaction and modification sites are mapped 
onto the putative hetero-dimer of BAP32 (orange) and BAP37 (blue). Putative phosphorylation sites are 
indicated by explicitly drawn residues: T108, S109, T141 (BAP32); S110, S190, T194 (BAP37). The 
interaction site of BAP32 with Rb is shown in green, the interaction site with E2F is shown in cyan. The 
putative palmitoylation site at Cys69 is indicated explicitly. The BAP37 interaction site with Akt is 
coloured in yellow, which also includes the binding site for estrogen receptor (purple). Figure prepared 





























Table 1: Prohibitin-protein interactions 
 
Target protein Prohibitin Context Binding sites Reference 
Akt BAP37 The protein kinase Akt competitively binds to BAP37 to inhibit binding to 




MyoD BAP37 The transcription factor MyoD belongs to the myogenic regulatory factors 
that are important for establishing the myogenic fate of muscle precursor 
cells. 
BAP37: 57-299 [27] 
MEF2 BAP37 MEF2 transcription factors increase the transcription of many muscle-specific 
genes. 






BAP32 and BAP37 represses transcription by recruiting the repressor histone 
deacetylase 1.  
Co-immunoprecipation 
of BAP32 and BAP37 
and HDAC1 
[23, 27] 
Rb BAP32 Binding to Rb is necessary for prohibitin to execute its anti-proliferative 
action via E2F. 
BAP32: 74-116 [6, 23, 38, 39, 48] 
E2F BAP32 Repression of E2F caused by prohibitin leads to abolished transcription of 
cell-cycle genes like cyclin E and A . 
BAP32: 185-214 
 
[38, 39, 48] 
Estrogen 
receptor (ER) 
BAP37 BAP37 dampens response of ER to extra-cellular estradiol stimulation. BAP37: 175-198 [30, 38, 39, 48] 
cRaf-1 BAP32 The signalling kinase cRaf-1 could effectively reverse prohibitin-mediated 
repression of E2F activity. 
BAP32 is needed for Ras-mediated activation and membrane targeting of 
cRaf. 
BAP32: 243-275 [39] 
 
[54] 
Annexin A2 BAP32 
BAP37 
Interaction negatively regulated by calcium, association with lipid rafts, 






Interaction negatively regulated by calcium, association with plasma 
membrane, interaction with other cytoskeletal proteins, possible 







BAP37 No data available.  [30] 
Hax-1 BAP37 BAP37 is involved in the regulation and stability of the anti-apoptotic Hax-1. Co-immunoprecipation 
of BAP37 and Hax-1 
[30] 
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